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Background: Cognitive rehabilitation (CR) is an individualised, person-centred intervention for people with
mild to moderate dementia that addresses the impact of cognitive impairment on everyday functioning.
Objectives: To determine whether or not CR is a clinically effective and cost-effective intervention for
people with mild to moderate Alzheimer’s disease or vascular or mixed dementia, and their carers.
Design: This multicentre randomised controlled trial compared CR with treatment as usual (TAU).
Following a baseline assessment and goal-setting to identify areas of everyday functioning that could
be improved or better managed, participants were randomised (1 : 1) via secure web access to an
independent randomisation centre to receive either TAU or CR and followed up at 3 and 9 months
post randomisation.
Setting: Community.
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Participants: Participants had an International Classification of Diseases, Tenth Edition, diagnosis of
Alzheimer’s disease or vascular or mixed dementia, had mild to moderate cognitive impairment (Mini
Mental State Examination score of ≥ 18 points), were stable on medication if prescribed, and had a family
carer who was willing to contribute. The exclusion criteria were people with a history of brain injury or
other neurological disorder and an inability to speak English. To achieve adequate power, we needed
350 people to complete the trial, with 175 people in each trial arm.
Intervention: Cognitive rehabilitation consisted of 10 therapy sessions over 3 months, followed by
four maintenance sessions over 6 months, delivered in participants’ homes. The therapists were nine
occupational therapists and one nurse.
Outcome measures: The primary outcome was self-reported goal attainment at 3 months. Goal attainment
was also assessed at 9 months. Carers provided independent ratings of goal attainment at both time points.
The secondary outcomes were participant quality of life, mood, self-efficacy and cognition, and carer stress,
health status and quality of life. The assessments at 3 and 9 months were conducted by researchers who
were blind to the participants’ group allocation.
Results: A total of 475 participants were randomised (CR arm, n = 239; TAU arm, n = 236), 427 participants
(90%) completed the trial and 426 participants were analysed (CR arm, n = 208, TAU arm, n = 218). At
3 months, there were statistically significant large positive effects for participant-rated goal attainment [mean
change in the CR arm: 2.57; mean change in the TAU arm: 0.86; Cohen’s d = 0.97, 95% confidence interval
(CI) 0.75 to 1.19], corroborated by carer ratings (Cohen’s d = 1.11, 95% CI 0.89 to 1.34). These effects were
maintained at 9 months for both the participant ratings (Cohen’s d = 0.94, 95% CI 0.71 to 1.17) and the
carer ratings (Cohen’s d = 0.96, 95% CI 0.73 to 1.20). There were no significant differences in the secondary
outcomes. In the cost–utility analyses, there was no evidence of cost-effectiveness in terms of gains in the
quality-adjusted life-years (QALYs) of the person with dementia (measured using the DEMentia Quality
Of Life questionnaire utility score) or the QALYs of the carer (measured using the EuroQol-5 Dimensions,
three-level version) from either cost perspective. In the cost-effectiveness analyses, by reference to the
primary outcome of participant-rated goal attainment, CR was cost-effective from both the health and
social care perspective and the societal perspective at willingness-to-pay values of £2500 and above for
improvement in the goal attainment measure. There was no evidence on the cost-effectiveness of the
self-efficacy measure (the Generalized Self-Efficacy Scale) from either cost perspective.
Limitations: Possible limitations arose from the non-feasibility of using observational outcome measures,
the lack of a general measure of functional ability and the exclusion of people without a carer or with rarer
forms of dementia.
Conclusions: Cognitive rehabilitation is clinically effective in enabling people with early-stage dementia to
improve their everyday functioning in relation to individual goals targeted in the therapy sessions.
Future work: Next steps will focus on the implementation of CR into NHS and social care services and on
extending the approach to people with rarer forms of dementia.
Trial registration: Current Controlled Trials ISRCTN21027481.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 23, No. 10.
See the NIHR Journals Library website for further project information.
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Plain English summary
Background
Cognitive rehabilitation (CR) is a personalised intervention to help people with early-stage dementia to
manage everyday activities. This individualised therapy is conducted in people’s own homes over several
sessions. A therapist works with the person and the carer to identify realistic and relevant goals, plan how
to tackle these and support people in achieving them. Previous small studies suggested that CR could
be beneficial.
Methods
The Goal-oriented cognitive Rehabilitation in Early-stage Alzheimer’s and related dementias: multicentre
single-blind randomised controlled Trial (GREAT) was run in eight centres to find out whether or not CR
improves everyday functioning. Participants were in the early stages of having Alzheimer’s disease, vascular
dementia or mixed dementia, with a family carer involved. At the first assessment, participants identified
areas in which they would like to see improvements, and set goals. Participants and carers rated how well
participants were currently doing in relation to these goals and completed questionnaires, for example
about mood and quality of life. Participants were then randomly selected to either receive CR or continue
with treatment as usual (TAU). CR consisted of 10 weekly sessions with the therapist over 3 months,
followed by four sessions over the next 6 months. Participants were reassessed after 3 and 9 months.
Results
We included 475 participants, and 427 participants (90%) completed the trial (209 participants in the CR
arm and 218 participants in the TAU arm). After 3 months, the ratings by both participants and carers in
the CR group showed that participants were doing significantly better in relation to their goals, and this
was maintained 6 months later. Ratings for the TAU-arm participants did not improve significantly. There
were no other differences between the groups. There was a strong economic case for CR.
Conclusions
Cognitive rehabilitation is effective in enabling people with early-stage dementia to improve their everyday
functioning in relation to individual goals targeted in the therapy sessions. Next steps will focus on the
implementation of CR into NHS and social care services.
DOI: 10.3310/hta23100 HEALTH TECHNOLOGY ASSESSMENT 2019 VOL. 23 NO. 10
© Queen’s Printer and Controller of HMSO 2019. This work was produced by Clare et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxix

Scientific summary
Background
Cognitive rehabilitation (CR) is an individualised, goal-oriented, problem-solving approach aimed at
managing or reducing functional disability and maximising engagement and social participation. This
intervention is intended to support everyday functioning by addressing the impact of cognitive impairment
on functional ability. People with dementia and their family members or other supporters (here referred
to as ‘carers’) work together with a CR therapist to identify personally relevant and meaningful goals
relating to their everyday activities. The therapist identifies the person’s intrinsic cognitive and functional
capacity and current level of functioning, assesses the requirements of the task or activity outlined in the
goal, pinpoints areas in which the two are mismatched and problems arise and helps to devise a plan
to overcome these problems using evidence-based rehabilitative methods. Participants and carers work
together with the therapist to implement this plan over several sessions conducted in the home setting.
Progress towards attaining the identified goals is evaluated through participant- and carer-reported levels
of goal attainment. Building on a series of feasibility studies and a successful pilot trial, the multicentre
Goal-oriented cognitive Rehabilitation in Early-stage Alzheimer’s and related dementias: multicentre
single-blind randomised controlled Trial (GREAT) aimed to provide definitive evidence about the clinical
and cost-effectiveness of CR for people with mild to moderate dementia.
Methods
Trial design
The trial design was a two-arm, single-blind, pragmatic randomised controlled trial comparing CR added to
usual treatment with usual treatment alone. Participants were assessed at baseline and at 3 and 9 months
post randomisation.
Participants
Participants were individuals of any age with an International Classification of Diseases, Tenth Edition
(ICD-10), diagnosis of Alzheimer’s disease, vascular dementia or mixed Alzheimer’s disease and vascular
dementia, and in the relatively early stages, as indicated by a Mini Mental State Examination (MMSE) score
of ≥ 18 points. If taking dementia-specific medication, the participants had to be receiving a stable dose
for at least 1 month before joining the trial, with no expectation of a change in dose during the course of
the trial. Participants had to have a carer who was willing to take part and provide collateral information,
and had to be able to give informed consent. The exclusion criteria were people with a prior history of
stroke, brain injury or other neurological disorder and an inability to communicate in English.
Participants were recruited in eight centres in England and Wales through NHS and voluntary sector
services and Join Dementia Research over a 36-month period from 1 April 2013 to 31 March 2016.
All assessments and intervention sessions were conducted in participants’ own homes.
Sample size
To achieve 80% power to detect a medium effect size of 0.3 with alpha 0.05 in the primary and secondary
outcomes, 175 people with dementia, together with their carers, were needed to complete the trial in each
arm. Allowing for a potential attrition of 27%, it was necessary to randomise 480 people with dementia,
each with a carer.
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Randomisation
Participants were individually randomised following consent and baseline assessment, through the online
randomisation centre that was managed by the Clinical Trials Unit. Randomisation was stratified by centre,
sex, age (< 75 years vs. ≥ 75 years) and MMSE score (< 24 points vs. ≥ 24 points).
Blinding
The trial researchers were blind to the participants’ group allocation.
Intervention
The intervention was 10 sessions of CR over 3 months, followed by four maintenance sessions over the
next 6 months. This was provided in addition to usual treatment. The intervention was delivered by trained
therapists (nine occupational therapists and one nurse) who received regular individual and group supervision
to ensure fidelity to the protocol.
Comparator
The comparator was treatment as usual (TAU).
Outcomes
The primary outcome was participant rating of goal attainment at the 3-month follow-up. All participants
identified up to three goals at baseline. Goals were elicited using the Bangor Goal-Setting Interview
(BGSI), with goal attainment rated using a previously validated simple and accessible rating scale on
which a 2-point improvement is considered to be clinically significant. This measure also yielded secondary
outcomes, as attainment ratings were made independently by participants and carers at each time point
and participants rated their satisfaction with goal attainment at each time point.
Other secondary outcomes were participant self-efficacy [Generalized Self-Efficacy Scale (GSES)], depression
and anxiety (Hospital Anxiety and Depression Scale), cognition (story recall from the Rivermead Behavioural
Memory Test), elevator counting from the Test of Everyday Attention, letter fluency from the Delis–Kaplan
Executive Function System, quality of life [DEMentia Quality Of Life questionnaire (DEMQOL)], service
utilisation (Client Services Receipt Inventory), carer stress (Relatives’ Stress Scale), health status [EuroQol-5
Dimensions (EQ-5D)] and quality of life (World Health Organization’s Quality of Life Instrument – brief version).
Participant goals were recorded. Therapists recorded the per cent attainment for all goals addressed in
therapy. Therapists completed therapy logs with details of each session and contributed to a focus group
discussion about perceived influences on outcome.
Participant and carer experience of the intervention was explored through interviews with a subset of
participants and carers. These were a consecutive series of participants completing the trial in three sites.
Interviews were conducted and the data were analysed by researchers who were not otherwise involved
in the trial.
Analyses
A statistical analysis was conducted as an intention-to-treat analysis. The main analysis for the primary
outcome was an analysis of covariance (ANCOVA) adjusted for baseline score, allocation group and
stratification variables (age, sex, MMSE score and centre), which were treated as random effects. The
analysis used a mixed-effects model. Additional regression modelling was undertaken to identify factors
that could be important in attaining and maximising the observed effects. This was done separately for
people with dementia and carers. The analyses for the secondary outcomes used the ANCOVA adjusted
for baseline score, allocation group and stratification variables.
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Goals identified by participants were categorised descriptively. Therapists recorded the extent of attainment
for all goals addressed in therapy as a percentage score using criteria identified at the outset. Data from
the therapy logs and focus group were examined in relation to factors perceived as affecting progress.
Participant and carer interviews were analysed thematically to identify key features of their experience of
the intervention.
The main economic evaluation was a cost-effectiveness analysis, conducted, first, from a health and social
care perspective and, second, from a societal perspective.
Changes to protocol
There were two changes to the protocol. The trial was initially set up in six centres, but two more centres
were added in June 2015 to ensure that recruitment targets were met. Interviews with participants and
carers were added to the protocol following discussion with the trial steering group, which included
experts by experience.
Results
Recruitment
A total of 583 participants were screened, of which 475 were randomised to receive either CR (n = 239)
or TAU (n = 236). One participant in the CR group was incorrectly included and was removed from the
analyses. At the 3-month follow-up, 219 CR participants and 227 TAU participants were reassessed. At the
9-month follow-up, 209 CR participants and 218 TAU participants were reassessed. Retention in the trial
was 94% at 3 months and 90% at 9 months.
The mean age of the participants was 78.56 years (range 53–95 years) and the mean MMSE score was
23.82 points (range 18–30 points). The majority of participants (59.5%) had a diagnosis of Alzheimer’s
disease. Carers were mainly spouses or partners (69.8%).
Primary outcome
For the CR group, participant attainment ratings improved at the 3-month follow-up by 2.57 points on
average, and this improvement was maintained at 9 months. Average ratings in the TAU group showed
a negligible improvement of less than 1 point at 3 months. The ANCOVA indicated that the differences
between CR and TAU groups were significant at both 3 and 9 months, with large effect sizes of 0.81 and
0.8, respectively.
The same pattern was observed for informant attainment ratings, with the CR group improving by an
average of 2.7 points and maintaining the improvement at 9 months; however, the TAU group ratings
showed a negligible improvement of < 1 point. The ANCOVA indicated that the differences between the
CR and TAU groups were significant at both 3 and 9 months, with large effect sizes of 0.93 and 0.79,
respectively.
In the CR group, the average satisfaction ratings improved by 2.7 points at 3 months and increased
further to give a 3-point improvement over baseline at 9 months. The average satisfaction ratings for the
TAU group improved by 1.2 points at 3 months with a further slight increase at 9 months. The ANCOVA
indicated that the differences between CR and TAU groups were significant at both 3 and 9 months, with
large effect sizes of 0.7 and 0.67, respectively.
Few predictors were identified to indicate which participants were most likely to benefit, but more positive
participant baseline ratings of readiness to change and a higher number of sessions completed were
associated with greater gains, and at the 9-month follow-up, participants with higher MMSE scores had
better outcomes.
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Secondary outcomes
Following correction for multiple comparisons, there were no significant changes in any secondary
outcome measures following intervention. Effect sizes were small to negligible, although in some cases
with wide confidence intervals (CIs). Exploratory analyses examining whether or not benefits were seen
for particular subgroups yielded no statistically significant models.
Process evaluation
Participants and carers engaged well in therapy, with 89% of CR participants completing at least
10 sessions.
The goals addressed in therapy related to engaging in activities, managing everyday tasks and situations,
using appliances and devices, being well oriented, retaining or keeping track of information and events,
locating belongings, recognising, identifying and naming people and objects, engaging in conversation,
keeping in contact with family and friends, being organised, managing emotions and basic self-care.
Therapists rated the per cent attainment for each goal addressed; 54.8% of goals were rated as being at
least 75% attained, and 79.8% were rated as being at least 50% attained. Only 5% of goals showed no
progress towards attainment. The therapists’ perception was that the degree of impairment or dementia
severity was the main determinant of progress.
Participants and carers were uniformly positive about the intervention and felt that they experienced
improvements in the activities of daily living and in well-being. They found that the intervention helped
with the process of psychological adjustment to living with dementia, leading to feelings of greater
confidence, less anxiety and better coping skills. The relationship they built up with the therapist was
important, both as a vehicle for providing information, education and support and as the means by which
rehabilitative strategies were developed, accepted and personalised.
Economic analyses
Cost-effectiveness analyses
The cost of an increase of 1.32 points in the BGSI attainment rating was £1296 from the health and social
care perspective and –£9 from the societal perspective. The cost of attaining an increase of 1.53 points
[incremental cost-effectiveness ratio (ICER) point estimate] on the GSES was £4470 from the health and
social care perspective and –£2961 from the societal perspective.
Cost–utility analyses
The cost per DEMQOL utility score (DEMQOL-U)-derived quality-adjusted life-year (QALY) was £1,110,000
from the health and social care perspective. The ICER was negative (–£1,052,000) from the societal
perspective, the cost being somewhat lower in the CR group than that in the TAU group (by £526,
95% CI –£3108 to £1927). There were no differences between the groups in terms of QALYs derived
from the DEMQOL-U. It was not possible to be certain that either strategy (CR or TAU) is cost-effective at
any level of willingness to pay. The cost-per-carer QALY (from the EQ-5D) was £632,000 from the health
and social care perspective. The ICER was negative (–£902,000) from the societal perspective, with costs
being somewhat lower in the CR group than those in the TAU group (by £902, 95% CI –£3616 to
£1705); there were no differences in the EQ-5D-derived QALYs between the groups.
Thus, there was no evidence for cost-effectiveness in terms of gains in the person-with-dementia QALY
(DEMQOL-U) or in the carer QALY (EQ-5D, three-level version) from either study perspective. By reference
to the primary outcome of participant-rated goal attainment, CR was cost-effective from both the health
and social care and societal perspectives at willingness-to-pay values of £2500 and above for improvement
in the goal attainment measure equivalent to the standardised mean difference (1.32). There was no
evidence for cost-effectiveness on the self-efficacy (GSES) measure from either cost perspective.
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Conclusions
Cognitive rehabilitation is clinically effective in enabling people with early-stage Alzheimer’s disease or
vascular or mixed dementia to improve their everyday functioning in relation to individual goals targeted
in the therapy. CR was not cost-effective when gauged against QALY gains for either participants with
dementia or carers, but would be cost-effective by reference to the primary outcome (goal attainment)
if decision-makers were willing to pay for gains in participant-rated goal attainment. The results showed
improved functioning in the targeted areas in the CR group at the 3-month follow-up, and this improvement
was maintained at the 9-month follow-up. Participants in the CR group were more satisfied with their ability
to carry out the everyday activities targeted in the intervention, and participants and carers felt that the
intervention helped them to develop and implement strategies and adjust to the challenges of living with
dementia. CR may be a useful addition to care pathways for those people with mild to moderate dementia
who would benefit from developing strategies to manage their everyday activities and maintain their
engagement in life, and may be particularly valuable if offered in the months following a dementia diagnosis.
Future research will aim to provide evidence on the longer-term outcomes of CR and to extend the
approach to people with rarer forms of dementia. The next steps will be to implement CR into health
and social care services.
Trial registration
This trial is registered as ISRCTN21027481.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Introduction
There is a greater need than ever before to identify effective and beneficial interventions for people withearly-stage dementia. Timely diagnosis of dementia creates an opportunity to equip people with dementia
and their carers to manage and live well with the condition. Psychological and social interventions can help to
reduce or delay the development or progression of functional disability, depression or behavioural difficulties,
maintain independence, support management of comorbid health conditions and, hence, avoid or reduce
hospitalisation, maintain quality of life and ultimately delay institutionalisation.1 At present, however, the
chances of accessing psychological or social interventions following a diagnosis of dementia are limited.2
There is a need to develop relevant and helpful interventions and to provide research evidence regarding the
efficacy of these interventions. Research priorities set out by the Ministerial Advisory Group on Dementia
Research in 2011 emphasised the need to identify ways of enabling people with dementia and their family
members or other supporters (here referred to as ‘carers’) to enjoy a better quality of life and to evaluate
the effects of psychological and social interventions for people with dementia living in the community.
Nevertheless, there is still a significant ‘psychosocial intervention gap’ that remains to be addressed.2
What is needed is a range of accessible psychological and social interventions that are effective in supporting
or enabling people to live well with dementia and tackling the specific challenges that people face in managing
everyday life with the condition. In the early stages of dementia, this includes approaches that can enable
people to function as well as possible and remain as independent as possible.3 Neuropsychological and
behavioural studies show that people with early-stage dementia have many retained cognitive and
behavioural capacities and are capable of behaviour change and new learning, although this is likely to
require extra support.4–7 It should be possible to harness these retained capabilities to enable people to
manage daily activities better and support engagement and participation. Models of disability8–10 make an
important distinction between underlying impairment, resulting from pathology, and disability, resulting
from limitations on activity and restrictions on social participation. Furthermore, the possibilities for
engaging in activity and participating in society are not solely determined by the extent of impairment,
but are influenced by a range of other personal, relational, social and environmental factors. Unhelpful,
unsupportive or negative influences can contribute to the development and maintenance of excess
disability,11 when functional disability is greater than would be predicted by the degree of impairment;
an example would be when an unsupportive environment leads to a loss of confidence. This is similar to
Kitwood’s12 account of the way in which a negative social context can undermine well-being for people
with dementia. In contrast, facilitative and positive influences can enable a person to function optimally.
A focus on support and overcoming barriers to activity and participation should therefore produce benefits
for people with dementia and their family members.
Traditionally, however, and despite the expressed concerns of clinicians,13 considerable effort has been
devoted to using non-pharmacological approaches to attempt to address the underlying impairments
in memory and other cognitive functions that are a defining feature of mild dementia, rather than
focusing directly on enabling people to function well in everyday life. An example is the use of cognitive
(or ‘brain’) training, which involves repeated, structured practice of tasks targeting specific cognitive
domains, such as working memory or attention. A Cochrane systematic review14,15 found no evidence for
significant benefits in early-stage dementia, and expert consensus endorses this finding.16 A general issue
with cognitive training (CT) that is a concern also in work with healthy older people or those with mild
cognitive impairment is the lack of generalisation of benefits. Even in people in whom improvements
are observed in trained domains, there is no evidence that these generalise to other areas, improve the
ability to undertake everyday activities or have any beneficial impact in real life.17 There is a need for more
directly relevant approaches that can enable better functioning or reduce functional disability for people
with dementia.
Interventions that aim to enable functional ability by targeting activity and participation, drawing on
retained strengths to support adaptive behaviour, are typically described as forms of rehabilitation.
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The aim of rehabilitation is to enable people to function at their optimal level in the context of their
intrinsic capacity and current health state.18 The rehabilitation of people with cognitive impairments is
termed cognitive (or neuropsychological) rehabilitation. The work described here has applied this approach
in the care and support of people with early-stage dementia.
Principles of cognitive rehabilitation
Cognitive rehabilitation (CR) is an individualised behavioural therapy based on a problem-solving
approach.3,19,20 It represents the application of rehabilitation principles to address the effects of cognitive
impairment. CR aims to address the impact of cognitive disability by enabling people with cognitive
impairments to function at the highest possible level, given the nature and extent of these impairments.
Supporting optimal functioning means enabling people to manage their daily lives, engage in worthwhile
and meaningful activities and sustain as much independence as possible. This, in turn, allows people to
feel more in control of their lives and supports the continuing experience of a coherent sense of identity.
CR is person centred, acknowledging that each person’s combination of life experience, motivations,
values, preferences, skills and needs is unique, and views the person holistically, taking account of the
person’s relationships and environment.
Cognitive rehabilitation does not aim to train cognition or directly improve performance on cognitive
tasks. Its goal is the functional rehabilitation of people with cognitive impairment. The focus is on better
management of the functional disability that results from cognitive impairment and on reducing any
excess or unnecessary disability resulting from secondary consequences, such as a loss of confidence.
This is achieved by working with people on the goals that are important to them and that will make a
difference in their daily lives.
Concept and terminology
Most people are familiar with the concept of rehabilitation following injury or illness, aiming to return the
person to a former state of functioning or, if this is not possible, to enable the person to adjust to altered
capacity and function at the best possible level given the residual impairments.18 In the acute phase during
recovery, intensive rehabilitation in specialist settings may be indicated, whereas at later stages, a less
intensive community-based approach may be appropriate. Rehabilitation may target physical or cognitive
functioning. The concept of rehabilitation is equally relevant for people with progressive impairments,
who may benefit from episodes of community-based rehabilitation at various stages or as circumstances change.
In community settings, the term ‘rehabilitation’ is now sometimes replaced by ‘reablement’, which is
derived from the same root and essentially shares the same meaning, but is perhaps viewed as a more
readily understandable label. Rehabilitation can also be considered as being related to the concept of
‘tertiary prevention’, which is used in public health. We will use the term ‘rehabilitation’ here. The key
point is that rehabilitation (or reablement) is grounded in a philosophy of enablement, which reflects a
positive approach to finding solutions and encouraging optimal functioning. This philosophy emphasises
a collaborative approach in service delivery, which can be summarised as ‘doing with’ rather than
‘doing for’ or ‘doing to’21 and which translates into specific individualised interventions aimed at
optimising functioning.
Application to dementia
Living with dementia means living with disability resulting from cognitive impairment. The United Nations
Convention on the Rights of Persons with Disabilities sets out a range of rights, including the right to be
able to attain and maintain as much independence as possible through the assistance of comprehensive
rehabilitation services [Article 26 (1)].22 For people with dementia, rehabilitation has been proposed both as an
overarching principle of care and service provision, reflecting the aim of enabling optimal functioning,3,20,23,24
and as a specific intervention approach that aims to support the attainment of practical functional goals.
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The principles of rehabilitation can be applied flexibly to address different types of need at various
stages of dementia. These might include needs resulting from the impact on functioning of cognitive,
behavioural, emotional, communication-related, relational, social or physical changes or difficulties. CR
for people with dementia focuses primarily on the effects on functioning of the cognitive, behavioural
and social communication impairments that form the core symptoms of dementia and the emotional
and relational impact of these. A person might have several episodes of rehabilitation over time as
needs change or in response to particular circumstances, such as being discharged after a period of
hospitalisation. CR is distinct from physical rehabilitation, but it is important to note that people with
dementia can benefit from exercise-based interventions and should of course have access to intensive
physical rehabilitation when needed following injury or illness.25
Rehabilitation, with its focus on optimising functioning, provides a highly relevant framework for
supporting people with dementia and their carers, and for designing interventions to meet their needs.
However, the term ‘cognitive rehabilitation’ (or ‘neuropsychological rehabilitation’), although familiar in
areas, such as brain injury research, needs to be better understood in the dementia field. ‘Rehabilitation’
signifies that the intervention aims to enable people to function optimally given any impairments they may
have and ‘cognitive’ signifies that the intervention specifically addresses the impact of cognitive impairment
on functional ability. This impact may be the direct result of the cognitive impairment (e.g. difficulty
remembering) or may reflect secondary effects, such as loss of confidence. CR has a different focus and
takes a different approach to other interventions that include the term ‘cognitive’ in their titles.15 CT
and cognitive stimulation focus on cognitive function and target specific domains or global functioning,
respectively; the term CR is sometimes incorrectly used to describe these types of interventions, or as an
umbrella term for them. Cognitive or cognitive–behavioural therapy targets unhelpful or self-defeating
thought patterns that may underlie mental health difficulties or adjustment issues. CR is distinct from all
of these other approaches, which include the term ‘cognitive’, and should not be confused with them.
Cognitive rehabilitation in practice
Cognitive rehabilitation is focused on the attainment of realistic personal goals26 that are meaningful to the
individual and address relevant needs. Goal-setting is a powerful behavioural strategy,27 and goal-oriented
approaches are widely used in rehabilitation interventions, including rehabilitation for people with brain
injury,28,29 stroke,30 neurological illness,31 memory difficulties,32 physical disability,33 chronic pain34,35 and
age-related frailty.36 Goals for rehabilitation are expressed in a form that meets the description captured in
the acronym SMART (specific, measurable, achievable, realistic, time-bound). The goal-oriented approach
has hitherto rarely been used in dementia care, but it is consistent with person-centred principles.
Goals are identified collaboratively and realistic targets are established, leading to the generation and
implementation of strategies to support goal attainment. This process is based on a formulation, or
understanding, of the individual’s intrinsic capacity, current functioning, strengths and needs, which
considers cognitive, behavioural, emotional, relational and environmental factors.
To arrive at a formulation reflecting this global level of understanding, the CR therapist assesses the
person’s intrinsic cognitive and functional capacity and current level of functioning. This makes it possible
to understand the person’s potential and to pinpoint any areas in which the person is functioning below
capacity. Understanding the reasons for this can indicate avenues that need to be addressed before
specific rehabilitation goals are tackled. For example, depression or a loss of confidence may lead to
reluctance to engage in activities, with a consequent loss of skills, creating an unnecessary burden of
excess disability. An early stage of therapy may therefore involve addressing issues of this kind.
The overall formulation provides a framework for identifying specific areas of daily life that the person
would like to manage better and establishing which of these may be amenable to change. Through a
collaborative process, which can be facilitated by using a structured interview schedule, individual
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personally meaningful and achievable goals are identified. These relate to particular activities or situations
that give rise to concern for the individual. For each of these, the CR therapist assesses the demands of the
activity or situation that the person wishes to engage in or manage better, identifies any areas of mismatch
between these demands and what the person is able to do, and pinpoints areas in which difficulties
are likely to arise and why. This is an important precursor to devising strategies for goal attainment. For
example, a person could encounter difficulty with engaging in an activity as a result of not remembering
what to do or being unable to concentrate (cognitive), lacking some of the skills needed (behavioural),
feeling anxious or fearful (emotional), being in surroundings that are not conducive to carrying out the
activity (environmental) or lacking someone to do the activity with (social), or some combination of these.
Understanding where the difficulties arise provides a focus for the problem-solving process and for starting
to work together to generate possible solutions that can support goal attainment. For example, if the
difficulty arises from a lack of necessary skills, the solution may be to teach these skills or to modify the
activity; if the difficulty is attributable to memory problems, the solution may be to provide support for
remembering; and if the difficultly is due to anxiety, the solution may be to find ways of regulating
emotions. The CR therapist can select from a range of methods and strategies, which could involve new
learning, relearning, use of compensatory strategies, task modification, environmental modification,
application of assistive technology, or some combination of these.
Once a possible solution is chosen, a plan for goal attainment is devised. Specific strategies that can help
with implementing the solution are identified collaboratively and tested out in practice. Evidence-based
rehabilitative strategies include techniques (such as spaced retrieval) that support new learning or
relearning of information or skills, techniques to support the introduction and use of compensatory aids
and the introduction of environmental adaptations. Assistive technology may be used to augment the
person’s capacity.
Progress towards attaining therapy goals is reviewed continually and strategies are adjusted as needed.
Throughout this process, the therapist provides important psychological support and models a positive,
problem-solving orientation. Alongside the focus on problem-solving, goal-setting and strategy application,
CR incorporates other behavioural therapy methods. First, many people with dementia experience low mood
and apathy, and this may need to be addressed at the outset of therapy. Behavioural activation is used to
increase engagement in activities that would usually be enjoyable, with the experience of engagement
and pleasure providing a source of motivation to make changes and improvements. Secondly, tackling
rehabilitation goals can trigger distress, including fear, despondency or frustration, and therapists provide
important psychological support in acknowledging these emotions and helping people to develop ways of
dealing with them and overcoming the barrier they can present.
Rehabilitation interventions for people with dementia need to offer practical benefits in daily life. When
providing behavioural interventions, it is essential to consider first whether or not benefits will transfer
from the specific situation to application in real life and second whether or not these benefits generalise,
for example to other similar activities. The potential for transfer and generalisation is often limited in the
absence of specific efforts, and this is a particular concern in the context of cognitive impairment. For
this reason, CR interventions for people with dementia are designed to circumvent the issue by being
conducted in the person’s everyday setting in which the skills and strategies learned need to be applied.
Whenever possible, carers and other family members are involved to help to implement and maintain
changes in daily life.
Supporting carers is an essential part of CR for people with dementia. For family carers, this includes
both explaining and demonstrating the strategies and skills employed to promote goal attainment and
attending to the carer’s own needs and well-being by providing psychological support, discussing needs
and signposting to appropriate sources of help. When the needs and wishes of the person with dementia
and those of the family carer differ, resulting in tensions, the therapist has to negotiate a balance between
the two perspectives, and this can be one of the most challenging aspects in delivering CR interventions,
requiring sensitivity and skill.
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Evaluating the outcomes of cognitive rehabilitation
For a behavioural intervention, the first requirement is to demonstrate change in the behaviour or
behaviours targeted, and hence progress with therapy goals must be the primary outcome for CR.19
As CR interventions are based on individual formulations and address personally relevant goals, this has
important implications for the assessment of primary outcomes at a group level, for example in clinical
trials. In a trial, the overall therapeutic approach and the structure of the intervention (e.g. number and
duration of sessions) will be consistent across all participants receiving the intervention, but the content
and focus of the intervention and the specific strategies applied will be different for each individual. This is
typical for psychological interventions based on individual formulations, for example cognitive–behavioural
therapy for depression. However, CR does not address a single defined clinical problem, such as depression,
which can be clearly targeted as a common outcome across all participants. Instead, it aims to enable
each individual to manage aspects of his or her daily life more effectively and with greater satisfaction.
Therefore, the appropriate proximal outcome is the individual’s performance in relation to these selected
aspects of daily life.
In single-case designs, the outcome can readily be assessed directly in relation to the therapy goal – for
example, whether or not a given activity is completed successfully or a desired behaviour is demonstrated.
For effective outcome evaluation in large trials, however, there is a need for a standardised means of
capturing individual functioning and changes in functioning. Observational methods can be used in
single-case or small-group studies, but are unlikely to be feasible for large trials. Patient-reported outcomes
are increasingly understood to be not only valuable but indeed an essential component in evaluating
the effectiveness of psychological and social interventions. This is particularly the case in rehabilitative
interventions in which the approach is one of collaboration in identifying and solving practical problems,
and patient-reported outcome measures are central to researching rehabilitation outcomes. Although goal
attainment scaling37 was developed as a means of evaluating the overall effectiveness of multicomponent
rehabilitation programmes,26,28,36 client-centred performance measures have been developed that aim
to identify outcomes for individuals. The most widely used example of such a measure is the Canadian
Occupational Performance Measure (COPM),38 which provides a structured format for identifying individual
goals and rating current performance in relation to these. Research using this measure has provided
evidence for the reliability, validity and sensitivity to change of the rating method.30,39–42
Patient-reported outcomes may raise questions about the accuracy with which people rate specific aspects
of their own experience. However, there is increasing recognition that people in the mild to moderate
stages of dementia can provide meaningful accounts of their own experience.43 This issue of awareness
and accuracy in reporting rehabilitation outcomes stimulated our extensive investigations of awareness
in people with early-stage dementia.44–46 Evidence from these studies shows that, although people with
early-stage dementia are likely to overestimate their cognitive abilities relative to their objective test score,47
they appear to be relatively accurate in estimating their functional ability in everyday tasks relative to
objective test scores based on observation, and indeed may be more accurate than carers.48 Therefore,
patient-reported outcomes in relation to performance of the activities that are the subject of rehabilitation
goals can be considered to be an appropriate means of evaluating intervention effectiveness.
Development work undertaken prior to GREAT
Experience with CR for people with cognitive disability resulting from non-progressive acquired brain injury
led to the formulation of the research question: ‘Can cognitive rehabilitation be adapted to enable people
with dementia and their carers to better manage the effects of cognitive disability?’ Literature searches
identified a few examples of interventions for people with dementia consistent with the principles of
CR,49–51 and some descriptions of the application of specific learning strategies, mainly using single-case
designs.52 We carried out a Cochrane systematic review,14 which confirmed that there were no relevant
randomised controlled trials (RCTs).
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A series of feasibility studies conducted by our group demonstrated that it was possible for people with
early-stage dementia to identify personal rehabilitation goals and to apply rehabilitation strategies to
change behaviour and improve functioning in relation to these goals. These were either single-case
experimental designs53–56 or small-group pre/post comparisons.57 Behavioural change was observed in
relation to the identified goals, and sometimes this generalised to other situations. Secondary benefits
included maintained social engagement and reduction in carer burden. Gains were maintained for several
months, and this was also the case for one participant with long-term follow-up over several years.58
Additional work extended the evidence for efficacy, relevance and acceptability of specific rehabilitation
methods, such as spaced retrieval or errorless learning.59,60 These findings were supported by reports from
other research groups.61,62
We next conducted a single-site pilot trial of individual, goal-oriented CR in North Wales from 2005 to 2009,
funded by the Alzheimer’s Society.63 This was the first RCT of CR for people with early-stage dementia. We
anticipated that the CR intervention would result in improvements in participants’ functioning in the areas
targeted in the intervention, but not in cognitive test scores. We included measures of mood and quality of
life to explore whether or not the intervention had any effects in these domains, and to allow us to check
that the intervention did not have any adverse effects, given the concerns expressed by clinicians that CT
interventions could adversely affect mood and well-being.13
The participants in the pilot trial were 69 people with dementia recruited from NHS memory clinics,
of whom 44 had a family carer who also contributed. Participants had an International Classification
of Diseases, Tenth Edition(ICD-10), diagnosis of Alzheimer’s disease or mixed Alzheimer’s disease and
vascular dementia, were in the early stages as indicated by a Mini Mental State Examination (MMSE)
score of ≥ 18 points, and were receiving a stable dose of either donepezil (Aricept®, Eisai Co., Ltd, Tokyo,
Japan; Pfizer, New York, NY, USA), galantamine (Reminyl®, Shire Plc, Dublin, Republic of Ireland) or
rivastigmine (Exelon®, Novartis, Basel, Switzerland). All participants identified personal rehabilitation goals
during the baseline assessment, using the structured interview format of the COPM.38 Participants were then
randomised to one of three trial arms: CR, relaxation therapy or treatment as usual (TAU). The CR intervention
involved weekly 1-hour home visits by the therapist for 8 weeks. The main focus of the intervention was
addressing the identified personal rehabilitation goals, and this was supported by improving strategies for
emotion regulation, retaining information and enhancing concentration and managing everyday activities.
Carers were included in part of each session when they were available and willing. Selected goals related
primarily to managing the impact of memory, communication or organisational difficulties, improving the
performance of practical skills and activities, learning new skills, regaining confidence and motivation to
engage in activities and increasing social interaction.64 The relaxation therapy intervention, delivered by the
same therapist, involved eight weekly 1-hour home visits in which participants were taught progressive muscle
relaxation and breathing exercises. Participants allocated to receive TAU had no contact with the therapist.
The primary outcome was participant-reported goal performance using the COPM rating system. At the
post-intervention follow-up, ratings of goal performance and satisfaction with functioning in relation to
goals improved significantly for the CR group and did not change for the other two groups; effect sizes in
favour of CR were large. Behavioural changes in the CR group were corroborated by therapist ratings of
performance and of the extent to which goals were attained. The average performance ratings made by
participants and therapists improved by a magnitude greater than the 2-point change required to indicate
clinical significance.38
For the secondary outcomes, CR produced benefits in quality of life, mood and cognition for the person with
dementia and in stress, well-being and quality of life for the carer, relative to relaxation therapy and TAU.
Some of these secondary benefits were maintained 6 months later. There were no differences between the
relaxation therapy and TAU groups. A subset of participants underwent functional magnetic resonance
imaging scanning using a recognition memory task;65 at the post-intervention follow-up, participants from
the CR group showed higher, and those from the control groups showed lower, brain activation in relevant
INTRODUCTION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
6
areas, although neither group improved performance on the task. This was interpreted as suggesting that CR
may have promoted a partial restoration of function in frontal brain areas.66
The intervention was acceptable to participants and carers. Attrition was low, with 64 out of the 69
randomised participants (93%) completing the post-intervention assessment and 56 participants (81%)
completing the 6-month follow-up (19% attrition overall). Reasons for loss to follow-up included death
(n = 3), illness (n = 1), moving out of the area (n = 3) and change of diagnosis (n = 1), with elective
withdrawal accounting for only five cases.
In summary, the pilot trial provided evidence to show that people with early-stage dementia can identify
realistic goals and make significant improvements in functioning with regard to their chosen goals during
a brief CR intervention.
Lessons learned from the pilot trial
We used the experience gained during the pilot trial to develop plans for a large, definitive trial. We
updated our Cochrane review during the course of the pilot trial in 200767 and continued to monitor
the emerging literature, but found no other RCTs to inform our development work.
A key area of learning from the pilot trial related to outcome measurement. In the pilot trial, we used the
COPM, which provides a pragmatic rating system based on a simple 0–10 scale. This is accessible for people
with cognitive impairments and can be presented visually as well as verbally. There was consistency in the
ratings over time for the non-treated groups, and for the CR group, the measure was sensitive to change,
corroborated by therapist observation. This reflects similar findings from other clinical groups30,40–42,68,69 and
suggests that goal performance ratings made by people with early-stage dementia can be considered to
be reliable and valid64 and that changes in ratings are a valid indicator of treatment effectiveness, with
improvements of 2 points being considered to be clinically significant.
Although the COPM rating system proved to be suitable in the pilot trial, the semistructured interview
format specified domains of self-care, leisure and productivity, reflecting its generic nature. These domains
do not necessarily cover everything that might be relevant for specific groups, such as people with early-stage
dementia, or that might be addressed in individual research projects. We therefore developed a semistructured
goal-setting interview that used the same rating method, but placed this within the context of a more directly
relevant and targeted discussion and goal-setting process, which could be adapted to the needs of specific
groups or projects. The measure we developed, the Bangor Goal-Setting Interview (BGSI), has been used to
elicit goals and evaluate progress towards goal attainment in trials with cognitively healthy older people70
and people with mild cognitive impairment,71 and is used in GREAT (Goal-oriented cognitive Rehabilitation
in Early-stage Alzheimer’s and related dementias: multicentre single-blind randomised controlled Trial), as
described here.
In the pilot trial, we included people who did not have a carer available to participate, as people living
alone with dementia may be in particular need of support to manage everyday activities, and therefore
carer ratings were not obtained for these participants. However, when conducting CR with people who
have cognitive impairments, it is good practice, if possible, to obtain a collateral perspective from a family
carer,30,42 and such a perspective is particularly valuable in research trials. For this reason, we concluded
that an inclusion criterion for participating in GREAT should be the availability of a carer who is willing to
provide collateral information. The BGSI provides for the inclusion of parallel informant ratings. A further
limitation in the pilot trial was that ratings were obtained post intervention only and not at the 6-month
follow-up. In GREAT, we assessed goal attainment at each follow-up.
In the pilot trial, 46% of goals were rated as being fully achieved, 50% were rated as being partially
achieved and 4% were rated as being not achieved within the 8-week time frame of the intervention.
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Reviewing the therapy logs kept by the therapist indicated that, in the case most of the ‘partially achieved’
goals, the therapist considered that further improvements could have been achieved with a little more
time. The therapist’s view was that a slightly longer intervention was needed in order to optimise and
consolidate benefits. For GREAT, we therefore decided on a 10-session intervention with four additional
maintenance sessions.
Finally, the lack of observed differences between the relaxation therapy and TAU groups suggested that in
a further trial, a two-arm design comparing CR with TAU should be acceptable.
Aims of GREAT
Building on our extensive development work, we aimed to provide definitive evidence about whether or
not goal-oriented CR is a clinically effective and cost-effective intervention for people with early-stage
Alzheimer’s disease or vascular or mixed dementia and their carers.
We hypothesised that:
l This personalised intervention would improve functioning in areas directly targeted in the therapy
sessions, and this would be reflected in self-ratings and carer ratings.
l The intervention might have an impact on perceived self-efficacy, reflecting a possible psychological
mechanism of action.
l Carers of participants receiving the intervention, having learned new ways of supporting and enabling
their relatives, might report feeling less stressed following the intervention.
In line with our theoretical model of CR, we did not anticipate changes in performance on cognitive tests,
as CR does not directly target or train specific underlying cognitive processes. We did not plan to select
participants on the basis of having clinical levels of depression or anxiety, poor scores on quality-of-life
measures or carers who reported that their quality of life was poor, although we expected that some
participants would show these features. This would necessarily limit the potential for demonstrating
improvements in these domains. Nevertheless, there were some improvements in these domains in
the pilot trial,63 and we therefore planned to include relevant measures in our assessment of secondary
outcomes. This would also make it possible to identify any harms arising if the intervention had a
negative impact on well-being.
We set the following specific objectives:
l To compare the effectiveness of goal-oriented CR with that of TAU, with regard to (1) improving
self-reported and carer-rated functional performance in areas identified as causing concern by people
with early-stage dementia, (2) improving the quality of life, self-efficacy, mood and cognition of people
with early-stage dementia and (3) reducing stress levels and ameliorating the quality of life of carers of
participants with early-stage dementia.
l To estimate the incremental cost-effectiveness of goal-oriented CR compared with TAU.
l To examine how the goal-oriented CR approach could most effectively be integrated into routine NHS
provision, to develop a pragmatic approach that could be directly applied within standard NHS services
and to develop materials to support the implementation of this approach within the NHS following
trial completion.
A short journal article presenting the results of the GREAT trial has been published in the International
Journal of Geriatric Psychiatry.72 The following chapters provide a detailed account of all aspects of
the trial.
INTRODUCTION
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Chapter 2 Methods
Design
This was a multicentre, two-arm, single-blind randomised (on a 1 : 1 basis) controlled trial comparing CR
added to usual treatment with TAU alone. The design and planned flow of participants through the trial
are summarised in Figure 1.
Potential participants who were thought to meet the inclusion criteria were
identified by a GREAT researcher or CLRN, MHRN or NISCHR CRC staff and invited
to express interest in participating
Researcher makes telephone contact to confirm interest
Information about study sent to those who are interested
Researcher follows up with second telephone call at least 1 week later
Meeting is arranged with those who are interested in proceeding
Second home visit by researcher
Baseline assessment: all PwD and their carers
Randomisation
Researcher triggers randomisation; results sent to therapist
Therapist telephones participant to explain next steps
Therapist triggers post-intervention assessment for all participants
Third home visit by blinded researcher
Post-intervention assessment 3 months post randomisation for PwD and their carers
Fourth home visit by blinded researcher
Follow-up assessment 9 months post randomisation for PwD and their carers
Four maintenance sessions with
therapist over 6 months
Adherence measures taken
CR for PwD, each
with carer involved when possible
10 sessions with therapist over 3 months
Process and adherence measures taken
TAU
3 months
First home visit by researcher to PwD and carer
Screening to ensure inclusion criteria are met and exclusion criteria are absent
(Inclusion for PwD: diagnosis of Alzheimer’s disease or vascular or mixed dementia; 
MMSE of ≥ 18; if taking dementia-specific medication, on stable dose for 1 month 
prior to trial entry; availability of a family carer who is either co-resident or in 
regular contact. Exclusion for PwD: unable to speak English; prior history of stroke, 
brain injury or other neurological condition)
Information about study discussed and questions answered
Consent taken from those who were willing to participate
FIGURE 1 Overview of trial design and planned flow of participants through the trial. CLRN, Comprehensive Local
Research Network; MHRN, Mental Health Research Network; NISCHR CRC, National Institute of Social Care and
Health Research Clinical Research Collaboration; PwD, person/people living with dementia.
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Ethics
The study was reviewed by Wales Research Ethics Committee (REC) 5, which issued a favourable opinion
on 25 June 2012 (reference number 12/WA/0185), and was approved by the Bangor University School of
Psychology REC. Based on findings from the pilot trial, it was expected that participants and carers who were
allocated to receive the CR intervention would derive some benefits, whereas people who were allocated to
receive TAU would not be harmed by this allocation. As there was no existing large-scale evidence about the
effects of CR, it was not considered to be unethical to withhold the treatment from those allocated to receive
TAU. In addition, based on existing evidence, there were no known risks associated with CR. However, trial
researchers and therapists were trained to be alert to any concerns about participants’ well-being and to refer
any serious concerns to the clinician responsible for the person’s care whenever possible, with the knowledge
and permission of the person and their carer.
Governance
The trial was sponsored first by Bangor University (from its start on 1 October 2012 to 28 February 2015)
and then, following transfer of the co-ordinating centre, by the University of Exeter (from 1 March 2015
until its completion on 31 December 2016). The governance was overseen by a Trial Steering Committee
(TSC), which included two Alzheimer’s Society research volunteers who were former carers and a sponsor’s
representative, and by a Data Monitoring and Ethics Committee.
Trial registration
The trial was registered with Current Controlled Trials under reference ISRCTN21027481.
Trial protocol
The trial protocol was published in 2013.73
Participants
Participants were individuals of any age who were diagnosed with Alzheimer’s disease or vascular or mixed
dementia, and who were in the mild stages of the condition. Each participant was recruited together with
a carer.
Eligibility
Inclusion criteria
l Participants had to have been assigned an ICD-10 diagnosis of Alzheimer’s disease, vascular dementia
or mixed Alzheimer’s disease and vascular dementia. These conditions are estimated to account for
89% of all dementia diagnoses.74 Although people with rarer subtypes of dementia could potentially
benefit from CR, they might require an intervention that is tailored to take account of the specific
profile of their condition, and we considered that this would best be assessed in separate studies.
l Participants had to be in the relatively early stages of dementia, with mild to moderate cognitive
impairment as indicated by a MMSE75 score of ≥ 18 points. Although people with more advanced
dementia could potentially benefit from CR, the focus and specific approach would differ, and using
a cut-off score in this way provided a basic means of ensuring that the approach was appropriately
targeted.
l It was acknowledged that some, but not all, participants would be receiving dementia-specific medication
in accordance with standard practice guidelines. To ensure that the results were not affected by changes
in medication use, participants taking dementia-specific medication, such as acetylcholinesterase inhibitors,
must have been receiving a stable dose for at least 1 month before entering the trial, with no expectation
that the dose would be changed during the course of the trial unless a specific clinical need emerged.
METHODS
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l Participants had to have a carer who was willing to take part. Having a carer involved is not essential,
although it is helpful, for CR; however, for the purposes of the trial, it was important to have collateral
information and informant ratings of progress, and it was valuable to be able to determine whether
or not CR provided any benefits for carers. By ‘carer’, we mean a family member or close friend who
provides unpaid care and support; we acknowledge that some people undertaking this role may not
use the term ‘carer’ to describe their role.
l Participants had to be able to give informed consent to participation. This CR intervention was aimed at
people in the earlier stages of dementia and involved engaging the person with dementia in a collaborative
process of identifying and addressing meaningful and personally relevant goals. It was therefore essential
for participants to understand the process and make a positive choice to engage with it.
Exclusion criteria
l Potential participants were excluded if they had a prior history of stroke, brain injury or other significant
neurological condition. Such conditions would be expected to affect cognitive, behavioural and emotional
functioning, and people who have one of these conditions prior to developing dementia could have
additional rehabilitation needs. Although such individuals might benefit from CR, their inclusion would
have represented a potential confounding factor.
l Participants were excluded if they were unable to speak English. This criterion was applied for practical
reasons, because of the time and costs that would be involved in translating standardised measures
and providing interpreters for assessment and therapy sessions. However, when setting this criterion,
we expected that no, or only very few, individuals would be excluded from participation owing to an
inability to communicate in English.
Any cases of participants for whom eligibility was unclear were referred to an eligibility panel consisting of
four clinically qualified co-investigators (two old age psychiatrists, one neuropsychiatrist and one clinical
psychologist) for a decision.
Recruitment
Participants were recruited through NHS services, such as memory clinics and old age psychiatry teams,
carer and patient support groups, led by NHS staff, support groups and networks run by the Alzheimer’s
Society and Join Dementia Research. Recruitment to the trial covered a 36-month period from 1 April 2013
to 31 March 2016.
Potentially eligible individuals were initially identified by either GREAT researchers or National Institute
for Health Research (NIHR) Clinical Research Network staff in England and Health and Care Research
Wales staff in Wales (previously the National Institute of Social Care and Health Research Clinical Research
Collaboration). GREAT researchers and research network staff visited clinics to provide information and
ascertain interest in participating. Research network staff also identified possible participants through
note-screening and wrote to them on behalf of the responsible clinician; they were invited to indicate their
interest by sending a reply slip directly to a GREAT researcher, who then made contact by telephone, sent
written information and made a further telephone call to ascertain the participant’s willingness to continue.
When a possible interest in participating was identified, a GREAT researcher visited the potential participant
and carer to explain the study in detail, answer any questions, recheck eligibility and ensure that the
person with dementia had the capacity to consent. Informed consent from both the person with dementia
and the carer was taken at this visit or, if either person required more time to decide, at a subsequent visit.
As participants were in the early stages of dementia, we expected that they would continue to have the
capacity to consent throughout the period of participation. However, on entry to the trial, participants were
asked whether or not, in the event that they did lose capacity, they would wish to continue to be included
in the trial and to have their data used in the analysis.
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Obtaining informed consent at the start of the trial was only the beginning of an ongoing process. This is
particularly crucial in an intervention of this kind, which requires the participant’s active engagement. The
trial researchers and therapists were trained to monitor ongoing consent and identify and respond to any
indication of a possible withdrawal of consent.
Locations
The trial was conducted in eight NHS sites throughout England and Wales. These were:
l North Wales – Betsi Cadwaladr University Health Board (Bangor site)
l South Wales – Cardiff and Vale University Health Board (Cardiff site)
l London – South London and Maudsley NHS Foundation Trust, with recruitment supported by King’s
College Hospital NHS Foundation Trust, Guy’s and St Thomas’ NHS Foundation Trust, St George’s
Healthcare NHS Trust, and Oxleas NHS Foundation Trust (London site)
l South East England – Kent and Medway NHS and Social Care Partnership Trust (Kent site)
l South West England – RICE (Research Institute for the Care of Older People), Bath, with recruitment
supported by Royal United Hospitals Bath NHS Foundation Trust and by general practitioner (GP)
practices within the Wiltshire NHS Clinical Commissioning Group [(CCG) Bath site]
l West Midlands – Birmingham and Solihull Mental Health NHS Foundation Trust, with recruitment
supported by Black Country Partnership NHS Foundation Trust and Heart of England NHS Foundation
Trust (Birmingham site)
l North West England – Manchester Mental Health and Social Care Trust, with recruitment supported by
Pennine Care NHS Foundation Trust (Manchester site)
l North East England – Northumberland, Tyne and Wear NHS Foundation Trust (Newcastle site).
Setting
All assessments and intervention sessions were conducted in participants’ own homes.
Sample size
Power calculations were based on findings from the pilot trial. Improvement in goal performance was
assessed in the pilot trial, with the rating scale of the COPM,38 which is equivalent to the rating of goal
attainment used as the primary outcome measure in GREAT. The effect size for improvement in goal
performance was large, with a standardised effect of > 1 at the post-intervention assessment. However, it
was important to be able to detect at least medium effect sizes of 0.3 for both the primary and secondary
outcomes. To achieve 80% power to detect a medium effect size of 0.3, with alpha 0.05, in primary and
secondary outcomes, 175 people with dementia, together with their carers, were needed to complete the
trial in each treatment arm. Attrition in the pilot trial was 19% overall, but as the rate could be higher in
a longer multicentre trial, we adopted a more conservative estimate of 27%. Allowing for the potential
attrition of 27%, it was necessary to randomise 480 people with dementia, each with a carer.
To meet this target, we calculated that each centre would need to recruit three participants per month
over 27 months, a total of 80 participants per site. Experience suggested that one in three of the people
with dementia who were identified as eligible and invited to participate would be successfully recruited;
thus, each month, nine potentially eligible participants would need to be approached in each centre.
Randomisation
Participants were individually randomised following consent and a baseline assessment. Randomisation
was triggered by the trial researchers on completion of the baseline assessment through secure web
access to the remote randomisation centre, the North Wales Organisation for Randomised Trials in Health
(NWORTH) Clinical Trials Unit (CTU) at Bangor University. In this system, which was maintained and
monitored independently of the trial statistician or other trial staff, the randomisation was performed by
dynamic allocation76 to protect against subversion while ensuring that the trial maintained good balance
to the allocation ratio of 1 : 1, both within each stratification variable and across the trial. Participants were
stratified by centre, sex, age (< 75 years vs. ≥ 75 years) and MMSE score (< 24 points vs. ≥ 24 points).
METHODS
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For validation purposes, additional information was recorded, including the participant’s trial number,
initials and date of birth and the details of the person requesting the randomisation. Group allocation was
notified to the trial therapists.
Blinding
The trial researchers were blind to participants’ group allocation. The importance of maintaining blinding
was emphasised in the training of both the researchers and the therapists. The potential for unblinding
could arise through the researchers’ contact with participants at the 3- and 9-month assessments and
through day-to-day contact between the researchers and the therapists at each site.
To address the potential for unblinding through day-to-day contact between researchers and therapists at
each site, we ensured that they were based in different offices and did not share telephones or printers.
Arrangements for the follow-up assessment visits by the researcher were made by the therapist for all
participants. As the participants and carers could not be blinded to their group allocation, they were
specifically asked not to comment at post-intervention and follow-up assessments on the nature of their
involvement in the study and not to reveal to the researcher whether or not they had been visited by
the therapist. This was explained by the researcher during baseline visits and included in the written
information given to participants, and it was reiterated by the therapists when they contacted participants
to confirm the dates of the 3- and 9-month assessments.
Following each assessment at the 3- and 9-month points, the blinded researcher noted to which condition
s/he thought the participant had been allocated and how certain s/he was of the allocation.
Owing to the nature of the intervention, it was not possible to blind participants and carers to group
allocation.
Intervention
Participants allocated to the intervention group received CR in addition to usual treatment. CR is an
individualised, goal-oriented, problem-solving approach aimed at managing or reducing functional disability
and maximising engagement and social participation, in which people with dementia and their carers work
together with a health professional over a number of sessions to identify personally relevant goals and
devise and implement strategies for achieving these. In this trial, CR was delivered by appropriately qualified
therapists with experience of rehabilitative interventions. We set out to recruit therapists with psychology,
occupational therapy or nursing backgrounds. In the event, our therapists were from occupational therapy
and nursing backgrounds. Ten therapists worked on the trial [nine occupational therapists (OTs) and one
nurse]; two sites (West Midlands and North West England) had a change of therapist during the trial.
Cognitive rehabilitation was delivered in 10 individual sessions over 3 months, followed by four maintenance
sessions over 6 months. Carers were involved in part of each session whenever possible, and were kept
informed when direct involvement was not possible (e.g. because the carer was at work). The involvement of a
carer helps to ensure that skills are maintained and applied to novel situations, and it facilitates communication
about how current or possible future difficulties might be managed.
Over the course of the 10 weekly sessions, participants with dementia worked collaboratively with the
therapist to address personal rehabilitation goals. Alongside the information from the initial assessment with
the BGSI, the therapists used the Pool Activity Level (PAL) instrument77 to facilitate their understanding of
participants’ current level of functioning and potential for goal attainment and to support the development of
a comprehensive formulation. The PAL instrument provides a framework for care-planning with people who
have cognitive impairments caused by conditions related to dementia, stroke and intellectual disability.77,78
The PAL instrument contains a valid and reliable tool for assessing functional ability in nine domains, with
ability being graded at one of four levels for each domain. It was recommended in the national clinical
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practice guideline for dementia79 for activity of daily living skill training and for activity planning. The
instrument also contains profiling tools for interpreting the assessment in order to plan and deliver effective
enabling care and support. As part of the assessment for each participant, the therapist completed the PAL
checklist with the carer, and used the resulting profile in planning and implementing the intervention.
Drawing on the goals identified at the baseline assessment, up to three behavioural goals were
operationalised for each participant and strategies for addressing these were devised and implemented.
These strategies could include environmental adaptations and prompts, use of compensatory memory
aids, procedural learning of relevant skills, supported learning of important new information and restorative
learning methods to reactivate prior knowledge. For each goal, a set of strategies was formulated into an
individual plan, following discussion of the possible options and selection of the most promising solutions.
Following the introduction and modelling of strategies and skills during the therapy sessions, the participant
and carer worked on the selected goal between sessions following an agreed schedule of activities. Progress
was reviewed and the strategies adopted were adjusted as necessary on a weekly basis. Goals were
introduced one at a time, in a flexible manner depending on the rate of progress. Performance for each
goal was independently rated at the outset and in week 10 by the participant, carer and therapist.
Work on the identified goals was supplemented by five key therapy components, which were considered
at appropriate stages across the 10 sessions:
1. Developing a problem-solving orientation. Introduction of, and practice in applying, a solution-focused
problem-solving approach by following a short sequence of steps to specify and test possible solutions.
This was emphasised at the start of therapy and provided a continued focus throughout.
2. Addressing motivational and affective issues. Strategies to tackle motivational and affective responses
that could affect the progress of therapy were considered at an early stage:
i. Emotion regulation strategies. Encountering problems with functioning in daily life can result in
emotional reactions, such as anxiety, distress or frustration. Tackling therapy goals and finding these
challenging could potentially trigger similar responses. Therefore, it was important to assess
participants’ strengths and needs in this area and, when appropriate, introduce, or enhance,
emotion regulation strategies for managing anxiety and other affective reactions, and provide
practice in strategy use and application.
ii. Behavioural activation strategies. Lack of interest, anhedonia, apathy and withdrawal are common
and can lead to further loss of skills and confidence. Therefore, it was important to assess participants’
activity levels and, when appropriate, to identify plans for increasing engagement in meaningful and
enjoyable activities and to support the implementation of these plans.
3. Addressing cognitive disability. A comprehensive set of skills and strategies was developed to help to
manage the effects of cognitive disability, complementing the goal-specific problem-solving work:
i. The participant’s use of compensatory strategies (e.g. calendars, diaries, reminder systems) was reviewed
and a plan for improving strategy use was developed and implemented, which might include both
increasing the efficiency of existing strategies and introducing new strategies.
ii. The participant’s knowledge and use of strategies for retaining new information or improving recall
was reviewed, and practice in applying key strategies (mnemonics, semantic association and spaced
retrieval) was provided, enabling the participant to identify a preferred strategy that could be used in
everyday situations.
– Difficulties with attention and concentration can interfere with strategy application. Methods for
maintaining or improving attention and concentration were taught and practised.
METHODS
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4. Carer support. Specific support for the carer included discussion of the carer’s well-being and sources of
stress, and identification of strategies the carer could use, or enhance, to manage stress more effectively.
5. Signposting to other sources of support. For both the carer and the participant, the therapist explored
options for further sources of help and support, and encouraged them to take advantage of these.
The four maintenance sessions were focused on supporting the maintenance of gains and encouraging
continued goal performance and strategy use.
It was acknowledged that participants’ progress with goals would be variable, and although it was
suggested that participants work on three goals, the number of goals tackled was likely to vary. Similarly,
participants’ needs with regard to the other therapy components were expected to vary, and hence both
the amount of time spent on these and the stage at which they were introduced could also vary for
different individuals. The therapists needed to be flexible in structuring the sessions in order to take
account of individual differences. An example of a session-by-session protocol for the CR intervention,
which assumes that three goals are addressed, is shown in Table 1.
Intervention fidelity
In line with practice recommendations,80 intervention fidelity was promoted through the provision of initial
training, a therapy manual, regular centralised supervision and the recording of information about each
session in therapy logs:
l Training – therapists participated in a 2-day training course to prepare them for delivering the
intervention at the start of the trial, and subsequently attended a refresher training day annually.
The co-investigator Jackie Pool, an OT, specialist consultant and experienced trainer with expertise
in applying rehabilitation in dementia care, delivered initial training to all of the trial therapists and
guided them throughout the trial in the effective and consistent application of the therapy protocol.
l Therapy manual – therapists were provided with a detailed therapists’ manual that included information
about the principles and key elements of CR, as well as session-by-session overviews and references to the
relevant literature.
l Supervision – therapists had monthly individual supervision via video-conferencing and 3-monthly
face-to-face group supervision meetings with Jackie Pool, with ad hoc advice available between
meetings if needed. Supervision meetings offered detailed guidance on the delivery of CR and enabled
ongoing monitoring of fidelity to the protocol, with potential concerns discussed and resolved as they
were raised. Each supervision session was documented and notes were reviewed annually to ensure
the appropriate involvement of all therapists in the supervisory process. The trial manager attended
the quarterly supervision meetings to review progress with therapy provision and regular updates
were given to the chief investigator and the trial management group. The supervision meetings were
focused on reviewing therapists’ plans for achieving individual therapy goals, resolving any specific
difficulties relating to individual participants and reviewing overall progress with implementing the
therapy protocol for current participants in the CR group. Advice was also given about achieving a
positive therapeutic relationship with participants and managing caseloads. Group meetings provided
a platform for sharing best practice and ensuring consistency across sites.
l Therapy logs – supervision was facilitated by the use of therapy logs summarising session content (with
participant details anonymised). A therapy log was maintained for each participant receiving CR, with notes
on session content added by the therapist after each session. The logs were submitted to the supervisor for
review prior to the supervision sessions and formed a basis for discussion during the sessions.
Treatment fidelity was considered in relation to form and function.81 While the therapy protocol was
prescriptive in relation to the number and length of sessions and provided guidelines on the typical content
of each session (form), a degree of flexibility was required in order to facilitate individual goal attainment,
as this was a key aspect of the intervention (function). Therapists could therefore make adjustments to the
content of therapy sessions in order to take account of participants’ preferences, levels of cognitive and
functional ability, and social and family context.
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TABLE 1 Sample session-by-session CR protocol
Session Participant with dementia Carer Between sessions
1 Orientation to the intervention and
explanation of between-session tasks; goal 1
selection and rating; emotion regulation
strategies; activity monitoring exercise
Orientation and explanation;
goal 1 rating; emotion
regulation; activity monitoring
Monitor current activities
using diary sheet; practise
emotion regulation strategies
2 Review of activity monitoring and plans
for increasing activities; introduction of
solution-focused problem-solving approach;
intervention plan for goal 1; emotion
regulation
Problem-solving; goal 1
intervention; plans for
increasing activities
Agreed tasks for goal 1;
practise emotion regulation
strategies; develop plans for
increasing activities; practise
solution-focused approach
3 Progress review for goal 1; progress
review for increasing activities; review of
adaptations and compensatory strategy use;
emotion regulation
Progress review; review
of adaptations and
compensatory strategy use;
increasing activities
Agreed tasks for goal 1;
practise emotion regulation
strategies; implement plans
for increasing activities
4 Progress review for goal 1; progress review
for increasing activities; goal selection
and rating – goal 2; plan to improve
compensatory strategy use
Progress review; goal 2a
rating; plan to improve
compensatory strategy use
Agreed tasks for goal 1;
implement changes to
compensatory strategies
5 Progress review for goal 1; progress review
for compensatory strategy use; intervention
plan for goal 2; strategies for improving
attention and concentration
Progress review; goal 2
intervention; strategies for
improving attention and
concentration
Agreed tasks for goals 1 and
2; changes to compensatory
strategies; practise
maintaining attention and
concentration
6 Progress review for goals 1 and 2; progress
review for compensatory strategy use; goal
selection and rating – goal 3; improving
attention and concentration
Progress review; goal 3a
rating; carer well-being
Agreed tasks for goals 1 and
2; practise in maintaining
attention and concentration
7 Progress review for goals 1 and 2;
intervention plan for goal 3; restorative
strategies for taking in new information
Progress review; restorative
strategies; carer well-being
Agreed tasks for goals 1–3;
practise restorative strategies
8 Progress review for goals 1–3; practise
restorative strategies
Progress review; application
of restorative strategies
Agreed tasks for goals 1–3;
practise restorative strategies
9 Progress review for goals 1–3; practise
restorative strategies; preparation for ending
weekly sessions
Progress review; discuss other
sources of help and support
Agreed tasks for goals 1–3;
practise restorative strategies;
investigate other sources of
support
10 Progress review for goals 1–3; review of
strategy use for emotion regulation,
attention and concentration strategies,
compensatory strategies and restorative
strategies; re-rating of goal performance
Progress review; re-rating of
goal performance; review
other sources of help and
support
Review written information
provided about strategies;
monitor progress; when
appropriate, access other
sources of support
M1 Reorientation to problem-solving approach;
review of progress with goals; review of
strategy use
Problem-solving approach;
progress review
Review information given;
monitor progress
M2 Problem-solving; review of progress with
goals; review of strategy use
Problem-solving; progress
review
Review information given;
monitor progress
M3 Problem-solving; review of progress with
goals; review of strategy use
Problem-solving; progress
review
Review information given;
monitor progress
M4 Review of progress; goal ratings; reminder of
problem-solving approach and strategies;
goodbyes
Progress review; goal ratings;
future orientation; goodbyes
N/A
M, maintenance session; N/A, not applicable.
a The exact timing of the introduction of goals 2 and 3 may vary depending on progress with earlier goal(s).
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Comparator
The comparator was TAU. Participants allocated to the control group received usual treatment only,
and had no contact with the research team between assessments. TAU consisted of dementia-specific
medication when prescribed and any other services normally provided, apart from specific programmes
of CR or other cognition-focused interventions. TAU could include, for example, routine monitoring by
the Memory Clinic, information provision and attendance at drop-in groups or support groups, or carer
participation in support groups, as well as the receipt of any services provided by voluntary organisations.
Outcomes
The assessment measures are summarised in Table 2, which indicates which measures were administered
at each time point by the trial researchers. The assessments were completed by 15 trial researchers, all with
backgrounds in psychology, nursing or clinical research. Some sites employed more than one researcher.
There were changes of researchers during the trial at three sites (West Midlands, South West England
and London).
TABLE 2 Summary of assessment measures by time point
Domain Measure
Time point
Baseline
3 months
post baseline
9 months
post baseline
Person with dementia
Goal attainment BGSI ✗ ✗ ✗
Satisfaction with goal attainment BGSI ✗ ✗ ✗
Quality of life DEMQOL ✗ ✗ ✗
Self-efficacy GSES ✗ ✗ ✗
Depression HADS ✗ ✗ ✗
Anxiety HADS ✗ ✗ ✗
Memory RBMT story recall ✗ ✗ ✗
Attention TEA elevator counting ✗ ✗ ✗
Executive function D-KEFS letter fluency ✗ ✗ ✗
Comorbid conditions Charlson Index ✗
Service utilisation CSRI ✗ ✗ ✗
Carer
Participant’s goal attainment BGSI ✗ ✗ ✗
Stress RSS ✗ ✗ ✗
Quality of life WHOQOL-BREF ✗ ✗ ✗
Health status EQ-5D ✗ ✗ ✗
CSRI, Client Service Receipt Inventory; DEMQOL, DEMentia Quality Of Life questionnaire; D-KEFS, Delis–Kaplan Executive
Function System; GSES, Generalized Self-Efficacy Scale; HADS, Hospital Anxiety and Depression Scale; RBMT, Rivermead
Behavioural Memory Test; RSS, Relatives’ Stress Scale; TEA, Test of Everyday Attention; WHOQOL-BREF, World Health
Organization’s Quality of Life Instrument – brief version.
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Demographic details
At the baseline assessment, we collected demographic and background information for the person with
dementia and their carer, including sex, age, relationship between the person with dementia and the carer
and whether they live together, age at onset of dementia, educational level, social class and comorbid health
conditions assessed using the Charlson Comorbidity Index,82 to provide both the number of conditions and
the weighted comorbidity score. A weighted score of ≥ 5 is used to indicate people with a particularly high
level of comorbidity translating into a high risk of mortality. This was intended to provide a profile of the
sample and to allow us to examine the effects of demographic and social variables on treatment efficacy.
Primary outcome measure
The primary outcome for GREAT was participant-reported goal attainment at 3 months post randomisation
(the 3-month follow-up). Participant-reported goal attainment was also assessed at 9 months post
randomisation (the 9-month follow-up). Parallel carer ratings of goal attainment were obtained at both
the 3-month and 9-month assessments. These ratings were obtained using the structured interview
protocol of the BGSI. The trial researchers participated in a 2-day initial training course to prepare them
for conducting goal-setting using the BGSI, attended annual refresher training days and participated in
monthly telephone supervision with two of the investigators (from a rotating panel of four), which was
focused specifically on optimising the goal-setting process.
During the initial assessment using the BGSI, participants were asked how memory and other cognitive
difficulties affect (1) everyday tasks, activities and routines, (2) the possibility of engaging in pleasurable and
meaningful activities and (3) social contacts and relationships. For each of these domains, participants rated
how important it was to them and how ready they were to try to make changes, in each case using a scale
of 1–10. This provided a basis for identifying areas in which participants would like to make changes or
improvements and for setting specific goals. Participants could select up to three goals. Goals were expressed
in behavioural terms using SMART principles: specific, measurable, achievable, realistic and attainable within a
defined period of time. Participants described what they want to be able to do and what they are currently
doing, and made ratings of their current level of goal attainment on a scale of 1–10, whereby 1 was unable
to do or not currently doing and 10 was able to do well with no difficulty. Participants also rated their
satisfaction with this level of attainment on the same scale of 1–10, where 1 was extremely dissatisfied and
10 was extremely satisfied. The scale was presented in a visual format as well as through verbal explanation.
The mean levels of attainment and satisfaction were calculated by summing the ratings across all of the
identified goals and dividing by the number of goals identified.
Carers provided their own descriptions of the person’s current functioning and made parallel ratings of
attainment on the same scale of 1–10. The mean ratings for attainment were calculated by summing the
ratings across all of the identified goals and dividing by the number of goals.
At the 3-month and 9-month follow-ups, participants and carers were shown the goal descriptions and
baseline ratings for the originally identified goals and asked to rate the current attainment and satisfaction
levels for each goal. The mean attainment and satisfaction ratings were calculated as before.
The key information that the performance and satisfaction ratings provide is an indication of the extent
and direction of change. In clinical practice, it is usual for people to remember and consider previous
ratings or previously obtained information when making such ratings, and this can make current ratings
more informative and the process of completing the ratings more transparent.83 However, people with
dementia may find it difficult to remember their previous ratings as a result of their memory difficulties.
Various approaches to obtaining follow-up ratings are used in clinical trials, and one question that arises
is whether or not participants should have access to their previous ratings when completing a new set of
ratings at follow-up. Evidence shows that participants prefer to be reminded of previous scores and that, in
the case of healthy adults, being reminded of previous scores produces no significant differences in ratings
compared with not being reminded.84 People with dementia, because of their difficulties with memory,
may benefit more than other groups from being reminded about the rating process and being given access
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to their earlier ratings. Furthermore, in GREAT, participants in the CR group made in-session ratings of goal
attainment in the sessions prior to the 3- and 9-month assessments, and providing a reminder of previous
scores to all study participants removed this source of inequity.
Secondary outcome measures for participants with dementia
The secondary outcomes for the person with dementia at the 3- and 9-month follow-ups were self-rated
quality of life, self-efficacy and mood, cognitive test scores (memory, attention and executive function) and
extent of service utilisation. The following measures were taken at baseline and follow-up.
DEMentia Quality Of Life questionnaire85
The DEMentia Quality Of Life (DEMQOL) questionnaire is a measure of the health-related quality of life
(HRQoL) of people with dementia, with good internal consistency (Cronbach’s alpha 0.87) and test–retest
reliability (intraclass correlation coefficient 0.76) in people with mild to moderate dementia. We used
the 28-item interviewer-administered questionnaire for the person with dementia to obtain participants’
ratings of their own quality of life. Items are rated on a 4-point scale, with potential scores ranging from
28 to 112. This measure was also used in the economic evaluation, drawing on the algorithm that has
been developed to generate quality-adjusted life-year (QALY) scores from DEMQOL questionnaire scores.86
Generalized Self-Efficacy Scale87
The Generalized Self-Efficacy Scale (GSES) is a 10-item scale that assesses a general sense of perceived
self-efficacy, which is the potential to influence one’s situation through one’s own actions. Responses are
made on a 4-point scale. Responses to all 10 items are summed to yield the final composite score with a
range from 10 to 40. Cronbach’s alphas range from 0.76 to 0.90.88
Hospital Anxiety and Depression Scale89
The Hospital Anxiety and Depression Scale (HADS) contains 14 items that form subscales for anxiety
and depression. Each item is rated on a 4-point scale, giving maximum scores of 21 for anxiety and for
depression. Scores of ≥ 11 on either subscale are considered to be a significant ‘case’ of psychological
morbidity, with scores of 8–10 being classified as ‘borderline’ and scores of 0–7 being classified as
‘normal’. The HADS has been employed and validated in studies of people with dementia and carers.90,91
Brief cognitive assessment battery
The brief cognitive assessment battery consisted of brief tests of memory, attention and executive function,
suitable for people with early-stage dementia, each taking < 5 minutes to administer:
l Memory – Rivermead Behavioural Memory Test (RBMT),92 a story recall subtest. The RBMT is a
well-established, ecologically valid test of everyday memory. In the story recall task, the researcher
reads out a short story, similar to a brief report of a newsworthy event in a daily newspaper, and
the participant is asked for immediate and, after 20 minutes, delayed recall of the content. Recall is
scored following a standard protocol (inter-rater reliability of > 0.9) with a maximum possible score
of 21 for the immediate and for the delayed component. Four parallel versions of equivalent difficulty
are available to permit reassessment without the risk of practice effects; practice effects are not
anticipated with test–retest intervals of 3 and 6 months, but as a precaution we used a different
version at each time point. The raw scores were used in the analysis, as they provide a greater range
than the condensed standardised profile score that is used in the calculation of the overall RBMT score.
l Attention – Test of Everyday Attention (TEA),93 elevator counting and elevator counting with distraction
subtests. The TEA is a well-established, ecologically valid test of everyday attention, with subtests
assessing different components of attention. The elevator counting subtest assesses sustained attention.
Participants are required to count a short string of monotonous tones and give the total number. Seven
strings are presented, and the total score is the number of strings correctly counted. The elevator counting
with distraction subtest assesses auditory selective attention. Ten strings of tones are presented, this time
also including distractor (high-pitched) tones that are not to be counted. The total score is the number of
strings correctly counted. Three equivalent versions of each subtest are available to permit reassessment
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without the risk of practice effects; as above, practice effects were not anticipated, but as a precaution we
used a different version at each time point.
l Executive function – letter fluency subtest of the Delis–Kaplan Executive Function System (D-KEFS).94
D-KEFS consists of a set of standardised tests of executive function. The verbal letter fluency task
evaluates the executive subdomains of initiation, response generation and inhibition,95 as well as
drawing on semantic memory and language ability. In this task, the participant is asked to list as many
words as possible beginning with a specific letter of the alphabet in a 1-minute period, excluding
proper nouns and repetitions. Three letters, F, A and S, are used. The total number of correct responses
to the three letters is the unit of analysis. This task has been extensively examined in people with
early-stage dementia.96 Evidence suggests that even in healthy participants there are no practice effects
for most components of this task, even at test–retest intervals of < 2 weeks; there are minimal practice
effects for the switching component with test–retest intervals of < 2 weeks, but not with longer intervals.
l The Client Service Receipt Inventory (CSRI),97 completed by the person with dementia and their carer
together. The CSRI provides a template that can be adapted to the needs of each specific study. In GREAT,
the CSRI focused on both the person with dementia and the carer. Respondents were asked about the
use of health and social care services by the person with dementia in the 3-month period preceding each
assessment. The questions cover contact with a range of health and social care professionals, prescription
of medications, hospital appointments and stays, participation in local authority-funded activities (such as
day centres), participation in activities run by voluntary organisations and the contribution of informal
carers. Questions to examine the nature and extent of any dementia-specific treatment received from the
Memory Clinic were included. Carers were asked about their own accommodation, the impact of caring
on employment (when applicable), the involvement of others in the person’s care and the costs involved in
accompanying the person with dementia to appointments.
Secondary outcome measures for the carer
The outcomes of interest for carers were stress, quality of life and health status, assessed with the
following self-rated measures at baseline and at the 3- and 9-month follow-ups:
l The Relatives’ Stress Scale (RSS).98 The RSS is a 15-item dementia-specific measure of caregiver stress
with items rated on a 5-point Likert scale and summed (score range 0–60). A higher overall score
indicates higher levels of caregiving-specific stress.
l World Health Organization’s Quality of Life Instrument – brief version (WHOQOL-BREF).99 The WHOQOL-BREF
is a 26-item scale assessing perceived quality of life, with each item scored on a 5-point Likert scale (with
the lowest score being 1 and the highest score being 5) giving scores in four domains: environment (raw
score range 8–40), social relationships (raw score range 3–15), psychological health (raw score range
6–30) and physical health (raw score range 7–35). Scores within each domain are summed and the
mean domain score is calculated (range 1–5); this is multiplied by 4, giving a score in the range of 4–20.
l EuroQol-5 Dimensions (EQ-5D).100 The EQ-5D is a standardised measure of health status and health
outcome, applicable to a wide range of health conditions. In the first section, the respondent is asked to
select one of three options for each of five dimensions: mobility, self-care, usual activities, pain/discomfort
and anxiety/depression. For each dimension, the three response options are coded on a 3-point scale
from 1 (no problems) to 3 (unable to perform/extreme problems). This yields a descriptive profile (e.g.
11232) across the five dimensions. Based on the EQ-5D descriptive categories, a summary index can be
calculated.101 Each level in each dimension has a weight attached, and the summary index is calculated by
deducting the appropriate weights from 1. The EQ-5D, three-level version (EQ-5D-3L) has an index score
from –0.594 to 1.0, with a higher index score indicating a higher quality of life and a negative index
score indicating a quality of life that is considered by some respondents to be ‘worse than death’. The
second part of the measure is a visual analogue scale (VAS) for the self-rating of HRQoL (‘your health
state today’) on a scale of 0–100. This measure was included so that the EQ-5D score could be used to
generate QALY scores using societal weights.
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Process evaluation measures
The process evaluation first addressed the process of goal-setting, and second, the process of therapy.
A summary of the process evaluation measures is provided in Table 3.
The goal-setting process
All participants, irrespective of allocation, identified personal goals in the baseline assessment. Participants
rated the importance to them of each goal and their readiness to change. We extracted details of the
goals that participants identified at baseline, together with the corresponding ratings.
The process of therapy
For participants allocated to receive the CR intervention, we evaluated the process of therapy through
several means, from the perspectives of the therapists and of the participants and carers.
Goals addressed in therapy
For every goal originally set at baseline by participants subsequently randomised to receive CR, we noted
whether or not the goal was addressed in therapy, any adjustments to the original phrasing or modifications
made by the therapist in order to operationalise the goal and details of the corresponding ratings by the
participant and the carer.
TABLE 3 Summary of the process evaluation measures
Source Measure Time point (when applicable)
Whole sample
BGSI Goals set Baseline
Goal ratings – importance Baseline
Goal ratings – readiness to change Baseline
CR group
Therapy logs Goals addressed
Adjustments made to BGSI goal statements
Goal attainment ratings by person with
dementia
When work on goal is introduced
and in session 10
Goal attainment ratings by carer When work on goal is introduced
and in session 10
Goal attainment ratings by therapist When work on goal is introduced
and in session 10
Therapist selection of goal attainment
scaling indicators
In sessions 10 and 14
Therapist rating of carer involvement in
therapy
Following session 14
Therapist rating of confidence in addressing
the participants’ goals
Following session 14
Compliance – number of sessions the
participant received
Following session 14
Therapy logs and therapist supervision Therapist adherence to protocol
Focus group with therapists Therapist experience of delivering therapy
Interviews with participants and carers Participant and carer experience of CR After the 9-month follow-up
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Therapist perceptions of goal attainment
Therapist perceptions of goal attainment were captured in two ways.
First, the therapist made in-session parallel ratings of goal attainment alongside the participant and the
carer when each goal was introduced, when the work on therapy goals concluded (usually in session 10)
and at the final maintenance session (usually session 14).
Second, the therapist applied a simplified goal attainment scaling procedure26 for each goal addressed in
the intervention. When starting work on the goal, clearly specified behavioural indicators of full and partial
goal achievement were established. The therapist subsequently rated progress in accordance with these
criteria following session 10 and again following session 14 (maintenance session 4).
Effectiveness of supervision
The supervision process was reviewed through annual evaluation of the supervision session attendance
rates and rates of submission and review of the therapy logs to ensure the appropriate involvement of
all therapists in the supervisory process.
Therapist perspectives on the process of therapy
Following each session, therapists noted relevant information in the therapy log. Therapy logs contained
the therapists’ notes from each session, with comments on participants’ progress in relation to goals and
other prespecified topics relating to the delivery of the intervention. The logs were not intended to provide
a comprehensive summary of every session. Each therapist completed a separate record for each session.
See Appendix 1 for full details of the topics recorded in the therapy logs.
Therapist experience of providing the intervention
A focus group was held with six therapists in June 2014, during an annual training event for the trial
team held at the end of the therapists’ first year. The aim was to explore their experience of delivering
the intervention.
Participant treatment compliance
Treatment compliance was indexed by the number of sessions completed for each participant, up to the
maximum of 14 sessions (10 therapy sessions and four maintenance sessions).
Participant and carer experience of the intervention
In three sites where an independent researcher not involved in the trial was available to contribute, a
consecutive series of participants and carers completing the trial in the CR arm were approached after the
9-month follow-up and invited to participate in an interview to reflect on their experience of the intervention.
The sites were Bangor, Cardiff and Manchester. The interviews addressed the following questions:
l How did participants and carers experience the intervention?
l What were their overall perceptions, how useful did they find it, and what did they feel about the
degree of effort required?
l What impact, if any, did the participants and carers feel the intervention had on their everyday life?
The interview schedule is presented in Appendix 2.
Data management
A detailed data management plan covering all of the quantitative data gathered in the trial was developed
in collaboration with the CTU and was followed throughout the trial. Quality-assurance procedures included
an audit of sites, random checks of the accuracy of data entry and ongoing monitoring of scoring accuracy.
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We used the online MACRO Electronic Data Capture (InferMed, London, UK) data management system,
which was managed by the NWORTH CTU. A range of built-in checks prevent the entering of invalid
information into MACRO. The accuracy of data entry was examined during initial site visits, and 5% of the
data at each time point were cross-checked against hard-copy case report forms. Additional checks were
conducted centrally, including missing data verification, searches for unusual patterns and identification of
unexpected data ranges. These checks indicated a high level of accuracy in data entry.
The GREAT researchers received training in administering all outcome measures and in following data
management procedures at the start of the trial, and thereafter through annual refresher training days,
and were provided with a detailed researcher’s handbook together with a number of other resources:
a guide to using the BGSI, an administration and scoring guide for all other measures, a MACRO user
guide, randomisation instructions, details of the safety monitoring and reporting procedure and template
spreadsheets for recording and managing contact with participants. The researchers recorded assessment
data manually during the participant visits and entered anonymised data item by item into MACRO.
The GREAT therapists received training in data management procedures and the use of the MACRO
system at the start of the trial and this was updated during their annual refresher training. In addition to
the therapists’ manual, they were provided with a MACRO user guide, randomisation instructions, details
of the safety monitoring and reporting procedure and template spreadsheets for recording and managing
contact with participants. The therapists entered into MACRO basic information about the participant,
details of the PAL assessment, the date and length of each therapy session and details of any missed
sessions, details of the goals worked on, ratings of goal attainment, goal attainment scaling indicators
and ratings of participant awareness and response to therapy.
Information about adverse events was recorded in the MACRO system by both researchers and therapists,
or it was provided on paper-based forms to the co-ordinating centre, where it was entered into the
MACRO system.
A separate plan covered management of the data gathered by the therapists and of the qualitative
interview data, and this was overseen by the trial manager. Therapy Record Sheets for each participant
(a therapy log, a goal-rating sheet and a goal intervention sheet) were stored within a secure shared drive
through which the documents could be updated by the therapists following each therapy session and
accessed by the supervisor to inform the monthly supervisory sessions. A similar data-sharing strategy
was used to manage interview substudy data. In Bangor, we used a shared drive accessed with WinSCP
software (developed by Martin Prˇikryl: https://sourceforge.net/projects/winscp) or the Oracle Secure Global
Desktop platform (Oracle Corporation, Redwood Shores, CA, USA), and in Exeter we used an Alfresco
web-based platform (Alfresco Software Inc., San Mateo, CA, USA).
Outcome analyses
The primary statistical analysis was based on the treatment-as-allocated principle and was conducted as
an intention-to-treat analysis. The trial statistician conducted analyses while being blind to allocation, not
knowing which of the two groups had received the intervention. The statistician was unblinded only after
the primary analysis had been completed and approved by the TSC. The analyses were conducted in R
version 3.3.1 (The R Foundation for Statistical Computing, Vienna, Austria) and IBM SPSS Statistics version
22 (IBM Corporation, Armonk, NY, USA).
Primary outcome
The main analysis was an analysis of covariance (ANCOVA) adjusted for baseline score, allocation group
and the stratification variables (age, sex, MMSE score and centre), which were treated as random effects.
The analysis used a mixed-effects model. However, the standardised effect size estimates (Cohen’s d) and
the confidence intervals (CIs) were based on a fixed-effects size model, as these parameters cannot be
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derived from a mixed-effects model. Effect sizes were calculated by converting eta-squared to r and then
converting r to Cohen’s d, using the formula provided by McGrath and Meyer.102
Additional regression modelling was undertaken to identify factors that could be important in attaining
and maximising the observed effects. This was done separately for people with dementia and carers.
For the participants with dementia, in addition to the stratification variables (age, sex, MMSE score
and centre), the following factors were retained in the final model on a priori theoretical grounds:
diagnosis, medication, education and comorbidity. The remaining factors [marital status, living situation,
first language, ethnicity, socioeconomic status (SES) and self-rated health] were each subjected to a
simple regression analysis to determine whether or not the given factor was significantly associated
with outcome; if so, that factor was added to the regression model. For the carers, the following factors
relating to the carer were included in the final model on a priori theoretical grounds: relationship with the
person with dementia, age, sex and education. The remaining factors (first language, ethnicity, SES and
self-rated health) were each subjected to a regression analysis to determine whether or not the given
factor was significantly associated with outcome; if so, that factor was added to the regression model.
Secondary outcomes
The main analyses for the secondary outcomes used an ANCOVA adjusted for baseline score, allocation
group and stratification variables.
We conducted exploratory analyses to examine the influence of demographic variables on key secondary
outcomes at baseline and follow-up. For the person with dementia, we examined the influence of the
following factors on BGSI performance ratings at 9 months and BGSI satisfaction ratings: centre, age, sex,
educational level, social class, ethnicity, living situation, diagnosis, baseline MMSE score, whether or not
the person was taking medication for dementia, comorbidity and effectiveness of blinding. For the carer,
we examined the influence of the following factors on carer stress: age, sex, education, social class,
ethnicity, relationship to the participant, whether or not the carer was co-resident with the person with
dementia and self-rated health status.
Sensitivity analyses
Sensitivity analyses for the primary and main secondary outcomes were planned based on:
l Treatment received irrespective of group allocation. This analysis was planned in order to compare the
outcomes of statistical analyses in which the group allocation was determined by random assignment
with the outcomes of statistical analyses in which group allocation was based on the treatment received.
Because the group allocation and treatment received was 100% consistent, a treatment-received
analysis was not necessary.
l Complete case with no data imputation. We compared the outcomes of statistical analyses that
included both imputed and complete-case data with the outcomes of statistical analyses that included
complete cases only. This proposed a comparison involved appraising whether or not the results from
the complete-case data analysis and the imputed data analysis are substantially different.
Adherence
For the CR group, we examined the impact of the ‘dose’ of treatment received on primary and secondary
outcomes at the 3- and 9-month follow-ups. Adherence was calculated as the number of therapy sessions
completed. The analysis was intended to be conducted on the basis of treatment received rather than
group allocation.
Effectiveness of blinding
We examined whether or not the researcher’s ability to correctly surmise the participant’s group allocation
was associated with the primary and secondary outcomes at the 3- and 9-month follow-ups, and whether
this ability varied by centre or depending on any participant characteristics.
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Process evaluation analyses
We undertook a range of process evaluation analyses. These are briefly detailed below. A fuller account of
the methods is presented along with the findings in Chapter 4.
Nature of goals identified
To better understand the concerns of participants and the areas addressed by therapists in the intervention,
we examined the goals set by participants in the trial and used descriptive content analysis to classify them
into groups based on the content and focus of the goal.
Goal-setting and goal attainment
We compared the goal attainment ratings made by the participant, the carer and the therapist at each
stage and the changes in these ratings between the point at which work on the goal was introduced and
sessions 10 and 14, in order to examine the similarities and differences in perspective regarding level of
functioning and change in functioning. We also compared the goal attainment ratings with the therapists’
goal attainment scaling process (which classified goals as being fully or partially achieved, with a percentage
score) to determine whether or not these two procedures yielded consistent information.
Intervention fidelity
Fidelity of form was evaluated in relation to the provision of core elements of the intervention. This was
indexed by the number and length of therapy sessions completed and the number of goals operationalised
and addressed.
Fidelity of function was considered in relation to the therapists’ ability to deliver the intervention in a flexible,
person-centred manner adapted to the needs of each individual participant. In order to evaluate the level
of flexibility applied by the therapists, we reviewed the times at which additional goals were introduced
and the nature and extent of modifications to goals formulated in the baseline assessment. As fidelity of
function was promoted through regular supervision, with the aid of the detailed therapy logs produced by
therapists, we also assessed attendance at supervision sessions and the rates of completion of therapy logs.
Therapist perspectives on the intervention and factors associated with
positive outcomes
We explored what factors were thought to influence treatment outcome and the characteristics of
participants who seemed most and least likely to benefit from the intervention, and why, with two sets
of data: (1) data from a focus group conducted with the therapists and (2) a selection of therapy logs.
We analysed data from the focus group conducted with the therapists to identify their views about
delivering the intervention and about what factors influence treatment outcome. From the existing literature,
we identified a number of factors that we expected the therapists to consider; these were the level of
cognitive impairment, health status, awareness of difficulties, motivation, the degree of carer involvement
and family circumstances. We used a deductive approach, coding the data in relation to these factors, but
also adopted an inductive perspective, which allowed new factors to emerge.
The therapy logs provided a rich source of data about the process of therapy for each individual participant
and were analysed to identify significant features and processes of the intervention. We analysed therapy
logs for the 25 participants with the best outcomes on the BGSI and the 25 participants with the worst
outcomes on the BGSI using a matrix analysis to examine which factors identified from the focus group
data were noted as being relevant in the therapy logs. This analysis was also inductive, allowing additional
factors to emerge from the therapy logs. The aim was to understand more about which participants were
or were not likely to benefit from the intervention.
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Participant and carer experience of the intervention
We analysed the transcribed recordings of the interviews with participants and carers using a thematic
analysis. The aim was to identify the level of satisfaction with the intervention and any features that
contributed to greater or lesser degrees of satisfaction.
Feasibility of implementation
Towards the end of the trial, once recruitment had finished and therapists had completed the majority of
the intervention work, sites were invited to consider examining the feasibility of future implementation of
CR within their routine services. This was achieved by therapists offering training in the approach to groups
of clinical staff and supporting these staff to use the approach. This initiative was evaluated informally
through reports from the local principal investigators (PIs). The findings are described in Appendix 3.
Economic analyses
The main economic evaluation was a cost-effectiveness analysis, conducted first from a health and social
care perspective and second from a societal perspective. The methods and results for the economic
analyses are described in Chapter 5.
Patient and public involvement
Two Alzheimer’s Society Research Network volunteers were involved as advisors to the pilot trial, and they
contributed to the development of the GREAT protocol and served as experts by experience on the TSC,
in which they were joined by a third Alzheimer’s Society Research Network volunteer.
Changes to protocol
There were two changes to the protocol.
The trial was initially set up in six sites. To meet our recruitment target, each site was requested to randomise
80 participants, representing approximately three participants per month over a 27-month recruitment
period. All centres regarded this recruitment target as feasible. However, it proved to be challenging for
some sites, and although other sites did meet and in some cases exceed targets (Bangor and Bath agreed to
increase their target to 90 participants each), under-recruitment was a concern. Attrition was lower than
expected, suggesting that randomisation targets could be reduced, but the funder advised that the original
estimate should be retained and no alteration should be made to the target sample size. To address the likely
shortfall in recruitment, two additional sites were identified, with a target of 25 randomisations each: Kent
and Medway NHS and Social Care Partnership Trust and Northumberland, Tyne and Wear NHS Foundation
Trust. The inclusion of these sites was agreed with the funder and approved as an amendment by Wales
REC 5. The two sites achieved their first randomisations in June 2015, allowing for a 10-month recruitment
period in each site.
The process evaluation component of the data analysis plan was initially envisaged to include (1) convergent
evidence about changes in goal performance in the CR group derived from in-session ratings and therapist
assessment of goal attainment, (2) intervention fidelity on the part of the therapists and (3) treatment
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compliance in terms of the number of sessions received by the participant. This was expanded following
discussion within the trial team and with the TSC. Qualitative interviews were added in order to capture the
experience and perspectives of participants, carers, therapists and researchers; this was approved as an
amendment by Wales REC 5. A subset of participants and carers was interviewed following completion of
the trial after the 9-month follow-up by an independent researcher who was not part of the trial team in
order to elicit the participants’ and carers’ experience of the intervention, and a focus group was conducted
with the therapists to capture their experience of delivering the therapy sessions.
DOI: 10.3310/hta23100 HEALTH TECHNOLOGY ASSESSMENT 2019 VOL. 23 NO. 10
© Queen’s Printer and Controller of HMSO 2019. This work was produced by Clare et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
27

Chapter 3 Results
Recruitment and participant flow
The flow of participants through GREAT is shown in the Consolidated Standards of Reporting Trials
diagram in Figure 2.
Participants were recruited in eight NHS sites in England and Wales: Bangor, Cardiff, London, Kent, Bath,
Birmingham, Manchester and Newcastle. Recruitment began on 1 April 2013 and was completed by
31 March 2016. Follow-up assessments were completed by 31 December 2016. The cumulative
recruitment figures are provided in Appendix 4.
Overall, 1731 participants were identified as being potentially eligible, of whom 583 (34%) were screened
for eligibility and 538 (31%) were seen for the baseline assessment. Following the baseline assessment,
475 participants (88% of those assessed) were randomised to either the CR (n = 239) arm or the TAU
(n = 236) arm. Of the participants who did not proceed, a small proportion had difficulty identifying any
goals to work on, as they felt content with their current situation and did not think that they had any
particular needs. One participant who did not meet the diagnostic criteria was incorrectly randomised
(to the CR arm) and was withdrawn from the analysis; this participant had a diagnosis of Parkinson’s
disease dementia. All other participants received their allocated condition. Six participants in the CR group
requested withdrawal from the intervention after at least two sessions, but remained in the trial to complete
the follow-up assessments. One person withdrew after two sessions, three people withdrew after four
sessions, one person withdrew after 10 sessions and one person withdrew after 11 sessions. The reasons
for withdrawal were stressful life circumstances, lack of motivation to engage in therapy, comorbid health
problems and rapid cognitive decline.
Retention in the trial was 94% at 3 months and 90% at 9 months. The overall figure of 10% attrition
was considerably lower than the conservative 27% estimate used in the sample size calculation. The trial
was adequately powered, and would have been adequately powered even with a smaller sample size
consisting of 385 participants randomised.
Sample characteristics
The demographic characteristics of participants and carers are summarised in Table 4. Details are provided
for the sample as a whole and separately for the CR and TAU groups. The demographic characteristics are
presented in more detail in Appendix 5.
We examined whether or not participants who were randomised but dropped out before the 3-month
follow-up had different demographic characteristics and substantially different scores on the primary
outcome from the participants who completed the 3-month follow-up. None of the comparisons between
non-completers and completers was statistically significant (p < 0.05) after correcting for multiple
comparisons (see Appendix 6).
The participants’ mean age was 78.56 years, with the age of individual participants ranging from 53 to
92 years. Only 20 (4.2%) were aged < 65 years on entry to the trial and four participants (0.8%) were
aged < 60 years. Most participants (69.6%) were currently married and 21.3% were widowed. Just over
half were male (52.1%) and the overwhelming majority of participants were of white ethnicity (95%) and
had English as their first language (93.3%). On average, they had 12.57 years of education, but nearly
half (42.2%) had left education by the age of 16 years and only 19% had completed higher education.
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Allocation
9-month follow-up
3-month follow-up
• Withdrew from trial between weeks 13 and
   39, n = 7:
   • Declined to participate, n = 2
   • Health problems, n = 2
   • Death, n = 3 
• Lost to follow-up, n = 3: uncontactable
• Excluded from analysis, n = 1: ineligible as
   diagnosed with Parkinson’s disease dementia
• Withdrew from trial before week 13, n = 18: 
   • Declined to participate, n = 7
   • Reluctant to engage, n = 5
   • Life stress, n = 2
   • Health problems, n = 2
   • Deteriorating cognition, n = 2 
• Death, n = 1
• Lost to follow-up, n = 1: uncontactable
• Excluded from analysis, n = 1: ineligible as
   diagnosed with Parkinson’s disease dementia
• Received CR intervention, n = 239
• Did not receive CR intervention, n = 0
• Discontinued intervention before week 13
   but completed follow-up assessments, n = 6: 
   • Health problems, n = 1
   • Life stress, n = 2
   • Reluctant to engage, n = 2
   • Deteriorating cognition, n = 1
• Withdrew from trial before week 13, n = 8: 
   • Declined to participate, n = 2
   • Life stress, n = 1
   • Health problems, n = 5 
• Death, n = 1
• Lost to follow-up, n = 0
• Excluded from analysis, n = 0
• Received TAU, n = 236
• Did not receive TAU, n = 0
• Withdrew from trial between weeks 13 and
   39, n = 6:
   • Life stress, n = 2
   • Health problems, n = 2
   • Death, n = 2
• Lost to follow-up, n = 3: uncontactable
• Excluded from analysis, n = 0
Assessed at baseline
(n = 538)
Screened for eligibility
(n = 583) Excluded
(n = 45)
• Uncontactable, n = 2
• Declined to participate, n = 14
• Did not meet inclusion criteria, n = 29
Randomised
(n = 475)
Enrolment
Allocated to CR intervention
(n = 239)
Allocated to TAU
(n = 236)
Assessed at 3 months
(n = 227)
Assessed at 9 months
(n = 218)
Assessed at 3 months
(n = 219)
Assessed at 9 months
(n = 209)
Analysed
(n = 218)
Analysed
(n = 208)
Analysed
(n = 218)
Analysed
(n = 227)
Excluded
(n = 63)
• Uncontactable, n = 4
• Declined to participate, n = 29
• Did not meet inclusion criteria, n = 2
• Content with current situation, n = 28
Identified as potentially eligible
(n = 1731)
Excluded
(n = 1148)
• Uncontactable, n = 41
• Did not respond to invitation, n = 502
• Declined invitation, n = 368
• Unavailable in time frame, n = 40
• Did not meet inclusion criteria, n = 197
FIGURE 2 Consolidated Standards of Reporting Trials chart showing participant flow through the trial. Reproduced
with permission from Clare et al.72
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TABLE 4 Demographic characteristics of the sample
Measure
Whole sample
(N= 474)
Treatment group
CR (N= 238) TAU (N= 236)
Participants with dementia
Age (years), mean (SD); range 78.56 (7.07); 53–95 78.25 (7.13); 53–95 78.87 (7.01); 55–95
Sex (male), n (%) 248 (52.3) 124 (52.1) 124 (52.5)
Ethnicity, n (%)
White 457 (96.4) 226 (95.0) 231 (97.9)
Mixed/multiple ethnic group 2 (0.42) 2 (0.84) 0 (0)
Asian/Asian British 6 (1.27) 3 (1.26) 3 (1.27)
Black/African/Caribbean/black British 7 (1.48) 5 (2.10) 2 (0.85)
Other ethnic group 2 (0.42) 2 (0.84) 0 (0)
First language (English), n (%) 445 (93.9) 222 (93.3) 223 (94.5)
Marital status (married), n (%) 330 (69.6)
n= 474
167 (70.2)
n= 238
163 (69.1)
n= 236
Years of education, mean (SD); range 12.57 (3.37); 5–33
n= 471
12.57 (3.33); 6–24
n= 236
12.58 (3.42); 5–33
n= 235
Occupational status, n (%)
I: professional 52 (11) 23 (9.7) 29 (12.3)
II: managerial/technical 157 (33.1) 81 (34) 76 (32.2)
III N: skilled, non-manual 103 (21.7) 54 (22.7) 49 (20.8)
III M: skilled, manual 80 (16.9) 41 (17.2) 39 (16.5)
IV: partly skilled 50 (10.5) 24 (10.1) 26 (11)
V: unskilled 32 (6.8) 15 (6.3) 17 (7.2)
Carers
Relationship to participant with dementia, n (%)
Spouse/partner 331 (69.8) 167 (70.2) 164 (69.5)
Adult child (including in-law) 118 (24.9) 58 (24.3) 60 (25.4)
Other 25 (5.3) 13 (5.5) 12 (5.1)
Age, mean (SD); range 68.74 (13.01); 17–92 68.45 (13.76); 17–92 69.04 (12.24); 23–92
Sex (male), n (%) 142 (30) 75 (31.5) 67 (28.4)
Ethnicity, n (%)
White 449 (94.7) 224 (94.1) 225 (95.3)
Mixed/multiple ethnic group 5 (1.1) 4 (1.7) 1 (0.42)
Asian/Asian British 10 (2.1) 4 (1.7) 6 (2.5)
Black/African/Caribbean/black British 8 (1.7) 6 (2.5) 2 (0.85)
Other ethnic group 2 (0.42) 0 (0) 2 (0.85)
First language (English), n (%) 443 (93.5) 222 (93.3) 221 (93.6)
continued
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Two-thirds had a previous occupational background that was professional, managerial/technical or skilled
non-manual.
The majority of carers were spouses or partners of the participants (70%) and another 25% were adult
children (or sons- or daughters-in-law). The carers’ mean age was 68.74 years. They were predominantly
female (70%), currently married (82.9%) and of white ethnicity (94.8%), with English as their first
language (93.5%). They were a relatively well-educated group, with a mean of 13.49 years of education,
although one-third (32.9%) had left education by the age of 16 years and only one-quarter (25.3%) had
engaged in higher education, and 72.5% had a current or previous occupational background that was
classed as professional, managerial/technical or skilled non-manual. Counter to protocol, there were four
paid carers in the sample. One was a long-term, live-in housekeeper with a longstanding knowledge of
the participant, who was not specifically employed to provide dementia care and was considered to be
appropriate for inclusion. Three were paid dementia care workers, of whom two (a support worker and
an activities co-ordinator) provided both baseline and follow-up data; these data were retained in the
analyses on the advice of the trial statistician.
The clinical characteristics are shown in Table 5. Over half of the sample (59.5%) had a diagnosis of
Alzheimer’s disease, around one-quarter had a diagnosis of mixed Alzheimer’s disease and vascular
dementia (24.5%), and the remainder (15.6%) had a diagnosis of vascular dementia.
Participants’ mean MMSE score was 23.82 points, with a range from 18 to 30. Over two-thirds of participants
(68%) rated their health as good, very good or excellent and only 6.3% rated their health as poor. However,
levels of comorbidity were high, with 312 participants (65.8%) having at least one other condition in addition
to dementia. The mean Charlson Comorbidity Index weighted score was 2.52, with 44 participants (9.28%)
identified as having a high risk of mortality, which is a score of ≥ 5.82 Full details of comorbidity are presented
in Appendix 5. Three-quarters of the carers (75.9%) rated their health as good, very good or excellent and
only 6.5% rated their health as poor. On average, the carers recorded low levels of stress and good scores for
quality of life, although there was individual variability.
TABLE 4 Demographic characteristics of the sample (continued )
Measure
Whole sample
(N= 474)
Treatment group
CR (N= 238) TAU (N= 236)
Marital status (married), n (%) 393 (82.9) 187 (78.6) 206 (87.3)
Years of education, mean (SD); range 13.49 (3.52); 4–26
n= 472
13.67 (3.45); 5–25
n= 237
13.32 (3.58); 4–26
n= 235
Occupational status, n (%)
I: professional 49 (10.3) 30 (12.6) 19 (8.1)
II: managerial/technical 158 (33.3) 74 (31.1) 84 (35.6)
III N: skilled, non-manual 137 (28.9) 64 (26.9) 73 (30.9)
III M: skilled, manual 47 (9.9) 24 (10.1) 23 (9.7)
IV: partly skilled 55 (11.6) 27 (11.3) 28 (11.9)
V: unskilled 20 (4.2) 14 (5.9) 6 (2.5)
NA 8 (1.7) 5 (2.1) 3 (1.3)
NA, not applicable; SD, standard deviation.
Adapted with permission from Clare et al.72
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TABLE 5 Baseline clinical characteristics of the sample
Measure
Whole sample
(N= 474)
Treatment group
CR (N= 238) TAU (N= 236)
Participants with dementia
Diagnosis, n (%)
Alzheimer’s disease 284 (59.9) 139 (58.4) 145 (61.4)
Vascular dementia 74 (15.6) 43 (18.1) 31 (13.1)
Mixed 116 (24.5) 56 (23.5) 60 (25.4)
MMSE, mean (SD); range 23.82 (3.02); 18–30 23.89 (3.04); 18–30 23.75 (3.02); 18–30
Charlson Comorbidity Index weighted
score, mean (SD); range
2.52 (1.47); 1–11 2.49 (1.47); 1–11 2.55 (1.48); 1–10
Subjective rating of health, n (%)
Excellent 39 (8.2) 20 (8.4) 19 (8.1)
Very good 125 (26.4) 65 (27.3) 60 (25.4)
Good 159 (33.5) 77 (32.4) 82 (34.7)
Fair 121 (25.5) 61 (25.6) 60 (25.4)
Poor 30 (6.3) 15 (6.3) 15 (6.4)
DEMQOL, mean (SD); range 92.3 (12.33); 39–112
n= 472
92 (12.9); 39–112
n= 237
92.61 (11.75); 39–112
n= 235
GSES, mean (SD); range 30.94 (5.09); 11–40;
n= 469
30.75 (4.81); 13–40;
n= 237
31.13 (5.35); 11–40;
n= 232
HADS, mean (SD); range N= 472 N= 238 N = 234
Depression 3.77 (2.79); 0–14 3.87 (2.83); 0–12 3.67 (2.75); 0–14
Anxiety 5.14 (3.64); 0–16 5.29 (3.67); 0–16 4.98 (3.62); 0–16
RBMT, mean (SD); range N= 473 N= 237 N = 236
Immediate recall 2.66 (2.11); 0–11.5 2.58 (2.1); 0–9.5 2.73 (2.12); 0–11.5
Delayed recall 0.38 (1.96); –1 to 9 0.39 (1.94); –1 to 8 0.37 (1.97); –1 to 9
TEA, mean (SD); range
Elevator counting 6.39 (1.16); 0–7
n= 463
6.35 (1.27); 0–7
n= 232
6.42 (1.05); 1–7
n= 231
Elevator counting with distraction 4.55 (2.72); 0–9
n= 448
4.39 (2.68); 0–9
n= 223
4.72 (2.75); 0–9
n= 225
D-KEFS verbal fluency, mean (SD); range 26.27 (11.82); 2–64
n= 470
25.78 (11.61); 2–64
n= 235
26.77 (12.03); 3–58
n= 235
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Eight participants with dementia (1.7%) had a HADS depression score of ≥ 11, indicating clinical levels
of depression [six participants in the CR group (2.5%) and two participants in the TAU group (0.9%)].
Forty-seven participants with dementia (10%) had a HADS depression score of 8–10, indicating possible
depression [22 participants in the CR group (9.2%) and 25 participants in the TAU group (10.7%)].
Forty-one participants with dementia (8.7%) had a HADS anxiety score of ≥ 11, indicating clinical levels
of anxiety [23 participants in the CR group (9.7%) and 18 participants in the TAU group (7.7%)].
Sixty-six participants with dementia (14%) had a HADS anxiety score of 8–10, indicating raised anxiety
levels [33 participants in the CR group (13.9%) and 33 participants in the TAU group (14.1%)]. Full
details of the HADS depression and anxiety scores are shown in Appendix 5.
TABLE 5 Baseline clinical characteristics of the sample (continued )
Measure
Whole sample
(N= 474)
Treatment group
CR (N= 238) TAU (N= 236)
Carers
Stress (RSS), mean (SD); range 18.96 (9.44); 0–52
n= 471
18.85 (9.04); 2–46
n= 236
19.08 (9.83); 0–52
n= 235
Subjective rating of health, n (%)
Excellent 68 (14.3) 30 (12.6) 38 (16.1)
Very good 113 (23.8) 59 (24.8) 54 (22.9)
Good 179 (37.8) 89 (37.4) 90 (38.1)
Fair 83 (17.5) 42 (17.6) 41 (17.4)
Poor 31 (6.5) 18 (7.6) 13 (5.5)
WHOQOL-BREF domains, mean (SD); range
Physical 15.34 (2.95); 5–20
n= 470
15.3 (3.0); 5–20
n= 237
15.37 (2.9); 7–20
n= 233
Psychological 15.14 (2.15); 8–20
n= 470
15.13 (2.19); 8–20
n= 237
15.15 (2.1); 8–20
n= 233
Social 15.13 (2.66); 5–20
n= 468
15.19 (2.67); 5–20
n= 235
15.07 (2.66); 7–20
n= 233
Environmental 16.43 (2.15); 10–20
n= 470
16.35 (2.3); 10–20
n= 237
16.52 (1.99); 10–20
n= 233
EQ-5D-3L, mean (SD); range
Index 0.78 (0.25); –0.18 to 1
n= 468
0.77 (0.25); –0.18 to 1
n= 235
0.79 (0.24); –0.07 to 1
n= 233
VAS 74.48 (19.95); 0–100
n= 467
73.52 (20.95); 1–100
n= 234
75.44 (18.9); 0–100
n= 233
SD, standard deviation.
Adapted with permission from Clare et al.72
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Intervention adherence in the cognitive rehabilitation group
The CR intervention consisted of 10 weekly sessions, followed by four maintenance sessions given at
6-week intervals; all sessions were conducted in participants’ own homes. The details of the number of
sessions completed are summarised in Table 6.
Ninety per cent of participants randomised to receive CR completed at least 10 sessions, with 166 participants
(70%) completing all 14 sessions. Another 46 participants (19.32%) completed between 10 and 13 sessions;
sessions were missed as a result of difficulty in scheduling therapy sessions in the available time frame (n= 40),
for example owing to sickness of the participant, carer and/or therapist or therapist annual leave, or because
the participant withdrew from therapy (n = 2) or from the trial entirely (n= 4). Only 26 participants (10.92%)
completed fewer than 10 sessions; 20 of these participants withdrew from the trial (three of these before
the first session) and six remained in the trial to complete the follow-up assessments (four participants
discontinued therapy, one participant completed only eight sessions because of the delayed start of a new
therapist following a staff change at the site and one participant did not receive any sessions, as the therapist
was on sick leave for an extended period). One ineligible participant with a diagnosis of Parkinson’s disease
dementia, who was excluded from the analysis because they did not meet the inclusion criteria, completed all
sessions but is not included in Table 6.
Data collection
The 3-month follow-up assessments were scheduled within a 4-week window from weeks 14 to 17 post
randomisation. The assessments were completed within this time frame for 420 participants (94%); five
participants (1%) completed the assessment over 1 month late. The 9-month follow-up assessments were
scheduled within a 4-week window in weeks 39–42 post randomisation. The assessments were completed
within this time frame for 367 participants (86%), with two participants (0.5%) completing the assessment
over 1 month late.
TABLE 6 Number of sessions completed by participants in the CR group (N= 234)a
Number of sessions completed Participants, n (%)
1 2 (0.9)
2 2 (0.9)
3 5 (2.1)
4 4 (1.7)
5 4 (1.7)
6 2 (0.9)
7 0 (0)
8 1 (0.4)
9 2 (0.9)
10 7 (3)
11 8 (3.4)
12 10 (4.3)
13 21 (9.0)
14 166 (70.9)
a Of the 239 participants allocated to CR, three withdrew before the first session, one received no sessions due to
unavailability of a therapist, and one ineligible participant with a diagnosis of Parkinson’s disease dementia completed all
sessions but was excluded from analysis.
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Adverse events
Details of serious adverse events (SAEs) recorded for participants and carers at each site are summarised
in Tables 7 and 8. The majority involved hospitalisation. There were 111 SAEs reported at eight sites.
Sixty-eight participants and 26 carers were involved in 83 and 28 SAEs, respectively.
Of the 111 events, 66 were reported in the CR group (54 different individuals) and 36 were reported in
the TAU group (32 different individuals); nine SAEs occurred prior to randomisation.
TABLE 7 Number of SAEs recorded for participants and carers at each site
Site
SAEs by treatment group (n)
Total
Participant Carer
CR TAU Before randomisation CR TAU Before randomisation
Bath 7 3 0 2 0 0 12
Birmingham 6 2 0 3 2 0 13
Cardiff 9 5 3 4 1 1 23
Kent 3 0 0 0 0 0 3
London 9 0 1 0 0 0 10
Manchester 8 10 3 5 3 0 29
Newcastle 2 1 0 0 0 0 3
North Wales 5 6 0 3 3 1 18
Total 49 27 7 17 9 2 111
TABLE 8 Classifications of the SAEs
Classification
Individual classification
reported (n)
Reported within a multiple
classification (n)
Total number
per classificationParticipant Carer Total Participant Carer Total
Death 7 1 8 0 0 0 8
Life-threatening 0 2 2 5 0 5 7
Hospitalisation or prolongation of
existing hospitalisation
62 19 81 8 2 10 91
Persistent or significant disability or
incapacity
1 1 2 9 2 11 13
Otherwise considered to be
clinically significant by the
investigator
1 3 4 5 0 5 9
Alleged/suspected abuse or neglect 0 0 0 1 0 1 1
Total 71 26 97 28 4 32 129
Note
A total of 13 SAEs were assigned to more than one SAE type.
RESULTS
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SAEs were reported in one of six categories: death, a life-threatening event, hospitalisation or prolongation of
existing hospitalisation, persistent or significant disability or incapacity, an event otherwise considered to be
clinically significant by the PI, and alleged or suspected abuse or neglect. Of the 111 SAEs, 98 were recorded
as a single-classification SAE and 13 SAEs had multiple classifications. Hospitalisation or prolongation of
existing hospitalisation was the most frequently reported type of SAE (82%). Eight deaths were notified to
the trial team.
None of these events was considered to be related to participation in the trial. The SAE reports were
reviewed biannually by the Data Monitoring and Ethics Committee, which concluded that the nature of
the SAEs appeared to reflect health problems commonly seen in an older population. An increased number
of SAEs in the CR group was seen as an artefact of the reporting procedure, as the CR group received
14 additional visits from the therapist over a 9-month period.
Numbers analysed
The analysis, by assigned group, included data from 474 participants at baseline (CR, n = 238; TAU,
n = 236), 445 participants at 3 months (CR, n = 218; TAU, n = 227) and 426 participants at 9 months
(CR, n = 208; TAU, n = 218).
Missing data
Details of missing data for the primary outcome at the 3-month and 9-month follow-ups are shown in
Table 9; there were no missing data on this measure at baseline. Details of missing data for the secondary
outcomes are provided in Appendix 7.
Multiple imputation of missing values was conducted using the mice R package.103 For all of the measures, a
predictive mean-matching algorithm was used. The missing outcome measures at baseline were imputed
using the centre-level factors and the participant’s sex, age and baseline MMSE scores. The missing outcome
measure scores at the 3-month and 9-month assessments were estimated based on centre-level factors,
baseline characteristics and scores for the same outcome at the earlier time point(s). In line with Grund et al.104
simulation-based observations of the D2 statistics performance for pooling p-values, 25 sets of imputations
were generated using the method described above.
TABLE 9 Missing data in the primary outcome measure (BGSI)
Measure at each follow-up point
Whole sample
Treatment group
CR TAU
Missing, n (%) Total Missing, n (%) Total Missing, n (%) Total
3 months
Participant rating of attainment 0 (0.00) 445 0 (0.00) 218 0 (0.00) 227
Participant rating of satisfaction 0 (0.00) 445 0 (0.00) 218 0 (0.00) 227
Carer rating of attainment 6 (1.27) 439 2 (0.84) 216 4 (1.69) 223
9 months
Participant rating of attainment 10 (2.11) 416 3 (1.26) 205 7 (2.97) 211
Participant rating of satisfaction 14 (2.95) 412 5 (2.09) 203 9 (3.81) 209
Carer rating of attainment 11 (2.32) 415 4 (1.67) 204 7 (2.97) 211
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Results for the primary outcome measure
The primary outcome was participants’ goal attainment ratings on the BGSI at the 3-month follow-up.
Participants’ goal attainment ratings were also obtained at the 9-month follow-up, and carers provided
informant ratings of attainment at the 3- and 9-month points. Participants gave ratings of satisfaction with
their goal attainment at both time points. For convenience, all of these BGSI measures will be considered
together here. Participant attainment and satisfaction ratings and carer attainment ratings across all time
points are summarised in Tables 10 and 11 and shown graphically in Figure 3. Tables 10 and 11 also
summarise the statistical analyses of changes in the BGSI ratings at 3 and 9 months.
For the CR group, participant attainment ratings improved at the 3-month follow-up by 2.57 points on
average, and this improvement was maintained at 9 months. The average ratings in the TAU group
showed a negligible improvement of < 1 point at 3 months. The ANCOVA indicated that the differences
between the CR and TAU groups were significant at both 3 and 9 months, with large effect sizes of 0.81
and 0.8, respectively.
The same pattern was observed for informant attainment ratings, with the CR group improving by an
average of 2.7 points and maintaining the improvement at 9 months, whereas the TAU group ratings
showed a negligible improvement of < 1 point. The ANCOVA indicated that the differences between the
TABLE 10 Bangor Goal-Setting Interview ratings for the CR and TAU groups at baseline, 3 and 9 months
Measure
Treatment group
CR TAU
Baseline
(N= 238)
3 months
(N= 218)
9 months
(N= 205)
Baseline
(N= 236)
3 months
(N= 227)
9 months
(N= 211)
Participant rating of attainment 3.53 (1.74) 6.10 (1.99) 6.05 (2.21) 3.55 (1.59) 4.41 (1.84) 4.22 (2.00)
Participant rating of satisfaction 3.76 (1.76) 6.47 (1.88) 6.75 (1.97) 3.86 (1.49) 5.05 (1.94) 5.26 (2.05)
Carer rating of attainment 2.76 (1.43) 5.46 (1.94) 5.21 (2.33) 2.72 (1.32) 3.55 (1.73) 3.31 (1.96)
Note
Data are mean (standard deviation).
Adapted with permission from Clare et al.72
TABLE 11 Bangor Goal-Setting Interview ratings at 3 and 9 months: ANCOVA adjusted for baseline score, allocation
group and stratification variables (age, sex, MMSE score and site)
Measure at each follow-up point p-value
Bonferroni-adjusted
p-value
Mean difference
(95% CI)
Cohen’s d
(95% CI)
3 months
Participant rating of attainment < 0.001 NA 1.58 (1.27 to 1.9) 0.81 (0.62 to 1)
Participant rating of satisfaction < 0.001 < 0.001 1.34 (1.01 to 1.66) 0.7 (0.51 to 0.88)
Carer rating of attainment < 0.001 < 0.001 1.75 (1.42 to 2.07) 0.93 (0.74 to 1.12)
9 months
Participant rating of attainment < 0.001 < 0.001 1.71 (1.35 to 2.08) 0.8 (0.61 to 0.99)
Participant rating of satisfaction < 0.001 < 0.001 1.36 (1 to 1.73) 0.67 (0.49 to 0.86)
Carer rating of attainment < 0.001 < 0.001 1.7 (1.32 to 2.09) 0.79 (0.6 to 0.97)
NA, not applicable.
Adapted with permission from Clare et al.72
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CR and TAU groups were significant at both 3 and 9 months, with large effect sizes of 0.93 and 0.79,
respectively. The carers’ informant ratings of attainment were slightly lower on average than the
participants’ attainment ratings, but followed similar trajectories. The participant and carer attainment
ratings were highly correlated at all time points, with Pearson’s product–moment correlation coefficients
of 0.68 at baseline, 0.77 at the 3-month follow-up and 0.81 at the 9-month follow-up.
In the CR group, the average satisfaction ratings improved by 2.7 points at 3 months and increased further
to give a 3-point improvement over baseline at 9 months. The average satisfaction ratings in the TAU
group improved by 1.2 points at 3 months, with a further slight increase at 9 months. The ANCOVA
indicated that the differences between the CR and TAU groups were significant at both 3 and 9 months,
with large effect sizes of 0.7 and 0.67, respectively.
These results demonstrate that, according to the patient- and informant-reported outcomes assessed by
the BGSI, the CR intervention was effective in improving functioning in the targeted areas. Furthermore,
participants in the CR group were more satisfied with their ability to carry out the everyday activities
targeted in the intervention.
Exploratory analyses for the primary outcome measure
Linear mixed-effects models were fitted to identify factors predicting change in the BGSI ratings from
baseline to follow-up for participants in the CR group. There were no significant group-by-centre
interactions in any of the models, indicating that the results did not differ across centres. Details of these
analyses are provided in Appendix 8.
Participants’ goal attainment ratings
A linear mixed-effects model was fitted to identify whether or not any factors predicted the difference in
participants’ goal attainment ratings at baseline and the 3-month follow-up. Centre was treated as a
random effect and the following factors were treated as fixed effects: sex, age (stratified), MMSE score
(stratified), diagnosis, medication use, education, comorbidity, SES and blinding efficiency. At the 3-month
follow-up, the model was not statistically significant [χ2(18) = 41.74, R2 = 0.19; p = 0.001]. Two factors
within the model had a statistically significant effect in predicting a change in BGSI attainment ratings:
blinding efficiency [b = 1.24, standard error (SE) = 0.30, t(216.87) = 4.12, 95% CI 0.54 to 1.76; p < 0.001]
and participant SES [χ2(5) = 16.66; p = 0.005]. Greater improvement was seen when blinding was ineffective.
For SES, there was a statistically significant difference in the change in BGSI goal attainment rating between
0
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Time point
Baseline
3 months
9 months
FIGURE 3 Goal attainment ratings by participants and carers in the CR and TAU groups at baseline and 3-month
and 9-month follow-ups. Data are mean scores and the error bars show the standard errors.
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professionals and non-manual skilled workers [b = –1.66, SE = 0.65, t(214.71)= –2.55, 95% CI –3.39 to
–0.56; p = 0.012], professionals and manual skilled workers [b = –2.11, SE = 0.65, t(216.57)= –3.28, 95% CI
–4.17 to –1.05; p= 0.001] and professionals and partly skilled workers [b= –1.93, SE= 0.75, t(216.88)= –2.58,
95% CI –3.83 to –0.67; p= 0.011]. These observed differences show that CR was more effective at improving
BGSI performance ratings at the 3-month follow-up for professionals than for non-manual skilled workers,
manual skilled workers or non-skilled workers.
A linear mixed-effects model was fitted to identify whether or not any factors predicted the difference
between the BGSI attainment ratings at baseline and the 9-month follow-up for participants in the CR
group. Centre was treated as a random effect and the following factors were treated as fixed effects:
blinding effectiveness, participant’s age (stratified), sex, education, social status, ethnicity, living situation
(alone or with others), diagnosis, MMSE score (stratified), medication use and comorbidity. The model was
statistically significant [χ2(28) = 68.61, R2 = 0.32; p < 0.001]. Factors within the model that were individually
statistically significant were participant’s age, MMSE score and blinding efficiency. Greater improvement
was seen in participants who were younger [b = –0.05, SE = 0.02, t(200.60) = –2.08, 95% CI –0.09 to
–0.00; p = 0.038] and had higher MMSE scores [b = 0.16, SE = 0.05, t(199.31) = 3.06, 95% CI 0.06 to
0.26; p = 0.002], and when the researcher was able to correctly identify the participant’s group allocation
[b = 1.35, SE = 0.32, t(199.86) = 4.21, 95% CI 0.71 to 1.99; p < 0.001].
Linear mixed-effects models were fitted to identify whether or not any carer factors predicted the difference
between the participants’ BGSI attainment ratings at baseline and the 3- and 9-month follow-ups for
participants in the CR group. Centre was treated as a random effect and the following factors were treated
as fixed effects: carer’s sex, carer’s age, carer’s education, hours spent helping the person with dementia per
day and the relationship between the carer and the participant. The models were not statistically significant
and no factors within the models were statistically significant.
Carers’ ratings of participant goal attainment
Linear mixed-effects models were fitted to identify whether or not any carer factors predicted the
difference between carers’ BGSI attainment ratings at baseline and at the 3- and 9-month follow-ups.
The models were not statistically significant and no factors within the models were statistically significant.
Linear mixed-effects models were fitted to identify whether or not any participant characteristics
predicted the difference between carers’ BGSI attainment ratings at baseline and the 3-month follow-up.
The overall model included centre as a random effect and the following factors as fixed effects: MMSE
score (stratified), diagnosis, medication use, education, comorbidity, SES. The model was not statistically
significant [χ2(17) = 27.24, R2 = 0.12; p = 0.055]. Within the model, SES was statistically significant
[χ2(5) = 14.54; p = 0.013]. There was a statistically significant difference in the change in carer BGSI
attainment rating between professionals and non-manual skilled workers [b = –1.83, SE = 0.68,
t(214.14) = –2.70, 95% CI –3.15 to –0.50; p = 0.007], professionals and manual skilled workers
[b = –1.63, SE = 0.67, t(214.99) = –2.46, 95% CI –2.94 to –0.33; p = 0.015]. These results mirror the
findings for participant goal attainment ratings at the 3-month follow-up.
Linear mixed-effects models were fitted to identify whether or not any participant characteristics predicted
the difference between the carers’ BGSI attainment ratings at baseline and the 9-month follow-up.
The overall model included centre as a random effect and the following factors as fixed effects: MMSE
score (stratified), diagnosis, medication use, education, comorbidity, SES. The model was not statistically
significant [χ2(17) = 31.18, R2 = 0.15; p = 0.019]. Within the model, MMSE (stratified) was a statistically
significant factor [χ2(1) = 7.91; p = 0.005]. This shows that there was a statistically significant difference
in carer attainment ratings for participants with MMSE scores of ≥ 24 points compared with participants
with MMSE scores of < 24 points [b = 0.96, SE = 0.34, t(202.98) = 2.81, 95% CI 0.29 to 1.63; p = 0.005].
The improvement in carer attainment ratings was greater when participants had higher MMSE scores.
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Participants’ ratings of satisfaction with goal attainment
A linear mixed-effects model was fitted to identify whether or not any participant characteristics predicted the
difference between the BGSI satisfaction ratings at baseline and the 3-month follow-up for participants in
the CR group. Centre was treated as a random effect and the following factors were treated as fixed effects:
sex, ethnicity, age (stratified), MMSE score (stratified), diagnosis, medication use, education, comorbidity
and SES. The model was statistically significant [χ2(28) = 49.89, R2 = 0.21; p = 0.007]. Factors within the model
that were individually statistically significant were participant social status [χ2(5) = 16.82; p= 0.005] and
blinding efficiency [chi-squared test (1) = 10.30; p= 0.001]. There was a statistically significant difference in
the change in BGSI satisfaction rating, showing that satisfaction ratings improved more in professionals than
in non-manual skilled workers [b = –1.73, SE = 0.65, t(217) = –2.67, 95% CI –3.01 to –0.46; p = 0.008],
manual skilled workers [b = –2.10, SE = 0.63, t(217) = –3.34, 95% CI –3.33 to –0.86; p = 0.001] and
partly skilled workers [b = –1.92, SE = 0.75, t(217) = –2.57, 95% CI –2.93 to –0.26; p = 0.011]. There
was greater improvement in the BGSI satisfaction ratings from baseline to the 3-month follow-up when
blinding was ineffective and the researcher was able to correctly identify that the participant belonged
to the CR group than when blinding was effective [b = 0.96, SE = 0.30, t(217) = 3.21, 95% CI 1.04 to
9.49; p = 0.002].
A linear mixed-effects model was fitted to predict the difference between the BGSI satisfaction ratings at
baseline and the 9-month follow-up for participants in the CR group. Centre was treated as a random
effect and the following factors were treated as fixed effects: blinding efficiency, participant’s age, sex,
education, social status, ethnicity, living situation (living alone or with others), diagnosis, MMSE score,
medication use and comorbidity. The model was statistically significant [χ2(27) = 54.26, R2 = 0.25; p = 0.001].
The only effects that were statistically significant were MMSE score [χ2(1) = 15.79; p < 0.001] and blinding
efficiency [χ2(1) = 14.35; p < 0.001]. Participants with higher MMSE scores at baseline showed greater
improvement in BGSI satisfaction ratings from baseline to the 9-month follow-up than participants with
lower MMSE scores [b = 0.20, SE= 0.05, t(199.45) = 3.97, 95% CI 0.22 to 0.27; p < 0.001]. There was
greater improvement in the BGSI satisfaction ratings from baseline to the 9-month follow-up when blinding
was ineffective and the researcher was able to correctly identify that the participant belonged to the CR group
than when blinding was effective [b = 1.23, SE= 0.33, t(200.33) = 3.79, 95% CI 0.58 to 1.88; p < 0.001].
Ratings of importance and readiness to change
We examined whether or not participants’ BGSI ratings of importance of the functional domain addressed
by each goal and ratings of readiness to change made at baseline were associated with the attainment
ratings at the 3-month follow-up. Participants’ baseline ratings of the importance of the functional domain
addressed by each goal did not predict improvement. Participants’ ratings of readiness to change at
baseline, however, were significantly associated with improvement in attainment ratings at the 3-month
follow-up [t(403) = 2.66, r = 0.13; p = 0.008].
Participants’ ratings of readiness to change remained significantly associated with improvement in their
BGSI attainment ratings at the 9-month follow-up [t(379) = 2.79, r = 0.14; p = 0.005].
Results for the secondary outcomes
The scores on secondary outcome measures at all time points and the ANCOVA results are summarised
in Tables 12 and 13. Following Bonferroni correction of the p-values for the secondary outcomes, there
were no significant between-group differences in any secondary outcome measures at the 3- or 9-month
follow-ups. The effect sizes were small to negligible, although in some cases these had wide CIs.
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TABLE 12 Scores for the secondary outcomes
Measure
Treatment group
CR TAU
Baseline 3 months 9 months Baseline 3 months 9 months
Participants with dementia
DEMQOL n= 237
92 (12.9); 39–112
n= 218
92.79 (11.95); 51–112
n= 204
92.36 (12.00); 54–112
n = 235
92.61 (11.75); 47–111
n = 227
93.198 (12.00); 51–111
n= 213
92.25 (12.82); 45–112
GSES n= 237
30.75 (4.81); 13–40
n= 215
30.98 (4.62); 18–40
n= 194
30.76 (4.91); 15–40
n = 232
31.13 (5.35); 11–40
n = 224
30.59 (5.61); 11–40
n= 207
30.62 (5.60); 10–40
HADS depression n= 238
3.87 (2.83); 0–12
n= 218
3.90 (2.86); 0–15
n= 194
4.19 (3.23); 0–17
n = 234
3.67 (2.75); 0–14
n = 226
3.74 (2.69); 0–12
n= 210
3.83 (2.82); 0–17
HADS anxiety n= 238
5.29 (3.67); 0–16
n= 216
5.13 (3.66); 0–17
n= 193
5.63 (3.83); 0–18
n = 234
4.98 (3.62); 0–16
n = 226
4.61 (3.41); 0–15
n= 210
4.88 (3.37); 0–20
RBMT immediate recall n= 237
2.58 (2.1); 0–9.5
n= 218
2.88 (2.16); 0–10.0
n= 200
2.34 (2.09); 0–10.0
n = 236
2.73 (2.12); 0–11.5
n = 226
2.79 (2.12); 0–11.0
n= 211
2.37 (1.96); 0–10.0
RBMT delayed recall n= 237
0.39 (1.94); –1 to 8
n= 217
0.94 (2.31); –1.0 to 8.5
n= 200
0.23 (1.97); –1.0 to 8.5
n = 236
0.37 (1.97); –1 to 9
n = 225
0.66 (2.16); –1.0 to 11.0
n= 210
0.36 (1.97); –1.0 to 9.5
TEA elevator counting n= 232
6.35 (1.27); 0–7
n= 210
6.31 (1.23); 0–7
n= 191
6.21 (1.41); 0–7
n = 231
6.42 (1.05); 1–7
n = 219
6.36 (1.22); 0–7
n= 206
6.24 (1.32); 1–7
TEA elevator counting
with distraction
n= 223
4.39 (2.68); 0–9
n= 198
4.62 (3.08); 0–10
n= 177
4.66 (3.11); 0–10
n = 225
4.72 (2.75); 0–9
n = 208
4.90 (3.15); 0–10
n= 193
4.52 (3.07); 0–10
D-KEFS verbal fluency n= 235
25.78 (11.61); 2–64
n= 217
26.29 (12.56); 0–58
n= 198
26.30 (13.32); 0–62
n = 235
26.77 (12.03); 3–58
n = 227
26.80 (12.38); 3–68
n= 211
25.9 (12.36); 1–67
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Measure
Treatment group
CR TAU
Baseline 3 months 9 months Baseline 3 months 9 months
Carers
RSS n= 236
18.85 (9.04); 2–46
n= 212
19.42 (9.62); 2–46
n= 200
21.23 (9.92); 2–51
n = 235
19.08 (9.83); 0–52
n = 221
20.42 (10.33); 1–54
n= 211
21.65 (10.74); 2–50
WHOQOL-BREF physical n= 237
15.3 (3.00); 5–20
n= 212
15.20 (2.93); 5–20
n= 199
14.95 (3.14); 6–20
n = 233
15.37 (2.9); 7–20
n = 220
15.07 (2.86); 6–20
n= 210
14.78 (2.97); 6–20
WHOQOL-BREF
psychological
n= 237
15.13 (2.19); 8–20
n= 212
14.98 (2.21); 7–20
n= 199
14.74 (2.41); 7–20
n = 233
15.15 (2.1); 8–20
n = 220
14.74 (2.20); 7–20
n= 210
14.53 (2.38); 7–20
WHOQOL-BREF social n= 235
15.19 (2.67); 5–20
n= 211
15.03 (2.47); 7–20
n= 197
15.04 (2.72); 8–20
n = 233
15.07 (2.66); 7–20
n = 219
14.80 (2.58); 7–20
n= 210
14.51 (2.83); 5–20
WHOQOL-BREF
environmental
n= 237
16.35 (2.3); 10–20
n= 212
16.33 (2.26); 9–20
n= 199
16.00 (2.40); 9–20
n = 233
16.52 (1.99); 10–20
n = 220
16.18 (2.04); 10–20
n= 210
16.04 (2.05); 11–20
EQ-5D-3L index n= 235
0.77 (0.25); –0.18 to 1
n= 209
0.75 (0.24); –0.18 to 1
n= 196
0.73 (0.27); –0.18 to 1
n = 233
0.79 (0.24); –0.07 to 1
n = 217
0.74 (0.25); –0.24 to 1
n= 211
0.75 (0.23); –0.07 to 1
EQ-5D-3L VAS n= 234
73.52 (20.95); 1–100
n= 208
74.13 (18.92); 0–100
n= 198
74.14 (19.16); 10–100
n = 233
75.44 (18.9); 0–100
n = 217
73.14 (18.95); 0–100
n= 211
72.42 (19.13); 0–100
Note
Data are mean (standard deviation); range.
Adapted with permission from Clare et al.72
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TABLE 13 Statistical analyses results at the 3- and 9-month follow-ups
Measure p-value Adjusted p-value
Mean difference
(95% CI) Cohen’s d (95% CI)
3-month follow-up
Participants with dementia
DEMQOL 0.738 1 0.24 (–1.27 to 1.75) 0.02 (–0.16 to 0.2)
GSES 0.126 1 0.58 (–0.16 to 1.32) 0.11 (–0.07 to 0.29)
HADS depression 0.861 1 0 (–0.42 to 0.41) 0.02 (–0.16 to 0.2)
HADS anxiety 0.478 1 0.17 (–0.3 to 0.65) 0.06 (–0.12 to 0.24)
RBMT immediate recall 0.189 1 0.19 (–0.1 to 0.48) 0.1 (–0.08 to 0.28)
RBMT delayed recall 0.096 1 0.24 (–0.04 to 0.52) 0.12 (–0.06 to 0.3)
TEA elevator counting 0.799 1 0.01 (–0.19 to 0.21) 0.02 (–0.16 to 0.2)
TEA elevator counting with distraction 0.784 1 0.01 (–0.45 to 0.47) 0.03 (–0.15 to 0.21)
D-KEFS verbal fluency 0.794 1 0.15 (–1.12 to 1.41) 0.02 (–0.16 to 0.2)
Carers
RSS 0.382 1 –0.5 (–1.61 to 0.62) 0.05 (–0.13 to 0.23)
WHOQOL-BREF physical 0.431 1 0.12 (–0.18 to 0.42) 0.04 (–0.14 to 0.22)
WHOQOL-BREF psychological 0.214 1 0.18 (–0.1 to 0.47) 0.08 (–0.1 to 0.26)
WHOQOL-BREF social 0.572 1 0.1 (–0.25 to 0.45) 0.05 (–0.13 to 0.23)
WHOQOL-BREF environmental 0.05 0.947 0.26 (0 to 0.51) 0.13 (–0.06 to 0.31)
EQ-5D-3L index 0.295 1 0.02 (–0.01 to 0.05) 0.07 (–0.11 to 0.25)
EQ-5D VAS 0.286 1 1.58 (–1.31 to 4.47) 0.09 (–0.09 to 0.27)
9-month follow-up
Participants with dementia
DEMQOL 0.215 1 1.08 (–0.62 to 2.78) 0.09 (–0.09 to 0.27)
GSES 0.38 1 0.37 (–0.45 to 1.18) 0.07 (–0.11 to 0.25)
HADS depression 0.614 1 0.12 (–0.35 to 0.6) 0.05 (–0.13 to 0.23)
HADS anxiety 0.334 1 0.26 (–0.26 to 0.77) 0.08 (–0.1 to 0.26)
RBMT immediate recall 0.496 1 0.1 (–0.19 to 0.4) 0.06 (–0.12 to 0.24)
RBMT delayed recall 0.466 1 –0.1 (–0.37 to 0.17) 0.06 (–0.12 to 0.24)
TEA elevator counting 0.718 1 –0.01 (–0.27 to 0.25) 0.04 (–0.14 to 0.22)
TEA elevator counting with distraction 0.334 1 0.23 (–0.23 to 0.69) 0.09 (–0.09 to 0.27)
D-KEFS verbal fluency 0.342 1 0.71 (–0.75 to 2.16) 0.06 (–0.12 to 0.24)
Carers
RSS 0.808 1 0.08 (–1.09 to 1.25) 0.02 (–0.16 to 0.2)
WHOQOL-BREF physical 0.399 1 0.14 (–0.19 to 0.47) 0.05 (–0.13 to 0.23)
WHOQOL-BREF psychological 0.346 1 0.15 (–0.16 to 0.45) 0.06 (–0.12 to 0.24)
WHOQOL-BREF social 0.049 0.93 0.41 (0 to 0.81) 0.15 (–0.03 to 0.33)
WHOQOL-BREF environmental 0.371 1 0.13 (–0.15 to 0.4) 0.06 (–0.12 to 0.24)
EQ-5D-3L index 0.547 1 –0.01 (–0.04 to 0.02) 0.04 (–0.14 to 0.22)
EQ-5D-3L VAS 0.071 1 2.6 (–0.22 to 5.42) 0.14 (–0.04 to 0.32)
Adapted with permission from Clare et al.72
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Exploratory analyses for the secondary outcomes
As there were no overall effects on secondary outcomes, we examined whether or not benefits were
seen for particular subgroups on key outcome measures. The subgroups reflected centre, age (< 75 years;
≥ 75 years), sex, SES, diagnosis, and MMSE score (< 24 points; ≥ 24 points). Details of these analyses are
provided in Appendix 9.
For the person with dementia, the measures examined were DEMQOL, HADS anxiety and depression
scores and GSES at the 3- and 9-month follow-ups. No statistically significant models or individual factors
were observed for DEMQOL or the HADS at either time point. For the GSES, the overall models were
also not significant, but at 3 months sex was significant (p = 0.044), and at 9 months diagnosis was
significant (p = 0.021).
For the carer, the measures examined were the RSS and the WHOQOL-BREF. No statistically significant models
or individual factors were observed for the RSS. For the WHOQOL-BREF, there were no statistically significant
models. The only significant individual factor was in the WHOQOL-BREF physical scale, in which centre was
significant at the 3-month follow-up [χ2(1) = 4.48; p = 0.034]. The model containing this factor was not itself
significant, [χ2(12) = 8.12, R2 = 0.07; p = 0.775] and the centre factor was not statistically significant at the
9-month follow-up.
Sensitivity analyses
As all participants received the allocated condition, it was not necessary to conduct the planned analysis
based on treatment received irrespective of group allocation.
The results from the analysis of complete-case data were very similar to those of the multiple imputation
analysis and did not alter the overall picture in any way. A summary of the statistical analyses for the primary
and secondary outcome measures using the full data set with no imputations is shown in Appendix 10.
An examination of the change from baseline at the 3- and 9-month follow-ups in the CR group alone
using an analysis of variance demonstrated the same pattern as the main analysis, with significant changes
in participant and carer BGSI attainment ratings and participant BGSI satisfaction ratings, all with large
effect sizes, and no significant changes in other outcomes. Details are shown in Appendix 11.
Effectiveness of blinding
At the 3- and 9-month follow-ups, researchers recorded their estimations of group allocation for each
participant. In the majority of cases, researchers were able to correctly guess the participant’s allocation
(see Appendix 12).
At the 3-month follow-up, researchers were very certain about the accuracy of their estimations in 16.6% of
cases, quite certain in 31.7% of cases, uncertain in 33.3% of cases and very uncertain in 18.2% of cases.
Participants explicitly disclosed their group allocation to the researchers in 14.8% of cases, whereas in 8.3%
of cases, researchers noticed some indirect clues, such as the presence of memory aids and adaptions. In
48.4% of cases, researchers acknowledged that their guesses were influenced by the presence or absence of
change in the participant’s goal performance rating. Researchers were more often very certain about their
estimations of participants in the CR group (20.6% of CR participants) than their estimations of participants
in the TAU group (12.8% of TAU participants), and they were more likely to be directly unblinded by
participants in the CR group (20.2% of CR participants) than by those in the TAU group (9.7% of TAU
participants). The picture at the 9-month follow-up was similar.
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Binomial tests to assess the difference in proportions between group allocation identified by the researcher
and group allocation not identified by the researcher showed a statistically significant difference for all sites
and follow-up combinations (p < 0.001). As noted above under the exploratory analyses for the primary
outcome measure, the researcher’s ability to correctly surmise the participant’s group allocation was
associated with participant attainment and satisfaction scores at the 3- and 9-month follow-ups.
Associations between adherence and outcomes
For the CR group, we examined the association of the number of sessions completed with all primary and
secondary outcomes at 3 and 9 months. These analyses are summarised in Appendix 13.
At the 3-month follow-up, adherence was significantly associated with BGSI participant attainment ratings
[b = 0.17, SE = 0.09, t(215) = 2.01, 95% CI 0 to 0.34; p = 0.046] and carer attainment ratings [b = 0.21,
SE = 0.08, t(213) = 2.46, 95% CI 0.04 to 0.37; p = 0.015]. At the 9-month follow-up, adherence was
significantly associated with BGSI participant attainment ratings [b = 0.24, SE = 0.10, t(202) = 2.36,
95% CI 0.04 to 0.44; p = 0.019] and carer attainment ratings [b = 0.28, SE = 0.10, t(201) = 2.68, 95% CI
0.07 to 0.48; p = 0.008], with participant BGSI satisfaction ratings [b = 0.25, SE = 0.11, t(200) = 2.33,
95% CI 0.04 to 0.47; p = 0.021] and with carer EQ-5D-3L VAS scores [b = –1.55, SE = 0.78, t(193) = –1.98,
95% CI –3.09 to –0.01; p = 0.049].
These adherence analyses indicate that attending more sessions was associated with more positive ratings
of goal attainment. For each therapy session attended, the participant’s BGSI attainment rating increased
on average by 0.24 at the 9-month follow-up.
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Chapter 4 Process evaluation
We undertook a range of process evaluation analyses to gain a better understanding of how the interventionwas delivered, the influences on treatment outcome and the mechanisms of action through which the
intervention operated. We also undertook work to assess the feasibility of implementation in NHS services.
As outlined in Chapter 2, we explored the following areas:
l goal-setting and goal attainment
l intervention fidelity
l factors associated with positive outcomes and therapist perspectives on delivering the intervention
l participant and carer experience of the intervention
l feasibility of implementation.
Goal-setting and goal attainment
The use of individual goals was central to the intervention and a range of process evaluation analyses were
undertaken to explore aspects of goal-setting and the goals chosen.
Goal-setting
All participants were invited to identify up to three therapy goals. Researchers were encouraged to
ensure that at least two goals were identified, to ensure that the participant understood the aims of the
therapy and was motivated to participate. In total, 1358 therapy goals were identified by 474 randomised
participants. The majority of participants (411; 86.7%) identified three therapy goals, 62 participants
(13.1%) identified two therapy goals and one participant (0.2%) identified one therapy goal. Further
details are provided in Table 14.
Goal selection
The 1358 goals identified by participants were listed and the content and focus were analysed to identify
the areas that were of concern to participants. This built on a preliminary analysis of 591 goals set by the
first 209 participants enrolled into the trial by December 2014.105 In the current analysis, the first 300 goals
were reviewed in detail and grouped thematically to form the basis of a detailed coding system. This
system was then applied to the remaining goals.
TABLE 14 Number of goals identified during the baseline assessment
Number of goals set by participants Whole sample (N= 474)
Treatment group
CR (N= 238) TAU (N= 236)
One goal identified, n (%) 1 (0.2) 0 1 (0.4)
Two goals identified, n (%) 62 (13.1) 35 (14.7) 27 (11.4)
Three goals identified, n (%) 411 (86.7) 203 (85.3) 208 (88.1)
Total number of goals in the group 1358 679 679
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The goals were grouped into the following categories:
l Engaging in activities and personal projects (21%). This included planning and engaging in enjoyable
activities, taking up new activities, restarting previously enjoyed activities, doing activities regularly or
more often, doing activities independently, practising skills, keeping occupied, undertaking personal
projects and doing things for others.
l Using appliances, devices and the internet (17%). This category focused on the use of household
appliances, such as washing machines or microwave ovens, devices such as mobile phones, smartphones,
tablets, TVs, computers, laptops, cameras, CD or DVD players, satnavs and personal safety aids, such as
wristbands or pull cords. Participants wanted to learn to use, or be able to use, appliances and devices, to
feel confident in using them or to use them independently. This was for a range of purposes, including
completing household tasks, communication, entertainment and occupation, obtaining information and
staying safe.
l Managing everyday activities, tasks and situations (16%). This included managing money, shopping,
cooking and baking, correspondence and telephone calls, carrying out household tasks, going out,
wayfinding, using transportation, telling time and staying safe. Participants wanted to feel confident in
doing their everyday activities or to be able to do them independently or safely.
l Knowing what is happening (9%). Participants wanted to know the day and the date, the schedule for
the day or the week ahead and the timing of any appointments. They were keen to know without
asking others or having to check repeatedly, and sometimes mentioned particular strategies that they
wished to use, such as a whiteboard, calendar or diary.
l Retaining or keeping track of information and events (8%). Participants wanted to find ways of
remembering important information, information that they were recently given, information that they
had told others, events and activities and messages to pass on. They wanted to be able to retain key
elements of the plot of a novel or TV programme or to keep the score when watching or playing sports
or games.
l Locating belongings (7%). This category was about finding personal items and items around the house,
knowing where things had been left and putting things back in the right place.
l Recognising, identifying and naming (6%). Participants wanted to remember the names of family
members, friends, people they met and prominent people involved in current affairs, as well as
information about these people. They wanted to be able to recognise and identify people and objects.
l Engaging in conversation (5%). This category was about being able to engage in and participate in
conversation, follow the thread of a conversation and retain key points, find words, keep the
conversation going and speak without repetition. Participants wanted to be able to contribute
confidently, in a range of settings, for example at family mealtimes or when walking with a group.
l Organising, improving and finishing (4%). Some participants emphasised a wish to organise aspects
of their lives or their environment, to complete tasks they had set themselves and to improve their
performance in areas like handwriting, spelling or vocabulary.
l Caring for self (3%). Participants wanted to be able to do some basic life tasks regularly or independently.
These included shaving, bathing, changing dirty clothes and eating and drinking regularly.
l Keeping in contact and staying engaged with family and friends (2%). In this category, participants
specifically mentioned wanting to keep in contact with family and friends through various means,
to take an interest in and remember what is going on in their lives and to attend family gatherings.
l Managing emotions (2%). Participants wanted to manage anxiety or frustration, be more patient and
worry less, or to cope better with changes in routine.
Goal attainment in the cognitive rehabilitation group
Participants randomised to the CR group had previously identified 679 goals at baseline. Of these, 591 goals
were introduced in therapy sessions by the therapist, initial in-session goal attainment ratings were made
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for 590 goals and follow-up ratings were made for 563 goals. In-session goal attainment ratings showed
a similar pattern to the ratings made at the baseline and follow-up assessments (details are shown in
Tables 15 and 16). Correlations between the goal attainment ratings made by the participant, the carer
and the therapist at each stage were large, ranging from 0.665 to 0.934, and were significant at a p-value
of < 0.0001 (two-tailed), indicating a high degree of consistency among the three raters. All ratings
improved, on average, by over 2 points, reflecting a clinically significant change. The change scores are
shown in Table 16; correlations among the change scores for participants, carers and therapists were large,
ranging from 0.679 to 0.861, and were significant at a p-value of < 0.0001 (two-tailed), again reflecting a
high degree of consistency.
On introducing goals, therapists also independently established indicators to classify the extent of goal
attainment in percentage terms. On completion of the therapy sessions, they rated the extent of
attainment for each goal. In total, 54.8% of goals were rated as being at least 75% attained and 79.8%
were rated as being at least 50% attained. Only 5% of goals showed no progress towards attainment.
Figure 4 provides a summary of the therapists’ goal attainment ratings made after session 10 and Table 17
breaks this down by the order of introduction of the goals.
We compared the therapists’ goal attainment scaling with the in-session goal attainment ratings made by
participants, carers and therapists in or following both sessions 10 and 14 to determine whether or not
these two procedures yielded consistent information. For the session 10 goal attainment scaling, the
correlations were 0.557 with participant ratings, 0.786 with carer ratings and 0.862 with therapist ratings,
and for the session 14 goal attainment scaling, the correlations were 0.652 with participant ratings,
0.881 with carer ratings and 0.932 with therapist ratings. All correlations were significant at a p-value of
< 0.0001, two-tailed. This indicates generally good consistency.
TABLE 15 Summary of in-session ratings of goal attainment
In-session attainment ratings On introduction of goal
Session
10 14
Participant rating of attainment (N = 232) 4.09 (1.79), 590 6.75 (1.68), 554 6.96 (1.91), 494
Carer rating of attainment (N = 232) 3.21 (1.58), 584 6.24 (1.75), 550 6.29 (2.14), 484
Therapist rating of attainment (N = 232) 3.03 (1.50), 590 6.36 (1.69), 557 6.55 (2.06), 496
Notes
Data are mean (standard deviation), number of goals rated.
Session 10 participant ratings, n= 212; carer ratings, n= 211. Session 14 participant ratings, n= 196; carer ratings, n= 192.
TABLE 16 Change from initial in-session goal attainment ratings at sessions 10 and 14
Change from initial in-session attainment ratings
Session
10 Session 14
Participant attainment rating 2.66 (1.95) 2.87 (2.08)
Carer attainment rating 3.03 (1.74) 3.07 (2.14)
Therapist attainment rating 3.33 (1.66) 3.52 (2.02)
Note
Data are mean (standard deviation).
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Intervention fidelity
We evaluated fidelity of form81 in relation to the provision of core elements of the intervention, completion
of the therapy sessions (in terms of number and length of sessions) and the number of therapy goals
identified at the baseline assessment that were introduced and addressed in the therapy sessions.
As presented in Chapter 3, Table 6, the majority of participants (70%) received all 14 sessions and only
26 participants (11%) completed < 10 sessions. Therapy sessions lasted between 43 and 120 minutes,
with an average of 75.5 minutes [standard deviation (SD) = 12.4 minutes] per session.
Out of the 679 goals identified at the baseline assessment, as noted above, the therapists discussed and
confirmed with the participants 591 of the therapy goals. Initial in-session ratings were completed for 590 goals
and 563 goals were subsequently re-rated at a later stage of therapy (details are shown in Tables 18–20). Some
goals were not introduced because the participants withdrew from the study, because the goals were no longer
seen as being suitable or relevant by the participant and no replacement was identified or because there was
not enough time to work on them.
TABLE 17 Therapists’ goal attainment scaling following session 10
Proportion achieved All goals
Goal
1 2 3
0% achieved 27 (5.0) 7 (2.9) 10 (4.2) 10 (4.2)
25% achieved 83 (15.3) 27 (11.3) 33 (13.9) 23 (9.7)
50% achieved 136 (25.0) 51 (21.4) 53 (22.3) 32 (13.4)
75% achieved 210 (38.6) 72 (30.3) 86 (36.1) 52 (21.8)
100% achieved 88 (16.2) 49 (20.6) 25 (10.5) 14 (5.9)
Note
Data are n (%).
5%
15%
25%
39%
16%
0%
Pr
o
p
o
rt
io
n
 o
f 
C
R
 p
ar
ti
ci
p
an
ts
10%
20%
30%
40%
50%
0%
achieved
25%
achieved
Attainment of therapy goals
50%
achieved
75%
achieved
100%
achieved
FIGURE 4 Attainment of therapy goals by session 10. Proportion of therapy goals rated as being fully achieved
(100%), partially achieved (25%, 50%, or 75%) and not achieved (0%) after session 10.
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TABLE 19 Stage of therapy at which work on each of the 590 goals commenced
Session number
Goal
1 2 3
1 207 (89.2) 33 (15.2) 29 (20.6)
2 20 (8.6) 6 (2.8) 4 (2.8)
3 4 (1.7) 15 (6.9) 4 (2.8)
4 1 (0.4) 100 (46.1) 12 (8.5)
5 43 (19.8) 9 (6.4)
6 10 (4.6) 42 (29.8)
7 8 (3.7) 28 (19.9)
8 1 (0.5) 10 (7.1)
10 1 (0.5) 2 (1.4)
11 1 (0.7)
Total introduced 232 (100) 217 (100) 141 (100)
Note
Data are n (%).
TABLE 20 Extent to which goals were addressed exactly as set at baseline
Approach taken All goals
Goal
1 2 3
Goal was addressed exactly as set at baseline or very slightly modified 525 (88.8) 213 (89.5) 193 (81.1) 119 (50.0)
Goal set at baseline was used, but significantly modified 21 (3.6) 8 (3.4) 7 (2.9) 6 (2.5)
New goal was developed with the therapist 36 (6.1) 8 (3.4) 13 (5.5) 15 (6.3)
Other 9 (1.5) 3 (1.3) 4 (1.7) 2 (0.8)
Note
Data are n (%).
TABLE 18 Number of goals identified at baseline that were introduced and addressed during therapy
Therapy goals at baseline All goals
Goal
1 2 3
Goal confirmed by therapist 591 (100) 232 (100) 217 (100) 142 (100)
Initial goal rating completed 590 (99.8) 232 (100) 217 (100) 141 (99.3)
Goal re-rated during therapy 563 (95.3) 214 (0.9) 213 (98.2) 136 (95.8)
Note
Data are n (%).
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In order to evaluate fidelity of function,81 we assessed the level of flexibility applied by the therapists in
relation to the timing of introducing additional therapy goals (as goals identified at baseline were introduced
one at a time during the course of therapy) and the extent to which goal statements formulated at baseline
were modified, for example to make them more specific, realistic or achievable (see Tables 18–20). In the
majority of cases, the first goal was introduced in the first session, with other goals being introduced
gradually in the subsequent sessions. Only a small proportion of participants had more than one goal
introduced at the first session.
As summarised in Tables 18–20, the majority (89%) of the goals introduced in the therapy sessions were
used exactly as formulated during the baseline assessment or were very slightly modified. This attests to the
skill the researchers developed in supporting participants to identify goals that were both meaningful and
realistic – a process that in routine practice would be undertaken by the therapist. However, therapists
showed flexibility in cases in which goal modification was required and a small proportion of goals were
significantly modified (4%) or replaced (6%). In 36 cases in which no third goal was identified at baseline or
when a goal set at baseline was no longer felt to be relevant, therapists were able to agree and introduce a
new goal. In two instances, two goals were amalgamated into one, in six instances participants decided
during the initial discussion that they did not want to work on a particular goal and no other goal was
introduced and in one case it was not possible to address the goal as a result of a change in circumstances.
As fidelity of function was promoted through regular supervision with the aid of the detailed therapy logs
produced by therapists, we also reviewed attendance at supervision sessions, rates of completion of therapy
logs and therapists’ confidence in their ability to address participants’ goals. Therapists had 16 hours of
face-to-face group supervision per year, with an average attendance rate of 90%. In addition, therapists
had, on average, 7 hours of individual supervision each year, conducted via telephone or Skype™ (Microsoft
Corporation, Redmond, WA, USA). Therapy logs were compiled for every participant in the CR group.
Therapists’ evaluation of their confidence in addressing participants’ therapy goals indicated that overall
they felt fairly confident, with a mean rating of 7 (SD 2.31) on a scale of 1 to 10, in which 1 is not at all
confident and 10 is completely confident.
Therapist views on factors associated with positive outcomes
We explored the therapists’ views about what factors influence treatment outcome and which groups of
participants were most and least likely to benefit from the intervention and why. Two sets of data were
analysed: data from a focus group conducted with the therapists and a selection of therapy logs. The
focus group was analysed using thematic analysis,106 with NVivo 11 (QSR International, Warrington, UK).
The focus group analysis and stage 1 of the therapy log analysis informed the development of a list of
significant features of the therapy experience. Stages 2 and 3 of the therapy log analysis involved an
exploration of the factors influencing good and poor therapy outcomes, and the potential causal
relationships contributing to outcomes, in more depth.
Focus group conducted with the therapists
Methods
A focus group was conducted with the trial therapists to examine how the intervention was delivered, the
nature of participant and carer engagement and the mechanisms of action through which the intervention
operated. The focus group was conducted in June 2014 with six therapists from the original research sites
and it lasted for 1 hour. The focus group was digitally recorded and transcribed verbatim.
The focus group data were analysed by a qualitative researcher who had not been otherwise involved in the
trial and who was independent of the trial team. The analysis was conducted by first developing a codebook
based on two initial readings of the focus group transcript, using a combined deductive and inductive approach.
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In the deductive approach, aspects of the intervention that were already thought to be critical to success at the
intervention development stage – participant motivation, participant acknowledgement of difficulties, cognitive
impairment, health status and carer involvement – were included as initial codes in the analysis. Data were
also coded inductively, whereby codes were identified in a ‘bottom-up’ way from the data rather than being
predetermined. Fourteen codes were identified, including the four deductive codes. One deductive code
(‘overall health status’) was dropped, as no data were associated with this code. Data were then coded in
NVivo 11 using the resulting 14 deductive and inductive codes, which were subsequently grouped into five
descriptive themes: trajectory of the intervention; characteristics and role of the participant; characteristics and
role of the carer; role of the therapist; and contextual factors affecting the intervention. The five themes and
14 codes were summarised in a report and translated into two graphics to further explore the relationships
between them. Data for each code were reread at each stage of the analysis, to ensure that the groupings and
interpretation of the data retained validity.
The two graphics and the summary of the themes and codes were then reviewed and discussed in a
meeting between the researcher and the trial manager to reflect on the findings, including consideration
of any surprising results, how the findings related to the intervention design and intervention manual and
any hypotheses about the implications of the findings. This formed the basis for reporting the findings.
Findings
There were several different aspects to the work that therapists conducted, including engaging carers,
tailoring the intervention in accordance with participant capacity and developing relationships and
providing support to both carers and participants. The participation of carers and participants’ cognitive
and functional ability and readiness to acknowledge difficulties emerged as important factors affecting the
success of the intervention. The development of relationships and working with goals flexibly over time
was a feature of how the intervention was implemented and it was clear that achievements could create a
positive cycle over time, although not all ‘small’ achievements were necessarily formally noted. These key
findings are presented below.
Therapists commented on several ways in which carers were important for the success of the intervention
and also described how they worked with carers to facilitate their involvement. The role of carers in the
intervention was regarded as an important one by therapists, because their facilitation of the intervention
(such as prompting the participant between sessions) was thought to have an impact on participant
motivation and engagement. Therapists thought that carers were more likely to engage with goals if the
goal affected the carer as well as the participant, and that carers’ engagement was negatively affected by
carer beliefs in a participant’s lack of functional ability, although this could change if participants made
progress. Therapists would adapt visit times to ensure that they met with carers who could be limited by
other commitments (such as work) and also made efforts to identify and meet the carers who were most
involved in the participant’s life, who were not always the same person as the nominated carer for the
intervention. Therapists also provided support for carers, which included education, socioemotional support
(which, one therapist commented, could be the primary benefit for the carer) and referral to other services.
Therapists commented on different participant profiles. Some had busy and active lives. Of concern,
however, were those participants who were functioning less well. Therapists felt that goal-centred therapy
was more difficult for this group, because they could be less likely to engage with goals in the first place
as a result of limited acknowledgement of difficulties, they could have difficulty setting relevant goals or
remembering them and they could find it hard to complete goal ratings. A lack of awareness of particular
difficulties resulted in lower motivation to engage in the intervention. Therapists also commented that it
was difficult for some participants to absorb all of the information that they wanted to deliver in the time
allocated for the session and that it was important to be able to present concepts in an accessible manner.
Therapists responded to differences in participant ability levels by tailoring the timing of material and
highlighting the most relevant sections in the session handouts provided.
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The therapists described various ways in which they tried to engage participants and carers in the intervention
and to help them to progress to achieving goals. In some cases, they explained the evidence-based nature
of the intervention in order to engage carers. They thought that participants who had a relatively recent
diagnosis, and their carers, were easier to engage because they were still adapting to the diagnosis and were
more open to change. The relationships created and the support provided by therapists seemed to be an
element that supported their work with participants and carers and promoted effective working towards
goals. Therapists worked with goals flexibly, as sometimes the goals set at baseline were not optimal and
therapists needed to get to know carers and participants in order to adapt and operationalise them or, if
necessary, identify a more relevant goal. Goals could also change in response to an event in a participant’s
life. Therapists reflected on the way in which goals could sometimes appear to reflect small issues, but
these could make a significant difference to the participant’s life. Achieving goals could be motivating for
participants and carers, although sometimes this could make them too ambitious, and achieving goals could
also have beneficial effects in other areas of their lives, for example through promoting social engagement.
Therapists described elements of the intervention they were delivering that were, or were perceived to be,
additional to the intervention protocol. These included social support, relationship-building, managing
relationship conflict between carers and participants, contacting social services to enable carers to have a
break and extending the length of their visits. For example, a few therapists mentioned evening visits or
additional hours, or made referrals to social services for specific needs.
In talking about the participants, therapists appeared to focus on several dichotomies. They compared
participants with lower and higher cognitive and functional ability, and felt that the approach was more
relevant for, or easier to apply with, those who were functioning better. They made a distinction between
those participants who had received a diagnosis relatively recently and those who had had a diagnosis for
longer, and felt that those currently adapting to a recent dementia diagnosis were more likely to engage
well with the intervention. These two categories, higher levels of functioning and recency of diagnosis,
naturally tended to overlap. They also differentiated between those needing longer and shorter
maintenance visits, whereby participants who were doing well needed shorter visits.
A limitation of these findings is that they are based on data from a single conducted focus group with six
therapists, and some points were made by only one or two individuals.
To summarise the findings, a number of features were perceived by the therapists as influencing the
outcomes of therapy:
1. Participants’ level of functioning. Participants who were functioning better were more likely to engage
well in setting goals and working on goals, and were more motivated to make changes.
2. Proximity of diagnosis. Participants who had been diagnosed more recently, and their carers, tended to
be more motivated to engage in the intervention.
3. Individual tailoring. Therapists tailored the intervention to individual goals and needs, and greater
individual tailoring was thought to be related to better outcomes.
4. Carer engagement. Low levels of carer engagement were thought to be linked to outcomes, but could
be mitigated by the therapists working to engage carers more fully.
5. Therapeutic relationship. The relationships that the therapists developed with participants and carers
were very important influences on outcome, and these relationships changed over time as
therapy progressed.
6. Positive cycles. The achievement of goals led to greater carer engagement and other benefits.
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Analysis of the therapy logs
Following the analysis of the focus groups, a set of therapy logs was analysed. The findings from the focus
group analysis informed the analysis of the therapy log data, as described below.
Methods
Two subsets of CR group participants were identified, representing the 25 participants with the best goal
attainment outcomes and the 25 participants with the poorest outcomes. The therapy outcome was
operationalised for this analysis as a change in the BGSI participant goal attainment ratings between baseline
and the 3-month follow-up. Scrutiny of the demographic and clinical characteristics of the two groups
showed no evident differences. Tables 21–25 summarise the demographic and clinical characteristics and
mean BGSI ratings for the two groups.
Therapy logs were maintained by the therapists in Microsoft Word (Microsoft Corporation, Redmond, WA,
USA) document format, and for the analysis, these documents were used to create two parallel summary
Excel spreadsheets, one for the ‘best outcome’ group and one for the ‘poor outcome’ group. Each file
contained 15 tabs; the first tab contained information about the participant’s current functional ability and
therapy goals, and each of the remaining 14 tabs referred to one therapy session. Within each tab, each
row contained data for one participant and each column contained comments about one topic relating to
treatment delivery (e.g. goal progress, use of restorative and compensatory strategies, anxiety management
strategies applied), with 6–7 columns in each tab. The trajectories of participants’ progress through the
intervention were analysed to identify factors that could help to explain good or poor outcomes.
TABLE 21 Demographic characteristics of the participants with dementia included in the therapy logs analysis
Measure
Participants with a
Poor outcome (N= 25) Good outcome (N= 25)
Age (years), mean (SD); range 79 (5.5); 66–90 77.36 (6.8); 62–91
Sex (male), n (%) 11 (44.0) 16 (64.0)
Ethnicity, n (%)
White 23 (92.0) 24 (96.0)
Mixed/multiple ethnic group 1 (4.0) 0
Black/African/Caribbean/black British 1 (4.0) 0
Other ethnic group 0 1 (4.0)
First language (English), n (%) 25 (100) 23 (92.0)
Marital status (married), n (%) 19 (76.0) 18 (72.0)
Years of education, mean (SD); range 12.1 (3.1); 8–20 12.3 (3.3); 8–21.5
Occupational status, n (%)
I: professional 1 (4.0) 4 (16.0)
II: managerial/technical 7 (28.0) 13 (52.0)
III N: skilled, non-manual 8 (32.0) 3 (12.0)
III M: skilled, manual 5 (20.0) 1 (4.0)
IV: partly skilled 4 (16.0) 1 (4.0)
V: unskilled 0 3 (12.0)
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TABLE 22 Demographic characteristics of the carers of participants included in the therapy logs analysis
Measure
Participants with a
Poor outcome (N= 25) Good outcome (N= 25)
Relationship to participant with dementia, n (%)
Spouse/partner 18 (72.0) 19 (76.0)
Adult child (including in-law) 5 (20.0) 6 (24.0)
Other 2 (8.0) 0
Age, mean (SD); range 70.1 (10.5); 50–89 68.4 (13.9); 29–82
Sex (male), n (%) 10 (40.0) 6 (24.0)
Ethnicity, n (%)
White 25 (100.0) 23 (92.0)
Mixed/multiple ethnic group 0 1 (4.0)
Other ethnic group 0 1 (4.0)
First language (English), n (%) 24 (96.0) 25 (100.0)
Marital status (married), n (%) 18 (72.0) 24 (96.0)
Years of education, mean (SD); range 12.0 (3.1); 5–20 13.8 (3.6); 8–22
Occupational status, n (%)
I: professional 3 (12.0) (24.0)
II: managerial/technical 9 (36.0) (24.0)
III N: skilled, non-manual 7 (28.0) 10 (40.0)
III M: skilled, manual 3 (12.0) 0
IV: partly skilled 2 (8.0) 1 (4.0)
V: unskilled 1 (4.0) 2 (8.0)
TABLE 23 Clinical characteristics of the participants with dementia included in the therapy logs analysis at baseline
Measure
Participants with a
Poor outcome (N= 25) Good outcome (N= 25)
Diagnosis, n (%)
Alzheimer’s disease 16 (64) 16 (64)
Vascular dementia 4 (16) 2 (8)
Mixed Alzheimer’s disease and vascular dementia 5 (20) 7 (28)
MMSE, mean (SD); range 23.08 (2.27); 18–26 24.92 (3.0); 20–29
Charlson Comorbidity Index weighted score, mean (SD); range 2.7 (2.1); 1–10 2.8 (2.2); 1–11
Subjective rating of health, n (%)
Excellent 1 (4.0) 0
Very good 8 (32.0) 5 (20.0)
Good 7 (28.0) 7 (28.0)
Fair 8 (32.0) 11 (44.0)
Poor 1 (4.0) 2 (8.0)
DEMQOL, mean (SD); range 90.5 (18.0); 39–109 92.28 (10.8); 68–112
PROCESS EVALUATION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
56
TABLE 23 Clinical characteristics of the participants with dementia included in the therapy logs analysis at
baseline (continued )
Measure
Participants with a
Poor outcome (N= 25) Good outcome (N= 25)
GSES, mean (SD); range 29.7 (4.5); 14–36; N= 24 30.20 (4.1); 18–36; N = 25
HADS, mean (SD); range
Depression 4.2 (2.9); 1–10 3.75 (2.3); 0–8
Anxiety 5.6 (3.7); 0–15 5.76 (3.5); 0–14
RBMT, mean (SD); range
Immediate recall 2.3 (2.0); 0–9.5 3.08 (2.1); 0–6.5
Delayed recall –0.4 (1.0); –1 to 2.5 1.16 (2.1); –1 to 5
TEA, mean (SD); range
Elevator counting 6.2 (1.1); 3–7; N = 22 6.36 (0.9); 4–7; N = 25
Elevator counting with distraction 4.8 (2.8); 1–9; N = 21 5.26 (2.9); 0–9; N = 23
D-KEFS verbal fluency, mean (SD); range 27.6 (11.6); 2–51; N= 24 22.24 (8.5); 7–43; N= 25
TABLE 24 Clinical characteristics of the carers of participants included in the therapy logs analysis at baseline
Measure
Participants with a
Poor outcome (N= 25) Good outcome (N= 25)
Subjective rating of health, n (%)
Excellent 0 1 (4.0)
Very good 3 (12.0) 8 (32.0)
Good 12 (48.0) 10 (40.0)
Fair 8 (32.0) 5 (20.0)
Poor 2 (8.0) 1 (4.0)
RSS, mean (SD); range 19.69 (8.0); 6–44; N= 24 19.06 (7.2); 6–35
WHOQOL-BREF domains, mean (SD); range
Physical 14.58 (3.1); 9–20 14.56 (3.3); 6–19
Psychological 15.13 (2.1); 11–20 15. 20 (2.0); 11–18
Social 14.42 (2.4); 11–20 15.32 (2.2); 11–20
Environmental 15.75 (2.2); 12–20 16.24 (2.5); 10–20
EQ-5D-3L, mean (SD); range
Index 0.69 (0.29); –0.02 to 1;
N = 24
0.79 (0.1); 0.5–1
VAS 72.48 (22.3); 8–99; N = 23 73.52 (19.5); 30–100
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The analysis was conducted through several stages, using an adapted framework analysis method,107 by a
researcher who was not otherwise involved in the trial and was independent of the trial team:
l In stage 1, the therapy logs were analysed by session, on the basis of the pre-existing topics. This was
to provide a perspective on the intervention in relation to how the intervention was structured and the
progress recorded after each session.
l In stage 2, the therapy logs were analysed by the participant, in order to identify critical factors
affecting involvement and progress. This stage was informed by findings from the stage 1 analysis and
findings from the therapists’ focus group.
l In stage 3, a ‘negative case analysis’ was conducted in order to explore in more depth the secondary
factors influencing therapy outcomes for those participants who did not fit with the general patterns
emerging from the analysis.
In the stage 1 analysis, the therapy logs for each participant were summarised using an adapted framework
analysis approach, with the framework categories representing pre-existing categories in the therapy logs
rather than being identified as themes in the data by the researcher. Summaries were produced for each
component of the intervention delivery (i.e. each column in the matrix), for each of the 14 therapy sessions.
The summaries produced were subdivided into different themes depending on the content, for example ‘carer
stress.’ The summaries included details, such as frequencies, for example numbers mentioning particular types
of goals at this stage, to avoid impressionistic bias in the analysis. These summaries also used the voice of the
therapist, such as terms employed, as much as possible, to maintain the validity of the analysis. The summaries
were then further summarised into short versions in accordance with the key content and themes in order
to identify patterns in how participants engaged with and benefited (or not) from different aspects of the
intervention. The findings for the two participant groups were then compared, to identify any differences in
treatment and treatment experience between the two groups, and to identify and refine explanatory themes
emerging from the analysis. Memos reflecting other features of the intervention and participants’ experiences
were also recorded, to help in identifying factors that appeared to be important but were not captured by the
therapy log categories; the factors noted were:
l progression or stage of dementia
l physical health of participants
l participants’ anxiety
l carer engagement – commitment to the intervention and participation in the sessions
l carer difficulties (e.g. stress, health problems)
l adaptation of goals, for example when participants rejected previously chosen goals, or extension
of goals or strategies when original aims were surpassed
l life events, holidays or family visits
l type of goal – for example, whether the goal related to household chores, personal projects or social
activities.
TABLE 25 Bangor Goal-Setting Interview ratings of participants included in the therapy logs analysis at each time point
Measure
Participants with a
Poor outcome (N= 25) Good outcome (N= 25)
Baseline 3 months 9 months Baseline 3 months 9 months
Participant rating of attainment 4.55 (2.30) 3.94 (2.08) 4.94 (2.55);
N= 24
1.91 (0.83) 8.13 (0.94) 7.86 (1.64)
Participant rating of satisfaction 4.09 (1.86) 4.91 (1.99) 6.24 (2.05);
N= 23
2.71 (1.34) 8.01 (0.71) 8.12 (1.39)
Carer rating of attainment 3.37 (1.85) 3.35 (1.63) 3.79 (2.27) 1.96 (1.18) 7.09 (1.62) 6.99 (1.90)
Note
Data are mean (SD).
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Factors emerging from the focus group analysis and from the stage 1 therapy log analysis were combined
into the following final list of nine significant features of therapy experience that was used for stage 2 of
the therapy log analysis:
1. stage or severity of dementia
2. participants’ physical health
3. low mood or depression
4. anxiety
5. carers’ difficulties (e.g. stress, health problems)
6. carer engagement
7. type of goal
8. changes in goals (either rejecting, changing or surpassing original goals)
9. life events, holidays or family visits.
In stage 2, a summary of each of these categories was produced for each participant, identifying the
therapist comments made for each domain (if any). The summaries for both groups were then compared,
to identify any differences in the experiences between the two groups of participants. The initial analysis
examined frequencies to identify broad differences between the groups and then explored potential
explanations of why groups were different. This included the consideration of differences with regard to
specific factors (e.g. the type of problematic carer engagement) and the exploration of links between the
initial findings (e.g. whether or not participants whose dementia had progressed further tended to select
different types of goals to work towards).
The summaries of the key findings from the analysis of the therapy logs included a comparison of the
findings from each of the three main stages of analysis and further refinement of themes. The findings
were discussed by the researcher and trial manager to confirm the basis for, and to discuss the implications
of, the findings.
The stage 3 analysis built on stages 1 and 2, to investigate negative cases in which participants did not
fit the general pattern for their group, for example when participants who had lower functional ability
achieved good BGSI outcomes. The analysis focused on therapy log entries from three milestone sessions
in which therapists summarised goal progress and the factors affecting progress: session 10 (the end of
the main phase of the intervention), session 11 (the beginning of the maintenance phase) and session 14
(the end of the maintenance phase). The similarities between negative cases in the ‘poor outcome’ and
‘good outcome’ groups were investigated to try to identify factors contributing to participant outcomes.
A limitation of the analysis is that the therapy logs were notes made by the therapists about significant
events or issues, rather than a systematic summary of each session. There were also aspects of the log
entries that could be unclear:
l Some entries were ambiguous; for example, some noted strategies without being clear about whether
these were being suggested by the therapist or if they were actually being applied by the
participant/carer.
l Some entries implied, rather than explicitly stated, the presence of features, such as anxiety (e.g.
references were made to ‘frustration’ or ‘stress’) or dementia symptoms (such as lack of motivation,
which could be caused by several quite different types of difficulties).
l Some entries noted ‘nil’/none and it was not clear whether this referred to lack of progress or if it
indicated that this topic was not covered in the session.
When the data were unclear, they were not included in the data reduction summaries for the analysis.
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Findings
The analysis identified differences between the two groups in relation to two areas: level of functioning
and anxiety, and there were also secondary factors influencing outcomes.
Level of functioning
The initial stage of the therapy logs analysis found that participants in the poor outcome group were more
likely to be described as experiencing greater cognitive difficulties, as being less likely to acknowledge
difficulties and as having limited motivation to engage in therapy. Cognitive decline over the study period
was noted for participants in both groups to an equal extent, but therapists were more likely to comment on
a lack of acknowledgement of difficulties in the group with poorer outcomes. This overarching difference
between the groups was reflected in several important themes that were evident in the therapy logs.
The nature of therapy goals Although there was some similarity in the type of goals identified by
participants in both groups (e.g. similar numbers of participants in both groups wanted to improve their
use of mobile phones), there were also marked differences. Participants in the poor outcome group tended
to select more basic goals, such as knowing the date, whereas participants in the best outcome group
tended to identify more recreational goals, such as engaging in social activities outside the house. In the
poor outcome group, notes from the initial therapy sessions contained more concerns about the person’s
ability to carry out basic daily activities, such as dressing.
Changing goals The frequency with which therapists amended the goals identified during the researchers’
visit was the same for both groups. Participants in the best outcome group were more likely to extend their
goals and aim for more ambitious targets, whereas those in the poor outcome group were more likely to
give up on a goal entirely. This could be linked to lower motivation or to difficulties in identifying suitable
objectives or it could possibly be seen as a way to avoid confronting difficulties.
Goal progress Differences in the rates of progression appeared following the first three sessions. In the best
outcome group, the first three sessions were often enough for the participants to start making noticeable
progress and there was an increase in positive comments about progress towards achieving therapy goals
from the third session onwards. In contrast, for participants in the poor outcome group, there were comments
about low levels of engagement with working on goals and insufficient between-session practice. The poor
outcome group were also less likely to engage with a third goal, if they had one, or else they started working
on it later. As expected, participants in the best outcome group gave more positive in-session ratings for goal
attainment, and both participants and therapists made more positive comments about progress towards
achieving goals than those in the poor outcome group. Therapists made more comments on wholly positive
progress for the best outcome group at the end of the maintenance phase. The lack of progress in the poor
outcome group was attributed by therapists to some participants not acknowledging difficulties.
Activity levels Participants in the best outcome group had slightly higher levels of functioning, as indicated
by the PAL77 score, and were more likely to report interest in increasing their activity levels and to make plans
to do so than those in the poor outcome group, who were more likely to be described as inactive.
Compensatory strategies The types of strategies adopted were similar for both groups, although
participants in the best outcome group were often already using some strategies and were more likely to
make positive progress with new ones.
Restorative strategies Participants in the best outcome group were also more likely to be already using
some restorative strategies to remedy their cognitive difficulties and were more likely to use new ones
successfully and to apply them to a wider range of areas. Participants in the poor outcome group were less
likely to engage with these strategies or to even have a discussion about using them.
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Attention and concentration Although there were similar types of strategies adopted in both groups to
support attention and concentration, participants in the best outcome group appeared to have adopted
strategies earlier in the course of therapy, and made more positive comments about using the strategies.
Perspectives of participants Participants in the poor outcome group tended to engage less with
therapy, expressed more reluctance, appeared to be withdrawn during sessions and had more difficulty
recalling previous sessions. At the end of the intervention, they were more likely to refer to the relational
or social aspect of the therapist visiting them as a positive element of the intervention or to make very
general positive comments. Participants in the best outcome group were more likely to give examples of
specific elements of the intervention that had benefited them.
The relationship between the participant and the carer In the poor outcome group, the relationships
between the participant and the carer appeared to be more unbalanced, with dominant carers and/or
more passive or dependent participants, although it was not clear to what extent this reflected participants’
cognitive or functional ability and to what extent it was a more intrinsic characteristic of the relationship.
Relationship strains were mentioned for both groups, but therapists were slightly more likely to report wholly
positive relationships for the participants in the best outcome group.
External support Towards the end of therapy, the plans for ongoing support differed between the good
outcome group and the poor outcome group. Participants in the poor outcome group tended to consider
whether or not additional external support, such as day care or respite, would be helpful, whereas those in
the best outcome group were more likely to discuss getting involved in social activities, such as support
groups or dementia choirs.
Anxiety
In both groups, the therapists noted a range of psychological difficulties experienced by participants,
including low levels of confidence, agitation, frustration and low mood. However, anxiety problems were
more often noted for participants in the best outcome group, whereas participants in the poor outcome
group and their carers were more likely to report that anxiety was not a problem.
Secondary factors influencing therapy outcomes
Stages 2 and 3 of the analysis explored in more detail the secondary factors influencing therapy outcomes.
In the second stage, therapy sessions were examined with regard to the final list of nine significant features of
the therapy experience that were perceived as being likely to influence outcome. The list included cognitive
difficulties as discussed above, as well as factors that did not appear to differentiate the groups clearly, such
as participants’ health, carer engagement in therapy and support provided by the carer. To further investigate
the impact of these factors on therapy, a negative case analysis explored potential relationships in more depth.
Specifically, therapy logs for participants who had poor outcomes, but for whom no particular dementia-related
problems were noted (n= 11), were reviewed as a group and therapy logs for participants who had good
outcomes, but for whom specific dementia-related problems were noted (n = 6), were reviewed as a group.
The negative case analysis of the six participants who were in the ‘good outcome’ group despite particular
dementia-related problems being noted, indicated that their symptoms were milder than those in the
‘poor outcome’ group or that their symptoms fluctuated, creating opportunities for more effective therapy
work. The analysis of this group of participants therefore supports the view that the extent of cognitive
difficulties or dementia-related problems is associated with outcome.
For the 11 participants in the ‘poor outcome’ group for whom no particular dementia-related problems were
noted, progress with therapy appeared to be affected by several secondary factors. The most significant of
these factors were either not engaging with goals or setting an inappropriate goal, lack of carer support for
between-session practice and significant health problems or additional disability, such as visual impairment.
Several participants in this subgroup had a combination of two or three of these factors hindering therapy
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progress. It is important to note, however, that these secondary factors appear to have less impact on the
therapy outcome than their level of functional ability, as discussed above.
There were a number of factors that did not appear from the therapists’ records to have any consistent
relationship with therapy outcomes, such as therapeutic alliance, number of sessions attended, carer health
and well-being, and therapist support in the areas not related to goals.
Summary
The main findings indicate that the intervention appears to be more effective for participants with less
severe cognitive difficulties and with better functional ability. This concurs with findings from the therapist
focus group. Although other factors, such as carer support and participant health, influence participants’
behaviour, such as levels of between-session practice, these factors do not seem to be linked to overall
intervention outcomes.
Participant and carer experience of the intervention
A subset of participants and carers from the CR group were interviewed about their experience of the
intervention to gain insight into the way in which they experienced the therapy and what aspects of the
therapy were found to be particularly challenging or helpful. An in-depth understanding of the participants’
subjective experience of the intervention is important for understanding the mechanisms of therapy. It also
enables participants to formally contribute their views and experiences to the therapy evaluation.
Method
Three sites were able to contribute to this component of the evaluation, as they each identified an
independent researcher not involved in the trial who could conduct detailed interviews. Interviews were
conducted in the Bangor (21 March 2014 to 20 January 2015), Cardiff (31 July 2015 to 9 December 2015)
and Manchester (1 April 2015 to 28 May 2015) sites. In each site, a consecutive series of participants
and carers was approached following the 9-month follow-up assessment and invited to participate in the
interview to discuss their experiences of the therapy sessions. The trial manager issued the researchers
with site-specific lists of all participants in the CR group who were due to complete their final follow-up
assessment in the designated recruitment period. In total, 36 couples were approached and 26 agreed
to be interviewed, although, in the case of one couple, only the carer participated in the interview.
We interviewed 12 carers and 11 participants at Bangor (100% of those approached), 10 carers and
10 participants at Cardiff (50% of those approached) and four carers and four participants at Manchester
(100% of those approached). The demographic and clinical characteristics of these participants, and
their BGSI ratings, are shown in Tables 26–30. Of note, six of the participants were also included in the
therapy logs analysis, two in the poor-outcome group and four in the good-outcome group.
The interviews followed a semistructured schedule, and interviewers encouraged the participants and
carers to talk freely about their experience of the intervention (see Appendix 2 for the interview schedules).
The interviews covered the following topics:
l How did participants and carers experience the intervention?
l What were their overall perceptions, how useful did they find it, and what did they feel about the
degree of effort required?
l What impact, if any, did the participants and carers feel that the intervention had on their
everyday life?
PROCESS EVALUATION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
62
TABLE 26 Demographic characteristics of the participants with dementia interviewed for the qualitative study
Measure Participants interviewed (N= 25)
Age (years), mean (SD); range 76.64 (5.7); 66–87
Sex (male), n (%) 13 (52.0)
Ethnicity, n (%)
White 24 (96.0)
Mixed/multiple ethnic group 0
Asian/Asian British 0
Black/African/Caribbean/black British 1 (4.0)
Other ethnic group 0
First language (English), n (%) 23 (92.0)
Marital status (married), n (%) 21 (84.0)
Years of education, mean (SD); range 12.74 (2.7); 10–21.5
Occupational status, n (%)
I: professional 3 (12.0)
II: managerial/technical 6 (24.0)
III N: skilled, non-manual 6 (24.0)
III M: skilled, manual 5 (20.0)
IV: partly skilled 4 (16.0)
V: unskilled 1 (4.0)
TABLE 27 Demographic characteristics of the carers interviewed for the qualitative study
Measure Participants interviewed (N= 26)
Relationship to participant with dementia, n (%)
Spouse/partner 21 (80.8)
Adult child (including in-law) 5 (19.2)
Other 0
Age, mean (SD); range 70.38 (11.2); 46–85
Sex (male), n (%) 8 (30.8)
Ethnicity, n (%)
White 26 (100)
Mixed/multiple ethnic group 0
Asian/Asian British 0
Black/African/Caribbean/black British 0
Other ethnic group 0
First language (English), n (%) 24 (92.3)
Marital status (married), n (%) 25 (96.2)
continued
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TABLE 27 Demographic characteristics of the carers interviewed for the qualitative study (continued )
Measure Participants interviewed (N= 26)
Years of education, mean (SD); range 14.40 (3.1); 10–20.5
Occupational status, n (%)
I: professional 6 (23.1)
II: managerial/technical 7 (26.9)
III N: skilled, non-manual 6 (23.1)
III M: skilled, manual 2 (7.7)
IV: partly skilled 4 (15.4)
V: unskilled 1 (3.8)
TABLE 28 Clinical characteristics of the participants with dementia interviewed for the qualitative study
Measure Participants interviewed (N= 25)
Diagnosis, n (%)
Alzheimer’s disease 19 (76.0)
Vascular dementia 3 (12.0)
Mixed Alzheimer’s and vascular dementia 3 (12.0)
MMSE, mean (SD); range 23.40 (2.3); 19–28
Charlson Comorbidity Index weighted score, mean (SD); range 2.1 (1.2); 1–6
Subjective rating of health, n (%)
Excellent 2 (8.0)
Very good 8 (32.0)
Good 7 (28.0)
Fair 8 (32.0)
Poor 0
DEMQOL, mean (SD); range 91.84 (12.3); 53–106
GSES, mean (SD); range 31.84 (3.7); 24–39 (n= 25)
HADS, mean (SD); range
Depression 3.28 (2.6); 0–9
Anxiety 4.88 (3.2); 1–14
RBMT, mean (SD); range
Immediate recall 2.84 (2.3); 0–7.5
Delayed recall 0.34 (1.9); –1 to 5
TEA, mean (SD); range
Elevator counting 6.6 (0.8); 4–7
Elevator counting with distraction 5.36 (2.7); 1–9
D-KEFS verbal fluency, mean (SD); range 25.04 (13.2); 2–55
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The interviewers had an overall understanding of what the intervention involved, but no specific knowledge
of the individual participants’ therapy goals or the therapy process, in order to avoid bias. Participants and
carers were interviewed separately whenever possible, starting with the person with dementia. Interviewers
took a photograph of the therapist on the visit to prompt the participant’s memory of the therapy sessions.
If the participant was struggling to recall the therapy sessions, the interview was completed jointly with the
carer. The first interview conducted by each interviewer was reviewed at the co-ordinating centre to ensure
adherence to the interview schedule. Interviews were found to have been conducted satisfactorily in each
case. All interviews were audio-recorded, transcribed verbatim and anonymised.
TABLE 29 Clinical characteristics of the carers interviewed for the qualitative study
Measure Participants interviewed (N= 26)
Subjective rating of health, n (%)
Excellent 1 (3.8)
Very good 9 (34.6)
Good 13 (50.0)
Fair 3 (11.5)
Poor 0
RSS, mean (SD); range 17.02 (7.7); 5–36
WHOQOL-BREF domains, mean (SD); range
Physical 16.00 (2.4); 10–19
Psychological 15.58 (1.4); 12–18
Social 15.19 (2.3); 11–20
Environmental 17.15 (1.7); 13–20
EQ-5D-3L, mean (SD); range
Index 0.82 (0.2); 0.09–1
VAS 80.42 (11.0); 60–100
TABLE 30 Bangor Goal-Setting Interview ratings at each time point
Rating
Time point
Baseline 3 months 9 months
Participant rating of attainment (N = 25) 3.37 (1.74) 6.10 (1.67) 6.66 (1.94)
Participant rating of satisfaction (N= 25) 3.57 (1.82) 6.54 (1.31) 7.06 (1.70); n= 24
Carer rating of attainment (N = 26) 2.59 (1.21) 5.49 (1.76) 5.72 (2.33)
Note
Data are mean (SD).
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Thematic analysis started from a critical realist position and was based on an inductive approach to
identifying and exploring patterns of meaning in relation to the research question.106,108 Four researchers
who were not involved in conducting the interviews analysed the interviews; three of these researchers
were independent from the trial and one was the trial manager. The process was overseen by the chief
investigator. Initially, two researchers read and reread the first five transcripts to familiarise themselves
with the data and then identified and coded (briefly summarised and characterised) units of meaning
within each transcript. Codes were listed separately, reviewed and organised into meaningful groups,
representing the initial themes for each interview. The resulting lists of themes were compared and
discussed by the two researchers until a consensus was reached about content and organisation, after
which each researcher recoded the transcripts. Related themes were clustered together and the clusters
were ordered into group-level themes and subthemes, and the two researchers worked together to
integrate these into an overall thematic map. The remaining transcripts within the set were then coded
by a single researcher, using the identified list of themes.
Findings
Overall, the therapy was received positively by both carers and people with dementia and, generally, there
were very few criticisms of the therapy. Participants mostly said that they had nothing negative to report
about the experience. Several key themes emerged, reflecting factors that influenced the experience of the
intervention and whether or not it was considered to be beneficial.
Therapeutic relationship
The relationship with the therapist played an important role in participants’ perceptions of the intervention,
especially as the participants with dementia were often unable to recall the specific goals that they had
been working towards in the therapy sessions. The therapeutic relationship was what both the carers and
the people with dementia enjoyed about their experience of the intervention. They looked forward to the
therapist’s visits, and they said that they would miss the visits now that the therapy had ended.
A positive interaction with the therapist was believed to be very important for the therapy by the people with
dementia and their carers. The therapists were described as being pleasant, nice, responsive, knowledgeable
and professional. The people with dementia described feeling comfortable, relaxed and at ease when talking to
their therapists. Moreover, they also said that they did not feel distressed or disturbed during these interactions.
The carers and the people with dementia believed that the therapeutic relationship was the foundation for
several aspects for the intervention. The three most commonly reported aspects were education for carers and
people with dementia about the dementia experience, provision of social support and provision of information
or resources that could help with daily functioning in the future.
The information and explanations that therapists gave about dementia were considered to be very beneficial
for both the carers and the people with dementia, who found it helpful to have written information and
educational materials about living with and caring for someone with the condition. Both the carers and the
people with dementia valued the chance to have any questions answered by the therapist. In particular, the
relationship with the therapist made asking questions and communication easy and less frightening, as one
person with dementia described:
Oh fine, yeah fine, got on well . . . Easy, yeah she explained everything and, you know, it was no hardship
[laughs] . . . That’s right, yeah, well sometimes when people come to see you, . . . you’re afraid to talk,
you know, afraid to say anything when it’s a little bit dumb. But she made me feel so, er, comfortable
and within a couple of minutes we were just like as though we’d been friends for a long time.
Person with dementia 1
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The educational component was related to several perceived positive outcomes for people with dementia
and their carers:
Yeah, she was very good explaining things and, you know . . . I did become very positive . . . after
she’d been . . . ’Cos she, she did, she made me feel good.
Person with dementia 1
Particularly, it increased participants’ understanding and awareness of dementia, to which they attributed
their resulting better psychological adjustment. Some participants reported a new and more positive
perspective on the diagnosis, which resulted in less worry. One person with dementia described how the
therapist increased awareness and reduced worry:
She explored areas, you know that I hadn’t thought about, and . . . I found a great help. I think it,
uh . . . I don’t think I’ve been sort of . . . on edge about the Alzheimer’s . . . But . . . it showed me to be
less worried about it . . .
Person with dementia 2
People with dementia described being wary of or worrying about performing tasks or coping in some
situations prior to the therapy. Participants discussed how the therapist empowered them to make their own
decisions about what they wanted to do and about working towards their goals. One person with dementia
described how the therapist improved their self-view and made them feel better about themselves:
I’m not as soft as I think I am.
Person with dementia 1
They went on to describe how the therapist had changed their self-view by enabling them to make more
decisions for themselves.
Carers also related this increased awareness and understanding to having more patience with the person
with dementia and to other improvements in their relationship (e.g. less conflict, more affection and
thoughtfulness). An increase in patience and a reduction in frustration with the person with dementia was
mentioned by several carers. For example, they reported ‘yelling’ less at the person with dementia and doing
tasks more slowly, to help the person with dementia to understand. This increase in patience was seen as
reducing conflicts and misunderstandings. In addition, a few people with dementia commented that they
had greater self-awareness and better social awareness. They said that they would now think before saying
something in social situations, and they would consider how others (particularly, their carer) would perceive
what they wanted to say before saying it. This change also seemed to benefit the relationship.
Social support and contact seemed to be important elements provided by the therapist. Carers reflected on
how the participants with dementia ‘enjoyed the company’, suggesting that they do not have visitors who
engage with them regularly:
I think my mum just enjoyed it more that somebody was, the social aspects of it, that somebody
was coming.
Carer 1
They described the visits as helpful because they offered opportunities to talk and provided support,
which was something that they described as lacking in their lives. These discussions were often conducted
with humour and included shared interests. The visits also became part of the routine for the person with
dementia, which was viewed positively.
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Several carers described how the therapist gave them a recognition that their experience was shared,
as described below:
And she made you feel that . . . this was a problem that other people have and in a way it sort of
normalises what is not a normal problem and she sort of made you feel it’s . . . something that other
people experience, that there are ways through it . . .
Carer 2
Other people who were also caring for a person with dementia were talked about as being ‘in the same
boat’. This knowledge helped the carers to feel that they were not alone or ‘neglected’ and ‘ignored’,
which was what they mostly experienced in relation to others or society as a whole. In a few cases, the
carer described how the therapist acted as a mediator, or a neutral person, for conflicts between the carer
and the person with dementia. Therapists could provide suggestions without seeming confrontational or
prompting other negative feelings (e.g. embarrassment). Sometimes, the carer reported that the person
with dementia would respond better to the therapist than to the carer or other people.
Strategies to improve functioning
Through the therapeutic relationship, carers and people with dementia learned about strategies to improve
functioning and how to implement these. One carer described how the input from the therapist helped to
develop ideas that were used to achieve goals:
It was a great help really to talk to somebody other than [person with dementia], obviously, and [the
therapist] gave us some ideas about goals which [person with dementia] couldn’t remember but they
were [about] your calendar and your medication. And we found that the calendar has worked very well.
Carer 3
Participants discussed the effectiveness of a variety of different strategies, such as simple instructions, memory
prompts or reminders. For carers, these strategies were deemed to be especially helpful for functioning if
they eased the burden of caregiving (e.g. by supporting dressing or cooking). Trying out these strategies
and practising them was key to improvements for the person with dementia. Carers expressed how the
intervention needed the investment of time and effort from the participants to gain any benefit. If the
strategies were too challenging, effortful or repetitive, the carers believed that the people with dementia
would get bored, ‘worn down’ or frustrated, and would no longer continue to use them.
The carers and the people with dementia both mentioned improvements as a result of the strategies.
These improvements related to general, daily functioning, and the strategies that were put into place
were deemed to be helpful for the person with dementia. For example, the new strategies helped with
remembering to take medication (as illustrated in the quote above) or knowing what activities were
planned for the day without prompting. Often, the improvements were in small tasks, but some were
deemed to be ‘vital’ for relieving some of the burden for the carer or they were things that brought the
person with dementia enjoyment, which seemed to enhance their well-being.
Many carers described how they developed a more problem-focused and practical viewpoint as a result of
the therapy sessions, which enabled them to create new goals and strategies:
[Therapist] made you think about things that you thought you perhaps knew, but think about them in
a different way . . . And approach them in a different way . . . That made it in a very practical way.
Carer 4
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This perspective was considered to be valuable, as it would help in coping with future decline or challenges.
There was also a shift in thinking that emphasised the ‘value [of] little things’ and enjoyment. Both the carers
and the people with dementia got great pleasure from small and simple tasks (e.g. trips into town, a walk
and a meal in a pub or a restaurant), and these tasks were thought to improve well-being.
Participants also discussed how the strategies had positive psychological outcomes – that is, they led to
greater confidence, autonomy and empowerment. The people with dementia found a sense of achievement
when they were able to remember or do something as a result of the intervention. One carer expressed how
the act of achieving the goal was beneficial:
I should think sometimes just reaching his goal, being able to do it after a few days. Something like
that, you know, seeing that he can do it and just putting whatever [therapist] said into place . . .
Just little things like that, they help I think.
Carer 3
Both the carers and the people with dementia described how the therapy had improved the confidence of the
person with dementia. Carers noted that the strategies and aids were helpful for improving or supporting
independence. Carers remarked how the person with dementia was more willing to try different things and
initiate conservations as a result of the enhanced confidence. For carers, perceiving any improvements or
achievements was a source of motivation to continue with the intervention.
Although the changes and strategies encouraged in the therapy were generally felt to be useful, a very
small number of carers commented that these were a ‘hindrance’ to an established routine.
Person-centred approach
Carers and people with dementia both appreciated the person-centred approach of the intervention. The
individual tailoring and flexibility that this approach provided was crucial for developing and implementing
strategies and gaining confidence with problem-solving and finding solutions. As one carer described,
there was flexibility to ensure that what was covered was relevant to the person and that this was done at
the right pace:
. . . they were always relevant to . . . obviously relevant to the issues that [therapist] wanted to raise . . .
And also relevant to, the issues that were important for [person with dementia] . . . And, the issues
that were – she worked at a pace that was good for him as well.
Carer 5
For people with dementia, this meant that time was taken to understand their needs and preferences,
as well as personalising intervention components to suit their interests, abilities and needs. That is, the
specific goal or task preferences of the people with dementia were considered and acknowledged.
By individualising goals and strategies, the people with dementia gained more enjoyment, empowerment
and a sense of achievement from completing these, and therefore, this potentially produced more positive
outcomes for both the person with dementia and the carer.
The flexibility of this approach also allowed for the adaption and modification of tasks or goals over time,
which was deemed to be important by the people with dementia and their carers. These changes made
the tasks ‘fit in’ to their lives, and alterations could be made to manage changes in cognitive or physical
health. This flexibility was closely related to the therapist’s responsiveness and the ability to address certain
challenges in order to accomplish the goals.
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Dementia-related beliefs
A few carers and people with dementia were not sure whether or not the therapy had been truly
beneficial, and they noted that it did not improve memory as such. This uncertainty about the impact
of the therapy was attributable to the progressive nature and inevitable decline associated with the
condition. This was illustrated by the response of one carer when asked about the impact of the therapy:
. . . now, we come onto the issue of . . . the problem of Alzheimer’s itself, so that, to be honest,
is very, very difficult to answer . . . Certain things have slipped away, but is that the fault of the
programme or the fault of the condition? And so it’s really difficult to equate what the programme
has done and what the condition has not allowed it to do . . .
Carer 6
A few carers questioned to what extent the intervention was worthwhile, given that normal functioning
could not be restored and that decline was inevitable. Furthermore, there was a concern about the lasting
benefit of the therapy. A couple of carers and people with dementia believed that the future deterioration
would possibly undo any improvements from the therapy. With this thought, a few carers suggested that
the intervention may be most relevant and beneficial in the earlier stages of dementia.
Summary
The main findings can be summarised as follows:
l The relationship with the therapist played a major role in the therapy. It was the vehicle for providing
information, education and support and was the means by which rehabilitative strategies were
developed, accepted and personalised.
l The most frequently reported impact of the therapy was improved psychological adjustment to
dementia and a more positive perspective, reflected in greater confidence, less anxiety, better coping,
empowerment and improved well-being.
l Participants and carers found that the intervention was effective in supporting activities of daily living
and in improving psychosocial well-being and quality of life.
l The perceived effect of the therapy on cognition and memory was mixed. Some carers and people with
dementia were not sure whether or not the therapy was beneficial for cognition as a result of the
believed progressive nature and the inevitable decline associated with the condition. It should be noted
that the therapy was not expected to benefit cognition as such and was not presented to participants
as a treatment to improve cognition.
l People with dementia and carers expressed an overarching need for social contact and support.
Case studies
People living with early-stage dementia face many challenges in everyday life as cognitive impairments
and other changes affect functioning. The exact nature of these challenges is different for each individual,
depending on personal characteristics, circumstances, interests and preferences. Appendix 14 presents four
illustrative case studies from GREAT, showing the kinds of needs and concerns that prompted participants
and carers to choose particular goals and demonstrating how the therapists worked with participants and
carers to address their goals during the CR intervention.
Feasibility of implementation
In the later stages of the trial, the GREAT team undertook to explore the feasibility of implementing the CR
approach within NHS services. This was an opportunity to examine the challenges that could arise when
translating the intervention to a real-world setting, and to consider how these might be overcome to
facilitate successful implementation. The results are presented in Appendix 3.
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Chapter 5 Economic evaluation
Research question
Using a multicentre, pragmatic randomised controlled design, the study compared goal-oriented CR with
TAU. The aim of the economic evaluation was to examine whether or not CR is a cost-effective intervention,
compared with TAU, for people with early-stage Alzheimer’s disease, or vascular or mixed dementia, and
their carers, over a 9-month period post randomisation.
Methods
Form of evaluation
The economic evaluation included cost-effectiveness and cost–utility analyses.
Effectiveness
The economic evaluation examined four outcome measures, three for participants with dementia and one
for carers.
Cost-effectiveness measures:
1. incremental cost of achieving a standardised mean difference (SMD) of 1.32 points in the participant-
reported goal attainment measure (the BGSI), the primary outcome for the trial
2. incremental cost of achieving a difference in effect of 0.30 in the GSES, which assesses a participant’s
general sense of perceived self-efficacy.
Cost–utility measures:
3. incremental cost per QALY assessed by the participant-rated DEMQOL
4. Incremental cost per QALY for carers’ self-rated HRQoL, using the EQ-5D-3L.
A SMD for the GSES was calculated by multiplying the effect size of 0.3 by the (non-imputed) SD of the mean
across sample participants at baseline following Samsa et al.109 The second outcome in the list above thus
equates to an incremental cost of achieving a SMD of 1.53 points in the GSES. These outcome measures are
described in more detail in Chapter 2.
We calculated utility scores for participants with dementia from the DEMQOL instrument (the DEMQOL-U
index) using published societal weights.110 We derived QALYs from these scores using the area-under-the-curve
method, with linear interpolation between the three assessment points. We calculated carers’ utility scores
from the EQ-5D-3L with published societal weights.111
Perspective
The economic evaluation first took a health and social care perspective, and second a societal perspective.
Broadly speaking, the health and social care perspective took into account those costs falling to the NHS and
to local authority social services departments (SSDs). Most service costs (e.g. hospital, community health care,
community day care and home-based care) were considered to fall entirely to these agencies. However, only
adaptations and equipment reported as being provided by the NHS or SSDs were considered within this
perspective. The societal perspective was considered to encompass not only health and social care costs, but
also the costs to the participant–carer dyad: lost production in terms of carer’s wages forgone because of
providing care; costs of providing care in terms of hours of care provided; out-of-pocket payments (privately
purchased equipment and travel costs of attending appointments related to dementia treatment).
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Time horizon
The outcomes and costs considered in the economic evaluation were measured at baseline and at the
3-month and 9-month assessment points. The costs collected using the CSRI covered the 3-month period
prior to each assessment point. The 9-month costs were calculated from these three data collections.
The costs of services between 3 months post baseline and 6 months post baseline were assumed to be
the same as the costs in the 3 months prior to the 9-month follow-up. In other words, to calculate the
9-month costs, we estimated the 3-month costs based on data from the second follow-up, multiplied
this estimate by two and added this to the costs in the 3 months prior to the first follow-up. It was not
necessary to apply discount rates to either costs or outcomes, because the time horizon was shorter than
1 year.
Costs
The analysis considered the comprehensive costs of care and support to the person with dementia.
The costs were calculated drawing on the following collections:
l data on services used by the person with dementia, as observed and reported by carers using
the CSRI112
l data on carer time spent on care and support activities and lost employment, using the CSRI
l data on time spent by professionals in delivering the intervention, using the therapy logs
l data on professionals’ labour costs, using a pro forma distributed to therapists
l costs of training (fees, materials) supplied by the project management team.
The costs of health and social care services were calculated from service use data by applying relevant,
nationally generalisable unit costs taken from NHS Reference Costs 2012 to 2013113 and the Personal
Social Services Research Unit (PSSRU)’s costs compendium.114 We calculated the costs of carers’ inputs
using opportunity costs (base case) and replacement costs (sensitivity) methods.115–117 The opportunity
costs approach involved attaching a value to each hour of unpaid carer time in providing care and support
equal to the minimum wage. In the replacement cost approach, the cost of an hour of home care was
used to value unpaid time spent providing care. The unit costs used in valuing resource use118–143 are
summarised in Table 31 and reported in full in Appendix 15.
Costs are reported in the following categories: hospital services, primary and community health, mental
health services, overnight respite care, community social care, day services, equipment and adaptations,
mental health medication, costs of the CR intervention and unpaid care. Costs are also reported as
aggregated total costs from the health and social care perspective and from the societal perspective.
The costs of the CR intervention were calculated by drawing on a number of sources. We gathered
comprehensive information on the time spent by therapists delivering the CR intervention. The intervention
time consisted of three elements:
l Direct (face-to-face) contact time with participants – therapists entered their contact time per visit in
‘therapy logs’ in the MACRO database system.
l Indirect contact time (planning, travel) with participants – the set-up time was estimated by the GREAT
project team as 10–15 minutes. Therefore, 12.5 minutes of indirect time were allocated per visit.
Therapists estimated the time taken to make a one-way journey by the participant as an average and
entered this into the MACRO database system.
l Non-contact time (general training and individual training/supervision) – a pro forma collected
non-contact costs (supervision and training of therapists) from the project team. These comprised the
number of hours spent in general training sessions, the costs of providing general training sessions
(trainers’ fees, costs of venues and materials), the travel costs of attending general training sessions,
the number of hours spent in individual training sessions, the costs of providing individual training
sessions (trainers’ fees, costs of venues and materials) and the travel costs of attending individual
training sessions.
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Therapists also completed a pro forma providing information on Agenda for Change (AfC) band, the
proportion of full-time equivalent (FTE) hours worked, the start and end dates of the project, the usual
mode of transport, the average number of miles travelled by car, the average parking charges and the
average cost of a public transport fare.
To value the time spent by therapists in direct, indirect and travel activities, we calculated comprehensive therapy
staff costs, including salary costs (by median FTE earnings per AfC band, including oncosts: superannuation at
14% of salary and national insurance contributions), administrative overheads (management and non-staff
costs) and capital overheads calculated as a percentage of salary cost. Staffing costs were weighted by salary
band and time contributions (FTEs at each band) to estimate a weighted cost per hour of therapy time. To value
the costs of therapists’ journeys made to participants, we estimated the costs of public transport or car travel per
centre using the data from each therapist-completed pro forma.
The study ran over 4 years: pro formas were issued every financial year. The costs of general training and
supervision in years following the base year (2013–14) were deflated to 2013–14 prices using the Hospital
and Community Health Service (HCHS) index.144 The total across all years was divided by the number of
CR participants (n = 238) multiplied by 14 sessions, to give a per-session overhead to be attached to each
session attended by participants.
Missing data
Resource use data collected using the CSRI may be missing for any use of a service, for the frequency
of using the service or for the duration of a service (e.g. length of a home care visit). When service use
was indicated but frequency was missing, a suitable nationally applicable unit cost was used if available
(e.g. cost per visit). For each case, items in each cost category were added together to give the total cost
TABLE 31 Unit costs in brief
Service use item Unit cost, £ (2013–14)
Inpatient bed-day, per specialty Range: 324–896
Inpatient bed-day, weighted average across adult specialties 495
Day attendances, per specialty Range: 374–1333
Day case, weighted average across specialties 698
Outpatient attendances Range: 42–271
A&E attendances, admitted and non-admitted 124
Outpatient, weighted average of follow-up attendances across adult specialties 102
Primary, community and community mental health services: contacts with services Range: 0.5–221
Primary and community health services: minutes Range: 0.5–4.43
Residential care per day Range: 79–157
Nursing home care per day 104
Community-based social care: minutes Range: 0.33–0.50
Day services per session per day Range: 3–146
Medications: standard quantity units Range: 0.029–8.45
Equipment and adaptations, cost over 3 months per item Range: 0.22–106
Carer hour, valued at replacement cost: home care worker, per hour 19.64
Carer hour, valued at opportunity cost: minimum wage, per hour 6.31
A&E, accident and emergency.
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for the category. The category-level costs were then summed to give a total overall cost per case. If all
costs in the category were missing, the category total (per case) was calculated as missing; if some items
were missing, these were treated as zeros and the case was assigned the cost of the sum of available costs
in the category.
Missing category-level costs were multiply imputed by predictive mean matching (k = 5 nearest neighbours)
in a regression model that included demographic variables of the dyad, centre and stratified MMSE score
and the outcome measures to be used in the cost-effectiveness analysis, using the Stata® programme
MI impute (StataCorp LP, College Station, TX, USA).145 Whether people with dementia who had been
lost to follow-up or withdrew prior to the 9-month follow-up had died during this time was unknown.
The model therefore also included the survival of the person with dementia to the end of the 9-month
assessment as an imputation variable. Carers who were part of a dyad that had been lost to follow-up or
withdrawn were assumed to have survived. Costs and outcomes were imputed separately by allocation
and depending on survival.146 The number of imputations was guided by White et al.’s147 rule of thumb
that the number of imputations should be set at the percentage of incomplete cases for variables to be
used in the analyses.
Analyses
The use of services and the mean use of services within allocation groups were compared descriptively,
with no tests of between-group differences, given the large numbers of potential comparisons. The
descriptive statistics of costs and outcomes are presented in terms of the mean and SE in each group, and
the between-group difference and the SE of the difference. All service use, cost and outcome data are
summarised in terms of the sample of dyads for which unpaid carers were available for the completion of
the CSRI section of the assessment at each time point. All analyses were conducted using Stata version 14.
Cost outliers were identified by following the adjusted box plot technique described by Vanderviere and
Huber148 and recommended for skewed data. This involved calculating the medcouple, a measure of
skewness (using a user-written programme medcouple in Stata),149 establishing the upper fence of a box
plot interval and defining the observations falling above the upper fence as high-cost outliers.
Cost-effectiveness
Cognitive rehabilitation was to be defined as cost-effective if it was:
l less costly and more effective than TAU or
l more costly and more effective than TAU, and society is willing to pay the additional cost in order to
achieve the gain in outcome, or
l less costly and less effective than TAU, and society is willing to sacrifice some of the outcome
difference in order to make a saving.
The intervention was to be defined as not cost-effective if it was both significantly more costly and less
effective than TAU or if society was not willing to pay the cost of a gain in outcome. The criteria for this
decision were based on the following rule:
ΔC/ΔE< λ. (1)
Here ΔC represents the additional cost, ΔE is the gain in outcome associated with the treatment, and
λ is the willingness to pay (WTP) for that outcome gain.150 The incremental cost-effectiveness ratio [(ICER)
ΔC/ΔE] must be below the decision-maker’s WTP (λ) to be considered cost-effective.
The ICER was calculated as the difference in the mean costs of the CR and TAU groups over the period of
follow-up (9 months) divided by the difference in the mean end-point outcome measure (the BGSI and the
GSES for participants with dementia) between groups. In the case of the ratio of incremental costs and
QALYs (based on the DEMQOL-U for participants with dementia and the EQ-5D for carers), the denominator
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was the difference in mean QALYs. The ICER point estimates presented in the tables are based on the ratio
of the cost results rounded to one decimal place and the outcome results rounded to two decimal places.
The cost-effectiveness decision rule can be rearranged in terms of the net monetary benefit, the monetary
value of a gain in effect associated with the treatment at a given WTP and the net of the additional cost of
the treatment:150
λΔE–ΔC> 0: (2)
The net monetary benefit must be greater than zero if the costs associated with the intervention are not to
outweigh the benefits of the intervention.
Cost-effectiveness analyses
The incremental costs and outcomes were estimated by seemingly unrelated regressions (SUR).151 This
approach was combined with non-parametric bootstrapping. The estimates were adjusted by centre,
baseline outcome measures and baseline costs, as well as demographic variables (sex, age and stratified
MMSE score). The regression coefficients on the allocation term were used to calculate the net monetary
benefit over a range of societal WTP levels for incremental differences in the primary outcome measures
and for QALY gains.
The number of bootstrap samples used in the analyses was determined by a method suggested by Gould
and Pitblado.152 This involves examining the bootstrap variance estimates for the variable of interest plotted
against the number of replications. The bootstrapped SE for the allocation term in the cost regression was
examined in this way. At the point when consecutive SEs produced by the bootstrap samples (increasing
from a base of 1000 replications by 1000 additional replications) differed by < 1%, this was considered to
be an adequate number of replications. The complete-case analyses used 60,000 replications; analyses
with multiply imputed data used 3000 replications.
The proportion of bootstrap replicates in which the net benefit was greater than zero was plotted over
a range of WTP values to produce cost-effectiveness acceptability curves (CEACs). These illustrate the
probability of making a correct decision to fund the intervention,150 and also the sampling uncertainty
around the point estimate of the ICER.153 The cost–outcome difference pairs were plotted as points on
the cost-effectiveness plane as a further means to illustrate sampling uncertainty, while providing graphical
information on the joint distribution of costs and outcomes across the quadrants of the plane. For
instance, cost–outcome differences that fall into the north-east quadrant of the plane indicate that CR is
associated with higher costs and better outcomes than TAU.154 Points falling into the south-east quadrant
indicate that lower costs and better outcomes are produced by the new intervention relative to the old
intervention (in which case the new intervention is said to ‘dominate’ the old intervention). Points falling
into the north-west and south-west quadrants represent situations in which the new intervention
respectively costs more (in which case, the new intervention is ‘dominated’) and in which the intervention
costs less than the alternative; in either case, the new intervention produces worse outcomes.
The analyses took into account the data of those participants and carers with sufficient information to
calculate both service costs and carer costs. Thus, the analyses did not consider data for which only one
member of the dyad had contributed information. In addition, given the need to reflect the societal
perspective, data from participants with only paid carers were not analysed. This was for two reasons: first,
paid carers were not providing unpaid care; and, second, the reason that the informant was a paid carer
was likely to reflect the absence of an unpaid carer who would incur any unpaid care costs.
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Results
Sample numbers
The numbers of people who formally participated in assessments were:
l at baseline, 474 people with dementia and their carers (238 in the CR arm; 236 in the TAU arm)
l at 3 months, 445 people with dementia (218 in the CR arm; 227 in the TAU arm) and 442 carers
(217 in the CR arm and 225 in the TAU arm)
l at 9 months, 426 people with dementia (208 in the CR arm; 218 in the TAU arm) and 422 carers
(207 in the CR arm; 215 in the TAU arm).
In terms of complete dyads who formally participated in the assessment:
l at baseline, 474 participated (238 in the CR arm; 236 in the TAU arm)
l at 3 months, 442 participated (217 in the CR arm; 225 in the TAU arm)
l at 9 months, 422 participated (207 in the CR arm; 215 in the TAU arm).
With regard to CSRI questionnaires that were partially or wholly completed by dyads consisting of a person
with dementia and an unpaid carer, the numbers were:
l at baseline, 469 CSRI questionnaires (236 in the CR arm; 233 in the TAU arm)
l at 3 months, 437 CSRI questionnaires (215 in the CR arm; 222 in the TAU arm)
l at 9 months, 415 CSRI questionnaires (205 in the CR arm; 210 in the TAU arm).
Information from complete dyads (who had not withdrawn or been lost to follow-up and had an unpaid
carer participating) that was sufficiently complete to calculate health and social care and societal costs
was available:
l at baseline, for 469 dyads (236 in the CR arm; 233 in the TAU arm)
l at 3 months, for 435 dyads (213 in the CR arm; 222 in the TAU arm)
l at 9 months, from 414 dyads (204 in the CR arm; 210 in the TAU arm).
The outcome data available at each assessment point are described in Chapter 3. The numbers of dyads
included in the cost-effectiveness analyses varied depending on the measures; the relevant valid numbers
of observations associated with each measure are presented with the results of the analyses. There were
four paid carers who completed the CSRI (see Chapter 3). At the end of the study, seven participants with
dementia had died and one carer had died.
The complete-case sample of economic data available for analysis at 9 months (those with data from
complete dyads across the three assessment points who had not withdrawn or been lost to follow-up and
had an unpaid carer participating) was 412 (203 in the CR arm; 209 in the TAU arm). The numbers of
cases available for the cost-effectiveness analyses varied depending on the outcome:
l For QALYs calculated using the DEMQOL-U, there were 401 cases available (196 in the CR arm; 205 in
the TAU arm).
l For BGSI scores, 407 cases were available (201 in the CR arm; 206 in the TAU arm).
l For GSES scores, 389 cases were available (190 in the CR arm; 199 in the TAU arm).
l For carers’ QALYs calculated using the EQ-5D-3L, there were 390 cases (192 in the CR arm; 198 in the
TAU arm).
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The sample of cases available in the analysis of complete data sets as a product of the multiple imputation
process was 462.
Use and costs of care and support services at each assessment point
At baseline, both the CR group and the TAU group used a wide variety of services (see Appendix 16,
Tables 125–127). The groups exhibited a high use of services, such as outpatient appointments and GP
and practice nursing contacts. In both groups, 11% of participants received some form of home help or
home care, and roughly the same number attended a day centre. One-fifth of the dyads had cleaning
services. The proportions using these services remained relatively stable over the course of the study.
The proportion of participants who reported taking any mental health medications was stable over the
three assessment points; approximately three-quarters of both groups took antidementia medications.
The mean number of home care contacts and hours demonstrates a problematic feature of the data.
There were small numbers receiving very high levels of home care at each assessment point and these were
concentrated in the TAU group. At baseline and 9 months, the average number of contacts and hours of
home care in the TAU group were twice those in the CR group. However, the variation in contacts and
hours was higher in the TAU group, as evidenced by larger SEs relative to the means. This complicates an
assessment of the size of these differences: a unit-free measure is useful in these circumstances. The SMD
(the mean CR – TAU difference divided by the SD across the groups) in home-care hours between CR and
TAU was –16% at baseline, 14% at 3 months and –33% at 9 months (not presented in the table). This
suggests very substantial variability in receipt, or reporting of receipt, of home care over the study period
and also a large difference in home care received at 9 months in the TAU versus CR comparison. The same
pattern occurred in unpaid care time of the principal carer: the number of unpaid care hours at baseline and
9 months was higher in the CR group than in the TAU group but at 3 months was higher in the TAU group.
The types of care and support provided by carers are described in Table 128 in Appendix 16. A majority
of carers reported providing social support (keeping the person with dementia company) and taking
the person to appointments, helping with medications, providing practical help and supervision. Fewer
than one-third of carers in either group reported assisting with personal care at baseline or 3-month
assessments. At the 9-month assessment point, however, the proportion of carers providing personal
care was 38% in the CR group and 43% in the TAU group.
The raw costs of health and social care services, unpaid care and out-of-pocket expenses in the 3 months
prior to assessment are presented in Table 32. The total health and social care and societal costs are also
given. The mean differences in costs between the groups exhibited wide CIs. The pattern of apparently
higher costs in the CR group at baseline and 9 months echoed that seen in the utilisation of home care
and unpaid care hours; however, the unadjusted differences were not significantly different from zero at
any point, as evidenced by CIs crossing zero.
The health and social care costs were, on average, relatively modest, being substantially lower than
societal costs at each assessment point. These averages mask some extremely high-cost cases, particularly
in the TAU group. At the 9-month follow-up, the maximum total health and social care costs over the
prior 3 months reached £18,063 (vs. the mean of £1282) in the CR group and £42,504 (vs. the mean of
£1647) in the TAU group. The data were highly skewed: on a test for normality, the hypothesis that
the data were distributed normally was rejected (p = 0.000) for both health and social care costs and
societal costs.
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TABLE 32 Mean costs for dyad: health and social care services for the person with dementia, unpaid carer costs,
out-of-pocket costs and total health and social care and societal costs over the prior 3 months, at baseline
assessment (£, 2013–14). Sample: complete casesa
Category of cost
Treatment group
CR (N= 238) TAU (N= 236) CR – TAU
n Mean SE n Mean SE
Mean
difference 95% CI
Baseline
Hospital 236 426 91 233 276 44 151 –50 to 351
Primary and community health 236 153 11 233 164 14 –11 –46 to 25
Respite residential/nursing home 236 3 3 233 0 0 3 –3 to 9
Community care 236 203 52 233 458 177 –255 –615 to 105
Community mental health 236 58 11 233 51 10 8 –21 to 36
Day care (any provider) 236 107 25 233 85 19 22 –40 to 83
Medicationsb 236 182 10 233 181 9 1 –26 to 27
Equipment and adaptationsc 236 10 2 233 10 2 0 –6 to 6
Health and social cared 236 1142 116 233 1224 194 –82 –524 to 360
Unpaid caree 236 5899 401 233 5632 369 267 –806 to 1340
Out of pocketf 236 53 5 233 71 6 –18 –33 to –3
Societal
g
236 7041 422 233 6857 418 185 –983 to 1352
Sensitivity: unpaid careh 236 15,236 1128 233 13,497 982 1739 –1202 to 4681
Sensitivity: societali 236 16,378 1143 233 14,721 1007 1657 –1339 to 4653
3 months
Hospital 213 292 53 222 310 77 –18 –203 to 168
Primary and community health 213 131 10 222 144 18 –14 –54 to 27
Respite residential/nursing home 213 62 55 222 0 0 62 –45 to 168
Community care 213 423 157 222 387 182 36 –439 to 510
Community mental health 213 43 15 222 24 5 18 –12 to 48
Day care (any provider) 213 112 23 222 107 22 5 –59 to 68
Medicationsb 213 174 11 222 192 10 –18 –48 to 12
Equipment and adaptationsc 213 13 3 222 11 2 2 –5 to 9
Health and social cared 213 1250 186 222 1177 234 73 –518 to 665
Unpaid caree 213 5985 385 222 6199 397 –214 –1303 to 875
Out of pocketf 213 56 5 222 66 6 –9 –25 to 6
Societal
g
213 7235 462 222 7376 452 –141 –1411 to 1130
Sensitivity: unpaid careh 213 14,846 1099 222 15,026 1061 –181 –3182 to 2820
Sensitivity: societali 213 16,096 1162 222 16,203 1080 –107 –3221 to 3007
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Unit costs and per-participant costs of the cognitive rehabilitation intervention
The cost components used to value the CR intervention are given in Table 33. CR-specific training and
supervision costs per session were substantial at £33, and may not reflect the level of supervision and
support that would be available in routine clinical practice. The mean number of visits in the 3 months
after baseline in the economic evaluation sample (n = 215) was 9.61 (SE 0.09), as shown in Table 34; the
costs in the first 3 months were £1259 (SE £18). In the period between the 3-month and the 9-month
assessments in the economic evaluation sample (n = 204), the mean number of visits was 3.74 (SE 0.07)
and the costs were £474 (SE £10).
TABLE 32 Mean costs for dyad: health and social care services for the person with dementia, unpaid carer costs,
out-of-pocket costs and total health and social care and societal costs over the prior 3 months, at baseline
assessment (£, 2013–14). Sample: complete casesa (continued )
Category of cost
Treatment group
CR (N= 238) TAU (N= 236) CR – TAU
n Mean SE n Mean SE
Mean
difference 95% CI
9 months
Hospital 204 424 114 210 308 69 116 –144 to 376
Primary and community health 204 129 9 210 168 14 –39 –72 to –5
Respite residential/nursing home 204 69 48 210 154 63 –86 –243 to 71
Community care 204 317 88 210 622 243 –305 –819 to 209
Community mental health 204 34 11 210 63 20 –29 –75 to 16
Day care (any provider) 204 123 24 210 133 29 –10 –84 to 63
Medicationsb 204 172 11 210 184 10 –12 –41 to 17
Equipment and adaptationsc 204 15 3 210 14 3 0 –8 to 9
Health and social cared 204 1282 155 210 1647 299 –365 –1033 to 303
Unpaid caree 204 6317 428 210 6276 410 41 –1123 to 1205
Out of pocketf 204 61 5 210 73 6 –12 –27 to 4
Societal
g
204 7599 490 210 7923 494 –324 –1691 to 1043
Sensitivity: unpaid careh 204 16,110 1198 210 15,695 1131 415 –2821 to 3650
Sensitivity: societali 204 17,391 1249 210 17,342 1160 50 –3299 to 3398
a Dyads completing baseline assessments: 236 in the CR arm; 233 in the TAU arm. Dyads completing 3-month assessments:
213 in the CR arm; 222 in the TAU arm. Dyads completing 9-month assessments: 204 in the CR arm; 210 in the TAU arm.
b Drugs for dementia, antiepileptics, hypnotics and anxiolytics, antipsychotics and antidepressants.
c Provided by the NHS or social services.
d Person with dementia’s health and social care costs.
e Unpaid carers’ time in care and support to participant with dementia, lost production; time valued at minimum wage.
f Expenditure on travel to appointments, equipment purchases.
g Person with dementia’s health and social care costs; unpaid carers’ time in care and support to the participant with
dementia, lost production; time valued at minimum wage; expenditure on travel to appointments, equipment purchases.
h Unpaid carers’ time in care and support to the participant with dementia, lost production; time valued at the hourly cost
of a home-care worker.
i Person with dementia’s health and social care costs; unpaid carers’ time in care and support to the participant with
dementia, lost production; time valued at the hourly cost of a home-care worker; expenditure on travel to appointments,
equipment purchases.
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TABLE 34 Health professionals delivering CR:a visits, time (hours) and costs per participant, over the 3 months to
first follow-up and over the 6 months between the first and second follow-ups. Sample: complete cases (economic
data available from person with dementia and unpaid carer dyad)
Health professional visits Valid (n) Mean (CR, N= 238) SE
3 months
Number of visitsb 213 9.61 0.09
Total hours of visitsb 213 20.17 0.33
Mean duration per completed visit (hours)c 213 2.10 0.03
Costs (£)
(a) Face-to-face visits 213 523 7
(b) Preparation 213 85 1
(c) CR training and individual supervision 213 320 3
(d) Travel (time and mileage) 213 331 12
Mean cost per person (includes a–d) 213 1259 18
9 months
Number of visitsb 204 3.74 0.07
Total hours of visitsb 204 7.46 0.17
Mean duration per completed visit (hours)c 197 2.00 0.03
Costs (£)
(a) Face-to-face visits 204 188 4
(b) Preparation 204 33 1
(c) CR training and individual supervision 204 124 2
(d) Travel (time and mileage) 204 128 5
Mean cost per person (includes a–d) 204 474 10
a Data from therapy log data collection.
b Includes 12.5 minutes’ preparation time per visit and time spent travelling to visits.
c Summarised hours of contact when contact occurred (participants who did not engage in sessions over the period
were excluded).
TABLE 33 Cognitive rehabilitation delivery: cost elements (£, 2013/2014)
Training and supervision costs for professionals delivering CR
Costs (£)
Total Unit
Spend in year 1 23,347
Spend in year 2a 26,153
Spend in year 3a 39,549
Spend in year 4a 9702
4-year total 98,751.01
4-year total divided by 2970 (total sessions provided to participants)b 33.25
Weighted cost per hour of professionals delivering CR 42.70
Mileage cost per centre of a one-way journeyc Range: 3–19
a Deflated to 2013–14 prices with HCHS.
b Source: therapy log data.
c Source: professional-completed pro forma.
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Use and costs of care and support services over the period of the study
Over the 9-month period of the study, the total cost of the CR intervention (as shown in Table 35) was
£1736 (SE £25) per participant. The average total estimated health and social care costs, including the
costs of CR over 9 months, were £3998 (SE £539) in the CR group and £4556 (SE £815) in the TAU
group. Societal costs were of the order of five times higher. Again, although the mean health and social
care costs over 9 months were quite modest, there was a small number of high-cost cases in the TAU
group, with the costs exceeding £130,000. A total of eight outliers were identified following the adjusted
box-plot method: three in the TAU group, ranging from approximately £28,000 to £133,000, and five in
the CR group, ranging from approximately £31,000 to £63,000. In contrast, no outliers were identified by
this method in the societal costs.
Cost-effectiveness analyses
Outcomes and costs for the person with dementia
The raw mean outcome scores in the economic evaluation sample (Table 35) show that the CR and TAU
groups had similar scores in the BGSI attainment ratings outcomes at baseline. At 3 months, the CR group
mean score was 1.63 points (95% CI 1.27 to 1.99 points) higher than that of the TAU group. The CR
group mean score at 9 months was also higher than that in the TAU group, by 1.79 points (95% CI 1.38
to 2.20 points). The groups did not differ on any other measure.
Adjusted differences in outcomes (derived from SUR models) between the groups are given in Table 36.
The BGSI attainment ratings were significantly higher in the CR group, by 1.35 points (95% CI 1.09 to
1.64 points). The adjusted differences in other outcomes were not significantly different from zero.
The adjusted health and social care cost differences varied substantially depending on the number of
complete cases available. In the case of the BGSI attainment ratings, the costs were significantly higher in
the CR group than in the TAU group (£1474, 95% CI £59 to £2646). In the slightly smaller samples
TABLE 35 Mean costs over the study period of 9 months (£, 2013–14 prices). Sample: complete cases
Total and CR costs
Treatment group
CR (N= 238) TAU (N= 236) CR – TAU
n Mean SE n Mean SE
Mean
difference 95% CI
Health and social carea 203 3787 455 209 4485 796 –698 –2514 to 1119
CRb 203 1736 25 209 0 0 1736 1687 to 1784
Health and social care plus CRa,b 203 5523 453 209 4485 796 1038 –777 to 2853
Societalc 203 22,417 1356 209 23,290 1335 –873 –4614 to 2868
Societal and CRb,c 203 24,153 1355 209 23,290 1335 863 –2877 to 4602
a Health and social care costs for the person with dementia. The costs of the interval between 3 and 6 months within the
study period were assumed to be constant with the costs in 3 months prior to the second (9-month) follow-up.
b The costs of the CR intervention include the costs of face-to-face visits, preparation time, travel time, mileage,
CR-specific training and individual supervision. Data collected covered the full 9-month study period.
c Health and social care costs for the person with dementia; unpaid carers’ time in care and support to the participant
with dementia, lost production; time valued at minimum wage; expenditure on travel to appointments, equipment
purchases. The costs of the interval between 3 and 6 months within the study period were assumed to be constant with
the costs in the 3 months prior to the second (9-month) follow-up.
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available in the case of the GSES and QALYs (DEMQOL-U), the adjusted costs did not differ between
groups. In contrast, the between-group difference in societal costs was not significantly different from
zero in the case of any of the outcome measures; the sign on the difference was negative.
Outcomes and costs for carers
There was no difference in carer QALYs (EQ-5D-3L) between groups, as shown in Table 37. The groups did
not differ in terms of health and social care costs or societal costs, with wide CIs around the differences.
TABLE 36 Summary statistics for outcomes: person with dementia and carer, at the baseline, 3-month and 9-month
assessments. Sample: complete cases per assessment pointa
Outcome
Treatment group
CR (N= 238) TAU (N= 236) CR – TAU
n Mean SE n Mean SE Mean difference 95% CI
Baseline
Person with dementia
BGSI attainment rating 236 3.51 0.11 233 3.56 0.1 –0.05 –0.35 to 0.25
GSES 235 30.74 0.31 229 31.07 0.35 –0.33 –1.25 to 0.60
DEMQOL-U 235 0.61 0.01 232 0.59 0.01 0.02 –0.00 to 0.03
Carer
EQ-5D-3L 233 0.76 0.02 230 0.78 0.02 –0.02 –0.07 to 0.02
3 months
Person with dementia
BGSI attainment rating 213 6.06 0.14 222 4.43 0.12 1.63 1.27 to 1.99
GSES 211 30.94 0.32 219 30.5 0.38 0.45 –0.53 to 1.42
DEMQOL-U 212 0.6 0.01 222 0.59 0.01 0.01 –0.01 to 0.03
Carer
EQ-5D-3L 207 0.75 0.02 215 0.74 0.02 0.01 –0.04 to 0.06
9 months
Person with dementia
BGSI attainment rating 202 6.04 0.16 207 4.25 0.14 1.79 1.38 to 2.20
GSES 191 30.72 0.36 202 30.62 0.4 0.1 –0.95 to 1.15
DEMQOL-U 199 0.59 0.01 207 0.59 0.01 0 –0.02 to 0.02
QALY (DEMQOL-U) 197 0.45 0 206 0.44 0 0.01 –0.01 to 0.02
Carer
EQ-5D-3L 194 0.72 0.02 207 0.75 0.02 –0.03 –0.08 to 0.02
9-month QALY (EQ-5D-3L) 192 0.56 0.01 198 0.56 0.01 0 –0.04 to 0.03
a Dyads completing baseline assessments: 236 in the CR group, 233 in the TAU group; dyads completing 3-month
assessments: 213 in the CR group, 222 in the TAU group; dyads completing 9-month assessments: 204 in the CR group,
210 in the TAU group.
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TABLE 37 Outcome scores and costs at 9 months from regression estimates. Sample: complete cases
Outcome CRa 95% CIb TAUa 95% CIb CR – TAU mean difference 95% CIb p-value
Person with dementia N = 201 N = 206
BGSIc 4.57 4.36 to 4.79 3.21 3.02 to 3.41 1.37 1.09 to 1.64 0.000
Health and social cared costs 5502 4683 to 6587 4027 3126 to 5355 1474 59 to 2646 0.024
Societald costs 23,366 21,229 to 25,665 23,379 21,186 to 25,774 –13 –2661 to 2628 0.896
Person with dementia N = 190 N = 199
GSESc 20.14 19.71 to 20.56 19.92 19.45 to 20.37 0.23 –0.32 to 0.78 0.427
Health and social cared costs 5197 4415 to 6151 4169 3219 to 5576 1028 –454 to 2067 0.109
Societald costs 22,703 20,603 to 24,976 23,384 21,249 to 25,765 –681 –3259 to 1796 0.626
Person with dementia N = 196 N = 205
QALYc,e (DEMQOL-U) 0.45 0.44 to 0.46 0.45 0.44 to 0.46 0.00 –0.01 to 0.01 0.906
Health and social cared costs 5397 4563 to 6388 4286 3353 to 5672 1110 –382 to 2187 0.091
Societald costs 23,271 21,104 to 25,538 23,798 21,662 to 26,179 –526 –3108 to 1927 0.684
Carer N = 192 N = 198
QALYe,f (EQ-5D-3L) 0.56 0.54 to 0.58 0.56 0.54 to 0.58 0.00 –0.02 to 0.02 0.893
Health and social careg costs 5146 4504 to 6006 4514 3316 to 6210 632 –1058 to 1880 0.389
Societalg costs 22,896 20,912 to 24,943 23,798 21,503 to 26,361 –902 –3616 to 1705 0.592
a Estimated marginal means.
b Bias-corrected bootstrapped 95% CIs (60,000 replications).
c Estimates from outcome equation; adjusted for centre, age and sex of the person with dementia, stratified MMSE score, allocation to treatment, baseline outcome.
d Estimates from cost equation; adjusted for centre, age and sex of the person with dementia, stratified MMSE score, allocation to treatment, costs in the 3 months prior to baseline.
e QALY calculated using the area-under-the-curve method, with linear interpolation between assessment points.
f Estimates from outcome equation; adjusted for centre, age and sex of the carer, stratified MMSE score, allocation to treatment, baseline outcome.
g Estimates from cost equation; adjusted for centre, age and sex of the carer, MMSE score above or below 24 points, allocation to treatment, costs in the 3 months prior to baseline.
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Incremental costs and outcomes: person with dementia
Cost-effectiveness
The ICER point estimates are given in Table 38. The cost of an increase of 1.32 points in the BGSI
attainment rating was £1296 from the health and social care perspective and –£9 from the societal
perspective. The probability of cost-effectiveness (Figure 5) was over 99% at a WTP of £2500 from the
health and social care perspective and from the societal perspective, and over 50% at a WTP of £1300 or
more. The distribution of costs and BGSI attainment rating differences on the cost-effectiveness plane is
illustrated in Figure 6. Because the difference in health and social care costs was significantly greater than
zero and the difference in the outcome was also significantly greater, the cloud of cost–outcome pairs lies
mostly in the north-east quadrant.
TABLE 38 Person with dementia and carer: ICERa; point estimates for CR over TAU, from the health and social care
and societal perspectives
Perspective BGSIa (n= 407) GSESb (n= 389)
QALY
DEMQOL-Uc (n= 401) EQ-5D-3Lc (n= 390)
Person with dementia: 9 months
Health and social
care
1474/1.37 = 1296 1028/0.23 = 4470 1110/0.001 = 1,110,000 N/A
Societal –13/1.37 = –9 –681/0.23 = –2961 –526/0.0005 = –1,052,000 N/A
Carer: 9 months
Health and social
care
NA NA NA 632/0.001 = 632,000
Societal NA NA NA –902/0.001 = –902,000
NA, not applicable.
a Cost of achieving a 1.32-point difference between groups at 9 months.
b Cost of achieving a 1.53-point difference between groups at 9 months.
c Cost of achieving a QALY gain over 9 months; difference in QALY rounded to first non-zero decimal place.
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On the GSES, the cost of attaining an increase of 1.53 points (ICER point estimate) was £4470 from
the health and social care perspective and –£2961 from the societal perspective. The probability of
cost-effectiveness (shown in Figure 7) was 76% at a WTP of £50,000 from the health and social care
perspective and 79% at the same WTP value from the societal perspective. However, as can be seen in
Figure 8, the position of the cloud of societal cost–outcome difference pairs covers all four quadrants of
the cost-effectiveness plane such that in any quadrant, no line drawn from the origin could exclude 2.5%
of the joint cost–outcome distribution. There is no WTP at which it would be possible to be confident that
CR would be more cost-effective than TAU (or vice versa) on this measure.153
Cost–utility
The cost per QALY derived from the DEMQOL-U (ICER point estimate) (see Table 38) was £1,110,000 from
the health and social care perspective. The ICER was negative (–£1,052,000) from the societal perspective,
with the cost being somewhat lower (difference of £526, 95% CI –£3108 to £1927) in the intervention
group from this perspective. There were no differences between the groups in terms of QALY gain.
0–1 1 2
–5000
–2500
0
2500
5000
M
ea
n
 B
G
SI
 s
co
re
 d
if
fe
re
n
ce
Health and social care
Societal
Mean cost difference (£)
 Perspective
FIGURE 6 Cost-effectiveness plane: incremental costs and end-point difference for the BGSI score at 9 months
(person with dementia).
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The probability of cost-effectiveness, shown in Figure 9, was very low at all WTP values per DEMQOL-U QALY
(from £0 to £50,000) from the health and social care perspective; the probability of cost-effectiveness was just
at or under 65% for all values of WTP over the same range. As illustrated in Figure 10, the cloud of societal
cost–outcome difference pairs covers all four quadrants of the plane in approximately equal proportions,
indicating that it is not possible to be certain that either strategy is cost-effective by reference to QALY gains
at any level of WTP.
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FIGURE 8 Cost-effectiveness plane: incremental costs and end-point difference for the GSES score at 9 months
(person with dementia).
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Pr
o
b
ab
ili
ty
 t
h
at
 C
R
 is
 c
o
st
-e
ff
ec
ti
ve
0 5 10 15 20 25 30 35 40 45 50
Perspective
WTP (£000) for an additional QALY (DEMQOL-U)
Health and social care
Societal
FIGURE 9 Cost-effectiveness acceptability curve: QALY [DEMQOL-U (person with dementia)].
ECONOMIC EVALUATION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
86
Incremental costs and outcomes: carers
Cost–utility
The cost per QALY for the carer, derived from the EQ-5D-3L (see Table 38), was £632,000 from the
health and social care perspective; the ICER was negative (–£902,000) from the societal perspective,
with costs being somewhat lower in the CR group than in the TAU group (by £902, 95% CI –£3616 to
£1705). There were no differences in terms of QALYs between the CR and TAU groups. The probability of
cost-effectiveness, shown in Figure 11, was between 17% and 22% at a range of WTP per EQ-5D-3L
QALY values between £0 and £50,000 from the health and social care perspective, and approximately
74% across this range from the societal perspective. The cloud of cost–outcome pairs (Figure 12) is fairly
evenly distributed across all four quadrants of the plane, suggesting no certainty in the cost-effectiveness
of the intervention versus TAU (or vice versa) at any WTP from this perspective.
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Sensitivity analyses
We investigated the robustness of results to several key assumptions made in the base-case analyses.
Replacement costs of unpaid care
We took a replacement-costs approach to calculating societal costs, valuing unpaid carer time at the
hourly cost of a home-care worker (the raw mean costs are given in Table 32; the regression results are
given in Appendix 16, Tables 129–131). The groups did not significantly differ in societal costs, with wide
CIs of the mean difference, across samples associated with all outcome measures. However, the size of
the differences (across samples associated with the outcome measures) was much greater than in the
base case; the sign on the differences remained negative. Point ICERs were much larger for each outcome
measure. In terms of the uncertainty around the point estimates (see Appendix 17, Figures 15–18) for the
GSES score and QALYs (DEMQOL-U and EQ-5D-3L), although the probability of cost-effectiveness over the
£0 to £50,000 WTP range was higher than in the base-case estimates, we could not be confident that
the intervention was more cost-effective, given that the CEAC cuts the y-axis at the 80% or 90% level and
remains relatively flat (or declines, in the case of the GSES) over the whole range. This point is illustrated
in the cost-effectiveness plane (see Appendix 17, Figures 19–22), in which the cloud of cost–outcome
differences is distributed widely on either side of the x-axis (crossing all quadrants of the plane).
Outliers
We examined the influence of cost outliers on health and social care costs and cost-effectiveness (see
Appendix 16, Tables 132–134). The exclusion of outliers had a large impact on costs so that, although
the size of the differences associated with all outcome measures was little different from the base-case
results, these differences were significantly different from zero. The point ICER associated with the BGSI
attainment rating was similar to that of the base case; the point ICER associated with the GSES was
approximately £3000 greater. The cost per DEMQOL-U QALY (the ICER) was approximately half the size
of that in the base case; the cost per EQ-5D-3L QALY (the ICER) was one-third the size of that in the
base case.
The CEACs (see Appendix 17, Figures 23–25) and cost-effectiveness plane plots (see Appendix 17,
Figures 26–29) were similar to those produced by the base-case results for the BGSI and the GSES. On
the person with dementia and carer QALY measures, the probability of cost-effectiveness over the £0 to
£50,000 range was low, such that the probability of cost-effectiveness on the person with dementia QALY
measure (DEMQOL-U) was close to zero (the CEAC for this outcome is not presented for this reason) and
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the probability of cost-effectiveness on the carer QALY measure (EQ-5D-3L) was low, not exceeding 5%
over this range. Nonetheless, the inferences to be drawn from these results remain the same as those
drawn from the base case.
Multiple imputations
The results drawing on the 25 completed data sets produced by the multiple imputation process
(see Appendix 16, Tables 135–137) produced a larger sample (231 participants in the CR group, 231
participants in the TAU group). The magnitude of the difference between the groups in BGSI score was
very similar to the main analysis (1.35 vs. 1.37 points, respectively). As in the base case, the groups did not
differ in GSES scores; however, the coefficient for the between-group difference was smaller than in the
base case. On the person with dementia QALY measure (DEMQOL-U), the coefficient was considerably
lower than in the base-case result (0.0003 vs. 0.001); on the carer QALY measure (EQ-5D-3L), the
coefficient was slightly larger (0.001 vs. 0.003). The (non-significant) difference between groups in health
and social care costs was similar to that of the complete-case analyses of GSES score and QALYs (DEMQOL
and EQ-5D-3L). The result of the imputed data analyses was in contrast to the complete-case BGSI
attainment rating analyses results, whereby the between-group difference in health and social care costs
was significant. Societal costs did not differ between the groups, as in the base case. From the health
and social care perspective, the point ICER for the BGSI was somewhat lower than in the complete-case
analyses (812 vs. 1296); the point ICER for the GSES was slightly higher (5224 vs. 4470). The cost per
QALY for participants with dementia was more than three times higher than in the base case; the cost
per QALY for carers was twice as high as in the base case. The CEACs and cost-effectiveness plane plots
were similar to the base case; however, the probability of cost-effectiveness across the £0–50,000 range
was lower across all measures (see Appendix 17, Figures 30–37). Thus, although most of the results
were similar to the complete-case analyses, the results for the BGSI attainment rating suggest that the
intervention was more effective and no more costly.
Conclusions
There was no evidence of QALY gains for participants or carers, or of cost-effectiveness by reference to
QALY gains over a range of WTP values. As assessed in the BGSI attainment rating, the CR intervention
was cost-effective at WTP values of ≥ £2500 from the health and social care and societal perspectives.
On the GSES, there was relatively little additional evidence of cost-effectiveness over a range of WTP
values. The average cost of the CR intervention for participants over 9 months was £1736 (SE £25).
Strengths and weaknesses
The data on the care and support received by participants who finished the trial were well completed,
with few items missing in most cases. The evaluation was able to collect detailed information on both
the number and the duration of CR visits made to participants, and thereby the per-participant costs of
the CR intervention could be estimated. Cost-effectiveness analytic methods have taken account of the
correlation between the cost and outcome error terms and presented information on the cost of achieving
improvements in outcomes in light of sampling uncertainty.
The analyses encountered some issues. Cost data in the complete-case sample were skewed and there
were a number of extreme outliers in the case of health and social care costs. The analyses therefore
combined a parametric approach (SUR models, which assume normality) with non-parametric bootstrap
sampling, which makes no distributional assumptions. A large number of replications were necessary to
produce more efficient bias-corrected SEs for the cost difference in the complete-case analyses. Other
analytic models that permit a mixture of distributions for costs and effects could be investigated, for
instance, gamma-normal or gamma-beta bivariate models, estimated using Bayesian techniques.155 The
3-month costs in the interval between 3 and 6 months post baseline were assumed to be the same as the
costs between 6 and 9 months post baseline, and the total costs could be overestimated if these were in
fact more similar to costs over the initial 3 months post baseline or were rising over this interval.
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Concerns with the validity of the EQ-5D86,156,157 to reflect the HRQoL of people with dementia led us to
choose DEMQOL, a condition-specific measure, as an outcome for the economic evaluation. The authors
of the instrument recommended using the EQ-5D alongside DEMQOL,86 as they considered that the
instrument required further testing to better understand its psychometric properties. However, the EQ-5D
was not included in the battery of questionnaires, and so whether or not using that instrument would
have changed the assessment of the cost-effectiveness of the CR intervention cannot be assessed.
Emerging evidence suggests that the EQ-5D and DEMQOL capture different aspects of changes in HRQoL
over time.158 In this study, it is possible that the DEMQOL domains (social relationships, loneliness, negative
emotion, positive emotion) were better suited to the types of goals identified by participants (engaging in
conversation, knowing what is happening, keeping track of information).
We did not examine the budget impact of introducing the intervention at a national level as part of the
economic evaluation. An implementation study following on from the trial will combine the data from the
original GREAT with observational data from at least 15 participating sites to model the impact of scaling
up the intervention at local and national levels.
The BGSI is a relatively new instrument; no societal WTP threshold has been established for attaining an
improvement in the BGSI attainment rating, such as that associated with a QALY gain in the NHS in the
deliberations of the National Institute for Health and Care Excellence.159
Implications
The results indicate that in terms of achieving an improvement in goal attainment as rated by the participant,
the intervention is cost-effective from the health and social care and societal perspectives at WTP values of
≥ £2500. This achievement does not appear to have affected parallel improvements in participants’ sense
of self-efficacy, or participants’ or carers’ QALYs (assessed by HRQoL and by quality of life in dementia,
respectively) or to have reduced costs from the health and social care or societal perspectives. Considering
the QALY results, there are a few possible reasons for the apparent lack of effect. The intervention was not
expected to affect survival, so there was no reason to expect a difference between groups in the quantity of
months lived. In addition, the goals that were chosen by each individual participant would vary depending on
that individual’s circumstances and interests. The goals that were set might therefore be unrelated to the
domains covered by DEMQOL; furthermore, goals that were set by the participant would not necessarily
impinge upon domains covered by the EQ-5D, which was chosen to measure carer quality of life (e.g. the
carer’s self-care and usual activities).
Funding decisions regarding CR programmes may not be limited to cost-effectiveness in terms of the cost
per QALY gained by the participant or carer (by which measures the intervention was not cost-effective).
There is also a need to consider the value of goal attainment – the primary focus of this trial – in the
context of other information provided in this report (see the evidence on clinical effectiveness in Chapter 3).
The costs of implementing CR in the trial included the costs of substantial supervision for the therapists. In
routine clinical practice, these levels of supervision and support would be lower, thus reducing the costs of
CR. In turn, the different level of supervision and support could affect the outcomes achieved, although we
cannot examine that possibility with the data from the present trial. A follow-on implementation study of
CR delivered at scale in routine practice will provide an opportunity to examine these possibilities.
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Chapter 6 Discussion
GREAT72 has provided definitive evidence about whether individualised, goal-oriented CR is a clinicallyeffective and cost-effective intervention for people with early-stage Alzheimer’s disease or vascular
or mixed dementia and their carers. Based on both participant-reported and carer-reported outcome
measures, the CR intervention was effective in improving functioning in the areas targeted in the therapy
at the 3-month follow-up, and this improvement was maintained at the 9-month follow-up. Improvements
met the criteria for clinical significance. Furthermore, participants in the CR group were more satisfied
with their ability to carry out the everyday activities targeted in the intervention. There were no significant
effects on secondary outcome measures for either participants with dementia or their carers. However,
participants and carers who were interviewed in depth about their experience of the intervention described
improved psychological adjustment to living with dementia and a more positive perspective, reflected in
greater confidence, less anxiety, better coping, a sense of empowerment and better well-being and quality
of life. CR was relatively inexpensive, given that it was individual, home-delivered, provided by skilled
therapists and comprised up to 14 sessions, and costs would be lower without the trial-specific centralised
supervision of therapists. CR was cost-effective from both the health and social care and societal
perspectives at WTP values of ≥ £2500, in terms of achieving an improvement in participant-rated goal
attainment.
We first consider these findings in relation to our objectives and hypotheses regarding clinical and
cost-effectiveness, and in relation to other relevant literature.
Evidence on clinical effectiveness
Our main objective was to compare the clinical effectiveness of goal-oriented CR with that of TAU. Our
first hypothesis was that this personalised intervention would improve functioning in areas directly targeted
in the therapy sessions, and that this would be reflected in self and informant ratings. This hypothesis
was supported by the quantitative data, with large effect sizes. The perceived improvements were also
reflected in the interview responses. These clinically significant improvements indicate that the therapy
was perceived as having enabled participants to manage their daily lives better, participate in meaningful
activities and address personally relevant needs and goals.
Our second hypothesis was that the intervention might work through improving self-efficacy. This was not
borne out by the quantitative data, as there were no differences in self-efficacy scores for the CR and TAU
groups. However, qualitative interview data obtained from consecutive series of people completing the trial
indicated that following intervention, participants and carers experienced greater confidence and felt that
they coped better with the challenges of life with dementia. These descriptions reflect the essence of the
self-efficacy construct. This suggests that the hypothesis, although not borne out by our quantitative data,
remains worthy of further exploration.
Our third hypothesis was that carers of participants receiving the intervention, having learned new ways
of supporting and enabling their relatives, might report feeling less stressed following the intervention.
This again was not borne out by quantitative data, as there were no differences in carer scores for stress
between the CR and TAU groups. However, as noted above, in the qualitative interviews, carers reported
positive outcomes of the intervention and commented that it had helped them to be more understanding
and patient in their interactions with the participant. CR does require some effort from carers, first to
engage when they may feel that they have already tried various strategies without success and second to
support the implementation of strategies through the therapy sessions, but most carers found the effort
worthwhile. Therefore, although the specific hypothesis was not supported, it appears that carers did
experience some benefits that were not captured by questionnaire measures.
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Examination of the clinical effectiveness covered several additional secondary outcomes, which showed
changes in the pilot trial.63 The finding of no differences in cognitive test scores was unsurprising, as the
intervention does not directly seek to improve cognitive function. The finding of no differences in scores
for depression or anxiety is understandable, as only a small proportion of participants reported clinical
levels of depression or anxiety at baseline, and therefore there was little scope for the intervention
to demonstrate improvements in these domains. At the same time, it provides confidence that the
intervention did no harm. There were also no differences between the groups in quality-of-life scores
for either participants with dementia or carers.
Relating the findings on clinical effectiveness to other literature
We updated the Cochrane review covering CR during the course of the trial.15 At this time, there were no
further RCTs of CR, correctly defined, that could be included, and our 2010 pilot63 trial remained the only
available trial. At present, we are preparing to update the review again, and to this end a new systematic
literature search using the search terms and methods outlined in the published review was conducted by
the Cochrane Dementia and Cognitive Improvement Group co-ordinating centre on 9 May 2017. We used
the results of this search to check that the three potentially relevant trials published since 2013 of which
we were already aware appeared in the output, and to identify any additional potentially relevant trials,
of which we found one, published in 2017. Of these four trials, one described what appeared to be
a CR intervention, although it is also described as ‘training’,160,161 one described a mixed CR and CT
intervention162 and two described the structured training of activities of daily living; one of these variously
described the intervention as ‘cognitive rehabilitation’ or ‘cognitive training’,163 whereas the other
described the intervention as ‘structured relearning’ or ‘training’.164
The most important of these trials for present purposes is the ETNA3 (Évaluation de 3 Thérapies Non
médicamenteuses dans la maladie d’Alzheimer trial,160,161 a large trial (n = 653 participants) conducted in
France, which compared individual CR with group CT, group reminiscence and usual treatment for people
with mild to moderate Alzheimer’s disease (MMSE score of 16–26 points). Participants in the CR group
received individual 90-minute sessions weekly for 3 months and then 6-weekly for the next 21 months,
and their carers received telephone support weekly for 3 months and 6-weekly for the next 21 months.
This equates to approximately 28 90-minute sessions of CR for participants and 28 sessions of telephone
support for carers. The CT and reminiscence conditions received group sessions weekly for 3 months and
6-weekly for 21 months, whereas their carers participated in parallel-group psychoeducation sessions.
The CR intervention in ETNA3, which was delivered by psychologists, was not well described. Furthermore,
an unspecified proportion of participants in this group did not receive CR, but instead followed an
individualised reminiscence programme; the reason for this is unclear. For those who did receive CR, the
goals involved either improving an activity of daily living or maintaining a leisure activity and had to be
personally meaningful, although it is not clear how this was defined or in what way participants and
carers were involved in choosing goals. The goals to be addressed were defined in the first two sessions
and could be changed by the treating psychologist at any time. The approach used to address goals is
described as ‘training’ of particular ‘activities’, without any further explanation, so it is possible that the
intervention was closer to the structured training approaches described below than to the approach used
in GREAT.
The design of the CR intervention in ETNA3 appears to have drawn on some of our early feasibility studies,
which are cited, but the authors do not acknowledge our pilot trial, even though they cite the updated
Cochrane review,15 in which the pilot trial is discussed. In their 2013 paper,160 they incorrectly stated that
there were no published RCTs of CR, and in their 2015 paper they modified this to state that there is
‘no large RCT’. Some of our early feasibility studies focused on the possible benefits of errorless learning
techniques, building on work on this topic in the brain injury field, and these techniques were used in
ETNA3,161 in which ‘the psychologist could rely on “errorless learning procedure” to train a particular
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activity’. However, by 2008 we had accumulated evidence ourselves and synthesised other available
evidence, showing, first, that people with early-stage Alzheimer’s disease appear to learn equally well with
errorless and trial-and-error methods and, second, that even for groups for which it does convey benefits,
errorless learning is more suited to some types of task than others.59,60 Interestingly, the most recent of
the four trials identified164 also failed to take note of this evidence; the REDALI-DEM (RElearning methods
on DAily LIving task performance of persons with DEMentia) trial164 assigned participants to structured
relearning of activities of daily living using either errorless or trial-and-error instructional methods, and
found no differences between the two groups, indicating, as we would expect, that the two types of
learning strategy were equally effective.
The primary outcome in ETNA3 was survival without moderately severe to severe dementia at 2 years.
This appears to suggest that the three psychological therapies were being evaluated as disease-modifying
treatments expected to alter the trajectory of decline. This is an unusual and probably unrealistic
expectation for interventions of this kind. Not surprisingly, in ETNA3 none of the three treatments was
effective in relation to this outcome. In relation to the kinds of outcomes more typically evaluated in
trials of these kinds of interventions, evidence was already available in 2003 to show that CT is not
effective in short- to medium-term outcomes for people with dementia,14 and a recent definitive trial of
group reminiscence failed to show any benefits in primary or secondary outcomes compared with usual
treatment.165 These findings were supported by ETNA3, as neither CT nor reminiscence yielded any
benefits over usual care. With regard to CR, there was no direct assessment of functional outcomes for
the CR group, and no information is provided about whether or not goals were addressed successfully
or if any changes in behaviour or perceptions of behaviour were seen as a result of the intervention.
However, in secondary outcomes, CR was the only one of the three interventions to show any benefits
relative to usual care. Participants in the CR group had lower functional decline at 24 months, measured
on the Disability Assessment for Dementia,166 a 6-month delay in institutionalisation compared with the
usual-treatment group and lower rates of institutionalisation than all other conditions. There were no other
significant differences in secondary outcomes, but the authors noted trends in neuropsychiatric symptoms,
caregiver burden and service utilisation. The authors concluded that cognition-focused group interventions
are not effective and that individualised CR interventions should be used to delay institutionalisation for
people with mild to moderate Alzheimer’s disease.
Another trial combined CR with CT exercises and cognitive strategy training. Kim162 reported a small
trial (n = 43 participants) conducted in South Korea, in which participants with early-stage Alzheimer’s
disease (MMSE score of ≥ 18 points) were randomised to receive eight weekly sessions of either CR (n = 22)
or an active control condition (n = 21) consisting of group meetings with structured conversation and
health-related videos. The CR sessions consisted of 30-minute group CT exercises and cognitive strategy
training and 30-minute individual CR, focused on addressing a personally meaningful goal. The primary
outcome was goal performance and satisfaction rated on the COPM.38 The CR group improved significantly
in goal performance and satisfaction, and quality-of-life scores also improved, whereas participants in the
control group did not show any changes. However, this was a small trial yielding evidence of limited quality;
analyses were restricted to separate pre–post comparisons for each group using t-tests, so the results should
be interpreted with caution.
In the other two trials identified, by Voigt-Radloff et al.164 and Thivierge et al.,163 the intervention involved
structured training of activities of daily living.
Voigt-Radloff et al.164 report an adequately powered trial (n = 161 participants) conducted in Germany,
in which participants were randomly assigned to receive nine 1-hour sessions in which everyday tasks
were trained through either errorless (n = 81) or trial-and-error (n = 80) instructional methods. Up to three
sessions were devoted to choosing the tasks to work on, which were selected from a list of 43, covering
household tasks, leisure activities and cognitively challenging tasks. Task performance was assessed with
ratings based on observation. Performance improved in both groups with no differences between the two
instructional methods. There were no changes in secondary outcomes for either group. As noted above,
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this trial failed to take note of available evidence, indicating that both types of learning strategy would be
expected to be equally effective.60
Thivierge et al.163 report a small trial (n= 20 participants) conducted in Canada, using a block-randomisation
wait-list control design. This tested an intervention that was variously described as ‘cognitive rehabilitation’ and
‘cognitive training’, but appeared to involve structured training of instrumental activities of daily living (IADLs).
In this study, following assessment to identify problematic IADLs, participants and carers selected one to be the
focus of training. Participants were trained in the chosen activity twice a week for 4 weeks, using errorless
learning and expanding rehearsal methods, and they practised between sessions. Observational assessment
indicated that task performance in the trained group improved and these gains were maintained at 3 months,
but the groups did not differ on any other outcome measures on completion of the training or 3 months later.
These four trials taken together all focus on functional ability. However, they reflect two distinct approaches:
one is goal-oriented CR addressing functioning in real-life contexts and the other is a form of CT involving
structured training in and practice of everyday tasks. The appearance of a form of CT applied to everyday
functional activities suggests that the concept of CT, which describes practice on abstract cognitive tasks
completed with pencil and paper or via a computer, is being adapted for people with dementia to address
the kinds of functional activities undertaken in everyday life. However, structured training does not address
issues of transfer and generalisation of learning to the real-life setting,163,164 and the learning may never be
integrated into or used in daily life. The focus on relevant everyday tasks in these studies is very positive, but
the potential difficulty with generalisation and integration into daily life precisely illustrates the reason why
we took a different approach in GREAT and focused on improving functioning in the real-life setting with the
activities participants were actually undertaking.
In terms of effectiveness, the results from these trials confirm that the interventions produce improvements in
the specific areas targeted and clearly demonstrate that it is possible to improve functional ability for people
with mild to moderate dementia. However, with the exception of the functional disability measure in ETNA3,
the interventions have no effect on scores on secondary outcome measures, such as quality of life or carer
burden. This is consistent with our findings in GREAT. One possibility is that changes in everyday functioning
or the ability to carry out specific activities, although very important in their own right and potentially very
beneficial, simply are not associated with appraisals of quality of life or carer stress. The quality of life of
people with dementia, for example, is associated to a small degree with many different factors, and changes
in one area may have little impact overall.167 Another possibility is that changes in functional ability do have
effects in other areas of life, but we do not have outcome measures that are sensitive to these changes.
This is suggested by the responses identified from in-depth interviews with GREAT participants and carers.
These interviews were undertaken and analysed by researchers otherwise independent of the trial, to reduce
the risk of positive response bias, and it seems unlikely that participants and carers would make strong
statements about feeling more confident and better able to cope if they did not genuinely feel some benefit
in these areas alongside their observations of improved functional ability.
Evidence on cost-effectiveness
Our second objective was to evaluate the cost–utility and cost-effectiveness of goal-oriented CR compared
with TAU.
There was no evidence for cost–utility in terms of QALY gains (using DEMQOL-U for people with dementia
or the EQ-5D-3L for carers) from either the health and social care system or the societal cost perspective. By
reference to the improvement of functioning in areas directly targeted in therapy, which was the primary clinical
outcome for the trial, CR could be cost-effective from the health and social care and societal perspectives,
depending on decision-makers’ WTP for these gains in participant-rated goal attainment. These improvements
associated with CR were perceived by participants as enabling them to achieve a number of goals that were
personally relevant to them. These included better management of their daily lives and participation in activities
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that were meaningful to them. Assessed against this effectiveness measure, CR intervention is cost-effective at
WTP values of ≥ £2500 for a SMD of 1.32 on the BGSI scale.
The economic evaluation had some strengths and weaknesses, over and above those discussed for the
overall trial below. Data completion was good in relation to care and support, and there was detailed
information on the number and duration of CR visits per participant, in contrast to some other studies
(e.g. Amieva et al.161). The cost-effectiveness analyses took account of the correlation between cost
and outcome error terms, and sampling uncertainty. The cost data were highly skewed, which is very
common in dementia studies, and statistical methods were used to address the issue, although there
were a number of extreme outliers in health and social care costs, requiring a large number of replications
in the non-parametric bootstrap analyses. Because the BGSI is a new instrument, there are no established
WTP thresholds to guide the economic evaluation.
No previous studies of CR for people with dementia have looked at cost-effectiveness. There are some
studies of cognitive remediation for other groups, such as people with schizophrenia,168 that have included
cost-effectiveness evaluations, but, although they might offer some methodological pointers, their findings
are not especially relevant to the interpretation of the findings from GREAT.
From an economics standpoint, the most relevant previous study of CR for people with dementia is the
ETNA3 trial.161 Despite a number of design differences from GREAT, there are some similarities in outcome
findings between the two studies. The ETNA3 study found that CR was associated with a significant
delay in institutionalisation over a 24-month follow-up period. We did not follow up participants for the
same duration of time in GREAT, and, although the health and social care systems differ between France
(where the ETNA3 trial was conducted) and the UK, this finding of delayed institutionalisation could
suggest that some similar longer-term economic gains might be achieved with CR in the UK, even though
no differences between the CR and TAU groups were observed in health care, social care or other costs
over the 9-month study period in GREAT.
It is important to consider what outcome domains are important for different decision-makers. For people
with dementia, and indeed also their carers, improvements in personally defined goal attainment is
fundamentally important, and it is therefore clearly relevant that CR is found to be cost-effective by
reference to that outcome. For commissioning purposes, however, we did not find that CR is cost-effective
when gauged against QALY gains for either participants with dementia or their carers. It would appear
that the attainment of personally set goals did not bring about changes in those domains that are
measured in the dementia-specific HRQoL measure (DEMQOL), and it did not improve carer HRQoL
(measured using the EQ-5D).
The average cost per participant for the CR intervention was £1736. In routine clinical practice, the levels
of supervision and support would be lower than in the trial, which would reduce the cost of CR below
that observed in an experimental context. It might, however, also alter the outcomes achieved from CR.
The next steps will be to examine the effectiveness and cost of CR implementation in routine practice.
Implications for future implementation
Our final objective in GREAT was to examine how the goal-oriented CR approach could most effectively
be integrated into routine NHS provision, to develop a pragmatic approach that could be directly applied
within standard NHS services and to develop materials to support the implementation of this approach
within the NHS following trial completion.
The feasibility pilot work undertaken in the later stages of GREAT demonstrated the potential for CR to
be integrated into NHS provision and showed that improvements in goal attainment comparable to those
seen in the main trial can be achieved, even using a pragmatic approach involving fewer sessions delivered
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by less qualified staff under local supervision. The experience gained, together with the results of
supplementary and process evaluation analyses, highlights a number of issues relevant for future
implementation efforts.
Goal-setting
Goals identified by participants and addressed in therapy reflected the multiple ways in which cognitive
impairment has an impact on everyday life for people with mild to moderate dementia. Some participants
used goal-setting as a means to promote engagement in activities. Other aspects of the need for
engagement were reflected in goals focusing on keeping in contact with family and friends and engaging
in conversation. Some participants focused on managing everyday tasks and being able to use household
appliances or devices, such as mobile phones, to help conduct their daily lives and to occupy and entertain
themselves. A small number of goals focused on basic aspects of self-care, such as washing and dressing.
Many goals reflected the challenges of living with memory difficulties; participants wanted to be well
oriented, organised and better able to retain or keep track of information and events, locate belongings
and recognise, identify and name people and objects. Managing emotions was an issue for a handful
of participants.
Furthermore, a more detailed analysis of the goals participants chose will help to further develop the
therapy, especially when goals can be cross-referenced with therapy logs to illustrate the different ways
in which cognitive impairment affected functional ability, the problems that therapists identified and the
strategies therapists used to overcome or offer solutions for these problems and help participants to
achieve their goals. This will provide valuable information to support wider implementation.
It is important to note that some participants who initially expressed interest in GREAT and were assessed
at baseline did not proceed to randomisation, because they felt content with their current situation and
were unable to identify any areas of need in which they could formulate goals. CR does require active
engagement and hence will not be appropriate for everyone. However, it is possible that carers in
these cases had a different perspective and may have benefited from support in solving problems and
developing strategies. In clinical practice, there may be opportunities to work directly with carers under
these circumstances, even if the person with dementia does not wish to engage.
Perceptions of participants and carers
The low attrition rates and good adherence rates, together with the positive evaluations recorded in the
qualitative interview data, suggest that the therapy was very acceptable to those participants and carers
who opted to take part. In addition to the specific focus on improving everyday functioning and the
opportunity to develop new or more effective strategies, they valued the person-centred approach, the
relationship they developed with the therapist and the support this provided. The strong emphasis on
the therapeutic relationship as the vehicle for change is instructive in terms of future implementation.
Some people with dementia and their carers may be able to make use of information about the approach
and strategies they could use to engage in self-management, but most are likely to require input from a
therapist who can build trust and provide support in finding solutions to everyday challenges.
The qualitative data revealed some areas in which participant and carer perceptions might have been
managed better. First, a few people were disappointed that, although the intervention improved functioning,
it did not improve memory. CR was not presented as an intervention to improve memory or cognition per
se, and indeed this is something that would have been made explicit from the start. Possibly this was not
sufficiently explained in some cases, or perhaps it may have needed to be emphasised more throughout the
therapy. Second, a few carers wondered if it was worthwhile intervening, given that dementia would progress
anyway. This is a completely understandable reaction from carers who are facing, and perhaps grieving over,
the gradual decline they observe in their relative, but also suggests that the aims of rehabilitation and what it
can realistically achieve may have needed more explanation in some cases in order to convince carers of the
value of optimising functioning and reducing excess disability at any stage of dementia. It will be important to
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ensure that these messages are conveyed effectively in any future implementation, so that people with
dementia and their carers have realistic expectations about what CR can help them to achieve.
Challenges in delivering the intervention
Therapists were able to deliver the intervention in line with the protocol. They could successfully engage
participants and carers, explain the rationale for the CR approach and conduct individually tailored
interventions, addressing goals that participants and carers identified as relevant and meaningful. Therapists
in GREAT faced the challenge of working with goals that had been set prior to their first meeting with the
participant and carer as part of the baseline assessment. In clinical practice, and hence also in any future
implementation, goals would typically be negotiated during the initial sessions with the therapist. Therapists
noted the importance of being able to explain the therapy approach and the kinds of strategies used in a
way that was accessible to participants and carers.
Therapists were expected to, and did, draw on their wider clinical skills and experience by developing good
therapeutic relationships, managing relationship conflict between participants and carers when this emerged
during sessions, providing information and, when necessary, making onward referrals, for example to social
services. These non-specific elements of the therapy need consideration in preparing therapists to work in
this way in any future implementation, especially when CR is delivered by less qualified staff, and need to be
taken into account in training and in providing appropriate supervision arrangements.
Identifying who is most likely to benefit
Rehabilitation focuses on ‘doing with’ rather than ‘doing for’ or ‘doing to’.21 For people in the early stages of
dementia, CR requires some degree of active engagement. This implies that participants need to be able to
identify something that they would like to change, improve or manage better. It is not necessary for them to
acknowledge a specific dementia diagnosis or even the full range of difficulties they may be experiencing,
but there needs to be something that they want to work on. This is not the case for everyone. We have
conducted detailed investigations of the awareness of difficulties among people with dementia; these show
that a small proportion of people with dementia are unwilling or unable to acknowledge any difficulties169
and a larger proportion underestimate the impact of memory problems,47 although there is some evidence
that people with early-stage dementia are more accurate in estimating their own functional ability than
their carers.48 Even when difficulties are acknowledged, people may have reached an acceptance of these or
may not wish to make the effort required to bring about changes. Approximately 5% of the people with
dementia assessed at baseline said that they were content with their situation and could not identify any
areas in which they felt changes were needed, and hence did not proceed to randomisation. Participants
joining GREAT were able to identify areas for improvement and to evidence some motivation for change.
Nevertheless, goal-setting could be challenging for some individuals, who required more time and support to
identify suitable goals. As noted above, although in the trial goals were set as part of the initial assessment
by the researcher, in usual practice, goals would be negotiated by the therapist and could evolve over a
number of therapy sessions, making this process more accessible.
Exploratory statistical analyses revealed few predictors to indicate those participants who were likely to
show the greatest gains in goal attainment. Ratings of readiness to change at baseline and the number
of sessions completed were associated with greater gains. At 3 months, participants from professional
occupational backgrounds had better outcomes than those from other occupational groups according to
both participant ratings and carer ratings. At 9 months, the MMSE score was predictive, and participants
with MMSE scores of ≥ 24 points had better outcomes according to both participant ratings and carer
ratings than those with MMSE scores of ≤ 23 points, whereas participants aged < 75 years did better than
those aged ≥ 75 years according to participant ratings only. Centre, sex, diagnosis, medication use and the
presence of comorbid conditions were not linked to outcomes.
Data from the therapy logs analysis supplement these findings and suggest that participants with the best
outcomes tended to have relatively good cognitive and functional ability, to be socially and physically active
and to be highly motivated. These participants were likely to acknowledge their difficulties and express
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anxiety about the impact of these, and to focus on challenging goals relating to IADLs or increasing
engagement in social or leisure activities, and progress was evident early in the course of therapy.
Participants who made the least progress were likely to have more extensive cognitive and functional
difficulties and lower motivation, and were less likely to acknowledge difficulties or express anxiety about
them. For these participants, goals were more likely to relate to basic activities of daily living, and progress
followed a slower trajectory.
In GREAT, participants had to have a carer who was willing to contribute, so that we could obtain collateral
information, such as carer ratings of goal attainment. However, in naturalistic settings, people with dementia
may not have a carer or may have a carer who is not able to support the intervention. This would not preclude
them from engaging in CR, but it would be an important factor for the therapist to consider when planning
the intervention.
Differing levels and types of need
In discussing their work in the focus group, the therapists seemed to distinguish different groups of
participants based on levels of cognitive and functional ability and on time since diagnosis. These different
groups were perceived to have different needs and to respond differently to the intervention. Participants
who had received a dementia diagnosis in the previous few months, and their carers, were in the process
of adjusting to dementia and were actively seeking strategies and solutions to help to manage their
everyday lives. Those who had been living with dementia for longer tended to have adapted to living with
the condition and to be less motivated to make changes, and in some cases carers felt that they had
already tried various strategies without much success. Although participants in this latter group also
benefited, working with these participants presented more of a challenge for the therapists.
This provides valuable guidance on how to target the CR intervention in future implementation. Participants
in GREAT had mild to moderate dementia, but this broad grouping encompasses a wide range of cognitive
and functional ability. In terms of UK NHS care pathways, it spans both the cluster 18 cognitive impairment
(low need) and cluster 19 cognitive impairment (moderate need) care clusters. The principles of CR can be
applied in different ways to optimise functioning, depending on need, and somewhat different approaches
are likely to be required for different groups. The protocol used in GREAT, although applied effectively with
both groups, appears to have been seen by therapists as more suitable for ‘cluster 18’ participants.
Cognitive rehabilitation may be a particularly valuable approach for people in the months following a
dementia diagnosis and could represent an important component of post-diagnostic support within the
first year of being diagnosed. For this group, the aim would be to support people in remaining active and
engaged, maintaining confidence and developing a range of strategies to support practical and emotional
coping. An additional element for some, although not attempted in GREAT, might be vocational rehabilitation
to support continuation in employment or transition to less demanding employment or voluntary roles.
For people who have been living with dementia for longer, the aims may be more about maintaining basic
skills of daily living, limiting the effects of excess disability, encouraging people to remain socially engaged
and ensuring opportunities to participate in pleasurable activities. As these individuals may find it harder to
identify goals, carers are likely to be more involved in the goal selection process. An additional element for
some might be the use of CR to support people with dementia who are returning home after a period of
hospitalisation caused by illness or injury, or who have additional physical or mental health conditions.
This highlights the need for flexibility in applying the principles of CR to support optimal functioning for
people with dementia. Although GREAT followed a structured protocol, CR itself is not a fixed intervention
and can be adapted to different contexts to meet a variety of needs.3 Although the number of sessions
was fixed for the trial, in practice the duration of the intervention could vary and could be tailored to
participants’ needs. Some individuals may need only one or a few sessions to address specific issues,
whereas others may need longer periods of support to develop and implement strategies, or perhaps
to regain function after a period of illness or hospitalisation. Some may benefit from several short episodes
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of CR as their needs change over time. In the pilot work on implementation that we conducted in NHS
sites, we trialled shorter, 6- and 8-session protocols as a starting point. However, experience with GREAT
suggests that the group of people defined as having early-stage Alzheimer’s or vascular or mixed dementia
could be further subdivided into two broad groups reflecting differing degrees of dementia progression.
In future implementation, it will be important to prepare CR intervention protocols that meet the needs of
each of these groups, to identify optimal timing and duration, and to explore outcomes accordingly.
Limitations
Some limitations relating to trial design, outcome measures and participant inclusion criteria must be
acknowledged.
Trial design
This was a pragmatic trial comparing CR with TAU. This design did not provide a means of controlling for the
time and attention provided by the therapist, raising questions about whether treatment gains are specific to
the therapy or non-specific. In this instance, however, the gains observed related specifically to the effects of
CR and were demonstrated in improvements in goal attainment for goals directly targeted in the therapy. It
is unlikely that these could be attributed to non-specific effects of the intervention. Furthermore, in the pilot
trial, CR demonstrated effectiveness when compared with an active control condition, relaxation therapy,
with an equivalent number of therapist visits as well as when compared with TAU.
In trials of behavioural interventions that involve active participation and engagement, it is not possible for
participants to remain blind to their group allocation, especially when, as in this case, the intervention is
compared with TAU, and this creates the potential for bias in responding on self-reported outcomes. The
inclusion of parallel carer ratings may go some way towards mitigating this concern. Furthermore, if bias were
present, we would expect to see it on all self-reported measures, and not just the ratings of goal attainment.
All possible precautions were taken to ensure that researchers collecting follow-up data remained blind
to participants’ group allocation. However, effective blinding is extremely difficult to achieve in trials of
psychosocial interventions that do not include an active control condition. Despite all precautions taken,
researchers conducting assessments are likely to surmise whether or not the participant received the
intervention, as was the case in GREAT. It could possibly be argued that the statistically significant
association of blinding inefficiency with greater improvement in BGSI ratings at follow-up could reflect
researcher bias. However, it is more plausible to consider that the ability of the researchers to correctly
identify which participants had received the intervention reflects the close relationship between the CR
therapy and the outcome measure. The BGSI provides a proximal measure of treatment outcome that
directly assesses whether or not the intervention addressed its intended targets. Participants who received
CR would be expected to be more engaged with the personal goals identified and to remember them
better. These participants would also have made ratings of progress with these goals in sessions with the
therapist. Therefore, it is likely that if a participant had engaged well with the CR intervention and derived
benefit from working on the identified goals, this would have been evident when making the BGSI ratings
in the follow-up assessment, and consequently the researcher would have been able to correctly identify
the participant’s group allocation. Conversely, if it was not evident to the researcher that a participant
who received CR was allocated in this way, it is likely that the participant was less engaged with the goals
identified in the BGSI and that the treatment was less effective.
Outcome measures
Primary and secondary outcomes in GREAT were evaluated mainly through participant-reported outcome
measures, with collateral information from carers. This was a positive choice, aiming to foreground the
perspective of people with dementia and carers. It was also a practical choice, because participant
numbers and the focus on behavioural change in real-life situations precluded observational assessment as
a means of evaluating therapy outcomes, and because, as CR was not expected to be a disease-modifying
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treatment, there was no particular justification for the use of physiological markers. The pilot trial63
included a neuroimaging component, which examined whether or not participation in therapy was
associated with changes in particular brain areas seen on functional MRI; the findings were difficult to
interpret, especially as only 28% of participants were able or willing to undergo MRI scanning, but some
differences in activation patterns between CR and control participants were found following intervention,
suggesting that the intervention produced a degree of restoration of function in frontal brain areas.66
Physiological markers, therefore, may have some relevance, but the crucial question is a behavioural one:
whether or not we can improve functioning in everyday life to enable people with dementia and carers
to manage everyday life more effectively and with greater satisfaction. For the present trial, therefore,
the focus was on behavioural change and on the perceptions of participants and carers.
The primary outcome measure, the BGSI, proved sensitive to changes resulting from the intervention. This
used a valid and reliable rating method and participant responses were corroborated by the independent
carer ratings. Ratings were collected by a blinded researcher not involved in the therapy, and given that
scores on secondary outcome measures showed no changes, it is unlikely that changes in BGSI ratings in
the CR group reflected a positive response bias. As discussed above, it is possible that secondary outcome
measures were not sensitive to other changes resulting from the therapy. One limitation in outcome
measurement is the lack of inclusion of a measure of functional ability. We did not have scope to include a
long-term follow-up to assess whether or not the intervention had any impact on rates of institutionalisation.
In future trials, this is more likely to be feasible through the use of routine data and data linkage, but this
option was not available to us when designing GREAT.
Participant selection
Because of the need for collateral information, we excluded any potential participants who did not have a
carer available to contribute. This will have encompassed those who had a carer who was unwilling to
contribute and those who had no carer involved and were perhaps living alone. People with dementia in
either of these groups may be most in need of psychosocial support, and in clinical practice it would be
important to be able to offer CR in these circumstances. Consideration would need to be given to the best
way of providing CR when there is no carer involved; this could include options, such as working with
volunteers or incorporating between-session contact with the therapist, as a means of supporting practice
with targeted activities.
Participation was restricted to people with Alzheimer’s disease or vascular or mixed dementia. Although
this accounts for the majority of dementia diagnoses,74 people with other forms of dementia also have
needs that could be addressed through CR. Although GREAT was in progress, we undertook a pilot trial
with people who have either Parkinson’s disease dementia or dementia with Lewy bodies.170,171 This pilot
trial replicated the methods used in our pilot trial of CR63 and yielded similar results. This indicates that CR,
in a similar form to that used in GREAT, is feasible and potentially effective for people with dementias
associated with Parkinson’s disease, and provides justification for a larger trial.172 There is scope for future
exploration of the adaptation of CR for people with other rare dementias.
Strengths
Alongside these limitations, it is important to bear in mind the strengths of the trial. It included a diverse
group of 474 people living with early-stage dementia and their carers, and attrition was low. The trial
was conducted in eight regions of England and Wales, encompassing both urban and rural contexts,
with consistent results across the eight centres. The intervention targeted real-life situations and aimed to
improve participants’ functioning in areas that were meaningful to them and that would make a difference
in their daily lives, avoiding any problems relating to lack of transfer or generalisation of effects. The
primary outcome measure was a proximal measure of outcome, directly evaluating perceptions of change
in the areas targeted in the intervention, and demonstrated that the intervention led to improvements in
ratings of goal attainment, with large effect sizes.
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Next steps
Building on the findings from GREAT, we will explore further the potential for implementation in health
and social care services offering support to people living with dementia in the early stages, with similar
profiles to those involved in the trial. We have secured implementation grant funding, which will enable
us to begin this process, starting in 2018. To support the implementation, we will develop materials,
resources and training programmes. We will work with a number of partner organisations, including NHS
Trusts, local authority and non-profit social-care providers to identify implementation plans, facilitate
adoption of the approach into routine practice and evaluate clinical and economic outcomes. We also aim
to explore further the effectiveness of CR for people with dementias associated with Parkinson’s disease
and the possible adaptation of this approach for people with other rare forms of dementia.
Conclusions
GREAT has demonstrated that individual, goal-oriented CR is clinically effective in enabling people with
early-stage Alzheimer’s disease or vascular or mixed dementia to improve their everyday functioning in relation
to individual goals targeted in the therapy. This approach can facilitate the process of adjustment to living
with dementia and increase confidence in managing the challenges dementia brings. The trial adds further
evidence to support the view that individualised interventions that can be tailored to the particular current
needs of people with dementia and their carers, and address these in a real-life context, offer important
benefits. CR represents an important contribution to improving the choice of interventions available to support
people living with early-stage dementia and addressing the ‘psychosocial intervention gap’.1,2
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Appendix 1 Topics recorded by therapists in the
therapy logs
Therapy log topic Therapist ratings or comments recorded under relevant sessions
Compliance Whether or not given session was completed
Relationships The relationship the therapist developed with the participant and the carer, and the relationship
between the participant and the carer
Goals Participant and carer responsiveness to the solution-focused problem-solving approach
Goal 1: agreed strategies, between-session practice and progress
Goal 2: agreed strategies, between-session practice and progress
Goal 3: agreed strategies, between-session practice and progress
Any adjustments or modifications to goal statements provided at baseline
In-session goal attainment ratings by participant, carer and therapist (sessions 10 and 14) and
comments on these
Selection of goal attainment scaling indicators for each goal (sessions 10 and 14) and comments
on these
Activity levels Review of activity levels, plan for behavioural activation to increase activity engagement and
comments on progress
Compensatory
strategy use
Review of the current use of compensatory strategies and environmental adaptations, plan to
develop strategy use and comments on progress
Restorative strategy
use
Response to information about restorative strategies, plan for developing restorative strategy use
and comments on progress
Attention and
concentration
Strategies introduced to help maintain attention and concentration, and progress with applying
these strategies
Anxiety management Current use of anxiety-management strategies, carer’s perspective on the participant’s use of
these strategies, introduction or refinement of anxiety management technique(s) and progress
with use of anxiety-management strategies
Carer well-being Review with carer, and plan for enhancing carer well-being
Carer involvement The extent to which the carer was engaged in supporting the process of therapy
Ending therapy Plans for maintaining progress after the end of the intervention, and review of other sources of
help and support
Experience of therapy Review with the participant and with the carer, and therapist reflection on the process of therapy;
therapist confidence in addressing participants’ goals (following the 9-month follow-up)
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Appendix 2 Interview schedule for exploring
participant and carer experience of the GREAT
intervention
Interview schedule for the person with dementia
The interview will take form of a conversation and the interviewer will encourage the participant to talk
freely about the experience of the CR intervention.
The researcher will begin by re-establishing consent for the interview and for audio-recording.
The researcher may begin with some general conversation to build rapport as appropriate.
The researcher will introduce the main part of the interview by saying:
You’ve been taking part in the GREAT study and having visits from the therapist, and I’d like to know
your views on what it was like. I’m interested in what it was like to take part in the study and how you
found the visits from the therapist.
Experiences
The researcher will explore the participant’s experiences and feelings starting with general questions:
How did you find the therapist’s visits over the past few weeks?
What was it like to work with the therapist on your goals?
More specific information will then be elicited using prompts, such as the following:
What were the more enjoyable things about your work with the therapist?
What were the less enjoyable things about your work with the therapist?
What aspects of your work with the therapist were more/less helpful?
Did you find it hard work to take part in the therapy?
What aspects of your work with the therapist were most challenging?
The interviewer will encourage the person to give specific examples, when possible.
Outcomes
The researcher will explore the impact of taking part in CR on the person’s everyday life and self-perceptions.
What difference (if any) has your work with the therapist made to your daily life?
Has the experience changed anything in the way you think about your dementia/about yourself/about
the future?
Has the experience changed anything in the way you relate to your carer/family?
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The researcher will draw on positive comments from the participant to end the conversation on a positive note.
Interview schedule for the carer
The interview will take the form of a conversation and the interviewer will encourage the carer to talk
freely about the experience of the CR intervention.
The researcher will begin by re-establishing consent for the interview and for audio-recording.
The researcher may begin with some general conversation to build rapport as appropriate.
The researcher will introduce the main part of the interview by saying:
[Your relative] has been taking part in the GREAT study and having visits from the therapist, and I’d
like to know your views on what it was like. I’m interested in what it was like to take part in the study
and how you found the visits from the therapist.
Experiences
The researcher will explore the carer’s experiences and feelings starting with general questions:
How did you find the therapist’s visits over the past few weeks?
How do you think [your relative] felt about working with the therapist on his/her goals?
More specific information will then be elicited using prompts, such as the following:
What were the more enjoyable things about working with the therapist on [your relative’s] goals?
What were the less enjoyable things about working with the therapist on [your relative’s] goals?
What aspects of working with the therapist were more/less helpful?
Do you think [your relative] found it hard work to take part in the therapy?
What aspects of working with the therapist were most challenging?
The interviewer will encourage the person to give specific examples, when possible.
Outcomes
The researcher will explore the impact of taking part in CR on the person’s everyday life, and the
perception of the person with memory difficulties.
What difference (if any) has the therapy made to your daily life?
What difference (if any) has the therapy made to [your relative’s] daily life?
Has the experience changed anything in the way you think about [your relative’s] memory difficulties/
about [him/her]/about the future?
Has the experience changed anything in the way you relate to [your relative]?
The researcher will draw on positive comments from the carer to end the conversation on a positive note.
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Appendix 3 Feasibility of implementation
In the later stages of the trial, the GREAT team undertook to explore the feasibility of implementing theCR approach within NHS services. This was an opportunity to examine the challenges that could arise
when translating the intervention to a real-world setting and to consider how these might be overcome to
facilitate successful implementation. The aims of this feasibility project were to:
l explore how best to approach the training of staff to enable them to offer CR
l explore how goal-oriented CR can best be incorporated into practice
l evaluate the effectiveness of the intervention for people with dementia and their carers under these
circumstances
l understand the views of the therapists delivering the intervention
l identify lessons learned to inform future implementation work.
Three sites were involved: Bangor, Birmingham and Kent.
Implementation methods
At the Bangor site, the Occupational Therapy Service within the Betsi Cadwaladr University Health Board
Older People’s Mental Health Directorate expressed interest and was identified as a suitable service to
provide the intervention. OTs and technical instructors (TIs) from the service attended a 1-day training
event in May 2016, facilitated by the GREAT therapist and researcher. Following training, 10 OTs and
their linked TIs from different memory clinics across Betsi Cadwaladr University Health Board offered the
intervention to a total of eight service users. Based on early feedback from the OTs, the intervention was
adapted from the 10 sessions used in the trial so that it could be delivered in either six sessions or eight
sessions. Typically, the OT undertook initial assessment and goal-setting, supervised the TI in conducting
the intervention and evaluated the outcome. Specialist supervision and support were provided to all OTs
and TIs involved by the GREAT therapist with the support of the GREAT local PI.
At the Kent site, staff from Kent and Medway NHS Partnership Trust were offered a 1½-day training
course. Six staff members completed the course: one OT, one OT assistant, two community psychiatric
nurses (CPNs) and two support workers. Following training, four staff members each worked with one
service user and one worked with two; one did not implement CR as a result of workload pressures.
The intervention was offered in the form of six weekly sessions followed by two fortnightly sessions,
with two fortnightly follow-up telephone calls. Small group supervision was provided and specialist advice
was available from the GREAT therapist on request. It should be noted that this site, having joined GREAT
at a late stage, overcame particular time constraints to join the feasibility study.
At the Birmingham site, eight OTs from Birmingham and Solihull Mental Health NHS Foundation Trust
participated in training workshops and were keen to try out the approach in practice. However, around
the time the workshops were delivered, the trust unexpectedly introduced a reorganisation of work roles
and proposed to downgrade all OTs, leading to uncertainty and loss of morale. As a result, the trained OTs
were not in a position to proceed with the implementation pilot.
Format of the intervention
The intervention delivered during the feasibility pilot in Bangor and in Kent followed the key principles
of the GREAT intervention: individualised, evidence-based rehabilitation, addressing needs through
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identification of personally meaningful goals that were SMART. The core element involved work on up to
two personally meaningful therapy goals, based on a problem-solving approach and using compensatory
and restorative strategies as appropriate. Additional content was provided in modular form and could
be selected or omitted depending on the needs of the person with dementia. These additional modules
covered behavioural activation to increase activity levels, emotion regulation and anxiety management,
improving attention and concentration, work on a further personal goal, identification of local sources of
support and a focus on carer well-being. In general, work focused mainly on personal goals, augmented
by other approaches when relevant.
The service users receiving CR ranged in age from 58 to 90 years and were diagnosed with either Alzheimer’s
disease or vascular or mixed dementia. Although the trial required the involvement of a carer who could
provide collateral information on progress and outcomes, in this clinical implementation we included people
with dementia who did not have support available from a carer or a friend.
Outcomes for participants
The CR therapists used the BGSI as a means of enabling participants to identify goals and eliciting ratings
of progress toward goal attainment. Ratings for each goal were made independently by participants, carers
(when available) and therapists at the start and end of therapy. To support the therapists in evaluating the
intervention, at the initial assessment, participants completed the Addenbrooke’s Cognitive Examination –
Third Revision (ACE-III) and DEMQOL, and carers completed the RSS. The DEMQOL and the RSS were
completed again on completion of the intervention.
Results
The results provided by the Bangor and Kent sites are presented below.
Bangor
Eight participants with dementia, five of whom were female, received the intervention. Five had a diagnosis
of Alzheimer’s disease, one had a diagnosis of vascular dementia and two, although known to have dementia,
were still awaiting a specific diagnosis from the memory service. Those with a diagnosis had received this
within the previous 12 months. The mean ACE-III score was 71 points (range 62–78 points). Six participants
had a carer involved; the carers were five spouses and an adult child. Five participants received a six-session
intervention and three received an eight-session intervention.
Participants identified a total of 16 goals: two identified one goal, four identified two goals and two identified
three goals. The goals included learning to use new technology, remembering names and activities undertaken
or planned, locating items around the house, orientation to the current day and date, planning activities and
engaging in social contact and community activities.
Participant and therapist pre- and post-intervention ratings of goal attainment and satisfaction with attainment
were available for 13 goals. Carer ratings were available for nine goals. Mean scores improved significantly
post intervention, as shown in Table 39. Scrutiny of individual goals indicated that a clinically meaningful
improvement of at least 2 points was obtained for attainment of 12 out of 13 goals as rated by participants.
Occupational therapists and TIs also rated the extent of goal attainment post intervention by matching
current functioning to the goal statements and goal attainment descriptors identified at the initial
assessment. Nine out of 16 goals (56%) were rated as fully achieved, six were rated as partially achieved
and only one was rated as not achieved.
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The mean DEMQOL scores, when available (n = 7), increased from 90.29 (SD 12.55) at initial assessment
to 96.14 (SD 6.47) at the end of the intervention, reflecting more positive ratings of quality of life, and the
mean RSS scores (n = 6) decreased from 16.5 (SD 3.51) at initial assessment to 13.5 (SD 5.68) at the end of
the intervention, reflecting lower levels of stress. However, the small numbers precluded statistical analysis.
Kent
Outcome information was available for five of the six service users included. Between them, these five
service users worked on eight goals. BGSI attainment ratings were made by service users for all eight goals,
by carers for seven goals and by therapists for four goals (two participants). The mean initial attainment
ratings by service users were 3.13 (SD 1.46) and the mean post-intervention ratings were 7.75 (SD 0.89),
reflecting a significant improvement [t(7) = –6.56; p < 0.001]. Carers’ mean initial attainment ratings were
3.43 (SD 1.27) and their mean post-intervention ratings were 7.86 (SD 1.07), which was a significant
improvement [t(6) = –7.75; p < 0.001]. Therapists’ mean initial ratings were 2.75 (SD 0.96) and their
post-intervention ratings were 8.25 (SD 0.96), again reflecting a significant improvement [t(3) = –8.52;
p < 0.05]. Service user satisfaction ratings improved from a mean of 2.88 (SD 0.99) at initial assessment to
8.13 (SD 0.83) post intervention, also reflecting a significant change [t(7) = –9.98; p < 0.01]. Carers’ scores
for stress decreased only minimally from 36.67 (SD 17.01) at initial assessment to 36.33 (SD 11.93) post
intervention, and this was non-significant.
Service users’ experience of the intervention
At the Bangor site, at the end of therapy, participants and carers were asked to complete a questionnaire
about their experiences and return it to the GREAT therapist in a prepaid envelope. Four responses were
received. Comments were sought on both helpful and less helpful aspects of the intervention. No unhelpful
aspects were identified. The responses suggested that the intervention had a positive impact on participants’
lives in various ways:
l I’m using the strategies to help in my everyday life.
l Getting back to some of the things I had stopped doing. Restarted my painting.
l Knowing there is help if we need it.
l Strategies to help memory retrieval, and ways to remember new things.
l Getting my wife to put down the day and date each day as part of a reminder each day. Similar
notes or reminders could be useful with our everyday tasks.
l Goals were something to work towards. Gave great satisfaction.
Feedback from the Kent site indicated that the most important benefit that service users mentioned was
an increase in confidence.
TABLE 39 Bangor Goal-Setting Interview goal performance and goal satisfaction ratings during implementation at
the Bangor site
Rating
Intervention
Statistical comparison
Pre Post
n Mean (SD), range n Mean (SD), range
Service user goal attainment 13 3.23 (1.83), 1–6 13 7.54 (1.98), 3–10 t(12)= –7.018; p< 0.005
Service user satisfaction 13 3.38 (1.98), 1–7 13 8.15 (1.51), 5–10 t(12)= –7.315; p< 0.005
Carer goal attainment 9 3.33 (1.73), 1–6 9 7.44 (1.74), 5–10 t(8) = –5.094; p< 0.005
Therapist goal attainment 13 2.38 (1.26), 1–4 13 7.85 (2.12), 4–10 t(12)= –8.309; p< 0.005
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Staff members’ experience of delivering the intervention
At the Bangor site, views of the OTs and TIs were sought at two time points. Following the training day,
they were asked to give their views on the training and orientation to the intervention via an anonymous
questionnaire. All found that the training was informative, easy to follow and pitched at the right level,
with useful materials provided. All felt that they would be able to apply what they had learned. Most felt
that adequate time was provided, but one would have liked more time for discussion. They felt that
completing the 1-day training in a single session was quite intensive and preferred the idea of training
being split over two half-days.
On completing their work with the feasibility pilot, the OTs and TIs were invited to complete anonymised
questionnaires reporting on their experiences of learning about and delivering the intervention, and to
share their experiences in a group discussion with the supervisor.
The therapists initially found it challenging at the start to get to grips with something new, and most had
taken the therapy resource materials home to study in their own time. However, once they had begun to
use the approach, they quickly became keen on working in this way and saw it as something that they
wanted to be involved in:
It’s what we joined the profession to do, actually do interventions with people.
They thought that the goal-setting process was useful, finding that it gave focus to the intervention,
facilitated the process of change for participants and family members and was a valuable source of
feedback. The intervention could make participants feel valued in that someone was taking the time to
help, and could create opportunities for carers to respond more positively to the person with dementia.
Positive responses from participants and carers stimulated the therapists’ enthusiasm:
It’s so rewarding, each time I went they were full of praise.
They felt that the intervention was of an appropriate length, although they could sometimes have
continued working for longer as additional needs emerged. Some found the modular approach confusing.
The therapists uniformly disliked paperwork and preferred not to use questionnaires to evaluate outcomes.
All were convinced that there was a service need for this kind of intervention to be more widely available:
We’re going out and seeing a lot more people that we could be doing it with, but with time restraints
and waiting lists and other work commitments, there’s just not the time to be able to do it with them
all is there. It’s such a shame.
They indicated that time constraints and existing workloads would make it difficult to continue using the
intervention, especially given current staff shortages, and that they were looking into ways of being able to
sustain their work; for example, one TI was introducing goal-setting into an existing group, one OT and TI
pair were putting together a business case for more TI hours and one TI was actively seeking to have CR
included in her role.
At the Kent site, the views of staff were obtained, first on the training and support provided and second
on delivering the therapy. Staff found the training helpful and the ratings at the end of training indicated
that they felt reasonably confident to start delivering CR. However, they found the training very intensive
and would have preferred it to be split over several days. They also felt that additional, or ‘refresher’, sessions
would have been useful once they were providing CR. They valued the small group supervision and access to
specialist advice. Reflecting on the experience of delivering CR, staff found the process of developing goals
that were genuinely important to the service user very helpful in focusing their work, and felt that this added
to their skills and transferred to other areas of work. They noted how service users increased in confidence,
and found it very motivating to see this positive change and receive positive feedback from service users
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and carers. Some commented that doing CR made them feel like a ‘proper OT’ or a ‘proper CPN’ again.
They were unsure about the value of adding follow-up telephone contacts and felt that this was helpful for
some service users but less so for others who struggled to use the telephone or were difficult to reach by
telephone. Some staff found the dual role of delivering therapy to service users for whom they acted as care
co-ordinator challenging.
Lessons for future implementation
This feasibility pilot has demonstrated that delivery on the ground can achieve improvements in goal
attainment comparable to those observed in the main trial, even with a considerably shortened
intervention period. The approach clearly appeals to staff and offers them the opportunity to work in a
way that they feel meets their professional aspirations, and the positive benefits they observe in service
users enhance motivation and morale. The pilot has also provided valuable insights into what will be
required to implement CR in routine clinical practice. These are discussed below.
Training
Sufficient time is needed for initial training to enable staff to assimilate new information and engage with
the approach. Staff prefer training spread over several days in shorter sessions rather than intensive 1- or
2-day workshops. Staff also need some study time to review training materials and consolidate their learning.
Training needs to be flexible to take account of different staff backgrounds and levels of experience, and
some types of staff will need more input than others. It may be helpful to provide follow-up training sessions
once staff are engaged in delivering CR. With regard to the content of training, it is important for staff to
understand how CR is different from their current everyday practice. Some staff may feel that they already
set treatment goals and suggest strategies, and need to understand how this differs from the goal-setting
and strategy application approaches used in CR, which is a more detailed and collaborative process based on
careful assessment of intrinsic capacity, current ability and task demands, and which uses a problem-solving
approach to identify goals and possible solutions and expresses goals in clear behavioural terms. Providing
staff with a checklist to use following training, to remind them of what they should be considering in their
work, may help to enhance and maintain adherence to the therapy model.
Supervision
Staff find supervision and access to advice extremely helpful and it is important that time is allocated
for staff to participate in supervision, especially in the early stages of familiarisation with the approach.
Intervention
The adaptation to a six- or eight-session format worked well, and increasing the length of time between later
sessions, for example by moving from weekly to fortnightly sessions, may be helpful. Telephone follow-up
was helpful in some cases but not others, and should be used flexibly. The modular protocol was intended to
allow for individual tailoring, but requires revision to enable staff to utilise the available guidance to tailor
the intervention optimally for each person. It will clearly be important to limit ‘paperwork’ and recording
requirements, and to ensure that any evaluation is not burdensome.
Service users
As with participants in the main trial, service users differed in the extent to which they were able to identify
goals and in their motivation to make changes. It is important to be able to identify those service users who
are likely to benefit from CR and, equally, to be able to offer other, more appropriate, kinds of support to
those who are not likely to engage with the approach. It is also important that the intervention approach
is sufficiently flexible to accommodate service users with different degrees of cognitive difficulty and that
therapists are trained and supported to apply CR in ways that meet the needs of a range of service users.
Staff
It may be preferable to avoid staff being in the dual roles of care co-ordinator and CR therapist.
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Service constraints
Unsurprisingly, time constraints, heavy workloads and staff shortages presented challenges for the
implementation. The unexpected reorganisation at the Birmingham site was a classic example of the way
in which wider issues can hinder implementation efforts. Future implementation work should be considered
only in services for which reorganisation is not envisaged within the time frame of the work. A fuller
implementation programme will need to address this through a top-down approach, by engaging service
managers and key decision-makers. The consistent support of management at all levels, both senior
managers and local line managers, is essential to achieve effective implementation and sustainability.
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Appendix 4 Participant recruitment
Here we present cumulative recruitment figures in relation to targets (Figure 13), month-by-monthrecruitment figures (Figure 14) and a breakdown of recruitment by site (Table 40).
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FIGURE 13 Cumulative recruitment figures in relation to targets.
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FIGURE 14 Recruitment figures by month. Number of recruiting sites: months 1–3, three sites; months 4–25,
six sites; months 26–30, eight sites; months 31–36, seven sites.
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TABLE 40 Trial recruitment by site
Site Recruitment started First randomisation Recruitment ended Months of recruitment Original (and adjusted)a targets, n
Actual randomisations,
n (%)
Bangor 24 April 2013 4 June 2013 31 March 2016 36 80 (90) 90 (19)
Bath 24 April 2013 30 May 2013 31 March 2016 36 80 (90) 85 (17.9)
Birmingham 24 April 2013 9 July 2013 30 September 2015 30 80 52 (11)
Cardiff 28 June 2013 9 January 2014 31 March 2016 34 80 82 (17.3)
Kent 16 May 2015 21 August 2015 31 March 2016 11 25 25 (5.3)
London 28 June 2013 25 September 2013 31 March 2016 34 80 51 (10.8)
Manchester 28 June 2013 20 August 2013 31 March 2016 34 80 62 (13.1)
Newcastle 16 May 2015 17 July 2015 31 March 2016 11 25 27 (5.7)
a These targets were adjusted during the course of the trial.
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Appendix 5 Demographic and clinical
characteristics of the sample: additional details
TABLE 41 Full demographic characteristics of the sample
Measure
Whole sample
(N= 474)
Treatment group
CR (N= 238) TAU (N= 236)
Participants with dementia
Age (years), mean (SD); range 78.56 (7.07); 53–95 78.25 (7.13); 53–95 78.87 (7.01); 55–95
Sex, n (%)
Male 248 (52.3) 124 (52.1) 124 (52.5)
Female 226 (47.7) 114 (47.9) 112 (47.5)
Ethnicity, n (%)
White 457 (96.4) 226 (95.0) 231 (97.9)
Mixed/multiple ethnic group 2 (0.42) 2 (0.84) 0 (0)
Asian/Asian British 6 (1.27) 3 (1.26) 3 (1.27)
Black/African/Caribbean/black British 7 (1.48) 5 (2.10) 2 (0.85)
Other ethnic group 2 (0.42) 2 (0.84) 0 (0)
First language, n (%)
English 445 (93.9) 222 (93.3) 223 (94.5)
Welsh 10 (2.1) 5 (2.1) 5 (2.1)
Other 19 (4) 11 (4.6) 8 (3.4)
Marital status, n (%)
Single 5 (1.1) 1 (0.4) 4 (1.7)
Married/remarried 330 (69.6) 167 (70.2) 163 (69.1)
Civil partnership 2 (0.4) 1 (0.4) 1 (0.4)
Separated/divorced 25 (5.3) 14 (5.9) 11 (4.7)
Widowed 101 (21.3) 48 (20.2) 53 (22.5)
Other 10 (2.1) 7 (2.9) 3 (1.3)
Missing 1 (0.2) 0 (0) 1 (0.4)
Length of marriage (years), mean (SD); range N= 437
39.86 (19.22); 0–70
N = 217
40.24 (19.79); 0–70
N= 220
39.5 (18.67); 0–69
Age (years) at start of education, mean (SD);
range
N= 473
4.86 (0.92); 2–15
N = 237
4.86 (0.79); 2–8
N= 236
4.85 (1.04); 3–15
Age (years) when left education, mean (SD);
range
16.03 (2.32); 11–29 15.98 (2.24); 11–27 16.09 (2.41); 11–29
continued
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TABLE 41 Full demographic characteristics of the sample (continued )
Measure
Whole sample
(N= 474)
Treatment group
CR (N= 238) TAU (N= 236)
Years of education, mean (SD); range N = 471
12.57 (3.37); 5–33
N= 236
12.57 (3.33); 6–24
N= 235
12.58 (3.42); 5–33
Further study, n (%)
Yes 243 (51.3) 124 (52.1) 119 (50.4)
No 231 (48.7) 114 (47.9) 117 (49.6)
Years in further study, mean (SD); range N = 472
1.38 (1.94); 0–10
N= 237
1.43 (1.89); 0–9.5
N= 235
1.34 (1.98); 0–10
Education type, n (%)
Left school at age 14–16 years and did not
go back to education
200 (42.2) 103 (43.3) 97 (41.1)
Left school at age 17–18 years and did not
go back to education
21 (4.4) 7 (2.9) 14 (5.9)
Further education (e.g. vocational
qualifications: GNVQ/NVQ/HND)
161 (34) 82 (34.5) 79 (33.5)
Higher education (BSc/BA or equivalent) 52 (11) 25 (10.5) 27 (11.4)
Postgraduate education (MSc/MA/PhD or
equivalent)
38 (8) 20 (8.4) 18 (7.6)
Missing 2 (0.4) 1 (0.4) 1 (0.4)
Occupational status, n (%)
I: professional 52 (11) 23 (9.7) 29 (12.3)
II: managerial/technical 157 (33.1) 81 (34) 76 (32.2)
III N: skilled, non-manual 103 (21.7) 54 (22.7) 49 (20.8)
III M: skilled, manual 80 (16.9) 41 (17.2) 39 (16.5)
IV: partly skilled 50 (10.5) 24 (10.1) 26 (11)
V: unskilled 32 (6.8) 15 (6.3) 17 (7.2)
Carers
Relationship to person with dementia, n (%)
Spouse 296 (62.4) 149 (62.6) 147 (62.3)
Partner 35 (7.4) 18 (7.6) 17 (7.2)
Son/daughter 108 (22.8) 52 (21.8) 56 (23.7)
Step-child 0 (0) 0 (0) 0 (0)
Son/daughter-in-law 10 (2.1) 6 (2.5) 4 (1.7)
Grandchild 2 (0.4) 2 (0.8) 0 (0)
Brother/sister 6 (1.3) 3 (1.3) 3 (1.3)
Nephew/niece 1 (0.2) 0 (0) 1 (0.4)
Friend 7 (1.5) 5 (2.1) 2 (0.8)
Neighbour 3 (0.6) 0 (0) 3 (1.3)
Other 6 (1.3) 3 (1.3) 3 (1.3)
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TABLE 41 Full demographic characteristics of the sample (continued )
Measure
Whole sample
(N= 474)
Treatment group
CR (N= 238) TAU (N= 236)
Age (years), mean (SD); range 68.74 (13.01); 17–92 68.45 (13.76); 17–92 69.04 (12.24); 23–92
Sex, n (%)
Male 142 (30) 75 (31.5) 67 (28.4)
Female 332 (70) 16 (68.5) 169 (71.6)
Ethnicity, n (%)
White 449 (94.7) 224 (94.1) 225 (95.3)
Mixed/multiple ethnic group 5 (1.1) 4 (1.7) 1 (0.42)
Asian/Asian British 10 (2.1) 4 (1.7) 6 (2.5)
Black/African/Caribbean/black British 8 (1.7) 6 (2.5) 2 (0.85)
Other ethnic group 2 (0.42) 0 (0) 2 (0.85)
First language, n (%)
English 443 (93.5) 222 (93.3) 221 (93.6)
Welsh 12 (2.5) 6 (2.5) 6 (2.5)
Other 19 (4) 10 (4.2) 9 (3.8)
Marital status, n (%)
Single 31 (6.5) 23 (9.7) 8 (3.4)
Married/remarried 393 (82.9) 187 (78.6) 206 (87.3)
Civil partnership 5 (1.1) 3 (1.3) 2 (0.8)
Separated/divorced 20 (4.2) 10 (4.2) 10 (4.2)
Widowed 12 (2.5) 8 (3.4) 4 (1.7)
Other 13 (2.7) 7 (2.9) 6 (2.5)
Marital status length (years), mean (SD); range N= 410
41.21 (17.7); 0–69
N = 196
41.9 (17.96); 1–68
N= 214
40.57 (17.4); 0–69
Age (years) at start of education, mean (SD);
range
4.66 (0.74); 2.5–8 4.64 (0.69); 2.5–7 4.69 (0.78); 3–8
Age (years) when left education, mean (SD);
range
N= 473
16.57 (2.35); 7.5–27
N = 237
16.7 (2.29); 11–25
N= 236
16.44 (2.41); 7.5–27
Years in education, mean (SD); range N= 472
13.49 (3.52); 4–26
N = 237
13.67 (3.45); 5–25
N= 235
13.32 (3.58); 4–26
Carer further study, n (%)
Yes 266 (56.1) 135 (56.7) 131 (55.5)
No 207 (43.7) 102 (42.9) 105 (44.5)
Not answered 1 (0.2) 1 (0.4) 0 (0)
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TABLE 41 Full demographic characteristics of the sample (continued )
Measure
Whole sample
(N= 474)
Treatment group
CR (N= 238) TAU (N= 236)
Years in further study, mean (SD); range N = 472
1.59 (2.12); 0–15
N= 237
1.61 (2.09); 0–12
N= 235
1.56 (2.15); 0–15
Education type, n (%)
Left school at age 14–16, and did not go
back to education
156 (32.9) 77 (32.4) 79 (33.5)
Left school at age 17–18, and did not go
back to education
31 (6.5) 16 (6.7) 15 (6.4)
Further education (e.g. vocational
qualifications: GNVQ/NVQ/HND)
163 (34.4) 79 (33.2) 84 (35.6)
Higher education (BSc/BA or equivalent) 72 (15.2) 35 (14.7) 37 (15.7)
Postgraduate education (MSc/MA/PhD or
equivalent)
48 (10.1) 29 (12.2) 19 (8.1)
Missing 4 (0.8) 2 (0.8) 2 (0.8)
Occupational status, n (%)
I: professional 49 (10.3) 30 (12.6) 19 (8.1)
II: managerial/technical 158 (33.3) 74 (31.1) 84 (35.6)
III N: skilled, non-manual 137 (28.9) 64 (26.9) 73 (30.9)
III M: skilled, manual 47 (9.9) 24 (10.1) 23 (9.7)
IV: partly skilled 55 (11.6) 27 (11.3) 28 (11.9)
V: unskilled 20 (4.2) 14 (5.9) 6 (2.5)
Missing 8 (1.7) 5 (2.1) 3 (1.3)
Carer health, n (%)
Excellent 68 (14.3) 30 (12.6) 38 (16.1)
Very good 113 (23.8) 59 (24.8) 54 (22.9)
Good 179 (37.8) 89 (37.4) 90 (38.1)
Fair 83 (17.5) 42 (17.6) 41 (17.4)
Poor 31 (6.5) 18 (7.6) 13 (5.5)
BA, Bachelor of Arts; BSc, Bachelor of Science; HND, Higher National Diploma; GNVQ, General National Vocational
Qualification; MA, Master of Arts; MSc, Master of Science; NVQ, National Vocational Qualification; PhD, Doctor of
Philosophy.
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TABLE 42 Numbers of participants with comorbid conditions
Condition Yes, n (%) No, n (%) Unknown, n (%)
Connective tissue disease 163 (34.4) 307 (64.8) 4 (0.8)
Peripheral vascular disease 76 (16.0) 389 (82.1) 9 (1.9)
Diabetes 71 (15.0) 402 (84.8) 1 (0.2)
Any tumour 52 (11.0) 421 (88.8) 1 (0.2)
Chronic pulmonary disease 49 (10.3) 423 (89.2) 2 (0.4)
Myocardial infarction 40 (8.4) 430 (90.7) 4 (0.8)
Congestive heart failure 39 (8.2) 428 (90.3) 7 (1.5)
Ulcer disease 15 (3.2) 456 (96.2) 3 (0.6)
Moderate or severe renal disease 8 (1.7) 464 (97.9) 2 (0.4)
Diabetes with end organ damage 3 (0.6) 471 (99.4) 0 (0)
Lymphoma 3 (0.6) 470 (99.2) 1 (0.2)
Metastatic solid tumour 3 (0.6) 470 (99.2) 1 (0.2)
Mild liver disease 2 (0.4) 468 (98.7) 4 (0.8)
Moderate or severe liver disease 2 (0.4) 469 (98.9) 3 (0.6)
Leukaemia 1 (0.2) 472 (99.6) 1 (0.2)
Hemiplegia 0 (0) 474 (100.0) 0 (0)
AIDS 0 (0) 474 (100.0) 0 (0)
AIDS, acquired immunodeficiency syndrome.
TABLE 43 Frequency of comorbid health conditions
Total number of comorbid conditions
Whole sample,
n (%) (N= 474)
Participants in each treatment group,
n (%)
CR (N= 238) TAU (N= 236)
0 162 (34.2) 83 (34.9) 79 (33.5)
1 177 (37.3) 86 (36.1) 91 (38.6)
2 78 (16.5) 38 (16.0) 40 (16.9)
3 38 (8.0) 21 (8.8) 17 (7.2)
4 16 (3.4) 9 (3.8) 7 (3.0)
5 2 (0.4) 1 (0.4) 1 (0.4)
6 1 (0.2) 0 (0.0) 1 (0.4)
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TABLE 44 Frequency of comorbid health conditions using the Charlson Comorbidity Weighted Index
Charlson Comorbidity
Weighted Index
Participants in each treatment group, n (%)
Whole sample (N= 474) CR (N= 238) TAU (N= 236)
1 125 (26.4) 63 (26.5) 62 (26.3)
2 151 (31.9) 78 (32.8) 73 (30.9)
3 103 (21.7) 53 (22.3) 50 (21.2)
4 51 (10.8) 22 (9.2) 29 (12.3)
5 27 (5.7) 14 (5.9) 13 (5.5)
6 10 (2.1) 6 (2.5) 4 (1.7)
7 3 (0.6) 0 (0.0) 3 (1.3)
8 1 (0.2) 0 (0.0) 1 (0.4)
10 2 (0.4) 1 (0.4) 1 (0.4)
11 1 (0.2) 1 (0.4) 62 (26.3)
TABLE 45 Number of participants scoring above and below the cut-off value of 5 on the Charlson Comorbidity
Weighted Index
Charlson Comorbidity
Weighted Index
Participants in each treatment group, n (%)
Whole sample (N= 474) CR (N= 238) TAU (N= 236)
0–4 430 (90.72) 216 (90.76) 214 (90.68)
5–11 44 (9.28) 22 (9.24) 22 (9.32)
TABLE 46 Number of participants scoring at each level on the age-adjusted Charlson Comorbidity Index
Age-adjusted Charlson
Comorbidity Index
Participants in each treatment group, n (%)
Whole sample (N= 474) CR (N= 238) TAU (N= 236)
3 4 (0.8) 4 (1.7) 0.0 (0.0)
4 24 (5.1) 9 (3.8) 15 (6.4)
5 70 (14.8) 40 (16.8) 30 (12.7)
6 117 (24.7) 60 (25.2) 57 (24.2)
7 113 (23.8) 51 (21.4) 62 (26.3)
8 77 (16.2) 39 (16.4) 38 (16.1)
9 40 (8.4) 19 (8.0) 21 (8.9)
10 20 (4.2) 13 (5.5) 7 (3.0)
11 3 (0.6) 1 (0.4) 2 (0.8)
12 3 (0.6) 0 (0.0) 3 (1.3)
14 1 (0.2) 1 (0.4) 0 (0.0)
15 2 (0.4) 1 (0.4) 1 (0.4)
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TABLE 47 Hospital Anxiety and Depression Scale scores for depression at baseline and follow-up assessments
HADS score
Participants at each time point, n (%)
Baseline 3 months 9 months
Total
(N= 472)
CR group
(N= 238)
TAU group
(N= 234)
Total
(N= 444)
CR group
(N= 218)
TAU group
(N= 226)
Total
(N= 404)
CR group
(N= 194)
TAU group
(N= 210)
≥ 11 8 (1.7) 6 (2.5) 2 (0.9) 12 (2.7) 8 (0.9) 4 (1.8) 10 (2.5) 7 (3.6) 3 (1.4)
8–10 47 (10.0) 22 (9.2) 25 (10.7) 35 (7.9) 17 (10.7) 18 (8.0) 38 (9.4) 22 (11.3) 16 (7.6)
0–7 417 (88.3) 210 (88.2) 207 (88.5) 397 (89.4) 193 (88.5) 204 (90.3) 356 (88.1) 165 (85.1) 191 (91.0)
TABLE 48 Hospital Anxiety and Depression Scale scores for anxiety at baseline and follow-up assessments
HADS score
Participants at each time point, n (%)
Baseline 3 months 9 months
Total
(N= 472)
CR group
(N= 238)
TAU group
(N= 234)
Total
(N= 442)
CR group
(N= 216)
TAU group
(N= 193)
Total
(N= 403)
CR group
(N= 226)
TAU group
(N= 210)
≥ 11 41 (8.7) 23 (9.7) 18 (7.7) 35 (7.9) 18 (8.3) 21 (10.9) 37 (9.2) 17 (7.5) 16 (7.6)
8–10 66 (14.0) 33 (13.9) 33 (14.1) 61 (13.8) 31 (14.4) 38 (19.7) 66 (16.4) 30 (13.3) 28 (13.3)
0–7 365 (77.3) 182 (76.5) 183 (78.2) 346 (78.3) 167 (77.3) 134 (69.4) 300 (74.4) 179 (79.2) 166 (79.0)
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Appendix 6 Comparison of participants who did
and did not complete the trial
Comparison of the demographic characteristics of completers and
non-completers who withdrew before the 3-month follow-up
TABLE 49 Participants with dementia: continuous data
Measure
Completers, n,
mean (SD)
Non-completers,
n, mean (SD)
Effect size
(completers –
non-completers)
95% CI
for mean
difference Test statistic
Unadjusted
p-value
Age (years) 474, 78.56
(7.07)
29, 78.69
(6.90)
–0.13 –2.83 to 2.56 t(31.7) = –0.1 0.92
Years of
education
471, 12.57
(3.37)
29, 12.05
(3.09)
0.52 –0.69 to 1.73 t(32.23) = 0.88 0.39
Length of
marriage
(years)
437, 39.86
(19.22)
29, 35.21
(19.09)
4.66 –2.80 to 12.12 t(31.88) = 1.27 0.21
Charlson
Comorbidity
Index age-
adjusted score
474, 6.84
(1.71)
29, 7.17
(2.14)
–0.34 –1.16 to 0.49 t(30.23) = –0.83 0.41
TABLE 50 Participants with dementia: categorical data
Participant characteristics Completers, n (%)
Non-completers,
n (%)
Fisher’s exact count
test: p-value
Group
CR 238 (50) 20 (69) 0.06
TAU 236 (50) 9 (31)
Sex
Male 248 (52) 15 (52) 1
Female 226 (48) 14 (48)
Ethnicity
White 457 (97) 28 (97) 0.62
Mixed/multiple ethnic group 2 (0) 0 (0)
Asian/Asian British 6 (1) 1 (0)
Black/African/Caribbean/black British 7 (1) 0 (0)
Other ethnic group 2 (0) 0 (0)
First language
English 445 (94) 28 (97) 1
Welsh 10 (2) 0 (0)
Other 19 (4) 1 (3)
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TABLE 50 Participants with dementia: categorical data (continued )
Participant characteristics Completers, n (%)
Non-completers,
n (%)
Fisher’s exact count
test: p-value
Occupational status
I: professional 52 (11) 4 (14) 0.55
II: managerial/technical 157 (33) 7 (24)
III N: skilled, non-manual 103 (22) 4 (14)
III M: skilled, manual 80 (17) 7 (24)
IV: partly skilled 50 (11) 4 (14)
V: unskilled 32 (7) 3 (10)
Health
Excellent 39 (8) 2 (7) 0.19
Very good 125 (26) 7 (24)
Good 159 (34) 11 (38)
Fair 121 (26) 4 (14)
Poor 30 (6) 5 (17)
Marital status
Single 5 (1) 0 (0) 0.81
Married/remarried 330 (70) 19 (66)
Civil partnership 2 (0) 0 (0)
Separated/divorced 25 (5) 1 (3)
Widowed 101 (21) 9 (31)
Other 10 (2) 0 (0)
Centre
Bangor 90 (19) 6 (21) 0.63
Cardiff 82 (17) 5 (17)
Manchester 62 (13) 6 (21)
Bath 85 (18) 3 (10)
Birmingham 52 (11) 1 (3)
London 51 (11) 4 (14)
Kent 25 (5) 1 (3)
Newcastle 27 (6) 3 (10)
TABLE 51 Carers: continuous data
Measure
Completers, n,
mean (SD)
Non-completers,
n, mean (SD)
Effect size
(completers–
dropouts)
Lower CI
limit Test statistic
Unadjusted
p-value
Carer age (years) 474, 68.84 (13.17) 11, 59.45 (18.6) 9.38 –3.15 to 21.91 t(10.23)= 1.66 0.13
Years of education 472, 13.49 (3.52) 11, 13.09 (3.22) 0.4 –1.78 to 2.58 t(10.56)= 0.41 0.69
Duration of marriage
for spouse carers
(years)
410, 41.21 (17.7) 9, 32.56 (21.35) 8.65 –7.8 to 25.11 t(8.24)= 1.21 0.26
APPENDIX 6
NIHR Journals Library www.journalslibrary.nihr.ac.uk
138
TABLE 52 Carers: categorical data
Carer characteristics Completers, n (%) Non-completers, n (%)
Fisher’s exact
count test: p-value
Carer relationship
Spouse/partner 331 (69) 18 (62) 0.69
Adult child (including in-law) 64 (14) 5 (17)
Other 79 (16) 6 (21)
Sex
Male 142 (30) 4 (36) 0.74
Female 332 (70) 7 (64)
Ethnicity
White 449 (94) 10 (91) 0.24
Mixed/multiple ethnic group 5 (1) 0 (0)
Asian/Asian British 10 (2) 0 (0)
Black/African/Caribbean/black British 8 (2) 1 (9)
Other ethnic group 2 (0) 0 (0)
First language
English 443 (93) 8 (73) 0.04
Welsh 12 (3) 1 (9)
Other 19 (4) 2 (18)
Marital status
Single 31 (7) 1 (9) 0.5
Married/remarried 393 (83) 9 (82)
Civil partnership 5 (1) 0 (0)
Separated/divorced 20 (4) 0 (0)
Widowed 12 (3) 1 (9)
Other 13 (3) 0 (0)
Occupational status
I: professional 49 (11) 1 (9) 0.16
II: managerial/technical 158 (34) 2 (18)
III N: skilled, non-manual 137 (29) 2 (18)
III M: skilled, manual 47 (10) 1 (9)
IV: partly skilled 55 (12) 4 (36)
V: unskilled 20 (4) 1 (9)
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TABLE 53 Comparison of primary and secondary outcomes for completers and non-completers who withdrew before the 3-month follow-up
Measure
Completers, n,
mean (SD)
Non-completers, n,
mean (SD)
Effect size
(completers –
non-completers)
95% CI for
mean difference Test statistic
Unadjusted
p-value
Primary outcome measure
Participant rating of goal attainment 474, 3.54 (1.67) 29, 3.20 (1.56) 0.33 –0.28 to 0.94 t(32.06)= 1.12 0.27
Participant rating of satisfaction 474, 3.81 (1.63) 29, 4.25 (1.55) –0.44 –1.05 to 0.16 t(31.89)= –1.49 0.15
Carer rating of goal attainment 474, 2.74 (1.38) 29, 2.36 (1.35) 0.39 –0.14 to 0.92 t(31.66)= 1.49 0.15
Secondary outcome measures: participants with dementia
DEMQOL 472, 92.30 (12.33) 29, 94.62 (11.28) –2.32 –6.73 to 2.10 t(32.25)= –1.07 0.29
GSES score 469, 30.94 (5.09) 28, 31.86 (4.36) –0.92 –2.67 to 0.83 t(31.55)= –1.07 0.29
HADS score 472, 8.91 (5.54) 29, 8.62 (5.21) 0.29 –1.75 to 2.33 t(32.02)= 0.29 0.77
HADS anxiety score 472, 5.14 (3.64) 29, 4.48 (3.29) 0.65 –0.64 to 1.95 t(32.36)= 1.03 0.30
HADS depression score 472, 3.77 (2.79) 29, 4.14 (3.31) –0.37 –1.65 to 0.92 t(30.49)= –0.58 0.56
RBMT immediate recall 473, 2.66 (2.11) 29, 2.52 (2.43) 0.14 –0.80 to 1.08 t(30.63)= 0.31 0.76
RBMT delayed recall 473, 0.38 (1.96) 29, 0.12 (1.54) 0.26 –0.35 to 0.87 t(33.79)= 0.86 0.40
TEA elevator counting 463, 6.39 (1.16) 28, 6.25 (1.40) 0.14 –0.42 to 0.69 t(29.29)= 0.5 0.62
TEA elevator counting with
distraction
448, 4.55 (2.72) 27, 4.07 (2.91) 0.48 –0.70 to 1.65 t(28.8) = 0.83 0.41
D-KEFS verbal fluency 470, 26.27 (11.82) 29, 21.76 (11.6) 4.52 –0.01 to 9.04 t(31.69)= 2.03 0.05
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Measure
Completers, n,
mean (SD)
Non-completers, n,
mean (SD)
Effect size
(completers –
non-completers)
95% CI for
mean difference Test statistic
Unadjusted
p-value
Secondary outcome measures: carers
RSS 471, 18.96 (9.44) 29, 21.14 (8.77) –2.17 –5.61 to 1.26 t(32.12)= –1.29 0.21
WHOQOL-BREF physical 470, 15.34 (2.95) 28, 15.86 (3.04) –0.52 –1.73 to 0.68 t(30.1) = –0.88 0.38
WHOQOL-BREF psychological 470, 15.14 (2.15) 28, 14.57 (2.70) 0.57 –0.49 to 1.63 t(29.07)= 1.09 0.28
WHOQOL-BREF social 468, 15.13 (2.66) 28, 15.18 (2.88) –0.05 –1.19 to 1.09 t(29.83)= –0.09 0.93
WHOQOL-BREF environmental 470, 16.43 (2.15) 28, 16.39 (2.20) 0.04 –0.83 to 0.91 t(30.15)= 0.09 0.93
EQ-5D-3L index 468, 0.78 (0.25) 29, 0.80 (0.24) –0.03 –0.12 to 0.07 t(31.71)= –0.6 0.55
EQ-5D-3L VAS 467, 74.48 (19.95) 28, 74.79 (23.64) –0.31 –9.64 to 9.02 t(29.35)= –0.07 0.95
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Appendix 7 Summary of missing data for
secondary outcomes
Missing data for the secondary outcome measures
TABLE 54 Baseline assessment
Measure
Whole sample
Treatment group
CR TAU
Missing,
n (%) Total, N
Missing,
n (%) Total, N
Missing,
n (%) Total, N
Participants with dementia
DEMQOL score 2 (0.42) 472 1 (0) 237 1 (0.42) 235
GSES score 5 (1.05) 469 1 (0) 237 4 (1.69) 232
HADS depression score 2 (0.42) 472 0 (0) 238 2 (0.85) 234
HADS anxiety score 2 (0.42) 472 0 (0) 238 2 (0.85) 234
RBMT immediate recall 1 (0.21) 473 1 (0) 237 0 (0.00) 236
RBMT delayed recall 1 (0.21) 473 1 (0) 237 0 (0.00) 236
TEA elevator counting 11 (2.32) 463 6 (3) 232 5 (2.12) 231
TEA elevator counting with distraction 26 (5.47) 448 15 (6) 223 11 (4.66) 225
D-KEFS verbal fluency 4 (0.84) 470 3 (1) 235 1 (0.42) 235
Carers
RSS 3 (0.63) 471 2 (1) 236 1 (0.42) 235
WHOQOL-BREF physical 4 (0.84) 470 1 (0) 237 3 (1.27) 233
WHOQOL-BREF psychological 4 (0.84) 470 1 (0) 237 3 (1.27) 233
WHOQOL-BREF social 6 (1.26) 468 3 (1) 235 3 (1.27) 233
WHOQOL-BREF environmental 4 (0.84) 470 1 (0) 237 3 (1.27) 233
EQ-5D-3L index 6 (1.26) 468 3 (1) 235 3 (1.27) 233
EQ-5D-3L VAS 7 (1.47) 467 4 (2) 234 3 (1.27) 233
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TABLE 55 Three-month follow-up
Measure
Whole sample
Treatment group
CR TAU
Missing,
n (%) Total, N
Missing,
n (%) Total, N
Missing,
n (%) Total, N
Participants with dementia
DEMQOL score 0 (0.00) 445 0 (0.00) 218 0 (0.00) 227
GSES score 6 (1.35) 439 3 (1.38) 215 3 (1.32) 224
HADS depression score 1 (0.22) 444 0 (0.00) 218 1 (0.44) 226
HADS anxiety score 3 (0.67) 442 2 (0.92) 216 1 (0.44) 226
RBMT immediate recall 1 (0.22) 444 0 (0.00) 218 1 (0.44) 226
RBMT delayed recall 3 (0.67) 442 1 (0.46) 217 2 (0.88) 225
TEA elevator counting 16 (3.60) 429 8 (3.67) 210 8 (3.52) 219
TEA elevator counting with distraction 39 (8.76) 406 20 (9.17) 198 19 (8.37) 208
D-KEFS verbal fluency 1 (0.22) 444 1 (0.46) 217 0 (0.00) 227
Carers
RSS 12 (2.70) 433 6 (2.75) 212 6 (2.64) 221
WHOQOL-BREF physical 13 (2.92) 432 6 (2.75) 212 7 (3.08) 220
WHOQOL-BREF psychological 13 (2.92) 432 6 (2.75) 212 7 (3.08) 220
WHOQOL-BREF social 15 (3.37) 430 7 (3.21) 211 8 (3.52) 219
WHOQOL-BREF environmental 13 (2.92) 432 6 (2.75) 212 7 (3.08) 220
EQ-5D-3L index 19 (4.27) 426 9 (4.13) 209 10 (4.41) 217
EQ-5D-3L VAS 20 (4.49) 425 10 (4.59) 208 10 (4.41) 217
TABLE 56 Nine-month follow-up
Measure
Whole sample
Treatment group
CR TAU
Missing,
n (%) Total, N
Missing,
n (%) Total, N
Missing,
n (%) Total, N
Participants with dementia
DEMQOL score 9 (2.11) 417 4 (1.92) 204 5 (2.29) 213
GSES score 25 (5.87) 401 14 (6.73) 194 11 (5.05) 207
HADS depression score 22 (5.16) 404 14 (6.73) 194 8 (3.67) 210
HADS anxiety score 23 (5.40) 403 15 (7.21) 193 8 (3.67) 210
RBMT immediate recall 15 (3.52) 411 8 (3.85) 200 7 (3.21) 211
RBMT delayed recall 16 (3.76) 410 8 (3.85) 200 8 (3.67) 210
TEA elevator counting 29 (6.81) 397 17 (8.17) 191 12 (5.50) 206
TEA elevator counting with distraction 56 (13.15) 370 31 (14.90) 177 25 (11.47) 193
D-KEFS verbal fluency 17 (3.99) 409 10 (4.81) 198 7 (3.21) 211
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TABLE 57 Missing data in the primary and secondary outcome measures in descending order of per cent missing,
with participants who withdrew counted as missing data
Measure Missing, n (%) Total, N
TEA distractor task at 9 months 104 (21.90) 370
TEA no distractor task at 9 months 77 (16.20) 397
GSES score at 9 months 73 (15.40) 401
HADS score at 9 months 71 (15.00) 403
TEA ECD at 3 months 68 (14.30) 406
WHOQOL-BREF social scale at 9 months 67 (14.10) 407
EQ-5D-3L index at 9 months 67 (14.10) 407
WHOQOL-BREF environmental scale at 9 months 65 (13.70) 409
WHOQOL-BREF psychological scale at 9 months 65 (13.70) 409
WHOQOL-BREF physical scale at 9 months 65 (13.70) 409
EQ-5D-3L VAS at 9 months 65 (13.70) 409
D-KEFS verbal fluency at 9 months 65 (13.70) 409
RBMT delayed recall score at 9 months 64 (13.50) 410
RSS at 9 months 63 (13.30) 411
RBMT immediate recall score at 9 months 63 (13.30) 411
BGSI participant satisfaction rating at 9 months 62 (13.10) 412
BGSI carer goal attainment rating at 9 months 59 (12.40) 415
BGSI participant goal attainment rating at 9 months 58 (12.20) 416
DEMQOL at 9 months 57 (12.00) 417
EQ-5D-3L VAS at 3 months 49 (10.30) 425
EQ-5D-3L index at 3 months 48 (10.10) 426
continued
TABLE 56 Nine-month follow-up (continued )
Measure
Whole sample
Treatment group
CR TAU
Missing,
n (%) Total, N
Missing,
n (%) Total, N
Missing,
n (%) Total, N
Carers
RSS 15 (3.52) 411 8 (3.85) 200 7 (3.21) 211
WHOQOL-BREF physical 17 (3.99) 409 9 (4.33) 199 8 (3.67) 210
WHOQOL-BREF psychological 17 (3.99) 409 9 (4.33) 199 8 (3.67) 210
WHOQOL-BREF social 19 (4.46) 407 11 (5.29) 197 8 (3.67) 210
WHOQOL-BREF environmental 17 (3.99) 409 9 (4.33) 199 8 (3.67) 210
EQ-5D-3L index 19 (4.46) 407 12 (5.77) 196 7 (3.21) 211
EQ-5D-3L VAS 17 (3.99) 409 10 (4.81) 198 7 (3.21) 211
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TABLE 57 Missing data in the primary and secondary outcome measures in descending order of per cent missing,
with participants who withdrew counted as missing data (continued )
Measure Missing, n (%) Total, N
TEA elevator counting at 3 months 45 (9.50) 429
WHOQOL-BREF social scale at 3 months 44 (9.30) 430
WHOQOL-BREF environmental scale at 3 months 42 (8.90) 432
WHOQOL-BREF psychological scale at 3 months 42 (8.90) 432
WHOQOL-BREF physical scale at 3 months 42 (8.90) 432
RSS at 3 months 41 (8.60) 433
GSES at 3 months 35 (7.40) 439
BGSI carer goal attainment rating at 3 months 35 (7.40) 439
RBMT delayed recall score at 3 months 32 (6.80) 442
HADS at 3 months 32 (6.80) 442
D-KEFS FAS test at 3 months 30 (6.30) 444
RBMT immediate recall score at 3 months 30 (6.30) 444
DEMQOL at 3 months 29 (6.10) 445
BGSI participant satisfaction rating at 3 months 29 (6.10) 445
BGSI participant goal attainment rating at 3 months 29 (6.10) 445
TEA ECD at baseline 26 (5.50) 448
TEA elevator counting at baseline 11 (2.30) 463
EQ-5D-3L VAS at baseline 7 (1.50) 467
WHOQOL-BREF social scale at baseline 6 (1.30) 468
EQ-5D-3L index at baseline 6 (1.30) 468
GSES at baseline 5 (1.10) 469
WHOQOL-BREF environmental scale at baseline 4 (0.80) 470
WHOQOL-BREF psychological scale at baseline 4 (0.80) 470
WHOQOL-BREF physical scale at baseline 4 (0.80) 470
D-KEFS verbal fluency at baseline 4 (0.80) 470
RSS at baseline 3 (0.60) 471
HADS at baseline 2 (0.40) 472
DEMQOL at baseline 2 (0.40) 472
RBMT delayed recall score at baseline 1 (0.20) 473
RBMT immediate recall score at baseline 1 (0.20) 473
BGSI carer goal attainment score at baseline 0 (0.00) 474
BGSI participant satisfaction score at baseline 0 (0.00) 474
BGSI participant goal attainment score at baseline 0 (0.00) 474
ECD, elevator counting with distraction sub-test.
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Appendix 8 Exploratory analyses for the primary
outcome measure
Participants’ goal attainment ratings
Participant characteristics as predictors of differences in participants’ own Bangor
Goal-Setting Interview goal attainment ratings
Linear mixed-effects model fitted to identify potential participant characteristics as
predictors of differences between the Bangor Goal-Setting Interview attainment ratings
at baseline and 3 months’ follow-up for participants in the cognitive rehabilitation group
TABLE 58 Analysis of variance examining the influence of participant characteristics as predictors of differences in
participant BGSI attainment scores between baseline and 3 months
Participant characteristics χ2 df p-value
(Intercept) 15.52 1 0.000
Sex 0.21 1 0.646
Age (stratified) 1.91 1 0.167
MMSE score 0.51 1 0.476
Diagnosis 2.05 2 0.358
Medication 0.18 1 0.674
Education 0.71 4 0.950
Comorbidity 0.02 1 0.897
Social status 16.66 5 0.005
Blinding inefficient 16.95 1 0.000
Centre 1.58 1 0.209
df, degrees of freedom.
Note
χ2(18)= 41.74, R2 = 0.19; p= 0.001.
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TABLE 59 Regression analysis examining the influence of participant characteristics as predictors of differences in
participant BGSI attainment scores between baseline and 3 months
Participant characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) 3.49 0.89 212.87 3.94 0.000 1.73 to 5.25
Aged ≥ 75 years vs. < 75 years –0.44 0.32 216.78 –1.38 0.168 –1.06 to 0.19
Blinding inefficient vs. maintained 1.24 0.30 216.87 4.12 0.000 0.54 to 1.76
Sex: male vs. female –0.14 0.31 213.81 –0.46 0.647 –0.77 to 0.48
MMSE score: ≥ 24 points vs. < 24 points 0.20 0.28 216.70 0.71 0.476 –0.35 to 0.75
Comorbidity 0.01 0.09 216.93 0.13 0.897 –0.18 to 0.20
Diagnosis: vascular dementia vs. Alzheimer’s
disease
–0.49 0.53 214.37 –0.92 0.359 –1.55 to 0.57
Diagnosis: mixed Alzheimer’s disease and
vascular dementia vs. Alzheimer’s disease
0.26 0.35 216.99 0.74 0.462 –0.44 to 0.96
Education: left school at age 17–18 years and
did not go back to education vs. left school
at age 14–16 years and did not go back to
education
–0.56 0.80 216.26 –0.70 0.484 –2.15 to 1.02
Education: further education (e.g. vocational
qualifications: GNVQ/NVQ/HND) vs. left school
at age 14–16 years and did not go back to
education
–0.15 0.33 216.77 –0.46 0.648 –0.79 to 0.49
Person with dementia: education – higher
education (BSc/BA or equivalent) vs. left
school at age 14–16 years and did not go
back to education
–0.22 0.52 212.44 –0.42 0.673 –1.25 to 0.81
Education: postgraduate education (MSc/MA/
PhD or equivalent) vs. left school at age
14–16 years and did not go back to education
–0.28 0.61 210.50 –0.47 0.640 –1.48 to 0.91
Medication: yes vs. no –0.18 0.44 216.02 –0.42 0.674 –1.04 to 0.68
Social status: II managerial/technical vs.
I professional
–0.86 0.56 211.15 –1.53 0.127 –2.48 to 0.08
Social status: III N skilled, non-manual vs.
I professional
–1.66 0.65 214.71 –2.55 0.012 –3.39 to –0.56
Social status: III M skilled, manual vs.
I professional
–2.11 0.65 216.57 –3.28 0.001 –4.17 to –1.05
Social status: IV partly skilled vs. I professional –1.93 0.75 216.88 –2.58 0.011 –3.83 to –0.67
Social status: V unskilled vs. I professional –0.84 0.81 216.41 –1.03 0.302 –2.73 to 0.56
BA, Bachelor of Arts; BSc, Bachelor of Science; df, degrees of freedom; GNVQ, General National Vocational Qualification;
HND, Higher National Diploma; MA, Master of Arts; MSc, Master of Science; NVQ, National Vocational Qualification;
PhD, Doctor of Philosophy.
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Linear mixed-effects model fitted to identify potential participant characteristics as
predictors of differences between the Bangor Goal-Setting Interview attainment ratings
at baseline and 9 months’ follow-up
TABLE 60 Analysis of variance examining the influence of participant characteristics as predictors of differences in
participant BGSI attainment scores between baseline and 9 months
Participant characteristics χ2 df p-value
(Intercept) 2.38 1 0.123
Blinding inefficient 17.75 1 0.000
Age 4.35 1 0.037
Sex 0.14 1 0.712
Education 1.82 4 0.769
Social status 8.96 5 0.111
Ethnicity 8.68 9 0.468
Living situation 0.00 1 0.976
Diagnosis 5.10 2 0.078
MMSE score 9.38 1 0.002
Medication 1.96 1 0.161
Comorbidity 0.03 1 0.855
df, degrees of freedom.
Note
χ2(28)= 68.61, R2 = 0.32; p< 0.001.
TABLE 61 Regression analysis examining the influence of participant characteristics as predictors of differences in
participant BGSI attainment scores between baseline and 9 months
Participant characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) 3.71 2.40 202.66 1.54 0.124 –1.03 to 8.45
Blinding inefficient vs. maintained 1.35 0.32 199.86 4.21 0.000 0.71 to 1.99
Aged ≥ 75 years vs. < 75 years –0.05 0.02 200.60 –2.08 0.038 –0.09 to 0.00
Sex: female vs. male 0.13 0.35 198.44 0.37 0.713 –0.56 to 0.82
MMSE score: ≥ 24 points vs. < 24 points 0.16 0.05 199.31 3.06 0.002 0.06 to 0.26
Comorbidity –0.02 0.11 199.72 –0.18 0.855 –0.24 to 0.20
Diagnosis: vascular dementia vs. Alzheimer’s
disease
–1.25 0.58 201.57 –2.14 0.034 –2.40 to –0.10
Diagnosis: mixed Alzheimer’s disease and
vascular dementia vs. Alzheimer’s disease
–0.58 0.39 200.38 –1.47 0.144 –1.35 to 0.20
Education: left school at age 17–18 years and
did not go back to education vs. left school at
age 14–16 years and did not go back to
education
0.32 0.90 200.09 0.36 0.719 –1.47 to 2.11
continued
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TABLE 61 Regression analysis examining the influence of participant characteristics as predictors of differences in
participant BGSI attainment scores between baseline and 9 months (continued )
Participant characteristics B (estimate) SE df t-value p-value 95% CI
Education: further education (e.g. vocational
qualifications: GNVQ/NVQ/HND) vs. left school
at age 14–16 years and did not go back to
education
–0.40 0.37 200.34 –1.08 0.283 –1.13 to 0.33
Education: higher education (BSc/BA or
equivalent) vs. left school at age 14–16 years
and did not go back to education
–0.46 0.56 197.23 –0.82 0.415 –1.56 to 0.64
Education: postgraduate education (MSc/MA/
PhD or equivalent) vs. left school at age
14–16 years and did not go back to education
–0.43 0.65 196.81 –0.65 0.514 –1.72 to 0.86
Ethnicity: any other Asian background vs.
Welsh/English/Scottish/Northern Irish/British
0.85 1.55 201.37 0.55 0.583 –2.22 to 3.92
Ethnicity: African vs. Welsh/English/Scottish/
Northern Irish/British
–0.11 2.12 199.11 –0.05 0.959 –4.30 to 4.07
Ethnicity: Caribbean vs. Welsh/English/
Scottish/Northern Irish/British
–0.79 1.48 198.49 –0.53 0.594 –3.72 to 2.13
Ethnicity: any other ethnic group vs. Welsh/
English/Scottish/Northern Irish/British
0.35 1.49 198.44 0.24 0.813 –2.58 to 3.29
Ethnicity: Irish vs. Welsh/English/Scottish/
Northern Irish/British
–1.40 0.98 200.21 –1.43 0.156 –3.34 to 0.54
Ethnicity: any other white background vs.
Welsh/English/Scottish/Northern Irish/British
1.19 1.07 198.49 1.11 0.268 –0.92 to 3.30
Ethnicity: white and black Caribbean vs.
Welsh/English/Scottish/Northern Irish/British
0.91 2.10 198.39 0.43 0.665 –3.23 to 5.05
Ethnicity: any other mixed/multiple ethnic
background vs. Welsh/English/Scottish/
Northern Irish/British
–2.26 2.12 200.30 –1.07 0.287 –6.46 to 1.93
Ethnicity: Indian vs. Welsh/English/Scottish/
Northern Irish/British
4.45 2.36 201.54 1.88 0.061 –0.24 to 9.12
Living situation: not alone vs. alone 0.01 0.41 197.96 0.03 0.977 –0.79 to 0.82
Medication: yes vs. no –0.68 0.48 198.58 –1.40 0.163 –1.63 to 0.27
Social status: II managerial/technical vs.
I professional
–1.02 0.61 196.38 –1.67 0.096 –2.21 to 0.18
Social status: III N skilled, non-manual vs.
I professional
–1.42 0.71 198.56 –2.01 0.045 –2.82 to –0.03
Social status: III M skilled, manual vs.
I professional
–1.77 0.69 200.80 –2.55 0.011 –3.13 to –0.40
Social status: IV partly skilled vs. I professional –2.02 0.82 199.67 –2.47 0.014 –3.63 to –0.41
Social status: V unskilled vs. I professional –0.98 0.90 201.09 –1.09 0.276 –2.76 to 0.79
BA, Bachelor of Arts; BSc, Bachelor of Science; df, degrees of freedom; GNVQ, General National Vocational Qualification;
HND, Higher National Diploma; MA, Master of Arts; MSc, Master of Science; NVQ, National Vocational Qualification;
PhD, Doctor of Philosophy.
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Carer characteristics as predictors of differences in participant’s own rating Bangor
Goal-Setting Interview goal attainment
Linear mixed-effects model to identify potential carer factors as predictors of differences
between the participants’ Bangor Goal-Setting Interview attainment ratings at baseline
and 3 months’ follow-up for participants in the cognitive rehabilitation group
TABLE 62 Analysis of variance examining the influence of carer characteristics as predictors of differences in
participant BGSI attainment scores between baseline and 3 months
Carer characteristics Sum of squares df F-value p-value
(Intercept) 0.02 1 0.00 0.946
Carer age 0.18 1 0.04 0.845
Carer sex 3.95 1 0.85 0.358
Carer education 36.00 4 1.93 0.107
Person with dementia and carer relationship 27.38 7 0.84 0.556
Carer hours 29.16 8 0.78 0.619
Residuals 866.40 186 NA NA
df, degrees of freedom; NA, not applicable.
Note
F(21,186) = 0.88, R2 = 0.09; p= 0.614.
TABLE 63 Regression analysis examining the influence of carer characteristics as predictors of differences in
participant BGSI attainment scores between baseline and 3 months
Carer characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) –0.13 1.97 186 –0.07 0.946 –4.02 to 3.76
Carer age 0.00 0.02 186 0.20 0.845 –0.03 to 0.04
Carer education: left school at age 17–18 years
and did not go back to education vs. left school
at age 14–16 years and did not go back to
education
1.51 0.66 186 2.28 0.024 0.21 to 2.82
Carer education: further education (e.g.
vocational qualifications: GNVQ/NVQ/HND) vs.
left school at age 14–16 years and did not go
back to education
0.36 0.39 186 0.93 0.355 –0.41 to 1.14
Carer education: higher education (BSc/BA or
equivalent) vs. left school at age 14–16 years
and did not go back to education
0.41 0.51 186 0.81 0.420 –0.59 to 1.41
Carer education: postgraduate education
(MSc/MA/PhD or equivalent) vs. left school at age
14–16 years and did not go back to education
1.06 0.52 186 2.05 0.042 0.04 to 2.08
Carer sex: male vs. female –0.32 0.35 186 –0.92 0.358 –1.00 to 0.36
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TABLE 63 Regression analysis examining the influence of carer characteristics as predictors of differences in
participant BGSI attainment scores between baseline and 3 months (continued )
Carer characteristics B (estimate) SE df t-value p-value 95% CI
Hours providing care in a typical day:
< 1 hour vs. none
0.51 0.72 186 0.71 0.476 –0.91 to 1.93
Hours providing care in a typical day:
> 1 hour and up to 2 hours vs. none
–0.02 0.76 186 –0.03 0.975 –1.52 to 1.47
Hours providing care in a typical day:
> 2 hours and up to 3 hours vs. none
0.52 0.79 186 0.65 0.515 –1.04 to 2.07
Hours providing care in a typical day:
> 3 hours and up to 5 hours vs. none
1.12 0.82 186 1.38 0.171 –0.49 to 2.73
Hours providing care in a typical day:
> 5 hours and up to 10 hours vs. none
1.01 0.80 186 1.26 0.209 –0.57 to 2.60
Hours providing care in a typical day:
> 10 hours, but not overnight vs. none
0.85 0.95 186 0.89 0.373 –1.02 to 2.72
Hours providing care in a typical day:
> 10 hours and/including overnight vs. none
0.57 0.74 186 0.77 0.445 –0.89 to 2.02
Hours providing care in a typical day:
other, describe vs. none
2.08 1.67 186 1.24 0.215 –1.22 to 5.38
Person with dementia and carer relationship:
friend vs. brother/sister
0.35 1.79 186 0.20 0.845 –3.18 to 3.88
Person with dementia and carer relationship:
grandchild vs. brother/sister
1.48 2.65 186 0.56 0.577 –3.74 to 6.70
Person with dementia and carer relationship:
other vs. brother/sister
2.77 1.79 186 1.55 0.124 –0.76 to 6.30
Person with dementia and carer relationship:
partner vs. brother/sister
1.00 1.39 186 0.72 0.470 –1.73 to 3.74
Person with dementia and carer relationship:
son/daughter vs. brother/sister
1.48 1.37 186 1.08 0.283 –1.23 to 4.19
Person with dementia and carer relationship:
son/daughter-in-law vs. brother/sister
0.62 1.72 186 0.36 0.720 –2.78 to 4.01
Person with dementia and carer relationship:
spouse vs. brother/sister
1.72 1.28 186 1.34 0.182 –0.81 to 4.26
BA, Bachelor of Arts; BSc, Bachelor of Science; df, degrees of freedom; GNVQ, General National Vocational Qualification;
HND, Higher National Diploma; MA, Master of Arts; MSc, Master of Science; NVQ, National Vocational Qualification;
PhD, Doctor of Philosophy.
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Linear mixed-effects model to identify potential carer factors as predictors of differences
between the participants’ Bangor Goal-Setting Interview attainment ratings at baseline
and 9 months’ follow-up for participants in the cognitive rehabilitation group
TABLE 64 Analysis of variance examining the influence of carer characteristics as predictors of differences in
participant BGSI attainment scores between baseline and 9 months
Carer characteristics Sum of squares df F-value p-value
(Intercept) 0.07 1 0.01 0.913
Carer age 2.31 1 0.39 0.532
Carer sex 1.39 1 0.24 0.627
Carer education 24.30 4 1.03 0.391
Person with dementia and carer relationship 34.18 7 0.83 0.563
Carer hours 84.75 8 1.80 0.080
Residuals 1017.09 173 NA NA
df, degrees of freedom; NA, not applicable.
Note
F(21,173) = 1.02, R2 = 0.11; p= 0.442.
TABLE 65 Regression analysis examining the influence of carer characteristics as predictors of differences in
participant BGSI attainment scores between baseline and 9 months
Carer characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) 0.25 2.25 173 0.11 0.913 –4.19 to 4.68
Carer age –0.01 0.02 173 –0.63 0.532 –0.06 to 0.03
Carer education: left school at age 17–18 years
and did not go back to education vs. left school
at age 14–16 years and did not go back to
education
0.80 0.75 173 1.07 0.287 –0.68 to 2.28
Carer education: further education (e.g.
vocational qualifications: GNVQ/NVQ/HND) vs.
left school at age 14–16 years and did not go
back to education
0.75 0.46 173 1.62 0.107 –0.16 to 1.65
Carer education: higher education (BSc/BA or
equivalent) vs. left school at age 14–16 years
and did not go back to education
0.38 0.59 173 0.64 0.523 –0.78 to 1.54
Carer education: postgraduate education
(MSc/MA/PhD or equivalent) vs. left school at age
14–16 years and did not go back to education
1.01 0.60 173 1.67 0.097 –0.18 to 2.20
Carer sex: male vs. female –0.20 0.41 173 –0.49 0.627 –1.00 to 0.61
Hours providing care in a typical day:
< 1 hour vs. none
2.42 0.83 173 2.93 0.004 0.79 to 4.05
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TABLE 65 Regression analysis examining the influence of carer characteristics as predictors of differences in
participant BGSI attainment scores between baseline and 9 months (continued )
Carer characteristics B (estimate) SE df t-value p-value 95% CI
Hours providing care in a typical day:
> 1 hour and up to 2 hours vs. none
1.55 0.85 173 1.81 0.072 –0.14 to 3.24
Hours providing care in a typical day:
> 2 hours and up to 3 hours vs. none
2.34 0.89 173 2.63 0.009 0.58 to 4.09
Hours providing care in a typical day:
> 3 hours and up to 5 hours vs. none
2.82 0.95 173 2.97 0.003 0.94 to 4.69
Hours providing care in a typical day:
> 5 hours and up to 10 hours vs. none
2.06 0.91 173 2.27 0.024 0.27 to 3.85
Hours providing care in a typical day:
> 10 hours, but not overnight vs. none
2.23 1.10 173 2.03 0.044 0.06 to 4.40
Hours providing care in a typical day:
> 10 hours and/including overnight vs. none
1.64 0.84 173 1.97 0.051 –0.01 to 3.29
Hours providing care in a typical day:
other, describe vs. none
4.07 1.88 173 2.16 0.032 0.35 to 7.78
Person with dementia and carer relationship:
friend vs. brother/sister
–1.81 2.25 173 –0.81 0.421 –6.25 to 2.62
Person with dementia and carer relationship:
grandchild vs. brother/sister
–1.33 2.98 173 –0.44 0.657 –7.22 to 4.56
Person with dementia and carer relationship:
other vs. brother/sister
–0.71 2.27 173 –0.32 0.753 –5.19 to 3.76
Person with dementia and carer relationship:
partner vs. brother/sister
0.71 1.57 173 0.45 0.653 –2.39 to 3.80
Person with dementia and carer relationship:
son/daughter vs. brother/sister
0.25 1.55 173 0.16 0.873 –2.81 to 3.31
Person with dementia and carer relationship:
son/daughter-in-law vs. brother/sister
–0.32 1.94 173 –0.17 0.867 –4.15 to 3.50
Person with dementia and carer relationship:
spouse vs. brother/sister
1.16 1.45 173 0.80 0.423 –1.69 to 4.01
BA, Bachelor of Arts; BSc, Bachelor of Science; df, degrees of freedom; GNVQ, General National Vocational Qualification;
HND, Higher National Diploma; MA, Master of Arts; MSc, Master of Science; NVQ, National Vocational Qualification;
PhD, Doctor of Philosophy.
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Carers’ ratings of participant goal attainment
Carer characteristics as predictors of differences in carer’s rating of Bangor Goal-Setting
Interview goal attainment
Linear mixed-effects model fitted to identify potential carer factors as predictors of
differences between the carers’ Bangor Goal-Setting Interview attainment ratings
at baseline and 3 months’ follow-up for carers of participants in the cognitive
rehabilitation group
TABLE 66 Analysis of variance examining the influence of carer characteristics as predictors of differences in carer
BGSI attainment ratings between baseline and 3 months
Carer characteristics Sum of squares df F-value p-value
(Intercept) 0.31 1 0.07 0.793
Carer’s age 0.26 1 0.06 0.809
Carer’s sex 7.92 1 1.76 0.186
Carer’s education 38.27 4 2.13 0.078
Person with dementia and carer relationship 32.22 7 1.03 0.415
Residuals 897.85 200 NA NA
df, degrees of freedom; NA, not applicable.
Note
F(13,200) = 1.28, R2 = 0.08; p= 0.226.
TABLE 67 Regression analysis examining the influence of carer characteristics in predicting differences in carer
BGSI attainment ratings between baseline and 3 months
Carer characteristics B (estimate) SE df t-value p-value 95% CI
Carer’s age 0.88 1.83 202 0.48 0.631 –2.73 to 4.49
Carer education: left school at age 17–18 years
and did not go back to education vs. left school
at age 14–16 years and did not go back to
education
–0.00 0.02 202 –0.12 0.908 –0.04 to 0.03
Carer education: further education (e.g.
vocational qualifications: GNVQ/NVQ/HND) vs.
left school at age 14–16 years and did not go
back to education
1.38 0.66 202 2.09 0.038 0.08 to 2.68
Carer education: higher education (BSc/BA or
equivalent) vs. left school at age 14–16 years
and did not go back to education
0.19 0.37 202 0.51 0.607 –0.54 to 0.93
Carer education: postgraduate education (MSc/
MA/PhD or equivalent) vs. left school at age
14–16 years and did not go back to education
0.20 0.49 202 0.41 0.685 –0.76 to 1.15
Carer sex: male vs. female 0.73 0.49 202 1.49 0.138 –0.24 to 1.70
Person with dementia and carer relationship:
friend vs. brother/sister
–0.22 0.33 202 –0.67 0.507 –0.88 to 0.43
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Linear mixed-effects model to identify carer characteristics predicting differences
between carers’ Bangor Goal-Setting Interview attainment ratings at baseline and
9 months’ follow-up for participants in the cognitive rehabilitation group
TABLE 67 Regression analysis examining the influence of carer characteristics in predicting differences in carer
BGSI attainment ratings between baseline and 3 months (continued )
Carer characteristics B (estimate) SE df t-value p-value 95% CI
Person with dementia and carer relationship:
grandchild vs. brother/sister
1.22 1.58 202 0.77 0.444 –1.91 to 4.34
Person with dementia and carer relationship:
other vs. brother/sister
1.32 2.62 202 0.51 0.614 –3.85 to 6.49
Person with dementia and carer relationship:
partner vs. brother/sister
2.90 1.78 202 1.63 0.106 –0.62 to 6.41
Person with dementia and carer relationship:
son/daughter vs. brother/sister
1.18 1.36 202 0.87 0.388 –1.51 to 3.86
Person with dementia and carer relationship:
son/daughter-in-law vs. brother/sister
1.43 1.36 202 1.05 0.294 –1.25 to 4.11
Person with dementia and carer relationship:
spouse vs. brother/sister
0.57 1.71 202 0.33 0.740 –2.80 to 3.94
BA, Bachelor of Arts; BSc, Bachelor of Science; df, degrees of freedom; GNVQ, General National Vocational Qualification;
HND, Higher National Diploma; MA, Master of Arts; MSc, Master of Science; NVQ, National Vocational Qualification;
PhD, Doctor of Philosophy.
TABLE 68 Analysis of variance examining the influence of carer characteristics as predictors of differences in carer
BGSI attainment ratings between baseline and 9 months
Carer characteristics Sum of squares df F-value p-value
(Intercept) 6.55 1 1.05 0.306
Carer’s age 4.15 1 0.67 0.415
Carer’s sex 4.56 1 0.73 0.393
Carer’s education 19.24 4 0.77 0.544
Person with dementia and carer relationship 65.52 7 1.51 0.168
Residuals 1169.09 188 NA NA
df, degrees of freedom; NA, not applicable.
Note
F(13,188) = 1.08, R2 = 0.07; p= 0.377.
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TABLE 69 Regression analysis examining the influence of carer characteristics as predictors of differences in carer
BGSI attainment ratings between baseline and 9 months
Carer characteristics B (estimate) SE df t-value p-value 95% CI
Carer’s age 2.67 2.15 189 1.24 0.217 –1.58 to 6.91
Carer education: left school at age 17–18 years
and did not go back to education vs. left school
at age 14–16 years and did not go back to
education
–0.02 0.02 189 –0.78 0.439 –0.06 to 0.03
Carer education: further education (e.g.
vocational qualifications: GNVQ/NVQ/HND) vs.
left school at age 14–16 years and did not go
back to education
0.62 0.77 189 0.80 0.422 –0.90 to 2.13
Carer education: higher education (BSc/BA or
equivalent) vs. left school at age 14–16 years
and did not go back to education vs. left school
at age 14–16 years and did not go back to
education
0.41 0.45 189 0.91 0.364 –0.48 to 1.29
Carer education: postgraduate education (MSc/
MA/PhD or equivalent) vs. left school at age
14–16 years and did not go back to education
0.19 0.58 189 0.32 0.749 –0.96 to 1.33
Carer sex: male vs. female 0.61 0.59 189 1.04 0.301 –0.55 to 1.76
Person with dementia and carer relationship:
friend vs. brother/sister
–0.01 0.40 189 –0.02 0.982 –0.79 to 0.77
Person with dementia and carer relationship:
grandchild vs. brother/sister
0.29 1.92 189 0.15 0.878 –3.50 to 4.08
Person with dementia and carer relationship:
other vs. brother/sister
–0.89 3.04 189 –0.29 0.771 –6.89 to 5.11
Person with dementia and carer relationship:
partner vs. brother/sister
–0.16 2.30 189 –0.07 0.943 –4.70 to 4.37
Person with dementia and carer relationship:
son/daughter vs. brother/sister
0.58 1.58 189 0.37 0.713 –2.54 to 3.70
Person with dementia and carer relationship:
son/daughter-in-law vs. brother/sister
0.35 1.58 189 0.22 0.824 –2.76 to 3.46
Person with dementia and carer relationship:
spouse vs. brother/sister
–0.62 1.98 189 –0.31 0.755 –4.52 to 3.28
BA, Bachelor of Arts; BSc, Bachelor of Science; df, degrees of freedom; GNVQ, General National Vocational Qualification;
HND, Higher National Diploma; MA, Master of Arts; MSc, Master of Science; NVQ, National Vocational Qualification;
PhD, Doctor of Philosophy.
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Participant characteristics as predictors of differences in carers’ Bangor Goal-Setting
Interview goal attainment ratings
Linear mixed-effects model to identify participant characteristics predicting the difference
between carer Bangor Goal-Setting Interview goal attainment ratings at baseline and at
3 months’ follow-up for participants in the cognitive rehabilitation group
TABLE 70 Analysis of variance examining the influence of participant characteristics as predictors of differences in
carer BGSI attainment ratings between baseline and 3 months
Participant characteristics χ2 df p-value
(Intercept) 16.18 1 0.000
Sex 0.07 1 0.797
Age 0.28 1 0.597
MMSE 2.41 1 0.121
Diagnosis 0.17 2 0.920
Medication 0.43 1 0.511
Education 3.74 4 0.442
Comorbidity 0.09 1 0.762
Social status 14.54 5 0.013
Centre 0.10 1 0.752
df, degrees of freedom.
Note
χ2(17)= 27.24, R2 = 0.12; p= 0.055.
TABLE 71 Regression analysis examining the influence of participant characteristics as predictors of differences in
carer BGSI attainment ratings between baseline and 3 months
Participant characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) 3.52 0.88 209.17 4.02 0.000 1.82 to 5.26
Aged ≥ 75 years vs. < 75 years –0.17 0.32 213.40 –0.53 0.598 –0.81 to 0.47
Sex: female vs. male –0.08 0.33 212.67 –0.26 0.797 –0.73 to 0.56
MMSE score: ≥ 24 points vs. < 24 points 0.45 0.29 214.41 1.55 0.122 –0.11 to 1.02
Comorbidity –0.03 0.10 212.65 –0.30 0.762 –0.22 to 0.16
Diagnosis: vascular dementia vs. Alzheimer’s
disease
0.18 0.55 182.80 0.33 0.741 –0.90 to 1.27
Diagnosis: mixed Alzheimer’s disease and
vascular dementia vs. Alzheimer’s disease
0.12 0.36 213.42 0.33 0.743 –0.60 to 0.83
Education: left school at age 17–18 years and
did not go back to education vs. left school
at age 14–16 years and did not go back to
education
–1.24 0.82 214.98 –1.51 0.133 –2.86 to 0.37
Education: further education (e.g. vocational
qualifications: GNVQ/NVQ/HND) vs. left
school at age 14–16 years and did not go
back to education
0.09 0.34 214.77 0.26 0.798 –0.58 to 0.75
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Linear mixed-effects model to identify participant characteristics predicting the
difference between the carer Bangor Goal-Setting Interview attainment ratings at
baseline and 9 months’ follow-up for participants in the cognitive rehabilitation group
TABLE 71 Regression analysis examining the influence of participant characteristics as predictors of differences in
carer BGSI attainment ratings between baseline and 3 months (continued )
Participant characteristics B (estimate) SE df t-value p-value 95% CI
Education: higher education (BSc/BA or
equivalent) vs. left school at age 14–16 years
and did not go back to education
0.38 0.54 211.43 0.70 0.482 –0.68 to 1.42
Education: postgraduate education (MSc/MA/
PhD or equivalent) vs. left school at age
14–16 years and did not go back to
education
–0.29 0.62 207.88 –0.47 0.636 –1.53 to 0.92
Medication: yes vs. no 0.30 0.46 214.45 0.66 0.512 –0.60 to 1.19
Social status: II managerial/technical vs.
I professional
–0.85 0.58 209.24 –1.46 0.146 –2.00 to 0.29
Person with dementia social status: III N
skilled, non-manual vs. I professional
–1.83 0.68 214.14 –2.70 0.007 –3.15 to – 0.50
Social status: III M skilled, manual vs.
I professional
–1.63 0.67 214.99 –2.46 0.015 –2.94 to –0.33
Social status: IV partly skilled vs. I professional –1.30 0.77 214.36 –1.70 0.091 –2.81 to 0.21
Social status: V unskilled vs. I professional –0.21 0.84 214.47 –0.25 0.803 –1.85 to 1.44
BA, Bachelor of Arts; BSc, Bachelor of Science; df, degrees of freedom; GNVQ, General National Vocational Qualification;
HND, Higher National Diploma; MA, Master of Arts; MSc, Master of Science; NVQ, National Vocational Qualification;
PhD, Doctor of Philosophy.
TABLE 72 Analysis of variance examining the influence of participant characteristics as predictors of differences in
carer BGSI attainment ratings between baseline and 9 months
Participant characteristics χ2 df p-value
(Intercept) 11.81 1 0.001
Sex 0.03 1 0.873
Age 1.46 1 0.227
MMSE 7.91 1 0.005
Diagnosis 1.28 2 0.528
Medication 0.56 1 0.454
Education 2.03 4 0.731
Comorbidity 0.27 1 0.603
Social status 9.97 5 0.076
Centre 2.48 1 0.115
df, degrees of freedom.
Note
χ2(17)= 31.1823, R2 = 0.1529; p= 0.019.
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TABLE 73 Regression analysis examining the influence of participant characteristics as predictors of differences in
carer BGSI attainment ratings between baseline and 9 months
Participant characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) 3.59 1.04 199.06 3.44 0.001 1.52 to 5.65
Aged ≥ 75 years vs. < 75 years –0.46 0.38 203.22 –1.21 0.228 –1.22 to 0.29
Sex: female vs. male 0.06 0.39 200.54 0.16 0.873 –0.71 to 0.83
MMSE score: ≥ 24 points vs. < 24 points 0.96 0.34 202.98 2.81 0.005 0.29 to 1.63
Comorbidity 0.06 0.11 203.31 0.52 0.604 –0.17 to 0.28
Diagnosis: vascular dementia vs. Alzheimer’s
disease
–0.75 0.66 203.73 –1.13 0.260 –2.06 to 0.56
Diagnosis: mixed Alzheimer’s disease and
vascular dementia vs. Alzheimer’s disease
–0.16 0.43 203.66 –0.37 0.712 –1.00 to 0.68
Education: left school at age 17–18 years and
did not go back to education vs. left school at
age 14–16 years and did not go back to
education
–1.04 1.01 203.00 –1.03 0.305 –3.07 to 0.98
Education: further education (e.g. vocational
qualifications: GNVQ/NVQ/HND) vs. left school
at age 14–16 years and did not go back to
education
–0.19 0.40 201.80 –0.47 0.640 –0.97 to 0.50
Education: higher education (BSc/BA or
equivalent) vs. left school at age 14–16 years
and did not go back to education
–0.69 0.62 199.50 –1.12 0.263 –1.92 to 0.53
Education: postgraduate education (MSc/MA/
PhD or equivalent) vs. left school at age
14–16 years and did not go back to education
–0.20 0.72 197.40 –0.27 0.784 –1.62 to 1.22
Medication: yes vs. no –0.42 0.55 200.68 –0.75 0.454 –1.51 to 0.68
Social status: II managerial/technical vs.
I professional
–0.50 0.68 197.44 –0.74 0.463 –0.94 to 0.42
Social status: III N skilled, non-manual vs.
I professional
–1.51 0.79 201.73 –1.92 0.056 –2.09 to –0.48
Social status: III M skilled, manual vs.
I professional
–1.06 0.78 203.06 –1.36 0.175 –1.73 to –0.09
Social status: IV partly skilled vs. I professional –1.87 0.90 203.39 –2.08 0.039 –2.71 to –0.78
Social status: V unskilled vs. I professional –0.13 1.00 203.32 –0.14 0.893 –0.54 to 1.30
BA, Bachelor of Arts; BSc, Bachelor of Science; df, degrees of freedom; GNVQ, General National Vocational Qualification;
HND, Higher National Diploma; MA, Master of Arts; MSc, Master of Science; NVQ, National Vocational Qualification;
PhD, Doctor of Philosophy.
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Participants’ ratings of satisfaction with goal attainment
Participant characteristics as predictors of differences in participants Bangor
Goal-Setting Interview satisfaction ratings
Linear mixed-effects model to identify participant characteristics predicting the
difference between Bangor Goal-Setting Interview satisfaction ratings at baseline
and at 3 months’ follow-up for participants in the cognitive rehabilitation group
TABLE 74 Analysis of variance examining the influence of participant characteristics as predictors of differences in
participant ratings of BGSI satisfaction scores between baseline and 3 months
Participant characteristics χ2 df p-value
(Intercept) 6.02 1 0.014
Blinding inefficient 10.30 1 0.001
Age (stratified) 3.08 1 0.079
Sex 0.50 1 0.478
Education 6.06 4 0.194
Social status 16.82 5 0.005
Ethnicity 4.41 9 0.882
Living situation 1.46 1 0.227
Diagnosis 2.36 2 0.307
MMSE score (stratified) 2.61 1 0.106
Medication 0.31 1 0.576
Comorbidity 0.00 1 0.973
df, degrees of freedom.
Note
χ2(28)= 49.89, R2 = 0.21; p= 0.007.
TABLE 75 Regression analysis examining the influence of participant characteristics as predictors of differences in
participant BGSI satisfaction ratings between baseline and 3 months
Participant characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) 5.26 2.15 217 2.45 0.015 1.04 to 9.49
Blinding inefficient vs. maintained 0.96 0.30 217 3.21 0.002 0.37 to 1.54
Aged ≥ 75 years vs. < 75 years –0.03 0.02 217 –1.75 0.081 –0.07 to 0.00
Sex: female vs. male –0.23 0.32 217 –0.71 0.479 –0.86 to 0.41
MMSE score: ≥ 24 points vs. < 24 points 0.07 0.05 217 1.62 0.107 –0.02 to 0.17
Comorbidity 0.00 0.10 217 0.03 0.973 –0.19 to 0.20
Diagnosis: vascular dementia vs. Alzheimer’s
disease
–0.57 0.52 217 –1.10 0.274 –1.58 to 0.45
Diagnosis: mixed Alzheimer’s disease and vascular
dementia vs. Alzheimer’s disease
0.23 0.35 217 0.66 0.512 –0.46 to 0.92
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TABLE 75 Regression analysis examining the influence of participant characteristics as predictors of differences in
participant BGSI satisfaction ratings between baseline and 3 months (continued )
Participant characteristics B (estimate) SE df t-value p-value 95% CI
Education: left school at age 17–18 years and did
not go back to education vs. left school at age
14–16 years and did not go back to education
0.12 0.79 217 0.15 0.878 –1.44 to 1.69
Education: further education (e.g. vocational
qualifications: GNVQ/NVQ/HND) vs. left school
at age 14–16 years and did not go back to
education
–0.63 0.33 217 –1.91 0.058 –1.29 to 0.02
Education: higher education (BSc/BA or
equivalent) vs. left school at age 14–16 years and
did not go back to education
0.06 0.52 217 0.11 0.915 –0.97 to 1.09
Education: postgraduate education (MSc/MA/PhD
or equivalent) vs. left school at age 14–16 years
and did not go back to education
–0.98 0.61 217 –1.60 0.112 –2.18 to 0.23
Ethnicity: any other Asian background vs. Welsh/
English/Scottish/Northern Irish/British
–0.85 1.42 217 –0.60 0.550 –3.64 to 1.94
Ethnicity: African vs. Welsh/English/Scottish/
Northern Irish/British
–0.82 1.98 217 –0.42 0.678 –4.71 to 3.07
Ethnicity: Caribbean vs. Welsh/English/Scottish/
Northern Irish/British
–0.72 1.02 217 –0.71 0.481 –2.73 to 1.29
Ethnicity: any other ethnic group vs. Welsh/
English/Scottish/Northern Irish/British
0.47 1.40 217 0.33 0.739 –2.28 to 3.21
Ethnicity: Irish vs. Welsh/English/Scottish/Northern
Irish/British
–1.06 0.91 217 –1.16 0.248 –2.85 to 0.74
Ethnicity: any other white background vs. Welsh/
English/Scottish/Northern Irish/British
0.67 1.00 217 0.67 0.504 –1.30 to 2.65
Ethnicity: white and black Caribbean vs. Welsh/
English/Scottish/Northern Irish/British
–2.09 1.97 217 –1.06 0.290 –5.97 to 1.79
Ethnicity: any other mixed/multiple ethnic
background vs. Welsh/English/Scottish/Northern
Irish/British
–0.41 1.97 217 –0.21 0.837 –4.30 to 3.48
Ethnicity: Indian vs. Welsh/English/Scottish/
Northern Irish/British
1.93 2.15 217 0.90 0.369 –2.29 to 6.15
Living situation: not alone vs. alone –0.45 0.37 217 –1.21 0.229 –1.18 to 0.28
Medication: yes vs. no –0.24 0.43 217 –0.56 0.577 –1.09 to 0.61
Social status: II managerial/technical vs.
I professional
–0.82 0.56 217 –1.46 0.145 –1.92 to 0.28
Social status: III N skilled, non-manual vs.
I professional
–1.73 0.65 217 –2.67 0.008 –3.01 to –0.46
Social status: III M skilled, manual vs.
I professional
–2.10 0.63 217 –3.34 0.001 –3.33 to –0.86
Social status: IV partly skilled –1.92 0.75 217 –2.57 0.011 –3.39 to –0.45
Social status: V unskilled vs. I professional –1.33 0.81 217 –1.64 0.102 –2.93 to 0.26
BA, Bachelor of Arts; BSc, Bachelor of Science; df, degrees of freedom; GNVQ, General National Vocational Qualification;
HND, Higher National Diploma; MA, Master of Arts; MSc, Master of Science; NVQ, National Vocational Qualification;
PhD, Doctor of Philosophy.
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Linear mixed-effects model fitted to predict the difference between the participants’
Bangor Goal-Setting Interview satisfaction ratings at baseline and 9 months’ follow-up
for participants in the cognitive rehabilitation group
TABLE 76 Analysis of variance examining the influence of participant characteristics as predictors of differences in
participant BGSI satisfaction ratings between baseline and 9 months
Participant characteristics χ2 df p-value
(Intercept) 0.36 1 0.549
Blinding inefficient 14.35 1 0.000
Age 0.99 1 0.320
Sex 0.04 1 0.846
Education 5.16 4 0.271
Social status 7.45 5 0.189
Ethnicity 6.55 8 0.586
Living situation 0.30 1 0.582
Diagnosis 4.07 2 0.131
MMSE score 15.79 1 0.000
Medication 0.71 1 0.399
Comorbidity 0.04 1 0.848
df, degrees of freedom.
Note
χ2(27)= 54.26, R2 = 0.25; p= 0.001.
TABLE 77 Regression analysis examining the influence of participant characteristics as predictors of differences in
participant BGSI satisfaction ratings between baseline and 9 months
Participant characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) 1.46 2.44 200.31 0.60 0.550 –3.35 to 6.27
Blinding inefficient vs. maintained 1.23 0.33 200.33 3.79 0.000 0.58 to 1.88
Aged ≥ 75 years vs. < 75 years –0.02 0.02 201.19 –0.99 0.321 –0.00 to 0.01
Sex: female vs. male 0.07 0.36 197.40 0.19 0.846 0.10 to 0.52
MMSE score: ≥ 24 points vs. < 24 points 0.20 0.05 199.45 3.97 0.000 0.22 to 0.27
Comorbidity –0.02 0.11 200.71 –0.19 0.848 –0.05 to 0.10
Diagnosis: vascular dementia vs. Alzheimer’s
disease
–1.18 0.59 201.99 –2.01 0.046 –2.34 to –0.02
Diagnosis: mixed Alzheimer’s disease and
vascular dementia vs. Alzheimer’s disease
–0.21 0.40 201.19 –0.54 0.592 –1.00 to 0.57
Education: left school at age 17–18 years and
did not go back to education vs. left school at
age 14–16 years and did not go back to
education
0.61 0.91 200.35 0.67 0.501 0.04 to 1.42
continued
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TABLE 77 Regression analysis examining the influence of participant characteristics as predictors of differences in
participant BGSI satisfaction ratings between baseline and 9 months (continued )
Participant characteristics B (estimate) SE df t-value p-value 95% CI
Education: further education (e.g. vocational
qualifications: GNVQ/NVQ/HND) vs. left school
at age 14–16 years and did not go back to
education
–0.73 0.38 200.91 –1.96 0.052 –0.53 to –0.21
Education: higher education (BSc/BA or
equivalent) vs. left school at age 14–16 years
and did not go back to education
–0.17 0.57 196.08 –0.29 0.771 –0.25 to 0.48
Education: postgraduate education (MSc/MA/
PhD or equivalent) vs. left school at age
14–16 years and did not go back to education
–0.62 0.67 194.91 –0.93 0.355 –0.66 to 0.17
Ethnicity: any other Asian background vs.
Welsh/English/Scottish/Northern Irish/British
0.27 1.56 201.79 0.17 0.864 –0.49 to 1.74
Ethnicity: Caribbean vs. Welsh/English/
Scottish/Northern Irish/British
–2.70 1.50 198.31 –1.80 0.073 –3.29 to –1.19
Ethnicity: any other ethnic group vs. Welsh/
English/Scottish/Northern Irish/British
0.29 1.51 198.61 0.19 0.848 0.27 to 2.10
Ethnicity: Irish vs. Welsh/English/Scottish/
Northern Irish/British
–0.37 0.99 200.81 –0.37 0.711 –0.85 to 0.57
Ethnicity: any other white background vs.
Welsh/English/Scottish/Northern Irish/British
1.34 1.09 198.63 1.24 0.218 1.14 to 2.55
Ethnicity: white and black Caribbean vs.
Welsh/English/Scottish/Northern Irish/British
–0.74 2.13 198.56 –0.35 0.729 –0.44 to 1.96
Ethnicity: any other mixed/multiple ethnic
background vs. Welsh/English/Scottish/
Northern Irish/British
–1.80 2.14 200.71 –0.84 0.399 –6.07 to 0.15
Ethnicity: Indian vs. Welsh/English/Scottish/
Northern Irish/British
2.47 2.38 201.86 1.04 0.300 –2.27 to 7.20
Living situation: not alone vs. alone –0.23 0.41 197.11 –0.55 0.582 –1.05 to 0.59
Medication: yes vs. no –0.41 0.49 198.71 –0.84 0.400 –0.46 to 0.16
Social status: II managerial/technical vs.
I professional
–1.14 0.62 194.38 –1.85 0.066 –1.20 to –0.41
Social status: III N skilled, non-manual vs.
I professional
–1.60 0.72 198.09 –2.23 0.027 –1.79 to –0.83
Social status: III M skilled, manual vs.
I professional
–1.61 0.70 201.23 –2.30 0.022 –1.85 to –0.90
Social status: IV partly skilled vs. I professional –2.05 0.83 199.62 –2.48 0.014 –2.31 to –1.18
Social status: V unskilled vs. I professional –1.38 0.91 200.01 –1.51 0.132 –1.21 to –0.20
BA, Bachelor of Arts; BSc, Bachelor of Science; df, degrees of freedom; GNVQ, General National Vocational Qualification;
HND, Higher National Diploma; MA, Master of Arts; MSc, Master of Science; NVQ, National Vocational Qualification;
PhD, Doctor of Philosophy.
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Appendix 9 Exploratory analyses for the
secondary outcomes
Participant outcomes
Linear mixed-effects model fitted to identify participant characteristics predicting
differences between participant DEMentia Quality Of Life scores at baseline and
3 months’ follow-up
TABLE 78 Analysis of variance examining the influence of participant characteristics as predictors of differences in
participant DEMQOL scores between baseline and 3 months
Participant characteristics χ2 df p-value
(Intercept) 0.22 1 0.635
Sex 0.13 1 0.720
Age 0.01 1 0.943
MMSE 0.08 1 0.774
Diagnosis 0.34 2 0.844
Social status 3.03 5 0.695
Centre 0.21 1 0.646
df, degrees of freedom.
Note
χ2(11)= 3.538, R2 = 0.0204; p= 0.982.
TABLE 79 Regression analysis examining the influence of participant characteristics as predictors of differences in
participant DEMQOL scores between baseline and 3 months
Participant characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) 1.16 2.44 191.98 0.47 0.636 –3.67 to 5.97
Aged ≥ 75 years vs. < 75 years 0.10 1.43 215.87 0.07 0.943 –2.64 to 2.94
Sex: female vs. male –0.52 1.45 214.82 –0.36 0.720 –3.36 to 2.33
MMSE score: ≥ 24 points vs. < 24 points –0.36 1.26 216.76 –0.29 0.775 –2.76 to 2.15
Person with dementia diagnosis: vascular
dementia vs. Alzheimer’s disease
–0.63 1.75 199.73 –0.36 0.719 –4.13 to 2.67
Person with dementia diagnosis: mixed
Alzheimer’s disease and vascular dementia vs.
Alzheimer’s disease
0.52 1.55 214.58 0.34 0.737 –2.61 to 3.42
Social status: II managerial/technical vs.
I professional
0.07 2.32 214.08 0.03 0.975 –4.52 to 4.55
Social status: III N skilled, non-manual vs.
I professional
0.48 2.60 216.95 0.18 0.855 –4.66 to 5.47
Social status: III M skilled, manual vs.
I professional
–1.01 2.53 214.51 –0.40 0.691 –6.03 to 3.84
Social status: IV partly skilled vs. I professional 1.76 2.91 209.83 0.60 0.547 –4.00 to 7.34
Social status: V unskilled vs. I professional 3.71 3.31 216.86 1.12 0.263 –2.74 to 10.16
df, degrees of freedom.
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Linear mixed-effects model fitted to identify participant characteristics as predicting
differences between participant DEMentia Quality Of Life scores at baseline and
9 months’ follow-up for participants in the cognitive rehabilitation group
TABLE 80 Analysis of variance examining the influence of participant characteristics as predictors of differences in
participant DEMQOL scores between baseline and 9 months
Participant characteristics χ2 df p-value
(Intercept) 0.31 1 0.577
Sex 0.53 1 0.466
Age 0.00 1 1.000
MMSE 1.94 1 0.164
Diagnosis 1.13 2 0.567
Social status 1.78 5 0.879
Centre 0.00 1 1.000
df, degrees of freedom.
Note
χ2(11)= 5.439, R2 = 0.0266; p= 0.908.
TABLE 81 Regression analysis examining the influence of participant characteristics as predictors of differences in
participant DEMQOL scores between baseline and 9 months
Participant characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) 1.45 2.60 203.00 0.56 0.577 –3.67 to 6.58
Aged ≥ 75 years vs. < 75 years 0.00 1.55 203.00 0.00 1.000 –3.05 to 3.05
Sex: female vs. male –1.13 1.55 203.00 –0.73 0.467 –4.18 to 1.92
MMSE score: ≥ 24 points vs. < 24 points –1.87 1.34 203.00 –1.39 0.165 –4.52 to 0.78
Person with dementia diagnosis: vascular
dementia vs. Alzheimer’s disease
1.68 1.85 203.00 0.91 0.365 –1.96 to 5.32
Person with dementia diagnosis: mixed
Alzheimer’s disease and vascular dementia vs.
Alzheimer’s disease
1.33 1.66 203.00 0.80 0.424 –1.94 to 4.61
Social status: II managerial/technical vs.
I professional
–0.60 2.53 203.00 –0.24 0.813 –5.59 to 4.39
Social status: III N skilled, non-manual vs.
I professional
0.66 2.83 203.00 0.24 0.814 –4.90 to 6.23
Social status: III M skilled, manual vs.
I professional
0.29 2.76 203.00 0.11 0.916 –5.15 to 5.73
Social status: IV partly skilled vs. I professional 2.16 3.11 203.00 0.69 0.488 –3.96 to 8.29
Social status: V unskilled vs. I professional 1.78 3.62 203.00 0.49 0.624 –5.35 to 8.91
df, degrees of freedom.
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Linear mixed-effects model fitted to identify participant characteristics predicting
differences between participant Hospital Anxiety and Depression Scale anxiety scores at
baseline and 3 months’ follow-up for participants in the cognitive rehabilitation group
TABLE 82 Analysis of variance examining the influence of participant characteristics as predictors of differences in
participant HADS anxiety scores between baseline and 3 months
Participant characteristics χ2 df p-value
(Intercept) 0.25 1 0.619
Sex 0.09 1 0.761
Age category 0.15 1 0.696
MMSE score level 1.70 1 0.192
Person with dementia diagnosis 3.16 2 0.206
Person with dementia social status 1.52 5 0.911
Centre 0.11 1 0.735
df, degrees of freedom.
Note
χ2(11)= 6.235, R2 = 0.0314; p= 0.857.
TABLE 83 Regression analysis examining the influence of participant characteristics as predictors of differences in
participant HADS anxiety scores between baseline and 3 months
Participant characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) –0.38 0.77 188.86 –0.50 0.619 –1.88 to 1.14
Aged ≥ 75 years vs. < 75 years –0.18 0.45 212.99 –0.39 0.696 –1.07 to 0.71
Sex: female vs. male –0.14 0.46 214.31 –0.30 0.761 –1.04 to 0.76
MMSE score: ≥ 24 points vs. < 24 points –0.52 0.40 214.79 –1.30 0.193 –1.30 to 0.26
Person with dementia diagnosis: vascular
dementia vs. Alzheimer’s disease
0.94 0.55 189.06 1.69 0.092 –0.15 to 2.02
Person with dementia diagnosis: mixed
Alzheimer’s disease and vascular dementia vs.
Alzheimer’s disease
–0.02 0.49 212.76 –0.04 0.970 –0.98 to 0.94
Social status: II managerial/technical vs.
I professional
0.30 0.73 212.86 0.41 0.680 –1.14 to 1.75
Social status: III N skilled, non-manual vs.
I professional
0.60 0.82 215.85 0.74 0.462 –1.01 to 2.21
Social status: III M skilled, manual vs.
I professional
–0.00 0.80 212.50 –0.00 0.999 –1.58 to 1.56
Social status: IV partly skilled vs. I professional 0.80 0.93 205.55 0.86 0.391 –1.03 to 2.61
Social status: V unskilled vs. I professional 0.16 1.04 215.78 0.16 0.875 –1.90 to 2.23
df, degrees of freedom.
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Linear mixed-effects model fitted to identify participant characteristics predicting
differences between participant Hospital Anxiety and Depression Scale anxiety scores at
baseline and 9 months’ follow-up for participants in the cognitive rehabilitation group
TABLE 84 Analysis of variance examining the influence of participant characteristics as predictors of differences in
participant HADS anxiety scores between baseline and 9 months
Participant characteristics χ2 df p-value
(Intercept) 0.01 1 0.932
Sex 0.11 1 0.740
Age 1.94 1 0.163
MMSE 0.14 1 0.707
Diagnosis 0.94 2 0.625
Social status 2.09 5 0.836
Centre 0.00 1 1.000
df, degrees of freedom.
Note
χ2(11)= 5.13, R2= 0.026; p= 0.925.
TABLE 85 Regression analysis examining the influence of participant characteristics as predictors of differences in
participant HADS anxiety scores between baseline and 9 months
Participant characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) 0.08 0.88 193.00 0.09 0.932 –1.66 to 1.81
Aged ≥ 75 years vs. < 75 years –0.72 0.52 193.00 –1.39 0.165 –1.75 to 0.30
Sex: female vs. male 0.18 0.53 193.00 0.33 0.741 –0.87 to 1.22
MMSE score: ≥ 24 points vs. < 24 points –0.17 0.46 193.00 –0.38 0.707 –1.07 to 0.73
Person with dementia diagnosis: vascular
dementia vs. Alzheimer’s disease
–0.12 0.63 193.00 –0.19 0.848 –1.37 to 1.12
Person with dementia diagnosis: mixed
Alzheimer’s disease and vascular dementia vs.
Alzheimer’s disease
–0.55 0.57 193.00 –0.96 0.337 –1.66 to 0.57
Social status: II managerial/technical vs.
I professional
0.99 0.87 193.00 1.14 0.258 –0.73 to 2.70
Social status: III N skilled, non-manual vs.
I professional
0.52 0.97 193.00 0.53 0.593 –1.40 to 2.44
Social status: III M skilled, manual vs.
I professional
1.03 0.94 193.00 1.10 0.273 –0.82 to 2.89
Social status: IV partly skilled vs. I professional 0.78 1.05 193.00 0.74 0.458 –1.28 to 2.84
Social status: V unskilled vs. I professional 0.35 1.22 193.00 0.29 0.772 –2.0 to 2.75
df, degrees of freedom.
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Linear mixed-effects model fitted to identify participant characteristics predicting
differences between participant Hospital Anxiety and Depression Scale depression scores
at baseline and 3 months’ follow-up for participants in the cognitive rehabilitation group
TABLE 86 Analysis of variance examining the influence of participant characteristics as predictors of differences in
participant HADS depression scores between baseline and 3 months
Participant characteristics χ2 df p-value
(Intercept) 0.08 1 0.779
Sex 0.05 1 0.822
Age 0.17 1 0.681
MMSE 1.81 1 0.179
Diagnosis 0.71 2 0.702
Social status 3.07 5 0.689
Centre 0.00 1 1.000
df, degrees of freedom.
Note
χ2(11)= 5.5314, R2 = 0.0252; p= 0.903.
TABLE 87 Regression analysis examining the influence of participant characteristics as predictors of differences in
participant HADS depression scores between baseline and 3 months
Participant characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) 0.19 0.69 218.00 0.28 0.779 –1.16 to 1.54
Aged ≥ 75 years vs. < 75 years –0.17 0.40 218.00 –0.41 0.681 –0.96 to 0.63
Sex: female vs. male 0.09 0.41 218.00 0.22 0.823 –0.71 to 0.89
MMSE score: ≥ 24 points vs. < 24 points –0.48 0.35 218.00 –1.34 0.180 –1.17 to 0.22
Person with dementia diagnosis: vascular
dementia vs. Alzheimer’s disease
0.23 0.49 218.00 0.47 0.636 –0.73 to 1.20
Person with dementia diagnosis: mixed
Alzheimer’s disease and vascular dementia vs.
Alzheimer’s disease
–0.23 0.44 218.00 –0.53 0.594 –1.09 to 0.62
Social status: II managerial/technical vs.
I professional
0.16 0.65 218.00 0.24 0.807 –1.13 to 1.45
Social status: III N skilled, non-manual vs.
I professional
–0.15 0.73 218.00 –0.21 0.836 –1.59 to 1.29
Social status: III M skilled, manual vs.
I professional
0.75 0.71 218.00 1.05 0.294 –0.65 to 2.16
Social status: IV partly skilled vs. I professional –0.00 0.82 218.00 –0.00 0.998 –1.61 to 1.61
Social status: V unskilled vs. I professional 0.64 0.93 218.00 0.68 0.494 –1.20 to 2.47
df, degrees of freedom.
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Linear mixed-effects model fitted to identify participant characteristics predicting for
differences between participant Hospital Anxiety and Depression Scale depression scores
at baseline and 9 months’ follow-up for participants in the cognitive rehabilitation group
TABLE 88 Analysis of variance examining the influence of participant characteristics as predictors of differences in
participant HADS depression scores between baseline and 9 months
Participant characteristics χ2 df p-value
(Intercept) 0.07 1 0.794
Sex 0.69 1 0.407
Age 0.90 1 0.343
MMSE 0.00 1 0.979
Diagnosis 0.20 2 0.907
Social status 2.00 5 0.849
Centre –0.00 1 1.000
df, degrees of freedom.
Note
χ2(11)= 3.27, R2= 0.017; p= 0.987.
TABLE 89 Regression analysis examining the influence of participant characteristics as predictors of differences in
participant HADS depression scores between baseline and 9 months
Participant characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) 0.19 0.74 194.00 0.26 0.795 –1.27 to 1.65
Aged ≥ 75 years vs. < 75 years 0.41 0.43 194.00 0.95 0.344 –0.44 to 1.27
Sex: female vs. male 0.37 0.44 194.00 0.83 0.408 –0.51 to 1.24
MMSE score: ≥ 24 points vs. < 24 points –0.01 0.38 194.00 –0.03 0.979 –0.77 to 0.75
Person with dementia diagnosis: vascular
dementia vs. Alzheimer’s disease
0.13 0.53 194.00 0.24 0.810 –0.92 to 1.17
Person with dementia diagnosis: mixed
Alzheimer’s disease and vascular dementia vs.
Alzheimer’s disease
–0.13 0.48 194.00 –0.28 0.779 –1.07 to 0.80
Social status: II managerial/technical vs.
I professional
–0.01 0.73 194.00 –0.02 0.987 –1.45 to 1.42
Social status: III N skilled, non-manual vs.
I professional
–0.65 0.82 194.00 –0.80 0.425 –2.26 to 0.96
Social status: III M skilled, manual vs.
I professional
–0.09 0.79 194.00 –0.12 0.905 –1.65 to 1.46
Social status: IV partly skilled vs. I professional –0.60 0.88 194.00 –0.69 0.493 –2.34 to 1.13
Social status: V unskilled vs. I professional –0.11 1.02 194.00 –0.11 0.914 –2.13 to 1.91
df, degrees of freedom.
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Linear mixed-effects model fitted to identify carer characteristics predicting differences
between participant total Generalized Self-Efficacy Scale scores at baseline and 3 months’
follow-up for participants in the cognitive rehabilitation group
TABLE 90 Analysis of variance examining the influence of carer characteristics as predictors of differences in
participant GSES scores between baseline and 3 months
Carer characteristics χ2 df p value
(Intercept) 0.04 1 0.847
Sex 4.04 1 0.044
Age 0.17 1 0.681
MMSE 0.14 1 0.710
Diagnosis 5.20 2 0.074
Social status 4.92 5 0.425
Centre 0.00 1 1.000
df, degrees of freedom.
χ2(11)= 12.2207, R2 = 0.0558; p= 0.347
TABLE 91 Regression analysis examining the influence of carer characteristics as predictors of differences in
participant GSES scores between baseline and 3 months
Carer characteristics B (estimate) SE t-value p-value 95% CI
(Intercept) 0.22 1.12 214.00 0.19 0.847
Aged ≥ 75 years vs. < 75 years –0.27 0.66 214.00 –0.41 0.682
Sex: female vs. male 1.35 0.67 214.00 2.01 0.046
MMSE score: ≥ 24 points vs. < 24 points –0.22 0.58 214.00 –0.37 0.711
Person with dementia diagnosis: vascular dementia
vs. Alzheimer’s disease
0.95 0.81 214.00 1.17 0.241
Person with dementia diagnosis: mixed Alzheimer’s disease
and vascular dementia vs. Alzheimer’s disease
–1.10 0.71 214.00 –1.54 0.125
Social status: II managerial/technical vs. I professional 0.01 1.06 214.00 0.01 0.995
Social status: III N skilled, non-manual vs. I professional –0.92 1.20 214.00 –0.77 0.444
Social status: III M skilled, manual vs. I professional 0.34 1.16 214.00 0.29 0.770
Social status: IV partly skilled vs. I professional –1.20 1.33 214.00 –0.90 0.368
Social status: V unskilled vs. I professional 1.31 1.52 214.00 0.86 0.390
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Linear mixed-effects model fitted to identify carer characteristics predicting differences
between participant Generalized Self-Efficacy Scale scores at baseline and 9 months’
follow-up for participants in the cognitive rehabilitation group
TABLE 92 Analysis of variance examining the influence of carer characteristics as predictors of differences in
participant GSES scores between baseline and 9 months
Carer characteristics χ2 df p-value
(Intercept) 0.80 1 0.371
Sex 1.09 1 0.296
Age 0.70 1 0.402
MMSE 1.22 1 0.269
Diagnosis 7.71 2 0.021
Social status 2.07 5 0.839
Centre 0.00 1 1.000
df, degrees of freedom.
Note
χ2(11)= 14.3, R2= 0.072; p= 0.216.
TABLE 93 Regression analysis examining the influence of carer characteristics as predictors of differences in
participant GSES scores between baseline and 9 months
Carer characteristics B (estimate) SE t-value p-value 95% CI
(Intercept) –1.19 1.33 193.00 –0.90 0.372 to –3.81
Aged ≥ 75 years vs. < 75 years –0.66 0.79 193.00 –0.84 0.403 to –2.21
Sex: female vs. male 0.83 0.80 193.00 1.04 0.297 to –0.74
MMSE score: ≥ 24 points vs. < 24 points 0.76 0.69 193.00 1.11 0.270 to –0.60
Person with dementia diagnosis: vascular dementia vs.
Alzheimer’s disease
2.67 0.96 193.00 2.77 0.006 to 0.77
Person with dementia diagnosis: mixed Alzheimer’s
disease and vascular dementia vs. Alzheimer’s disease
0.82 0.86 193.00 0.96 0.337 to –0.86
Social status: II managerial/technical vs. I professional 0.42 1.30 193.00 0.32 0.748 to –2.15
Social status: III N skilled, non-manual vs. I professional 0.35 1.46 193.00 0.24 0.809 to –2.53
Social status: III M skilled, manual vs. I professional 0.24 1.42 193.00 0.17 0.868 to –2.55
Social status: IV partly skilled vs. I professional –0.64 1.60 193.00 –0.40 0.688 to –3.79
Social status: V unskilled vs. I professional 1.77 1.83 193.00 0.97 0.335 to –1.84
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Carer outcomes
Linear mixed-effects model fitted to identify carer characteristics predicting differences
between carer Relatives’ Stress Scale scores at baseline and 3 months’ follow-up for
carers of participants in the cognitive rehabilitation group
TABLE 94 Analysis of variance examining the influence of carer characteristics as predictors of differences in carer
RSS scores between baseline and 3 months
Carer characteristics Sum of squares df F-value p-value
(Intercept) 21.38 1 0.62 0.433
Carer age 9.20 1 0.27 0.607
Carer sex 121.97 1 3.52 0.062
Carer education 192.63 4 1.39 0.240
Carer social status 243.56 5 1.41 0.225
Carer ethnicity 282.88 6 1.36 0.234
Person with dementia diagnosis and carer relationship 327.08 7 1.35 0.231
Carer health 54.27 4 0.39 0.815
Carer hours 194.42 8 0.70 0.690
Residuals 5581.21 161 NA NA
df, degrees of freedom; NA, not applicable.
Note
F(36,161) = 0.92, R2 = 0.17; p= 0.601.
TABLE 95 Regression analysis examining the influence of carer characteristics as predictors of differences in carer
RSS scores between baseline and 3 months
Carer characteristics B (estimate) SE t-value p-value 95% CI
(Intercept) –5.32 6.77 –0.79 0.433 –18.69 to 8.05
Carer age 0.03 0.06 0.52 0.607 –0.09 to 0.15
Carer education: left school at age 17–18 years
and did not go back to education vs. left school
at age 14–16 years and did not go back to education
0.73 2.01 0.36 0.716 –3.24 to 4.70
Carer education: further education (e.g. vocational
qualifications: GNVQ/NVQ/HND) vs. left school at
age 14–16 years and did not go back to education
0.63 1.20 0.53 0.597 –1.73 to 2.99
Carer education: higher education (BSc/BA or equivalent)
vs. left school at age 14–16 years and did not go back to
education
0.06 1.74 0.03 0.975 –3.38 to 3.49
Carer education: postgraduate education (MSc/MA/PhD
or equivalent) vs. left school at age 14–16 years and
did not go back to education
–3.25 1.88 –1.72 0.086 –6.96 to 0.47
Carer ethnicity: any other Asian background vs. Welsh/
English/Scottish/Northern Irish/British
–5.50 4.56 –1.21 0.229 –14.50 to 3.50
continued
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TABLE 95 Regression analysis examining the influence of carer characteristics as predictors of differences in carer
RSS scores between baseline and 3 months (continued )
Carer characteristics B (estimate) SE t-value p-value 95% CI
Carer ethnicity: Caribbean vs. Welsh/English/Scottish/
Northern Irish/British
0.64 2.72 0.23 0.815 –4.73 to 6.01
Carer ethnicity: Irish vs. Welsh/English/Scottish/Northern
Irish/British
6.74 3.36 2.00 0.047 0.10 to 13.39
Carer ethnicity: any other white background vs. Welsh/
English/Scottish/Northern Irish/British
0.57 4.65 0.12 0.902 –8.62 to 9.76
Carer ethnicity: any other mixed/multiple ethnic
background
6.16 3.75 1.64 0.102 –1.24 to 13.56
Carer ethnicity: Indian vs. Welsh/English/Scottish/
Northern Irish/British
–2.21 6.30 –0.35 0.727 –14.66 to 10.24
Carer sex: male vs. female –2.11 1.13 –1.88 0.062 –4.34 to 0.11
Carer health: fair vs. excellent –0.27 1.70 –0.16 0.874 –3.63 to 3.09
Carer health: good vs. excellent –0.71 1.51 –0.47 0.641 –3.69 to 2.28
Carer health: poor vs. excellent –1.96 2.14 –0.91 0.362 –6.18 to 2.27
Carer health: very good vs. excellent –1.37 1.54 –0.89 0.374 –4.42 to 1.67
Hours providing care in a typical day: < 1 hour vs. none –0.57 2.13 –0.27 0.789 –4.79 to 3.64
Hours providing care in a typical day: > 1 hour and up to
2 hours vs. none
–0.12 2.22 –0.05 0.958 –4.50 to 4.26
Hours providing care in a typical day: > 1 hour and up
to 3 hours vs. none
–0.77 2.37 –0.33 0.744 –5.45 to 3.90
Hours providing care in a typical day: > 3 hours and up
to 5 hours vs. none
–0.74 2.41 –0.31 0.758 –5.50 to 4.01
Hours providing care in a typical day: > 5 hours and up
to 10 hours vs. none
1.12 2.44 0.46 0.648 –3.71 to 5.94
Hours providing care in a typical day: > 10 hours, but
not overnight vs. none
–2.75 2.76 –1.00 0.321 –8.21 to 2.71
Hours providing care in a typical day: > 10 hours and/
including overnight vs. none
1.34 2.19 0.61 0.540 –2.98 to 5.66
Hours providing care in a typical day: other vs. none 1.06 4.64 0.23 0.820 –8.11 to 10.23
Carer social status: II managerial/technical vs.
I professional
–1.42 1.66 –0.86 0.392 –4.70 to 1.85
Carer social status: III N skilled, non-manual vs.
I professional
–2.63 1.95 –1.35 0.180 –6.49 to 1.22
Carer social status: III M skilled, manual vs.
I professional
1.50 2.29 0.65 0.514 –3.03 to 6.02
Carer social status: IV partly skilled vs. I professional –0.73 2.24 –0.33 0.745 –5.16 to 3.70
Carer social status: V unskilled vs. I professional –3.85 2.77 –1.39 0.168 –9.33 to 1.63
Person with dementia and carer relationship: friend
vs. brother/sister
1.33 5.79 0.23 0.819 –10.10 to 12.76
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Linear mixed-effects model fitted to identify carer characteristics predicting differences
between carer Relatives’ Stress Scale scores at baseline and 9 months’ follow-up for
carers of participants in the cognitive rehabilitation group
TABLE 95 Regression analysis examining the influence of carer characteristics as predictors of differences in carer
RSS scores between baseline and 3 months (continued )
Carer characteristics B (estimate) SE t-value p-value 95% CI
Person with dementia and carer relationship:
grandchild vs. brother/sister
12.90 7.73 1.67 0.097 –2.37 to 28.16
Person with dementia and carer relationship: other vs.
brother/sister
0.95 5.33 0.18 0.858 –9.57 to 11.48
Person with dementia and carer relationship: partner
vs. brother/sister
7.21 4.16 1.73 0.085 –1.00 to 15.42
Person with dementia and carer relationship:
son/daughter vs. brother/sister
6.52 4.12 1.58 0.115 –1.61 to 14.65
Person with dementia and carer relationship:
son/daughter-in-law vs. brother/sister
10.45 5.34 1.96 0.052 –0.10 to 20.99
Person with dementia and carer relationship: spouse
vs. brother/sister
7.24 3.91 1.85 0.066 –0.47 to 14.95
BA, Bachelor of Arts; BSc, Bachelor of Science; GNVQ, General National Vocational Qualification; HND, Higher National
Diploma; MA, Master of Arts; MSc, Master of Science; NVQ, National Vocational Qualification; PhD, Doctor of Philosophy.
TABLE 96 Analysis of variance examining the influence of carer characteristics as predictors of differences in carer
RSS scores between baseline and 9 months
Carer characteristics Sum of squares df F-value p-value
(Intercept) 27.77 1 0.76 0.385
Carer age 24.16 1 0.66 0.417
Carer sex 124.16 1 3.40 0.067
Carer education 44.90 4 0.31 0.873
Carer social status 83.90 5 0.46 0.806
Carer ethnicity 313.05 6 1.43 0.207
Person with dementia and carer relationship 229.18 7 0.90 0.511
Carer health 148.86 4 1.02 0.400
Carer hours 150.49 8 0.51 0.844
Residuals 5516.54 151 NA NA
df, degrees of freedom; NA, not applicable.
Note
F(36,151) = 0.89, R2 = 0.17; p= 0.652.
DOI: 10.3310/hta23100 HEALTH TECHNOLOGY ASSESSMENT 2019 VOL. 23 NO. 10
© Queen’s Printer and Controller of HMSO 2019. This work was produced by Clare et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
175
TABLE 97 Regression analysis examining the influence of carer characteristics as predictors of differences in carer
RSS scores between baseline and 9 months
Carer characteristics B (estimate) SE t-value p-value 95% CI
(Intercept) –6.23 7.14 –0.87 0.385 –20.35 to 7.89
Carer age 0.05 0.06 0.81 0.417 –0.07 to 0.18
Carer education: left school at age 17–18 years and
did not go back to education vs. left school at age
14–16 years and did not go back to education
–2.21 2.09 –1.06 0.292 –6.35 to 1.92
Carer education: further education (e.g. vocational
qualifications: GNVQ/NVQ/HND) vs. left school at
age 14–16 years and did not go back to education
–0.16 1.25 –0.13 0.896 –2.64 to 2.31
Carer education: higher education (BSc/BA or
equivalent) vs. left school at age 14–16 years and did
not go back to education
–0.70 1.87 –0.38 0.708 –4.39 to 2.99
Carer education: postgraduate education (MSc/MA/PhD
or equivalent) vs. left school at age 14–16 years and
did not go back to education
–0.82 1.98 –0.41 0.680 –4.73 to 3.09
Carer ethnicity: any other Asian background vs. Welsh/
English/Scottish/Northern Irish/British
–8.93 4.72 –1.89 0.060 –18.26 to 0.40
Carer ethnicity: Caribbean vs. Welsh/English/Scottish/
Northern Irish/British
4.18 3.58 1.17 0.246 –2.90 to 11.25
Carer ethnicity: Irish vs. Welsh/English/Scottish/Northern
Irish/British
5.80 3.47 1.67 0.097 –1.06 to 12.65
Carer ethnicity: any other white background vs. Welsh/
English/Scottish/Northern Irish/British
1.35 6.51 0.21 0.836 –11.51 to 14.21
Carer ethnicity: any other mixed/multiple ethnic
background
2.59 3.87 0.67 0.504 –5.06 to 10.25
Carer ethnicity: Indian vs. Welsh/English/Scottish/
Northern Irish/British
–4.24 6.52 –0.65 0.516 –17.14 to 8.65
Carer sex: male vs. female –2.32 1.26 –1.84 0.067 –4.82 to 0.17
Carer health: fair vs. excellent 2.18 1.86 1.17 0.243 –1.50 to 5.86
Carer health: good vs. excellent –0.49 1.61 –0.30 0.761 –3.66 to 2.68
Carer health: poor vs. excellent –0.44 2.27 –0.19 0.846 –4.92 to 4.04
Carer health: very good vs. excellent –0.52 1.66 –0.31 0.754 –3.79 to 2.75
Hours providing help in a typical day: < 1 hour vs. none –0.36 2.22 –0.16 0.870 –4.74 to 4.02
Hours providing help in a typical day: > 1 hour and up
to 2 hours vs. none
0.69 2.31 0.30 0.764 –3.87 to 5.26
Hours providing help in a typical day: > 2 hours and up
to 3 hours vs. none
1.38 2.42 0.57 0.570 –3.40 to 6.15
Hours providing help in a typical day: > 3 hours and up
to 5 hours vs. none
1.63 2.62 0.62 0.535 –3.54 to 6.80
Hours providing help in a typical day: > 5 hours and up
to 10 hours vs. none
2.68 2.47 1.09 0.280 –2.20 to 7.57
Hours providing help in a typical day: > 10 hours but
not overnight vs. none
1.03 2.91 0.35 0.724 –4.72 to 6.78
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TABLE 97 Regression analysis examining the influence of carer characteristics as predictors of differences in carer
RSS scores between baseline and 9 months (continued )
Carer characteristics B (estimate) SE t-value p-value 95% CI
Hours providing help in a typical day: > 10 hours and/
including overnight vs. none
1.72 2.26 0.76 0.447 –2.73 to 6.18
Hours providing help in a typical day: other, describe
vs. none
–0.98 4.76 –0.21 0.837 –10.39 to 8.43
Carer social status: II managerial/technical vs.
I professional
0.30 1.77 0.17 0.864 –3.20 to 3.81
Carer social status: III N skilled, non-manual vs.
I professional
1.07 2.09 0.51 0.608 –3.05 to 5.20
Carer social status: III M skilled, manual vs.
I professional
1.92 2.51 0.76 0.445 –3.04 to 6.88
Carer social status: IV partly skilled vs. I professional –0.41 2.38 –0.17 0.863 –5.11 to 4.29
Carer social status: V unskilled vs. I professional –1.53 3.12 –0.49 0.625 –7.70 to 4.64
Person with dementia and carer relationship:
friend vs. brother/sister
–0.20 6.13 –0.03 0.974 –12.31 to 11.91
Person with dementia and carer relationship:
grandchild vs. brother/sister
11.23 8.09 1.39 0.167 –4.76 to 27.22
Person with dementia and carer relationship:
other vs. brother/sister
0.66 5.54 0.12 0.906 –10.29 to 11.60
Person with dementia and carer relationship:
partner vs. brother/sister
4.53 4.38 1.03 0.303 –4.13 to 13.18
Person with dementia and carer relationship:
son/daughter vs. brother/sister
5.29 4.37 1.21 0.228 –3.34 to 13.91
Person with dementia and carer relationship:
son/daughter-in-law vs. brother/sister
8.51 5.28 1.61 0.109 –1.93 to 18.96
Person with dementia and carer relationship:
spouse vs. brother/sister
5.16 4.12 1.25 0.213 –2.99 to 13.30
BA, Bachelor of Arts; BSc, Bachelor of Science; GNVQ, General National Vocational Qualification; HND, Higher National
Diploma; MA, Master of Arts; MSc, Master of Science; NVQ, National Vocational Qualification; PhD, Doctor of Philosophy.
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Linear mixed-effects model fitted to identify characteristics predicting differences
between carer World Health Organization’s Quality of Life Instrument – brief version
physical scores at baseline and 3 months’ follow-up for carers of participants in the
cognitive rehabilitation group
TABLE 98 Analysis of variance examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF physical scores between baseline and 3 months
Person with dementia and carer characteristics χ2 df p-value
(Intercept) 1.17 1 0.280
Person with dementia and carer relationship 2.37 7 0.937
Carer sex 1.02 1 0.311
Person with dementia diagnosis 0.71 2 0.702
Person with dementia MMSE score 0.22 1 0.641
Centre 4.48 1 0.034
df, degrees of freedom.
Note
χ2(12)= 8.12, R2= 0.07; p= 0.775.
TABLE 99 Regression analysis examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF physical scores between baseline and 3 months
Person with dementia and carer
characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) –1.12 1.04 211.30 –1.08 0.281 –3.16 to 0.92
Carer’s sex: male vs. female –0.27 0.27 205.29 –1.01 0.313 –0.79 to 0.25
MMSE score: ≥ 24 points vs. < 24 points –0.12 0.25 210.15 –0.47 0.641 –0.62 to 0.38
Person with dementia and carer relationship:
friend vs. brother/sister
1.49 1.29 207.44 1.15 0.250 –1.05 to 4.04
Person with dementia and carer relationship:
grandchild vs. brother/sister
0.54 1.61 206.90 0.33 0.739 –2.64 to 3.73
Person with dementia and carer relationship:
other vs. brother/sister
1.28 1.44 207.82 0.89 0.375 –1.56 to 4.12
Person with dementia and carer relationship:
partner vs. brother/sister
1.22 1.10 206.57 1.10 0.271 –0.96 to 3.39
Person with dementia and carer relationship:
son/daughter vs. brother/sister
1.00 1.05 206.69 0.95 0.344 –1.08 to 3.08
Person with dementia and carer relationship:
son/daughter-in-law vs. brother/sister
0.51 1.44 208.43 0.36 0.722 –2.33 to 3.36
Person with dementia and carer relationship:
spouse vs. brother/sister
1.17 1.04 209.03 1.13 0.260 –0.88 to 3.22
Person with dementia and carer relationship
diagnosis: vascular dementia vs. Alzheimer’s
disease
0.20 0.35 211.87 0.57 0.566 –0.49 to 0.89
Person with dementia and carer relationship
diagnosis: mixed Alzheimer’s disease and
vascular dementia vs. Alzheimer’s disease
–0.14 0.31 211.86 –0.44 0.661 –0.74 to 0.47
df, degrees of freedom.
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Linear mixed-effects model fitted to identify characteristics predicting differences
between carer World Health Organization’s Quality of Life Instrument – brief version
physical scores at baseline and 9 months’ follow-up for carers of participants in the
cognitive rehabilitation group
TABLE 100 Analysis of variance examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF physical scores between baseline and 9 months
Person with dementia and carer characteristics χ2 df p-value
(Intercept) 1.59 1 0.207
Person with dementia and carer relationship 4.25 7 0.751
Carer sex 0.15 1 0.698
Person with dementia diagnosis 0.79 2 0.672
Person with dementia MMSE score 0.33 1 0.563
Centre 1.88 1 0.171
df, degrees of freedom.
Note
χ2(12)= 7.56, R2= 0.053; p= 0.819.
TABLE 101 Regression analysis examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF physical scores between baseline and 9 months
Person with dementia and carer
characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) –1.25 0.99 198.87 –1.26 0.209 –3.20 to 0.70
Carer’s sex: male vs. female 0.10 0.26 193.28 0.39 0.699 –0.42 to 0.62
MMSE score: ≥ 24 points vs. < 24 points –0.15 0.25 198.65 –0.58 0.564 –0.64 to 0.35
Person with dementia and carer relationship:
friend vs. brother/sister
2.07 1.30 197.15 1.59 0.114 –0.50 to 4.65
Person with dementia and carer relationship:
grandchild vs. brother/sister
–0.13 1.55 195.57 –0.08 0.934 –3.19 to 2.94
Person with dementia and carer relationship:
other vs. brother/sister
1.25 1.39 196.15 0.90 0.369 –1.48 to 0.98
Person with dementia and carer relationship:
partner vs. brother/sister
1.14 1.07 194.98 1.06 0.290 –0.97 to 3.25
Person with dementia and carer relationship:
son/daughter vs. brother/sister
0.81 1.02 195.49 0.80 0.423 –1.19 to 2.82
Person with dementia and carer relationship:
son/daughter-in-law vs. brother/sister
0.99 1.39 197.33 0.71 0.476 –1.74 to 3.73
Person with dementia and carer relationship:
spouse vs. brother/sister
1.05 1.00 197.92 1.05 0.296 –0.93 to 3.02
Person with dementia diagnosis: vascular
dementia vs. Alzheimer’s disease
–0.25 0.34 197.18 –0.73 0.469 –0.93 to 0.43
Person with dementia diagnosis: mixed
Alzheimer’s disease and vascular dementia
vs. Alzheimer’s disease
0.09 0.30 198.68 0.30 0.765 –0.50 to 0.68
df, degrees of freedom.
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Linear mixed-effects model fitted to identify characteristics predicting differences
between carer World Health Organization’s Quality of Life Instrument – brief version
psychological scores at baseline and 3 months’ follow-up for carers of participants in
the cognitive rehabilitation group
TABLE 102 Analysis of variance examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF psychological scores between baseline and 3 months
Person with dementia and carer characteristics χ2 df p-value
(Intercept) 5.37 1 0.020
Person with dementia and carer relationship 8.62 7 0.281
Carer sex 0.01 1 0.907
Person with dementia diagnosis 0.50 2 0.781
Person with dementia MMSE score 0.79 1 0.375
Centre 1.04 1 0.307
df, degrees of freedom.
Note
χ2(12)= 10.5, R2= 0.061; p= 0.57.
TABLE 103 Regression analysis examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF psychological scores between baseline and 3 months
Person with dementia and carer
characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) –2.04 0.88 211.89 –2.32 0.021 –3.78 to –0.31
Carer’s sex: male vs. female 0.03 0.23 206.53 0.12 0.907 –0.42 to 0.48
MMSE score: ≥ 24 points vs. < 24 points 0.19 0.22 211.67 0.89 0.376 –0.24 to 0.62
Person with dementia and carer relationship:
friend vs. brother/sister
3.06 1.11 209.23 2.76 0.006 0.88 to 5.25
Person with dementia and carer relationship:
grandchild vs. brother/sister
1.75 1.39 208.87 1.26 0.209 –0.99 to 4.49
Person with dementia and carer relationship:
other vs. brother/sister
2.00 1.24 209.05 1.62 0.108 –0.44 to 4.44
Person with dementia and carer relationship:
partner vs. brother/sister
1.82 0.95 208.40 1.92 0.056 –0.05 to 3.69
Person with dementia and carer relationship:
son/daughter vs. brother/sister
1.58 0.90 208.48 1.75 0.081 –0.20 to 3.37
Person with dementia and carer relationship:
son/daughter-in-law vs. brother/sister
1.94 1.24 210.50 1.57 0.118 –0.50 to 4.38
Person with dementia and carer relationship:
spouse vs. brother/sister
1.60 0.89 211.08 1.80 0.074 –0.16 to 3.35
Person with dementia diagnosis: vascular
dementia vs. Alzheimer’s disease
0.07 0.29 207.32 0.24 0.810 –0.52 to 0.66
Person with dementia diagnosis: mixed
Alzheimer’s disease and vascular dementia
vs. Alzheimer’s disease
0.18 0.26 211.10 0.70 0.484 –0.33 to 0.70
df, degrees of freedom.
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Linear mixed-effects model fitted to identify characteristics predicting differences
between carer World Health Organization’s Quality of Life Instrument – brief version
psychological scores at baseline and 9 months’ follow-up for carers of participants
in the cognitive rehabilitation group
TABLE 104 Analysis of variance examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF psychological scores between baseline and 9 months
Person with dementia and carer characteristics χ2 df p-value
(Intercept) 1.23 1 0.268
Person with dementia and carer relationship 1.74 7 0.973
Carer sex 0.37 1 0.545
Person with dementia diagnosis 2.13 2 0.344
Person with dementia MMSE score 0.01 1 0.917
Centre 0.92 1 0.338
df, degrees of freedom.
Note
χ2(12)= 5.00, R2= 0.040; p= 0.959.
TABLE 105 Regression analysis examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF psychological scores between baseline and 9 months
Person with dementia and carer
characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) –1.01 0.91 198.86 –1.11 0.269 –2.81 to 0.79
Carer’s sex: male vs. female 0.15 0.24 190.77 0.61 0.546 –0.30 to 0.60
MMSE score: ≥ 24 points vs. < 24 points 0.02 0.23 198.76 0.10 0.917 –0.38 to 0.47
Person with dementia and carer relationship:
friend vs. brother/sister
0.43 1.20 196.79 0.35 0.724 –1.67 to 2.82
Person with dementia and carer relationship:
grandchild vs. brother/sister
–0.06 1.43 194.44 –0.04 0.967 –2.62 to 2.66
Person with dementia and carer relationship:
other vs. brother/sister
0.25 1.28 195.05 0.20 0.843 –2.03 to 2.68
Person with dementia and carer relationship:
partner vs. brother/sister
0.86 0.99 193.47 0.87 0.385 –0.96 to 2.68
Person with dementia and carer relationship:
son/daughter vs. brother/sister
0.59 0.94 194.27 0.63 0.528 –1.08 to 2.37
Person with dementia and carer relationship:
son/daughter-in-law vs. brother/sister
0.30 1.28 197.04 0.23 0.815 –2.04 to 2.66
Person with dementia and carer relationship:
spouse vs. brother/sister
0.44 0.92 197.90 0.48 0.630 –1.17 to 2.21
Person with dementia diagnosis: vascular
dementia vs. Alzheimer’s disease
–0.30 0.31 194.16 –0.95 0.346 –0.91 to 0.24
Person with dementia diagnosis: mixed
Alzheimer’s disease and vascular dementia
vs. Alzheimer’s disease
0.22 0.27 197.85 0.82 0.414 –0.27 to 0.73
df, degrees of freedom.
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Linear mixed-effects model fitted to identify characteristics predicting differences
between carer World Health Organization’s Quality of Life Instrument – brief version
social scores at baseline and 3 months’ follow-up for carers of participants in the
cognitive rehabilitation group
TABLE 106 Analysis of variance examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF social scores between baseline and 3 months
Person with dementia and carer characteristics χ2 df p-value
(Intercept) 0.79 1 0.374
Person with dementia and carer relationship 2.90 7 0.894
Carer sex 0.06 1 0.811
Person with dementia diagnosis 2.40 2 0.301
Person with dementia MMSE score 0.21 1 0.647
Centre 0.00 1 1.000
df, degrees of freedom.
Note
χ2(12)= 6.23, R2= 0.029; p= 0.904.
TABLE 107 Regression analysis examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF social scores between baseline and 3 months
Person with dementia and carer
characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) –1.07 1.20 211.00 –0.89 0.375 –3.44 to 1.30
Carer’s sex: male vs. female 0.07 0.31 211.00 0.24 0.811 –0.54 to 0.69
MMSE score: ≥ 24 points vs. < 24 points 0.14 0.30 211.00 0.46 0.648 –0.45 to 0.72
Person with dementia and carer relationship:
friend vs. brother/sister
1.03 1.52 211.00 0.68 0.498 –1.96 to 4.02
Person with dementia and carer relationship:
grandchild vs. brother/sister
–0.07 1.90 211.00 –0.03 0.972 –3.81 to 3.68
Person with dementia and carer relationship:
other vs. brother/sister
1.01 1.70 211.00 0.60 0.551 –2.33 to 4.36
Person with dementia and carer relationship:
partner vs. brother/sister
0.26 1.30 211.00 0.20 0.839 –2.29 to 2.82
Person with dementia and carer relationship:
son/daughter vs. brother/sister
0.92 1.24 211.00 0.74 0.459 –1.52 to 3.36
Person with dementia and carer relationship:
son/daughter-in-law vs. brother/sister
–0.36 1.69 211.00 –0.21 0.830 –3.70 to 2.97
Person with dementia and carer relationship:
spouse vs. brother/sister
0.61 1.22 211.00 0.50 0.616 –1.78 to 3.00
Person with dementia diagnosis: vascular
dementia vs. Alzheimer’s disease
0.62 0.40 211.00 1.55 0.123 –0.17 to 1.40
Person with dementia diagnosis: mixed
Alzheimer’s disease and vascular dementia
vs. Alzheimer’s disease
0.17 0.36 211.00 0.46 0.643 –0.54 to 0.87
df, degrees of freedom.
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Linear mixed-effects model fitted to identify characteristics predicting differences
between carer World Health Organization’s Quality of Life Instrument – brief version
social scores at baseline and 9 months’ follow-up for carers of participants in the
cognitive rehabilitation group
TABLE 108 Analysis of variance examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF social scores between baseline and 9 months
Person with dementia and carer characteristics χ2 df p-value
(Intercept) 3.10 1 0.078
Person with dementia and carer relationship 7.08 7 0.420
Carer sex 3.34 1 0.068
Person with dementia diagnosis 0.63 2 0.730
Person with dementia MMSE score 0.12 1 0.728
Centre 0.00 1 1.000
df, degrees of freedom.
Note
χ2(12)= 10.81, R2 = 0.054; p = 0.545.
TABLE 109 Regression analysis examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF social scores between baseline and 3 months
Person with dementia and carer
characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) –2.25 1.28 196.00 –1.76 0.080 –4.76 to 0.27
Carer’s sex: male vs. female 0.63 0.34 196.00 1.83 0.069 –0.05 to 1.31
MMSE score: ≥ 24 points vs. < 24 points 0.11 0.33 196.00 0.35 0.728 –0.53 to 0.76
Person with dementia and carer relationship:
friend vs. brother/sister
3.31 1.69 196.00 1.96 0.052 –0.02 to 6.64
Person with dementia and carer relationship:
grandchild vs. brother/sister
1.63 2.02 196.00 0.81 0.419 –2.34 to 5.61
Person with dementia and carer relationship:
other vs. brother/sister
2.81 1.80 196.00 1.56 0.120 –0.74 to 6.36
Person with dementia and carer relationship:
partner vs. brother/sister
1.82 1.39 196.00 1.30 0.194 –0.93 to 4.56
Person with dementia and carer relationship:
son/daughter vs. brother/sister
1.69 1.32 196.00 1.28 0.201 –0.91 to 4.29
Person with dementia and carer relationship:
son/daughter-in-law vs. brother/sister
–0.23 1.80 196.00 –0.13 0.900 –3.77 to 3.32
Person with dementia and carer relationship:
spouse vs. brother/sister
1.78 1.29 196.00 1.38 0.170 –0.76 to 4.33
Person with dementia diagnosis: vascular
dementia vs. Alzheimer’s disease
0.11 0.44 196.00 0.24 0.808 –0.76 to 0.98
Person with dementia diagnosis: mixed
Alzheimer’s disease and vascular dementia
vs. Alzheimer’s disease
0.31 0.39 196.00 0.79 0.429 –0.46 to 1.07
df, degrees of freedom.
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Linear mixed-effects model fitted to identify characteristics predicting differences
between carer World Health Organization’s Quality of Life Instrument – brief version
environmental scores at baseline and 3 months’ follow-up for carers of participants in
the cognitive rehabilitation group
TABLE 110 Analysis of variance examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF environmental scores between baseline and 3 months
Person with dementia and carer characteristics χ2 df p-value
(Intercept) 0.61 1 0.434
Person with dementia and carer relationship 6.59 7 0.473
Carer sex 1.54 1 0.215
Person with dementia diagnosis 1.84 2 0.399
Person with dementia MMSE score 0.23 1 0.629
Centre 0.00 1 1.000
df, degrees of freedom.
Note
χ2(12)= 9.3171, R2 = 0.0432; p= 0.676.
TABLE 111 Regression analysis examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF environmental scores between baseline and 3 months
Person with dementia and carer
characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) –0.61 0.78 212.00 –0.78 0.435 –2.16 to 0.93
Carer’s sex: male vs. female –0.25 0.20 212.00 –1.24 0.216 –0.66 to 0.15
MMSE score: ≥ 24 points vs. < 24 points 0.09 0.19 212.00 0.48 0.629 –0.29 to 0.47
Person with dementia and carer relationship:
friend vs. brother/sister
0.03 0.99 212.00 0.03 0.976 –1.92 to 1.98
Person with dementia and carer relationship:
grandchild vs. brother/sister
0.02 1.24 212.00 0.02 0.987 –2.42 to 2.46
Person with dementia and carer relationship:
other vs. brother/sister
1.38 1.11 212.00 1.25 0.212 –0.79 to 3.56
Person with dementia and carer relationship:
partner vs. brother/sister
0.40 0.85 212.00 0.47 0.641 –1.27 to 2.06
Person with dementia and carer relationship:
son/daughter vs. brother/sister
0.83 0.81 212.00 1.02 0.307 –0.76 to 2.42
Person with dementia and carer relationship:
son/daughter-in-law vs. brother/sister
–0.31 1.10 212.00 –0.28 0.777 –2.49 to 1.86
Person with dementia and carer relationship:
spouse vs. brother/sister
0.77 0.79 212.00 0.98 0.331 –0.79 to 2.33
Person with dementia diagnosis: vascular
dementia vs. Alzheimer’s disease
–0.05 0.26 212.00 –0.19 0.853 –0.56 to 0.46
Person with dementia diagnosis: mixed
Alzheimer’s disease and vascular dementia
vs. Alzheimer’s disease
–0.31 0.23 212.00 –1.35 0.180 –0.77 to 0.14
df, degrees of freedom.
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Linear mixed-effects model fitted to identify characteristics predicting differences
between carer World Health Organization’s Quality of Life Instrument – brief version
environmental scores at baseline and 9 months’ follow-up for carers of participants in
the cognitive rehabilitation group
TABLE 112 Analysis of variance examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF environmental scores between baseline and 9 months
Person with dementia and carer characteristics χ2 df p-value
(Intercept) 2.57 1 0.109
Person with dementia and carer relationship 11.65 7 0.113
Carer sex 0.01 1 0.944
Person with dementia diagnosis 0.21 2 0.901
Person with dementia MMSE score 0.19 1 0.662
Centre –0.00 1 1.000
df, degrees of freedom.
Note
χ2(12)= 11.5908, R2 = 0.0569; p= 0.479.
TABLE 113 Regression analysis examining the influence of characteristics as predictors of differences in carer
WHOQOL-BREF environmental scores between baseline and 9 months
Person with dementia and carer
characteristics B (estimate) SE df t-value p-value 95% CI
(Intercept) –1.37 0.85 199.00 –1.60 0.110 –3.05 to 0.31
Carer’s sex: male vs. female 0.02 0.23 199.00 0.07 0.944 –0.44 to 0.47
MMSE: ≥ 24 points vs. < 24 points 0.10 0.22 199.00 0.44 0.662 –0.33 to 0.52
Person with dementia and carer relationship:
friend vs. brother/sister
0.79 1.13 199.00 0.70 0.484 –1.43 to 3.02
Person with dementia and carer relationship:
grandchild vs. brother/sister
0.28 1.35 199.00 0.20 0.839 –2.38 to 2.93
Person with dementia and carer relationship:
other vs. brother/sister
3.34 1.21 199.00 2.77 0.006 0.97 to 5.72
Person with dementia and carer relationship:
partner vs. brother/sister
1.32 0.93 199.00 1.42 0.157 –0.51 to 3.16
Person with dementia and carer relationship:
son/daughter vs. brother/sister
0.94 0.88 199.00 1.06 0.289 –0.80 to 2.68
Person with dementia and carer relationship:
son/daughter-in-law vs. brother/sister
–0.02 1.20 199.00 –0.02 0.985 –2.39 to 2.35
Person with dementia and carer relationship:
spouse vs. brother/sister
1.02 0.86 199.00 1.18 0.239 –0.68 to 2.72
Person with dementia diagnosis: vascular
dementia vs. Alzheimer’s disease
–0.06 0.29 199.00 –0.21 0.831 –0.64 to 0.51
Person with dementia diagnosis: mixed
Alzheimer’s disease and vascular dementia
vs. Alzheimer’s disease
0.09 0.26 199.00 0.33 0.739 –0.42 to 0.59
df, degrees of freedom.
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Appendix 10 Complete-case analyses with
no imputation
TABLE 114 Analysis of covariance: summary table for BGSI ratings without imputations
Measure p-value
Adjusted
p-value
Mean
difference
95% CI for
mean difference Cohen’s d
95% CI for
Cohen’s d
3-month follow-up
Participant rating of attainment < 0.001 < 0.001 1.71 1.32 to 2.1 0.91 0.7 to 1.13
Participant rating of satisfaction < 0.001 < 0.001 1.56 1.14 to 1.98 0.78 0.56 to 0.99
Carer rating of attainment < 0.001 < 0.001 1.89 1.51 to 2.28 1.03 0.81 to 1.25
9-month follow-up
Participant rating of attainment < 0.001 < 0.001 1.81 1.34 to 2.28 0.86 0.63 to 1.09
Participant rating of satisfaction < 0.001 < 0.001 1.69 1.21 to 2.17 0.78 0.55 to 1.01
Carer rating of attainment < 0.001 < 0.001 1.85 1.38 to 2.31 0.88 0.65 to 1.11
TABLE 115 Analysis of covariance: summary table for analysis of secondary outcomes without imputations
Measure p-value
Adjusted
p-value
Mean
difference
95% CI for
mean difference Cohen’s d
95% CI for
Cohen’s d
3-month follow-up
Participants with dementia
DEMQOL score 0.505 1 0.59 –1.14 to 2.31 0.07 –0.14 to 0.28
GSES score 0.157 1 0.65 –0.25 to 1.56 0.15 –0.06 to 0.36
HADS score 0.659 1 –0.2 –1.07 to 0.68 –0.05 –0.25 to 0.16
RBMT immediate recall 0.259 1 0.22 –0.16 to 0.6 0.12 –0.09 to 0.33
RBMT delayed recall 0.668 1 0.07 –0.27 to 0.41 0.05 –0.16 to 0.25
TEA elevator counting 0.391 1 0.1 –0.13 to 0.32 0.09 –0.12 to 0.3
TEA elevator counting with
distraction
0.427 1 0.21 –0.31 to 0.73 0.08 –0.12 to 0.29
D-KEFS verbal fluency 0.924 1 0.07 –1.35 to 1.49 0.01 –0.2 to 0.22
Carers
RSS 0.362 1 –0.59 –1.87 to 0.68 –0.1 –0.3 to 0.11
WHOQOL-BREF physical 0.171 1 0.23 –0.1 to 0.55 0.15 –0.06 to 0.35
WHOQOL-BREF psychological 0.133 1 0.25 –0.08 to 0.57 0.16 –0.05 to 0.37
WHOQOL-BREF social 0.930 1 –0.02 –0.46 to 0.42 –0.01 –0.22 to 0.2
WHOQOL-BREF environmental 0.029 0.488 0.33 0.03 to 0.63 0.23 0.03 to 0.44
EQ-5D-3L index 0.189 1 0.02 –0.01 to 0.06 0.14 –0.07 to 0.35
EQ-5D-3L VAS 0.153 1 2.72 –1.02 to 6.47 0.15 –0.06 to 0.36
continued
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TABLE 115 Analysis of covariance: summary table for analysis of secondary outcomes without imputations
(continued )
Measure p-value
Adjusted
p-value
Mean
difference
95% CI for
mean difference Cohen’s d
95% CI for
Cohen’s d
9-month follow-up
Participants with dementia
DEMQOL score 0.254 1 1.23 –0.89 to 3.36 0.13 –0.09 to 0.35
GSES score 0.357 1 0.48 –0.54 to 1.5 0.1 –0.12 to 0.32
HADS score 0.121 1 0.76 –0.2 to 1.72 0.18 –0.05 to 0.4
RBMT immediate recall 0.704 1 0.08 –0.32 to 0.47 0.04 –0.18 to 0.26
RBMT delayed recall 0.335 1 –0.18 –0.54 to 0.19 –0.11 –0.33 to 0.11
TEA elevator counting 0.764 1 –0.04 –0.33 to 0.24 –0.03 –0.25 to 0.19
TEA elevator counting with
distraction
0.176 1 0.38 –0.17 to 0.93 0.15 –0.07 to 0.37
D-KEFS verbal fluency 0.679 1 0.36 –1.34 to 2.05 0.05 –0.17 to 0.27
Carers
RSS 0.529 1 0.44 –0.93 to 1.81 0.07 –0.15 to 0.29
WHOQOL-BREF physical 0.126 1 0.31 –0.09 to 0.72 0.17 –0.05 to 0.39
WHOQOL-BREF psychological 0.544 1 0.11 –0.25 to 0.46 0.07 –0.15 to 0.29
WHOQOL-BREF social 0.165 1 0.36 –0.15 to 0.87 0.16 –0.06 to 0.38
WHOQOL-BREF environmental 0.607 1 0.09 –0.24 to 0.41 0.06 –0.16 to 0.28
EQ-5D-3L index 0.858 1 0 –0.05 to 0.04 –0.02 –0.24 to 0.2
EQ-5D-3L VAS 0.009 0.147 4.72 1.21 to 8.24 0.3 0.08 to 0.52
APPENDIX 10
NIHR Journals Library www.journalslibrary.nihr.ac.uk
188
Appendix 11 Analyses of the change in scores
between baseline and follow-ups
TABLE 116 Analysis of variance of the difference between outcome scores for the 3-month follow-up and baseline
without imputations
Measure F-value df p-value
Adjusted
p-value Cohen’s d
95% CI for
Cohen’s d
Mean
difference
95% CI for
Mean
difference
BGSI performance
rating by participant
with dementia
73.82 1344 < 0.001 < 0.001 0.91 0.7 to 1.13 1.71 1.32 to 2.1
BGSI satisfaction rating
by participant with
dementia
53.61 1344 < 0.001 < 0.001 0.78 0.56 to 0.99 1.56 1.14 to 1.98
BGSI performance
rating by carer
93.3 1344 < 0.001 < 0.001 1.03 0.81 to 1.25 1.89 1.51 to 2.28
DEMQOL score 0.45 1344 0.505 1 0.07 –0.14 to 0.28 0.59 –1.14 to 2.31
GSES score 2.01 1344 0.157 1 0.15 –0.06 to 0.36 0.65 –0.25 to 1.56
HADS score 0.19 1344 0.659 1 –0.05 –0.25 to 0.16 –0.2 –1.07 to 0.68
RBMT immediate recall 1.28 1344 0.259 1 0.12 –0.09 to 0.33 0.22 –0.16 to 0.6
RBMT delayed recall 0.18 1344 0.668 1 0.05 –0.16 to 0.25 0.07 –0.27 to 0.41
TEA elevator counting 0.74 1344 0.391 1 0.09 –0.12 to 0.3 0.1 –0.13 to 0.32
TEA elevator counting
with distraction
0.63 1344 0.427 1 0.08 –0.12 to 0.29 0.21 –0.31 to 0.73
D-KEFS verbal fluency 0.01 1344 0.924 1 0.01 –0.2 to 0.22 0.07 –1.35 to 1.49
RSS 0.83 1344 0.362 1 –0.10 –0.3 to 0.11 –0.59 –1.87 to 0.68
EQ-5D-3L index 1.73 1344 0.189 1 0.14 –0.07 to 0.35 0.02 –0.01 to 0.06
EQ-5D-3L VAS 2.05 1344 0.153 1 0.15 –0.06 to 0.36 2.72 –1.02 to 6.47
WHOQOL-BREF
physical
1.89 1344 0.171 1 0.15 –0.06 to 0.35 0.23 –0.1 to 0.55
WHOQOL-BREF
physchological
2.26 1344 0.133 1 0.16 –0.05 to 0.37 0.25 –0.08 to 0.57
WHOQOL-BREF social 0.01 1344 0.930 1 –0.01 –0.22 to 0.2 –0.02 –0.46 to 0.42
WHOQOL-BREF
environmental
4.83 1344 0.029 0.488 0.23 0.03 to 0.44 0.33 0.03 to 0.63
df, degrees of freedom.
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TABLE 117 Analysis of variance of the difference between outcome scores for the 9-month follow-up and baseline
without imputations
Measure F-value df p-value
Adjusted
p-value Cohen’s d
95% CI for
Cohen’s d
Mean
difference
95% CI
for Mean
difference
BGSI performance
rating by participant
with dementia
58.01 1305 < 0.001 < 0.001 0.86 0.63 to 1.09 1.81 1.34 to 2.28
BGSI satisfaction rating
by participant with
dementia
47.34 1305 < 0.001 < 0.001 0.78 0.55 to 1.01 1.69 1.21 to 2.17
BGSI performance
Rating by carer
60.97 1305 < 0.001 < 0.001 0.88 0.65 to 1.11 1.85 1.38 to 2.31
DEMQOL score 1.31 1305 0.254 1 0.13 –0.09 to 0.35 1.23 –0.89 to 3.36
GSES score 0.85 1305 0.357 1 0.10 –0.12 to 0.32 0.48 –0.54 to 1.5
HADS score 2.42 1305 0.121 1 0.18 –0.05 to 0.4 0.76 –0.2 to 1.72
RBMT immediate recall 0.14 1305 0.704 1 0.04 –0.18 to 0.26 0.08 –0.32 to 0.47
RBMT delayed recall 0.93 1305 0.335 1 –0.11 –0.33 to 0.11 –0.18 –0.54 to 0.19
TEA elevator counting 0.09 1305 0.764 1 –0.03 –0.25 to 0.19 –0.04 –0.33 to 0.24
TEA elevator counting
with distraction
1.84 1305 0.176 1 0.15 –0.07 to 0.37 0.38 –0.17 to 0.93
D-KEFS verbal fluency 0.17 1305 0.679 1 0.05 –0.17 to 0.27 0.36 –1.34 to 2.05
RSS 0.4 1305 0.529 1 0.07 –0.15 to 0.29 0.44 –0.93 to 1.81
EQ-5D-3L index 0.03 1305 0.858 1 –0.02 –0.24 to 0.2 0 –0.05 to 0.04
EQ-5D-3L VAS 6.98 1305 0.009 0.147 0.30 0.08 to 0.52 4.72 1.21 to 8.24
WHOQOL-BREF
physical
2.35 1305 0.126 1 0.17 –0.05 to 0.39 0.31 –0.09 to 0.72
WHOQOL-BREF
physchological
0.37 1305 0.544 1 0.07 –0.15 to 0.29 0.11 –0.25 to 0.46
WHOQOL-BREF social 1.94 1305 0.165 1 0.16 –0.06 to 0.38 0.36 –0.15 to 0.87
WHOQOL-BREF
environmental
0.26 1305 0.607 1 0.06 –0.16 to 0.28 0.09 –0.24 to 0.41
df, degrees of freedom.
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Appendix 12 Effectiveness of blinding
TABLE 118 Researchers’ accuracy in estimating group allocation at follow-up assessments
Researcher estimates Whole sample, n (%)
Treatment group, n (%)
CR TAU
3-month follow-up (N = 444)
Incorrect estimation 86 (19.3) 64 (29.4) 22 (9.7)
Correct estimation 358 (80.4) 154 (70.6) 204 (89.9)
9-month follow-up (N = 426)
Incorrect estimation 93 (21.8) 66 (31.7) 27 (12.4)
Correct estimation 333 (78.2) 142 (68.3) 191 (87.6)
TABLE 119 Researchers’ responses regarding their estimations of group allocation for each participant at the
3-month follow-up
Questions asked of researchers Whole sample (N= 444), n (%)
Treatment group, n (%)
CR (N= 218) TAU (N= 226)
Which condition the researcher thought the person with dementia had been allocated to
Indicated CR 176 (39.6) 154 (70.6) 22 (9.7)
Indicated TAU 268 (60.2) 64 (29.4) 204 (89.9)
How confident/certain was the researcher of their judgement about group allocation?
Very uncertain (complete guess) 81 (18.2) 43 (19.7) 38 (16.7)
Uncertain 148 (33.3) 73 (33.5) 75 (33.0)
Quite certain 141 (31.7) 57 (26.1) 84 (37.0)
Very certain 74 (16.6) 45 (20.6) 29 (12.8)
Did the participant make the group allocation explicit to the researcher?
Yes 66 (14.8) 44 (20.2) 22 (9.7)
No 378 (84.9) 174 (79.8) 204 (89.9)
Were there any indirect clues about group allocation? (e.g. new adaptations at home)?
Yes 37 (8.3) 33 (15.1) 4 (1.8)
No 407 (91.5) 185 (84.9) 222 (97.8)
Were the responses to these questions influenced by change/no change in the participant’s goal performance rating?
Yes 215 (48.3) 93 (42.7) 122 (53.7)
No 229 (51.5) 125 (57.3) 104 (45.8)
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TABLE 120 Researchers’ responses regarding their estimations of group allocation for each participant at the
9-month follow-up
Questions asked of researchers
Whole sample
(N= 426), n (%)
Treatment group, n (%)
CR (N= 208) TAU (N= 218)
Which condition the researcher thought the person with dementia had been allocated to
Indicated CR 169 (39.7) 142 (68.3) 27 (12.4)
Indicated TAU 257 (60.3) 66 (31.7) 191 (87.6)
How confident/certain was the researcher of their judgement about group allocation?
Very uncertain (complete guess) 63 (14.8) 31 (14.9) 32 (14.7)
Uncertain 149 (35.0) 66 (31.7) 83 (38.1)
Quite certain 130 (30.5) 54 (26.0) 76 (34.9)
Very certain 84 (19.7) 57 (27.4) 27 (12.4)
Did the participant make the group allocation explicit to the researcher:
Yes 71 (16.7) 54 (26.0) 17 (7.8)
No 355 (83.3) 154 (74.0) 201 (92.2)
Were there any indirect clues about group allocation? (e.g. new adaptations at home)?
Yes 38 (8.9) 32 (15.4) 6 (2.8)
No 388 (91.1) 176 (84.6) 212 (97.2)
Were the responses to these questions influenced by change/no
change in the participant’s goal performance rating?
N= 425 N= 207
Yes 188 (44.2) 84 (40.6) 104 (47.7)
No 237 (55.8) 123 (59.4) 114 (52.3)
TABLE 121 Researchers’ responses regarding blinding effectiveness at 3 months when blinding was either effective
or ineffective
Question
Blinding, n (%)
Ineffective (N= 358) Effective (N= 86)
Which condition the researcher thought the person with dementia had been allocated to
Indicated CR 154 (43.0) 22 (25.6)
Indicated TAU 204 (57.0) 64 (74.4)
How confident/certain was the researcher of their judgement about group allocation?
Very uncertain (complete guess) 52 (14.5) 29 (33.7)
Uncertain 112 (31.3) 36 (41.9)
Quite certain 121 (33.8) 20 (23.3)
Very certain 73 (20.4) 1 (1.2)
Did the participant make the group allocation explicit to the researcher?
Yes 66 (18.4) 0 (0)
No 292 (81.6) 86 (100.0)
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TABLE 121 Researchers’ responses regarding blinding effectiveness at 3 months when blinding was either effective
or ineffective (continued )
Question
Blinding, n (%)
Ineffective (N= 358) Effective (N= 86)
Were there any indirect clues about group allocation (e.g. new adaptations at home)?
Yes 35 (9.8) 2 (2.3)
No 323 (90.2) 84 (97.7)
Were the responses to these questions influenced by change/no change in the participant’s goal performance rating?
Yes 183 (51.1) 32 (37.2)
No 175 (48.9) 54 (62.8)
TABLE 122 Researchers’ responses regarding blinding effectiveness at 9 months when blinding was either effective
or ineffective
Question
Blinding, n (%)
Ineffective (N= 333) Effective (N= 93)
Which condition the researcher thought the person with dementia had been allocated to
Indicated CR 142 (42.6) 27 (29.0)
Indicated TAU 191 (57.4) 66 (71.0)
How confident/certain was the researcher of their judgement about group allocation?
Very uncertain (complete guess) 44 (13.2) 19 (20.4)
Uncertain 105 (31.5) 44 (47.3)
Quite certain 107 (32.1) 23 (24.7)
Very certain 77 (23.1) 7 (7.5)
Have the participants made the group allocation explicit to the researcher?
Yes 70 (21.0) 1 (1.1)
No 263 (79.0) 92 (98.9)
Were there any indirect clues about group allocation (e.g. new adaptations at home)?
Yes 34 (10.2) 4 (4.3)
No 299 (89.8) 89 (95.7)
Were the responses to these questions influenced by change/no change in the participant’s goal performance rating?
Yes 154 (46.4) 34 (36.6)
No 178 (53.6) 59 (63.4)
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Appendix 13 Relationship of adherence
to outcome
TABLE 123 Analyses examining whether or not adherence (number of sessions completed) was associated
with outcome
Outcome Estimate SE df t-value p-value 95% CI
3-month follow-up
Primary outcomes
Participant rating of attainment 0.17 0.09 215 2.01 0.046 0 to 0.34
Participant rating of satisfaction 0.15 0.09 215 1.8 0.073 –0.01 to 0.32
Carer rating of attainment 0.21 0.08 213 2.46 0.015 0.04 to 0.37
Secondary outcomes: participants with dementia
DEMQOL score –0.3 0.37 214 –0.81 0.421 –1.02 to 0.43
GSES score –0.33 0.18 211 –1.8 0.073 –0.69 to 0.03
HADS depression score 0.14 0.12 213 1.18 0.241 –0.09 to 0.37
HADS anxiety score 0.02 0.1 215 0.23 0.816 –0.18 to 0.23
RBMT immediate recall –0.03 0.07 214 –0.36 0.722 –0.16 to 0.11
RBMT delayed recall 0 0.06 213 –0.01 0.995 –0.12 to 0.12
TEA elevator counting 0.07 0.05 207 1.44 0.151 –0.03 to 0.17
TEA elevator counting with distraction 0 0.11 190 –0.04 0.971 –0.22 to 0.21
D-KEFS verbal fluency 0.2 0.28 211 0.72 0.472 –0.35 to 0.74
Secondary outcomes: carers
RSS –0.1 0.25 208 –0.39 0.698 –0.6 to 0.40
WHOQOL-BREF physical 0.03 0.08 209 0.35 0.729 –0.13 to 0.18
WHOQOL-BREF psychological 0.04 0.07 209 0.65 0.516 –0.09 to 0.18
WHOQOL-BREF social 0.1 0.09 208 1.09 0.278 –0.08 to 0.27
WHOQOL-BREF environmental –0.04 0.06 209 –0.65 0.514 –0.16 to 0.08
EQ-5D-3L index 0 0.01 204 0.62 0.535 –0.01 to 0.02
EQ-5D-3L VAS –0.73 0.79 205 –0.92 0.361 –2.29 to 0.84
9-month follow-up
Primary outcomes
Participant rating of attainment 0.24 0.1 202 2.36 0.019 0.04 to 0.44
Participant rating of satisfaction 0.25 0.11 200 2.33 0.021 0.04 to 0.47
Carer rating of attainment 0.28 0.1 201 2.68 0.008 0.07 to 0.48
Secondary outcomes: participants with dementia
DEMQOL score –0.43 0.44 200 –0.98 0.329 –1.3 to 0.44
GSES score –0.38 0.25 190 –1.54 0.126 –0.86 to 0.11
HADS depression score –0.06 0.15 190 –0.43 0.671 –0.36 to 0.23
continued
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TABLE 123 Analyses examining whether or not adherence (number of sessions completed) was associated with
outcome (continued )
Outcome Estimate SE df t-value p-value 95% CI
HADS anxiety score –0.04 0.12 191 –0.3 0.763 –0.28 to 0.21
RBMT immediate recall –0.07 0.08 197 –0.89 0.376 –0.24 to 0.09
RBMT delayed recall –0.01 0.06 197 –0.16 0.874 –0.14 to 0.12
TEA elevator counting –0.1 0.07 186 –1.4 0.162 –0.23 to 0.04
TEA elevator counting with distraction 0.1 0.13 168 0.72 0.472 –0.17 to 0.36
D-KEFS verbal fluency 0.25 0.36 193 0.71 0.481 –0.46 to 0.96
Secondary outcomes: carers
RSS 0.09 0.28 197 0.32 0.749 –0.47 to 0.65
WHOQOL-BREF physical 0 0.01 194 –0.44 0.657 –0.02 to 0.01
WHOQOL-BREF psychological –1.55 0.78 193 –1.98 0.049 –3.09 to 0.01
WHOQOL-BREF social –0.06 0.08 196 –0.79 0.432 –0.22 to 0.09
WHOQOL-BREF environmental –0.06 0.07 196 –0.81 0.419 –0.2 to 0.08
EQ-5D-3L index –0.14 0.1 194 –1.4 0.164 –0.34 to 0.06
EQ-5D-3L VAS –0.12 0.07 196 –1.81 0.071 –0.25 to 0.01
df, degrees of freedom.
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Appendix 14 Four case studies from GREAT
Four illustrative case studies from GREAT show the kinds of needs and concerns that promptedparticipants and carers to choose particular goals and demonstrate how the therapists worked with
participants and carers to address their goals during the CR intervention. Names and identifying details
have been changed.
David: overcoming anxiety to maintain independence
David, a retired factory worker aged 70 years, lived with his wife Julie on the outskirts of a small town.
Both were involved in numerous community activities. David had been diagnosed with Alzheimer’s disease
a few months prior to joining the trial.
Although quite capable in everyday activities and household tasks, David was afraid to use appliances of
any kind for fear of making a mistake and getting things wrong. He found this tremendously frustrating.
It was severely compromising his independence, and his increasing reliance on Julie was causing friction
between them. Julie felt frustrated when she tried unsuccessfully to explain how things worked, and she
regretted that at times she could be very impatient with David. At the same time, she felt that David was
capable of managing better and that she should be pushing him to do more for himself. David and Julie
wanted to work on this area of difficulty.
The therapist’s assessment showed that David had the capacity to manage daily activities with only a small
amount of guidance or support but was functioning considerably below this level. David’s anxiety needed
to be understood in the context of his previous experience of episodes of anxiety and depression, and the
therapist noted that he was currently taking antidepressants to try to stabilise his mood. The results of his
cognitive tests indicated that he would be able to direct his attention to a task or activity but would need
extra support with taking in information or remembering instructions, as it would be difficult for him to
take in and retain information or instructions given verbally, especially if the surroundings were distracting.
Although David was worried about his memory, the therapist found that he had some good strategies for
managing memory difficulties; for example, when he needed to learn new songs for the choir he belonged
to, he would break down the lyrics and learn a couple of lines at a time, building up to the whole song.
This suggested that David had good potential to develop new ways of coping and should be able to learn
to overcome his anxiety and manage to use various appliances. Both David and Julie were keen to try out
any strategies that might help. The therapist’s work with David and Julie therefore focused mainly on
enabling David to achieve his aim of being able to use various appliances without experiencing crippling
levels of anxiety, with the wider aim of allowing him to function more independently.
We illustrate this here in relation to one of the goals: for David to be able to use his mobile phone
whenever he wanted or needed to. Being able to use the mobile phone would give David the confidence
to be out and about on his own, either to do shopping or errands or to participate in his chosen activities,
knowing that he could contact Julie if he needed to. At the start of therapy, David could ‘wake up’ the
phone and display the contacts list on the screen, but could not get beyond this step as he developed
feelings of panic at the thought that he might do the wrong thing and then the phone would not work at
all. David, Julie and the therapist all independently rated his current use of the phone at 2 out of 10. Julie
was sceptical that any progress could be made as she had already obtained a simple ‘Doro’ phone for
David and tried to teach him to use it, without success, but the therapist convinced her that it was worth
trying to apply more specific learning techniques.
The first priority was to find a way to reduce David’s extreme anxiety. This was done by identifying a single
key-press that would always take David back to the main menu if necessary. The phone had two smart
keys. One of these was for cancelling choices and returning to the main menu; David and the therapist
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called this the ‘No, go back’ key. The other was for confirming choices on the display; David and the
therapist labelled this the ‘Yes, go ahead’ key. The therapist initially taught David, using action-based
learning with spaced retrieval, the functions of two smart keys on the phone. The left-hand key was
designated ‘Yes’ and the right-hand key was designated ‘No, go back’. David was encouraged to use the
‘No, go back’ key to return to the main menu at any time, so that he did not need to fear that he would
make a mistake.
Once the use of the ‘No, go back’ key was well established, the therapist and David identified the different
ways in which David needed to use the phone. Initially, the focus was on receiving and making calls, and
this was later extended to receiving and sending texts. Each activity was taught in sequence, with an
appropriate set of learning strategies applied. The therapist worked with David to list the steps involved in
the activity and develop step-by-step instructions that made sense to David. David had to engage in
thinking about each step and write down the instructions for himself, reflecting effortful processing of the
information. He kept these instructions together in a folder that he could refer to at any time.
Using an action-learning approach, each step was taught in turn, with the therapist demonstrating the
actions needed and David repeating them, using an expanding rehearsal approach, with practice spaced
at gradually increasing intervals. David was encouraged to practise in a quiet environment without
distractions and to allow plenty of time in order to help him stay focused. Simple steps were taught first
and more complex ones were taught later, following the principle of graded activity. For example, David
first learned to access the text screen, and then when he was confident in doing this, he learned to write a
text. This was followed, in sequence, by learning to sending the text, then receiving a text and reading it.
David then practised the full sequence of steps, including sending texts to the therapist between sessions
and receiving texts from the therapist. As David became more confident, Julie demonstrated how to
add punctuation to his text messages and taught him how to delete old messages. She did this using
expanding rehearsal strategies, focusing on one instruction at a time.
Having learned how to carry out a task, such as making a call, the next stage involved gaining confidence
in using the phone through graded exposure to increasingly demanding situations. David began to practise
using the phone in the house. First he used it in staged situations, such as making a test call to Julie or to
the therapist, and then moved on to using it for real-life purposes, such as making a call about one of his
activities or to a company representative. David then practised using the phone while out in the garden,
with Julie on standby in the house in case he needed help. Finally, he practised using the phone while he
was out and about, initially contacting the therapist and then using it for real-life purposes. Julie helped by
identifying situations in which David could use the phone and encouraging him to do so. Julie gave verbal
prompts to ensure that David took his phone with him and had switched it on before leaving the house;
these prompts were gradually faded out as the routine became established.
At this stage, one last issue emerged. Now that David had largely mastered the skills of using his phone,
he needed to remember to always take it with him when he went out, so that he could contact Julie if
needed. A solution-focused problem-solving approach was used to develop a strategy to help David
remember to take the phone with him. The method David and the therapist selected involved creating a
cue card as a reminder. When going out, he usually remembered to take his bus pass and his wallet, both
of which he kept in the same specific place, so the cue card was placed in the same location. The card
contained the mnemonic BMW, standing for Bus pass, Mobile phone and Wallet and had ‘I’m taking the
BMW’ written on it. David first had to learn the mnemonic and this was achieved by Julie prompting him
twice daily, with the prompts gradually faded out once David was reliably able to respond.
By the end of the intervention period, David, Julie and the therapist all found that David’s ability to use the
mobile phone had improved considerably. David and Julie both rated his ability to use the phone as 7 out
of 10, and the therapist as 8 out of 10. David’s ability and confidence continued to improve throughout
the 6-month maintenance period, as he regularly practised his new skills. He still experienced occasional
anxiety, but was much better able to manage it. In session 14, David and Julie both gave attainment
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ratings of 8 out of 10 and the therapist rated his goal attainment as 9 out of 10. Using predefined goal
attainment descriptors, the therapist rated the goal as 100% achieved in both session 10 and session 14,
as David was able to use the phone routinely to make and receive calls and return to the home screen
when any difficulties arose, and in addition he was using the phone to send and reply to texts.
During the therapy, David and Julie also worked on David’s ability to use other appliances independently,
and similar improvements were seen in these other areas. Julie gained some valuable new skills to help with
learning and relearning, and during the course of the therapy she applied these to help David to learn to
use the cooker and the washing machine, using compensatory strategies, such as colour-coding controls.
At the end of therapy, David said that his ‘fear has gone’. The anxiety around using appliances had
considerably abated and he was much less afraid of making mistakes. David felt more confident to try
things out and gain new skills, knowing that he could determine how to learn at his own pace. Julie felt
that she had become more willing to allow him to complete activities at his own pace and was much
more patient with him, which meant that there were fewer tensions between them.
Doris: staying safe and in control
Doris, aged 63 years, lived independently in an inner-city area. She had a large extended family, many
of whom would call in during the course of each day. Doris said she had been experiencing memory
problems for around 4 years, and these had worsened considerably over the past 2 years. She had been
diagnosed with vascular dementia within the previous month. Her eldest daughter, Dawn, was the main
carer and was very protective of Doris, being justifiably concerned about her safety. Dawn frequently
expressed anger about other family members who she felt were not doing enough to support her. Doris
also frequently dealt with her feelings of stress by expressing anger at Dawn and other family members.
Doris valued her independence and it was important to her to feel in control. She was worried about her
difficulties with memory and decision-making, found that her thoughts were muddled and felt that she
had trouble making herself understood. She often experienced feelings of fear, even panic, as if something
awful was about to happen, and was especially anxious in new situations or situations in which something
was expected of her. She used to be very sociable and outgoing, and enjoyed going into town or to the
pub but was now uncomfortable in crowds and had almost completely stopped going out alone. Even
going along the road to the local post office could produce feelings of panic, which Doris could not
account for.
The therapist’s work with Doris focused largely on enabling her to safely remain in control and be as
independent as possible, both in and out of the house. Doris readily adopted the problem-solving
approach; she considered solving problems one of her particular strengths. One important consideration
for the therapist was the discovery that Doris had struggled at school as a child and had never learned to
read or write, other than her name.
Doris usually forgot to lock her door when she went out or went to bed, creating a security risk, and Doris
and Dawn agreed that this was an important goal to work on. They, and the therapist, all scored current
attainment at 1 out of 10. The therapist worked with Doris to rehearse the procedure of locking the doors,
followed by telephoning Dawn to confirm that she had done it, using an action-learning approach. To
stimulate this behaviour, visual prompts were created, consisting of a photograph of the door keys, and
these were placed next to the front door, in the living room and at the top of the stairs where Doris
transferred off the stair lift. Family members were asked to prompt Doris to lock the door whenever they
were leaving at the end of a visit, and to telephone Doris at night to remind her to lock the door before
going to bed, although this did not happen consistently. In session 10, Doris and her daughter both rated
attainment as 6 out of 10 and the therapist rated it as 7 out of 10. All of these ratings increased to 8 out
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of 10 at session 14, and at this stage the therapist rated this goal as 75% achieved, as Doris was mostly
locking the door independently but still required some prompting on occasion.
Doris used a cash machine at the local post office to withdraw money but found that this was anxiety-
provoking and was unable to remember the PIN (personal identification number) she had to enter into the
cash machine to retrieve her money, describing herself as ‘stupid’. She had written the number on a piece
of paper and placed it in her purse under a clear plastic window visible on opening the purse. This was
very unsafe, especially as she tended to misplace her purse. She was increasingly anxious about using her
card and inclined to avoid going altogether. Instead, family members had started to withdraw money on
her behalf. Current attainment was rated by Doris, Dawn and the therapist as 1 out of 10. Doris could
recognise numbers and indeed was considered to be ‘good with numbers’, and the therapist judged that
she was capable of learning the PIN to enable her to use her bank card independently, while removing the
risk of financial exploitation. She herself was very motivated to work on this, as she found it important
to be in control of her finances and saw this as a marker of independence. This was a sensitive area,
however, for the therapist to work with, and one that required extra safeguards. The approach to be taken
was discussed in depth with Doris, with her family and with the trial team. Doris was deemed to have the
capacity both to choose the goal and to give an opinion about the proposed strategy; had there been
concerns about capacity for these specific decisions, a best-interests decision would have been needed.
It might have been possible to work indirectly through the carer, but Doris’s daughter preferred the
therapist to work on this goal directly with Doris rather than providing her with strategies to assist Doris
and guidance on implementing them. In weighing up all of these factors, everyone involved agreed that
given the risks Doris was exposed to currently, sharing the PIN with the therapist represented a safer
option and, in this instance, was the best way to proceed. Full details of the circumstances and the team’s
discussions were also recorded in Doris’s clinical notes held by the NHS memory service.
To help Doris learn the PIN, the number was first changed to something that would be relatively easy
to remember. Chunking the information meant that initially the first two numbers were learned using
expanding rehearsal, followed by the second two numbers, and finally all four digits. Visual mapping of
the numbers on the key pad was attempted using action-based learning to set up a habitual pattern of
movement. By session 10, Doris and Dawn rated attainment as 5 out of 10, with the therapist selecting
6 out of 10.
The therapist introduced controlled breathing techniques that Doris thought she could put into practice
quickly and effectively. Doris understood the principles of controlled breathing and was able to demonstrate
the technique when relaxed, but found it hard to put the technique into practice when she was anxious.
Dawn and Doris used solution-focused problem-solving to identify ways of reducing anxiety about going to
the post office and fear of experiencing a panic attack; this included identifying the days and times when
the post office was quiet and planning to go at these specific times, so that Doris could use her card
independently without feeling rushed. A plan for graded exposure was followed, whereby Doris gradually
increased the frequency of visits to the post office to practise using her card. By session 14, Doris could
reliably remember her PIN, and Doris, Dawn and the therapist rated attainment as 10 out of 10, with the
goal rated as 100% achieved. Doris continued to work on managing her anxiety about going to the
post office.
Other work focused on ensuring that Doris remembered to have her mobile phone with her at all times so
that she could be in contact with her family, while retaining her independence. Everyone was concerned
that she might fall or otherwise need help and wanted to make sure she could summon help if needed.
This was achieved by using visual prompts to remind Doris to take her phone with her when going out
and return it to a designated place in the house when indoors. Doris made good use of these strategies
and her family felt reassured about her safety.
The therapist spent time with Dawn to help her to understand and deal with Doris’s behaviour and to
point her towards local resources for carers. As a consequence, Dawn established an extensive network to
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support Doris’s needs, identified some sources of support for herself and started to allocate time for her
own needs. Dawn was very engaged in the intervention and provided considerable support with grading
activity and prompting the use of anxiety-management strategies. Following the intervention, she felt that
she had a better understanding of Doris’s abilities, and began to apply similar principles to other situations,
such as helping Doris to create and use her own shopping lists using visual prompts, such as collecting
and storing product labels. Dawn was very positive about Doris’s progress with goals, development of
compensatory strategies and general increase in motivation, and felt that participation had been beneficial
in terms of helping Doris to maximise goal attainment and maintain independence and well-being.
Doris and Dawn both felt that they had always been ‘problem solvers’ but they found the framework for
solution-focused problem-solving used in the intervention particularly useful in that it gave consideration
to what had worked in the past. This enabled them to identify and develop strategies to maximise Doris’s
independence, self-efficacy and self-esteem and apply these to a range of situations, as well as bringing
the family together to support Doris’s goal attainment.
Shahid: re-engaging with people and activities
Shahid, aged 77 years, had worked in marketing prior to retirement. He lived with his wife Sylvia near
their daughter and grandchildren. He had previously been actively involved in his local community and an
accomplished public speaker. He was a keen photographer but had not done any photography for over
1 year. Shahid had been diagnosed with Alzheimer’s disease around 2 months before joining the trial.
Shahid had lost confidence and had become anxious about engaging with people and activities. One
reason for this was his difficulty with word-finding, which made it hard to engage in conversation. He
sometimes had trouble finding the correct words to use, which interrupted his flow of speech, and this
led to him feeling embarrassed and getting quite frustrated and annoyed with himself. Often Sylvia would
supply the word for him, but sometimes she was unsure of the word he was searching for, leading to
more frustration. He wanted to be able to speak fluently again, and in particular he wanted to find the
right word during a conversation to enable him to participate. Shahid also wanted to take up photography
again and meet up with other photographers. However, he was confused and unsure about how to
manage the camera settings and lacked the confidence to try.
The therapist’s assessment showed that Shahid was able to carry out most activities independently but he
had difficulty motivating himself or initiating activity, and occasionally needed reminding about self-care.
He was worried and anxious about his poor memory and lack of concentration and had become quite
withdrawn and reluctant to participate in social interactions.
The therapist’s work with Shahid focused on helping him to feel more confident about engaging with
people and activities. The first priority was to help Shahid feel better able to find his words during a
conversation and hence less anxious about engaging with people. Initially, Shahid and Sylvia rated his
current attainment as 5 out of 10, whereas the therapist opted for 4 out of 10. This indicated that his
ability in conversation was fair, but reflected his desire for improvement.
The therapist, Shahid and Sylvia developed a plan to tackle word-finding problems. This had several
elements. The first involved effortful processing and errorless learning. Instead of supplying the missing
word, Sylvia instead gave either a cue, such as the first letter, or a clue to help Shahid find the word, so
that he was more likely to retrieve the correct word himself. The cues or clues were intended to be precise
enough to prompt the desired word, increasing the probability that this would also be recalled in future;
this provided a natural opportunity for errorless learning.
The second element involved providing support for naming everyday items and objects. Items around the
room were labelled to encourage Shahid to associate each object with its name, and he practised naming
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both labelled and unlabelled items when requested by Sylvia. The therapist prepared a set of picture cards
and Shahid practised naming the items depicted, with Sylvia’s help. As Shahid gained confidence with
naming the objects, these activities were graded by gradually increasing the number of items shown in any
one session and by presenting them at greater speed.
The third element was the use of word exercises. These were practised during the session and further
examples were left for Shahid and Sylvia to practise between sessions. Several different types of exercises
were used, including supplying missing words in a sentence, providing antonyms or synonyms, listing items
under a given category (e.g. modes of transport), identifying similarities and differences between pairs of
words and answering comprehension questions about short stories.
The fourth element involved devising specific strategies for particular words or types of words. Shahid
developed mnemonics and used expanding rehearsal within an errorless learning framework to remember
specific words that often eluded him.
Shahid seemed to enjoy focusing on word-finding and doing the various exercises, and he made good
progress. Sylvia became adept at providing cues or clues whenever he was unable to retrieve a word. By
session 10, Shahid felt much better able to engage in conversation, and he no longer saw word-finding or
engaging in conversation as a problem. Shahid and Sylvia both rated his attainment as 8 out of 10. The
therapist observed that his conversation was much more fluent and rated his attainment as 9 out of 10.
Shahid kept up his progress and the ratings made in session 14 were identical. The therapist rated the goal
as 100% achieved in both session 10 and session 14, noting that Shahid was more confident about his
word-finding ability and was usually able to find the necessary word and able to continue a conversation.
During the therapy, Shahid also worked on re-engaging with his interest in photography. There were
technical issues with managing camera settings and using digital cameras, and Shahid preferred to discuss
these with his son rather than with the therapist. The therapist’s role was to encourage Shahid to persist with
solving the problems. The eventual solution was to provide Shahid with a phone that had a good-quality
camera and was easy to link to his computer and TV screen to download and show images. This did enable
Shahid to take photographs, and the good results that ensued gave him confidence and motivated him to
continue. Holidays and visits to family provided interesting photographic opportunities, and he was able to
produce some good photographs. Ratings of attainment improved from 2 at the start of therapy to 8 in
session 10 and 9 (Shahid and Sylvia) or 10 (the therapist) in session 14. The therapist identified this goal as
75% achieved by session 10 and 100% achieved by session 14.
Shahid also developed his use of compensatory strategies, such as using a calendar to remember
appointments, and began to carry a small notebook in his pocket containing a daily ‘to do’ list. This
increased self-determination was mirrored by Sylvia offering prompts rather than doing things for him.
He learned a strategy of intentional chanting for times when he might get distracted or interrupted, for
example when going upstairs to fetch something, and practised various anxiety-management strategies
before settling on using music to calm himself. He managed to motivate himself to clear his computer
room and make space for working on his photographs, and this increased motivation also extended to
getting other tasks done around the house. Shahid and Sylvia both became more active, developing a
routine of playing golf once a week and going for a walk together once a week.
Gareth: managing everyday challenges
Gareth, a 71-year-old widower, had retired from a skilled technical job a few years previously. He lived
independently and kept in contact with his daughters and grandchildren, mainly by telephone, although
they lived nearby. Gareth had been diagnosed with mixed Alzheimer’s disease and vascular dementia
3 months before joining the trial. He also had some other health problems, which meant that he needed
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to eat regularly and keep to a healthy diet, and which limited his physical ability. His main source of
support was his eldest daughter, Ginny.
Gareth was troubled by difficulties with concentrating, planning and organising his activities, remembering
appointments, remembering things he needed to do, such as taking his medication, and finding key
items, such as his keys, wallet or phone. His strategy of using a Dictaphone to record notes and messages
was only partially successful. These difficulties were making it hard for him to complete everyday tasks
independently and safely, manage his health problems and participate in social events. Gareth was
particularly frustrated by his difficulties with planning and the impact these were having on his everyday
life. He and Ginny identified some basic everyday skills in which improvements would help him to maintain
independence and reduce the need to rely on Ginny. The therapist’s assessment showed that although
Gareth had the potential to manage many activities and tasks independently, he needed some practical
guidance and support to enable him to function optimally.
The therapist’s work with Gareth focused on improving everyday skills to support his independence.
The first priority was cooking. Gareth prepared his own meals, but tended to lose track of what he was
doing and forget that food was in the oven. This meant that food was often burnt and inedible. To make
matters worse, Gareth had lost his sense of smell, so that he could not detect the olfactory cues associated
with food overcooking. Gareth often felt tired and would leave the kitchen to sit down comfortably while
food was cooking, but he was hard of hearing, so that if he was not in the kitchen, he did not hear the
oven timer. In addition, he often fell asleep while waiting for food to be ready and then woke up feeling
confused about what he had been doing or what he needed to do. When Gareth was in the kitchen, his
tendency to lose track meant that he often picked up trays or plates from the oven without realising that
they were hot and burnt himself, and there was a risk of the gas hob being turned on but unlit. Because
of these difficulties, Gareth was limiting the extent to which he cooked for himself, either eating out,
which was proving to be too expensive, or just having snacks. Gareth was keen to manage his cooking
better and Ginny was very concerned about his safety, wanting to make sure that he was able to eat a
healthy diet without hurting himself or setting fire to the kitchen. Gareth, Ginny and the therapist rated
Gareth’s current ability in cooking his own meals as 4 out of 10.
The strategy that Gareth and the therapist devised involved two main components. First, Gareth was
encouraged to focus his attention on the process of planning the meal and to work through a series of
steps, reading the food packaging, writing down the cooking instructions, listing what preparation was
needed and then recording what time the food went into the oven and when it was due to be ready.
For this, Gareth used a whiteboard in the kitchen. Second, a portable timer was introduced to provide an
auditory cue to check the oven at the appropriate time. Gareth learned to take the whiteboard and timer
with him when leaving the kitchen, so that he would be able to hear it if he was in another room or if he
fell asleep. Gareth opted to set the alarm to go off shortly before the food was due to be ready as this
gave him time to get to the kitchen.
One additional practical change that the therapist recommended and Gareth and Ginny followed up was
to purchase a halogen worktop cooker that turned off automatically, to remove safety concerns about
leaving the gas on. This was intended to replace using the oven as it had a built-in timer and so turned
itself off and ‘beeped’ when done. Gareth had no difficulty adjusting to using this and was able to
demonstrate to the therapist how it worked. The therapist also involved telecare for an assessment of
gas safety and provision of additional sensors, over and above Gareth’s two functioning smoke detectors.
Gareth could see an immediate improvement as a result of using the whiteboard and timer and readily
adopted the use of these aids. By week 10, he was cooking meals safely without burning the food.
He now cooked for himself at home most days. Having got used to the halogen cooker, Gareth gained
confidence in using the hob to boil vegetables and rediscovered how to use the microwave. At both
session 10 and session 14, Gareth rated his current ability as 7 out of 10, Ginny rated it as 6 out of 10
and the therapist rated it as 8 out of 10. The therapist rated this goal as 100% achieved in week 10.
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A second area of concern for which similar strategies were adopted was remembering to take essential
medication. Gareth had to take medication both in the morning and in the evening and, although he
usually remembered his morning regime, he often forgot his evening medication, especially when he had
been out during the day, potentially putting his health at risk. Some tablets were in a blister pack, but
others were not, which made it harder to determine whether or not a dose had been missed. Usually
one of his daughters would telephone to remind him, but this was not always possible and was proving
stressful for the family. Gareth rated his current functioning as 5 out of 10, Ginny rated it as 6 out of 10
and the therapist rated it as 3 out of 10.
The strategy adopted had several components. First, a specific ‘workstation’ was set up on a table in
the living room as the special place where medication would be taken. This was clearly visible from
Gareth’s favourite chair, as this was where he usually went to take his tablets. The medication was placed
permanently on the table along with a bottle of water, so that Gareth would always be able to see his
medication and would not be distracted by leaving the room to get a drink of water. An attempt to link
evening medication with an established routine, such as watching the 6 p.m. news on television was
trialled, but this was not effective, as Gareth often went out in the evening, especially in the summer. As
an alternative, an alarm clock was set for 7.30 a.m. and 7.30 p.m. as an auditory cue to remind Gareth
to take his morning and evening doses. Gareth chose the timing of the alarm himself as the one that
best fitted with his routine, and the therapist taught Gareth to respond to the alarm clock cue by taking
medication at the appropriate time. To adapt the strategy for use on days out, Gareth’s mobile phone was
also set to give an alarm at 7.30 p.m., and if going out, Gareth took his medication with him in a small
container. Gareth found the strategy very useful, and when the alarm went off he would only cancel it
after he had taken his tablets, to ensure that he did not get distracted. The therapist rated this goal as
75% achieved in week 10 and 100% achieved in week 14. Gareth rated his current ability as 8 in week
10 and 9 in week 14; Ginny’s ratings were 7 and 6, respectively, and the therapist rated his ability as
8 and 10, respectively.
During the intervention, Gareth also worked on other areas with the therapist, including remembering
names of family and friends, staying engaged in conversation and improving attention. He became anxious
when confronted with tasks, events or activities for which he was not prepared; to manage this better,
the therapist introduced the idea of using a wall calendar to write down appointments and messages and
a notebook for details. The therapist modelled the use of these aids and enabled Gareth to incorporate
them in his daily routine. Gareth himself used the problem-solving approach to tackle other challenges,
such as keeping his paperwork in order, organising telecare documents and managing his financial
information. He used filing boxes and made lists, and he reviewed things weekly with Ginny to make sure
everything was as it should be.
Gareth tended to get bored on his own at home and this was another area that the therapist focused on.
Gareth’s usual strategy for dealing with boredom was to go out for a drive but he did not like to drive in
the dark or when the weather was bad. The therapist worked with Gareth to identify activities he could do
at home to occupy himself in the evenings or during bad weather. Gareth was also encouraged to practise
using public transport, to prepare for a time when driving may no longer be feasible, and he began to try
using the bus instead of driving. As Gareth often felt lonely, the therapist introduced him to the local
Alzheimer’s Society branch and he started to attend their groups and activities, which he engaged with
enthusiastically, feeling that his social life had been greatly improved.
Gareth embraced the CR intervention, was enthusiastic about adopting a range of compensatory strategies
and integrated these very effectively into his daily life. He enjoyed working with the therapist and thought
that he would miss the regular visits. Ginny and his other daughters were equally enthusiastic and willing
to try new ideas. They all gained skills in problem-solving and developing new strategies and felt able to
manage daily challenges better.
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Concluding comments
These four typical case studies taken from the therapy logs compiled by GREAT therapists illustrate the
types of goals participants chose and the way in which participants, carers and therapists worked together
to apply a problem-solving approach and to develop strategies to enable participants to improve their
functioning and attain their goals. They are consistent with the findings from the qualitative analysis
of interviews with participants and carers. These emphasised the key importance of the relationship
with the therapist as the vehicle for change and the time taken to understand needs and develop
personalised strategies.
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Appendix 15 Full unit costs
TABLE 124 Unit costs
Variable name
Unit cost, £
(2013–14) Unit Source Notes/assumptions
Respite and care home use
Private-sector residential
care for older people, cost
of stay
79 Per day PSSRU 2014, table 1.2114 Excludes personal living
expenses
Private- and other
independent-sector
residential home for people
with dementia, cost of stay
91 Per day PSSRU 2014, table 1.3114 Excludes personal living
expenses
Local authority residential
care for older people, cost
of stay
157 Per day PSSRU 2014, table 1.3114 Excludes personal living
expenses
Private-sector nursing
home for older people,
cost of stay
104 Per day PSSRU 2014, table 1.1114 Excludes personal living
expenses
Social care schemes, cost
of stay
84 Per day PSSRU 2014, table 1.2114 Average across the four
schemes
Community health and social care services
GP time, home visit 3.60 Per minute PSSRU 2013, table 10.8b115 No information about home
visits in the 2014 volume.
Assumed that the ratio of
clinic-to-home cost per
minute remained the same
GP time, home visit
average visit cost
(23.4 minutes)
85 Per visit PSSRU 2013, table 10.8b115 No information about home
visits in the 2014 volume.
Assumed that the ratio of
clinic-to-home cost per
minute remained the same.
Assumed that the average
duration of the visit
remained the same
GP time, clinic visit 2.90 Per minute PSSRU 2014, table 10.8b114 No direct care staff and no
qualification costs
GP time, clinic visit 50 Per visit PSSRU 2014, table 10.8b114 No direct care staff and no
qualification costs
Practice nurse, face-to-face
time
0.73 Per minute PSSRU 2014, table 10.6114 Excludes qualification costs
Practice nurse, face-to-face
time
11.37 Per
consultation
PSSRU 2014, table 10.6114 Excludes qualification costs
District nursing time,
face-to-face contact
37 Per contact NHS Reference Costs 2013
to 2014118
District nursing time, direct
contact time
1.23 Per minute NHS Reference Costs 2013
to 2014118
Assumes 30-minute contact
District nursing time, home
visit
1 Per minute PSSRU 2013, table 10.1115 Excludes qualification cost
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TABLE 124 Unit costs (continued )
Variable name
Unit cost, £
(2013–14) Unit Source Notes/assumptions
District nursing visit, per
home visit
56 Per visit PSSRU 2013, table 10.1115 Excludes qualification cost
Nurse (mental health),
face-to-face contact
1.1 Per minute PSSRU 2014, table 10.2114 Excludes qualification costs
Nurse (mental health),
face-to-face contact
33 Per contact PSSRU 2014, table 10.2114 Excludes qualification costs
Consultant: psychiatrist,
face-to-face session
4.43 Per minute PSSRU 2014, table 15.7114 Excludes qualification costs
Consultant: psychiatrist,
face-to-face session
221.45 Per contact PSSRU 2014, table 15.7114 Excludes qualification costs
Clinical psychologist 2.23 Per minute PSSRU 2014, table 9.5114 Excludes qualification costs
(no information on them)
Social worker, face-to-face
time
2.65 Per minute PSSRU 2014, table 11.2114 Excludes qualification costs
Community physiotherapist,
home visit
52 Per contact NHS Reference Costs 2013
to 2014118
Home/clinic not specified
Community physiotherapist,
home visit
0.5 Per minute PSSRU 2014, table 9.1114 Excludes qualification costs
Community physiotherapist,
per clinic visit
12.43 Per contact PSSRU 2014, table 13.1114 Home/clinic not specified.
Excludes qualification costs
Community physiotherapist,
per clinic visit
0.53 Per minute PSSRU 2014, table 13.1114 Home/clinic not specified.
Excludes qualification costs
NHS OT, cost per hour 0.53 Per minute PSSRU 2014, table 9.2114 Excludes qualification costs
NHS clinical support
worker, cost per hour
0.33 Per minute PSSRU 2014, table 10.5114 Excludes qualification costs
Community pharmacist,
patient-related activities
1.07 Per minute PSSRU 2014, table 10.5114 Excludes qualification costs
Community OT (social
services), cost per hour
0.68 Per minute PSSRU 2014, table 11.5114 Excludes qualification costs
Dietitian, cost per hour 0.55 Per minute PSSRU 2014, table 13.4114 Excludes qualification costs
Dietitian, cost per visit 80 Per contact NHS Reference Costs 2013
to 2014118
Counselling services in
primary care
0.83 Per minute PSSRU 2014, table 2.7114
Counselling services in
primary care
45.83 Per visit PSSRU 2014, table 2.7114
NHS community mental
health team (CMHT)
worker for older people
(OP) with mental health
problems, per team
member
0.68 Per minute PSSRU 2014, table 12.1114
NHS Community Mental
Health Team worker for
older people with mental
health problems, per team
member
41 Per visit PSSRU 2014, table 12.1114
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TABLE 124 Unit costs (continued )
Variable name
Unit cost, £
(2013–14) Unit Source Notes/assumptions
Home care: average of
independent and social
services (average cost per
hour: £19.64)
0.33 Per minute PSSRU 2014, table 11.6114 Average cost of private and
social services costs; weighted
average of weekday and
weekend costs
Cleaner 0.17 Per minute Greenleaf Cleaning,119
Hassle.com,120 Homeclean121
Internet search of three
cleaning companies; average
across prices
Deflated using the HCHS
index
Meals on Wheels 5.8 Per meal PSSRU compendium 2014,
table 8.1.1114
Uprated using the HCHS Pay
& Price Index
Laundry service, cost per
week per service user
26.43 Per service
user per
week
Wandsworth Council122 Uprated from 2008 to 2014
prices using HCHS Pay &
Price inflator
Sitting service (i.e.
Crossroads)
0.29 Per minute Evaluation of the East Sussex
Carers’ Breaks Demonstrator
Site123
Cost of a short break for
carers
Carer support worker 0.5 Per minute Evaluation of the East Sussex
Carers’ Breaks Demonstrator
Site123
Chiropodist 0.53 Per minute PSSRU 2014, table 9.4114
Chiropodist 39 Per visit NHS Reference Costs 2013
to 2014118
Optician 21.1 Per visit Optics at a Glance 2014;
Optical Confederation124
Cost of sight test
Optician 57.92 Per visit Department of Health and
Social Care125
Adds the fee payable for the
first patient seen at one
domiciliary visit, NHS
Dentist, weighted average
cost per hour of patient
contact for a performer
only and providing
performer
1.71 Per minute PSSRU 2014114 Tables 10.9 and 10.10
Dentist, community dental
service
125 Per visit NHS Reference Costs 2013
to 2014118
Dentist, general dental
service
85 Per visit NHS Reference Costs 2013
to 2014118
Audiologist 51.94 Per contact NHS Reference Costs 2013
to 2014118
Health visitor, patient-
related work
1.08 Per minute PSSRU 2014, schema 10.3114
Health visitor, per contact 45.07 Per contact NHS Reference Costs 2013
to 2014118
CHS tab, N03F – health
visitor, other clinical
intervention
Speech and language
therapist
84 Per contact NHS Reference Costs 2013
to 2014118
A13A1 – speech and
language therapist, adult,
one to one
Speech and language
therapist
0.53 Per minute PSSRU 2014, table 13.3114 Excludes qualifications
continued
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TABLE 124 Unit costs (continued )
Variable name
Unit cost, £
(2013–14) Unit Source Notes/assumptions
Day care for older people,
per session
56 Per session PSSRU 2014, table 1.6114
Day care in NHS facilities,
per attendance
146 Attendance NHS Reference Costs 2013
to 2014118
CHS tab
Day care for people with
mental health problems,
per session
40 Per session PSSRU 2014, table 2.5114
Lunch club 7.71 Per session Romeo et al.126 Uprated using the HCHS Pay
& Price inflator
Patient education classes Range:
9–36
11–9
Per session NHS West Norfolk CCG,127
D’Amico et al.,128 Orgeta
et al.,129 Quinn et al.130
2015 prices, downrated
using the HCHS inflator;
Uprated to 2013–14 prices
using the HCHS Pay & Price
inflator; uprated to 2013–14
using the HCHS Pay & Price
inflator
Respiratory support group 5.50 Per session Romeo et al.126 Assumed social club; uprated
using the HCHS Pay & Price
inflator
Community memory café
run by voluntary sector
3 Per session Dementia Partnerships131
Befriending of older adults 7.33 Per session PSSRU 2014, schema 2.11114
Choral singing, people with
dementia
3.13 Per session Alzheimer’s Society132–135 Charges across four choirs
Exercise classes 38.66 Per person
per class
Witham et al.136 Uprated to 2013–14 using
the HCHS Pay & Price inflator
Paramedic visit, see and
treat and refer
180 Per
attendance
NHS Reference Costs 2013
to 2014118
ASS01 – see and treat or
refer
Memory clinic 422 Per
attendance
PSSRU 2014, table 1.10114 Assumes 1-hour contact
Minor injuries unit,
weighted average of all
attendances (admission
and non-admission)
55.16 Per
attendance
PSSRU 2010, table 7.1137 Uprated to 2013–14 Pay &
Price inflator
Consultant contact:
community-based
1.68 Per minute PSSRU 2014, table 15.5114 Assumed the same cost
as a medical consultant in
hospital
Non-emergency ambulance
use, average cost of a non-
emergency patient transfer
43.26 Per transfer PSSRU 2010 (p. 60)137 Uprated using HCHS Pay &
Price inflator. The 2013
compendium does not
record
Equipment and adaptations
Wheelchair (non-powered
average of active user and
self-/attendant propelled),
mean annual equipment
cost
34.25 Per item PSSRU 2014, table 7.2114 Annuitised over 10 years;
cost over 3 months
Wheelchair (powered),
mean annual equipment
cost
106 Per item PSSRU 2014, table 7.2114 Annuitised over 10 years;
cost over 3 months
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TABLE 124 Unit costs (continued )
Variable name
Unit cost, £
(2013–14) Unit Source Notes/assumptions
Outdoor rail 0.85 Per item PSSRU 2014, table 7.3.2114 Annuitised over 10 years;
cost over 3 months
Stair/grab rail 0.6 Per item PSSRU 2014, table 7.3.2114 Annuitised over 10 years;
cost over 3 months
Over-bath shower 36 Per item PSSRU 2014, table 7.3.2114 Annuitised over 10 years;
cost over 3 months
Walk-in shower/shower
cubicle replacing bath
119.75 Per item PSSRU 2014, table 7.3.1114 Annuitised over 10 years;
cost over 3 months
Outdoor ramp 3.5 Per item PSSRU 2014, table 7.3.2114 Annuitised over 10 years;
cost over 3 months
Perching stool 0.68 Per item PSSRU 2013, table 7.3.1115 Uprated using the HCHS Pay
& Price inflator – annuitised
over 10 years;* cost over
3 months
Commode 1.73 Per item PSSRU 2013, table 7.3.1115 Uprated using the HCHS Pay
& Price inflator – annuitised
over 10 years;* cost over
3 months
Kitchen trolley 1.04 Per item PSSRU 2013, table 7.3.1115 Uprated using the HCHS Pay
& Price inflator – annuitised
over 10 years;* cost over
3 months
Toilet frame/raised toilet
seat
0.91 Per item PSSRU 2013, table 7.3.1115 Annuitised over 10 years;
cost over 3 months. Uprated
to 2013–14 prices using the
HCHS Pay & Price inflator
Walking stick 0.22 Per item Transforming Community
Equipment Services National
Catalogue and Tariff for
Simple Aids to Daily Living138
Annuitised over 10 years;
cost over 3 months. Uprated
to 2013–14 prices using the
HCHS Pay & Price inflator
All four-wheeled and
four-footed walking frames
0.93 Per item Transforming Community
Equipment Services National
Catalogue and Tariff for
Simple Aids to Daily Living138
Annuitised over 10 years;
cost over 3 months. Uprated
to 2013–14 prices using the
HCHS Pay & Price inflator
Bath seat 0.51 Per item Transforming Community
Equipment Services National
Catalogue and Tariff for
Simple Aids to Daily Living138
Annuitised over 10 years;
cost over 3 months. Uprated
to 2013–14 prices using the
HCHS Pay & Price inflator
Bed lever/rail 0.91 Per item Transforming Community
Equipment Services National
Catalogue and Tariff for
Simple Aids to Daily Living138
Annuitised over 10 years;
cost over 3 months. Uprated
to 2013–14 prices using the
HCHS Pay & Price inflator
Individual alarm system 98.53 Per item Building Telecare in England
(pp. 1–21)139
Uprated using the HCHS Pay
& Price inflator – annuitised
over 10 years;* cost over
3 months
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TABLE 124 Unit costs (continued )
Variable name
Unit cost, £
(2013–14) Unit Source Notes/assumptions
Medications
Various Range:
0.029–8.45
Standard
quantity
units
Prescription Cost Analysis,
England 2013140
Unpaid carer costs
National minimum wage 6.31 Per hour National Minimum Wage
and National Living Wage
Rates141
Travel costs
Cost per mile of travel for
carer (car running costs),
per mile
0.25 Per mile Automobile Association car
running costs 2013142
Price when new between
£22,000 to £26,000
Professional travel for
delivery of CR: NHS
reimbursement rate
0.43 Per mile NHS mileage rates 2013143
Hospital services
A&E attendances, weighted
average of admitted and
non-admitted
124 Attendance NHS Reference Costs 2013
to 2014118
Minor injury unit 55 Attendance PSSRU 2010, table 7.1137 Uprated using HCHS Pay &
Price inflator
Inpatients
Subchapter AA: nervous
system procedures and
disorders
420 Day NHS Reference Costs 2013
to 2014118
NEL and NEL _ XS tabs
Subchapter BZ: eyes and
periorbital procedures and
disorders
565 Day NHS Reference Costs 2013
to 2014118
NEL tab
Subchapter CA: ear, nose,
mouth, throat and neck
procedures
841 Day NHS Reference Costs 2013
to 2014118
NEL tab
Subchapter DZ: thoracic
procedures and disorders
370 Day NHS Reference Costs 2013
to 2014118
NEL and NEL _ XS tabs
Subchapter EA: cardiac
procedures
896 Day NHS Reference Costs 2013
to 2014118
NEL and NEL _ XS tabs
Subchapter EB: cardiac
disorders
412 Day NHS Reference Costs 2013
to 2014118
NEL and NEL _ XS tabs
Subchapter FZ: digestive
system procedures and
disorders
482 Day NHS Reference Costs 2013
to 2014118
NEL and NEL _ XS tabs
Subchapter HA:
orthopaedic trauma
procedures
1661 Day NHS Reference Costs 2013
to 2014118
NEL and NEL _ XS tabs
Subchapter HB:
orthopaedic non-trauma
procedures
567 Day NHS Reference Costs 2013
to 2014118
NEL and NEL _ XS tabs
Subchapter HC: spinal
surgery and disorders
651 Day NHS Reference Costs 2013
to 2014118
NEL tab
APPENDIX 15
NIHR Journals Library www.journalslibrary.nihr.ac.uk
212
TABLE 124 Unit costs (continued )
Variable name
Unit cost, £
(2013–14) Unit Source Notes/assumptions
Subchapter HD:
musculoskeletal disorders
374 Day NHS Reference Costs 2013
to 2014118
NEL tab
Subchapter LA: renal
procedures and disorders
522 Day NHS Reference Costs 2013
to 2014118
NEL and NEL _ XS tabs
Subchapter LB: urological
and male reproductive
system procedures and
disorders
598 Day NHS Reference Costs 2013
to 2014118
NEL tab
Subchapter MB: urological
and male reproductive
system procedures and
disorders
452 Day NHS Reference Costs 2013
to 2014118
NEL tab
Subchapter VC:
rehabilitation
298 Day NHS Reference Costs 2013
to 2014118
REHAB tab
Subchapter WA: multiple
trauma
356 Day NHS Reference Costs 2013
to 2014118
NEL and NEL _ XS tabs
Subchapter WD: treatment
of mental health patients
by non-mental health
service providers
474 Day NHS Reference Costs 2013
to 2014118
NEL and NEL _ XS tabs
Subchapter YR: vascular
imaging interventions
646 Day NHS Reference Costs 2013
to 2014118
NEL tab
Day cases
Subchapter CA: ear, nose,
mouth, throat and neck
procedures
938 Day NHS Reference Costs 2013
to 2014118
DC tab
Subchapter EA: cardiac
procedures
1333 Day NHS Reference Costs 2013
to 2014118
DC tab
Subchapter BZ: eyes and
periorbital procedures and
disorders
784 Day NHS Reference Costs 2013
to 2014118
DC tab
Subchapter FZ: digestive
system procedures and
disorders
566 Day NHS Reference Costs 2013
to 2014118
DC tab
Subchapter HD:
musculoskeletal disorders
374 Day NHS Reference Costs 2013
to 2014118
DC tab
Subchapter JD: skin
disorders
513 Day NHS Reference Costs 2013
to 2014118
DC tab
Day cases, weighted
average across specialties
698 Day NHS Reference Costs 2013
to 2014118
DC tab
Outpatients
Service code 100: general
surgery
112 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 101: urology 92 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
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TABLE 124 Unit costs (continued )
Variable name
Unit cost, £
(2013–14) Unit Source Notes/assumptions
Service code 103: breast
surgery
118 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 104:
colorectal surgery
110 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 105:
hepatobiliary and
pancreatic surgery
156 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 107: vascular
surgery
138 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 108: spinal
surgery service
133 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 110: trauma
and orthopaedics
104 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 120: ear, nose
and throat
83 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 130:
ophthalmology
80 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 141:
restorative dentistry
117 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 144:
maxillofacial surgery
104 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 150:
neurosurgery
172 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 160: plastic
surgery
85 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 170:
cardiothoracic surgery
271 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
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TABLE 124 Unit costs (continued )
Variable name
Unit cost, £
(2013–14) Unit Source Notes/assumptions
Service code 191: pain
management
121 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 301:
gastroenterology
118 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 302:
endocrinology
131 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 303: clinical
haematology
156 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 304: clinical
physiology
60 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 307: diabetic
medicine
142 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 320:
cardiology
118 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 324:
anticoagulant service
27 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 330:
dermatology
93 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 340:
respiratory medicine
138 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 341:
respiratory physiology
128 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 350:
infectious diseases
210 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 361:
nephrology
141 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
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TABLE 124 Unit costs (continued )
Variable name
Unit cost, £
(2013–14) Unit Source Notes/assumptions
Service code 370: medical
oncology
138 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 400:
neurology
156 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 410:
rheumatology
122 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 430: geriatric
medicine
175 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 502:
gynaecology
120 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 650:
physiotherapy
44 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 652: speech
and language therapy
84 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 653: podiatry 42 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 654: dietetics 61 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 656: clinical
psychology
184 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 657:
prosthetics
53 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 658: orthotics 111 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 662:
optometry
95 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
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TABLE 124 Unit costs (continued )
Variable name
Unit cost, £
(2013–14) Unit Source Notes/assumptions
Service code 715: old age
psychiatry
107 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 812:
diagnostic imaging
44 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Service code 840:
audiology
122 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
Weighted average of
follow-up attendances
across service codes
102 Attendance NHS Reference Costs 2013
to 2014118
Consultant and
non-consultant-led follow-up
face-to-face attendances,
CL tab
A&E, accident and emergency; CHS, Community Health Services; CL, outpatients – consultant led; DC, day case;
NEL, non-elective inpatients; NEL_XS, non-elective inpatients–excess bed days.
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Appendix 16 Participant resource use and
replacement costs
TABLE 125 Resources used by the person with dementia over the prior 3 months, at baseline assessment. Sample:
all available cases for which the CSRI was partially or wholly completed
Resources Units
Treatment group
CR (N= 238) TAU (N= 236)
Users,
N/n valid
Sample mean
(SE)
Users,
N/n valid
Sample mean
(SE)
Hospital services
A&E Attendances 28/236 0.19 (0.05) 15/233 0.07 (0.02)
Inpatient Days 13/236 0.66 (0.28) 12/233 0.17 (0.06)
Outpatient Attendances 123/236 1.10 (0.11) 107/233 0.98 (0.10)
Day hospital Days 2/236 0.01 (0.01) 4/233 0.04 (0.02)
Primary and community health
GP Contactsa 161/236 1.60 (0.13) 172/233 1.69 (0.15)
Practice nurse Contactsa 115/236 0.85 (0.09) 131/233 1.16 (0.12)
Community nurse Contactsa 21/236 0.36 (0.14) 24/233 0.48 (0.23)
Physiotherapist Contactsa 24/236 0.25 (0.07) 22/233 0.38 (0.10)
OT Contactsa 15/236 0.18 (0.06) 11/233 0.15 (0.07)
Specialist nurse Contactsa 40/236 0.25 (0.04) 36/233 0.38 (0.17)
Dietitian Contactsa 4/236 0.02 (0.01) 5/233 0.03 (0.01)
Counsellor Contactsa 1/236 0.01 (0.01) 0/233 0
Optician Contactsa 75/236 0.40 (0.04) 62/233 0.33 (0.04)
Chiropodist Contactsa 71/236 0.39 (0.04) 83/233 0.54 (0.06)
Dentist Contactsa 90/236 0.53 (0.06) 84/233 0.49 (0.05)
Mental health
Mental health nurse Contactsa 23/236 0.19 (0.05) 18/233 0.12 (0.04)
Psychiatrist Contactsa 38/236 0.17 (0.03) 32/233 0.16 (0.03)
Psychologist Contactsa 24/236 0.17 (0.06) 20/233 0.17 (0.05)
Mental health team worker Contactsa 4/236 0.03 (0.01) 5/233 0.06 (0.04)
Community care
Social worker/care manager Contactsa 18/236 0.11 (0.03) 12/233 0.07 (0.02)
Home care/home help Contacts 25/236 6.32 (1.65) 26/233 12.07 (3.18)
Home care/home help Hours 25/236 73.43 (6.68) 26/233 105.01 (13.80)
Cleaner Contacts 50/236 2.20 (0.41) 53/233 2.53 (0.36)
Meals on Wheels Contacts 1/236 0.05 (0.05) 3/233 0.48 (0.37)
Laundry service Contacts 3/236 0.13 (0.08) 9/233 0.24 (0.10)
Sitting service Contacts 1/236 0.05 (0.05) 7/233 0.22 (0.10)
Carer support worker Contacts 9/236 0.09 (0.04) 9/233 0.07 (0.03)
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TABLE 125 Resources used by the person with dementia over the prior 3 months, at baseline assessment. Sample:
all available cases for which the CSRI was partially or wholly completed (continued )
Resources Units
Treatment group
CR (N= 238) TAU (N= 236)
Users,
N/n valid
Sample mean
(SE)
Users,
N/n valid
Sample mean
(SE)
Other health and social care services
SALTb Contacts 1/230 0.01 (0.01) 1/230 0
Health visitorb Contacts 1/230 0.01 (0.01) 0/230 0
Medical consultantb Contacts 1/230 0 0/230 0
Paramedicb Contacts 0/230 0 0/230 0
Audiologyb Contacts 2/229 0.02 (0.01) 5/230 0.02 (0.01)
Community pharmacistb Contacts 0/229 – 0/230 –
Health-care support workerb Contacts 6/233 0.09 (0.05) 4/231 0.03 (0.01)
Day care
Day centre Attendances 23/236 1.51 (0.44) 25/233 1.26 (0.31)
Lunch club Attendances 23/236 0.83 (0.24) 12/233 0.47 (0.15)
Patient education course Attendances 8/236 0.29 (0.12) 10/233 0.24 (0.09)
Other day services
Memory café/dementia supportc Attendances 16/236 0.33 (0.11) 12/233 0.25 (0.09)
Befrienderc Attendances 2/236 0.06 (0.06) 2/233 0.11 (0.11)
Singing for the brain/dementia choirsc Attendances 3/236 0.08 (0.06) 5/233 0.10 (0.05)
Exercise classes for older peoplec Attendances 3/236 0.14 (0.08) 1/233 0.06 (0.06)
Respiratory support groupsc Attendances 1/236 0.04 (0.04) 0/233 0
Other
Equipment adaptations (NHS/SSD) Items 76/236 0.86 (0.11) 76/233 0.80 (0.10)
Equipment privately purchased Items 130/236 1.27 (0.11) 140/233 1.45 (0.11)
Medications Units 190/236 1.15 (0.06) 193/233 1.11 (0.05)
Hypnotics and anxiolytics Units 3/236 0.02 (0.01) 2/233 0.01 (0.01)
Antipsychotics Units 2/236 0.01 (0.01) 2/233 0.01 (0.01)
Antidepressants Units 59/236 0.26 (0.03) 42/233 0.21 (0.03)
Antiepileptics Units 1/236 0.00 (0.00) 1/233 0.00 (0.00)
Dementia medications Units 170/236 0.82 (0.04) 182/233 0.83 (0.03)
Principal carer care Hours 207/235 609.43 (52.25) 200/232 534.91 (47.67)
Other carer care Hours 81/236 92.94 (19.80) 75/232 57.50 (10.87)
A&E, accident and emergency; SALT, speech and language therapist.
a Combines home and office contacts
b New categories of service use derived from textual descriptions of other health and social care services.
c New categories of day-care service use derived from textual descriptions of other day-care services.
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TABLE 126 Resources used by the person with dementia over the prior 3 months, at 3 months. Sample: all available
cases for which the CSRI was partially or wholly completed
Resources Units
Treatment group
CR (N= 238) TAU (N= 236)
Users,
N/n valid
Sample mean
use (SE)
Users,
N/n valid
Sample mean
use (SE)
Hospital services
A&E Attendances 21/215 0.13 (0.03) 22/223 0.11 (0.02)
Inpatient Days 8/215 0.35 (0.15) 15/223 0.52 (0.23)
Outpatient Attendances 114/215 1.23 (0.21) 96/223 0.93 (0.19)
Day hospital Days 3/215 0.05 (0.03) 0/223 0
Primary and community health
GP Contactsa 143/215 1.37 (0.10) 147/223 1.41 (0.11)
Practice nurse Contactsa 104/215 0.89 (0.09) 113/223 1.07 (0.13)
Community nurse Contactsa 12/215 0.38 (0.17) 14/223 0.74 (0.40)
Physiotherapist Contactsa 19/215 0.42 (0.15) 15/223 0.27 (0.09)
OT Contactsa 14/215 0.16 (0.06) 9/223 0.08 (0.03)
Specialist nurse Contactsa 23/215 0.15 (0.04) 23/223 0.15 (0.03)
Dietitian Contactsa 5/215 0.03 (0.01) 6/223 0.03 (0.01)
Counsellor Contactsa 1/215 0.02 (0.02) 0/223 0
Optician Contactsa 56/215 0.30 (0.04) 62/223 0.35 (0.04)
Chiropodist Contactsa 66/215 0.46 (0.06) 75/223 0.51 (0.06)
Dentist Contactsa 78/215 0.55 (0.06) 79/223 0.52 (0.06)
Mental health
Mental health nurse Contactsa 10/215 0.05 (0.02) 8/223 0.09 (0.06)
Psychiatrist Contactsa 24/215 0.11 (0.02) 20/223 0.09 (0.02)
Psychologist Contactsa 7/215 0.07 (0.04) 6/223 0.04 (0.02)
Mental health team worker Contactsa 5/215 0.09 (0.06) 8/223 0.11 (0.05)
Community care
Social worker Contacts 16/215 0.17 (0.05) 15/223 0.14 (0.05)
Home care/home help Contacts 27/215 8.43 (2.22) 30/223 11.02 (2.72)
Home care/home help Hours 27/215 95.98 (8.60) 30/223 67.61 (7.40)
Cleaner Contacts 48/215 2.84 (0.59) 52/223 2.71 (0.38)
Meals on Wheels Contacts 1/215 0.01 (0.01) 3/223 0.33 (0.27)
Laundry service Contacts 5/215 0.20 (0.09) 7/223 0.23 (0.12)
Sitting service Contacts 2/215 0.05 (0.04) 4/223 0.11 (0.06)
Carer support worker Contacts 9/215 0.11 (0.06) 8/223 0.05 (0.02)
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TABLE 126 Resources used by the person with dementia over the prior 3 months, at 3 months. Sample: all available
cases for which the CSRI was partially or wholly completed (continued )
Resources Units
Treatment group
CR (N= 238) TAU (N= 236)
Users,
N/n valid
Sample mean
use (SE)
Users,
N/n valid
Sample mean
use (SE)
Other health and social care services
SALTb Contacts 1/215 0 0/223 0
Health visitorb Contacts 0/215 0 0/223 0
Medical consultantb Contacts 1/215 0 0/223 0
Paramedicb Contacts 3/212 0.01 (0.01) 1/218 0
Audiologyb Contacts 1/209 0 2/216 0.01 (0.01)
Community pharmacistb Contacts 0/209 – 0/216 –
Health-care support workerb Contacts 2/211 0.03 (0.02) 3/217 0.06 (0.05)
Day care
Day centre Attendances 30/215 1.72 (0.40) 28/223 1.63 (0.38)
Lunch club Attendances 17/215 0.64 (0.22) 21/223 0.91 (0.23)
Patient education course Attendances 8/215 0.31 (0.12) 3/223 0.04 (0.04)
Other day services
Memory café/dementia supportc Attendances 21/215 0.48 (0.13) 14/223 0.39 (0.13)
Befrienderc Attendances 2/215 0.07 (0.06) 5/223 0.04 (0.03)
Singing for the brain/dementia choirsc Attendances 6/215 0.19 (0.11) 5/223 0.13 (0.07)
Exercise classes for older peoplec Attendances 0/215 0 2/223 0.17 (0.13)
Respiratory support groupsc Attendances 1/215 0.06 (0.06) 0/223 0
Other
Equipment adaptations (NHS/SSD) Items 86/215 1.04 (0.12) 82/223 0.83 (0.10)
Equipment privately purchased Items 130/215 1.36 (0.12) 131/223 1.43 (0.11)
Medications Items 170/215 1.16 (0.06) 186/223 1.13 (0.06)
Hypnotics and anxiolytics Units 1/215 0.00 (0.00) 2/223 0.01 (0.01)
Medications used in psychoses Units 2/215 0.01 (0.01) 4/223 0.02 (0.01)
Antidepressants Units 57/215 0.31 (0.04) 41/223 0.21 (0.03)
Antiepileptics Units 1/215 0.00 (0.00) 1/223 0.00 (0.00)
Dementia medications Units 157/215 0.80 (0.04) 175/223 0.86 (0.04)
Principal carer care Hours 189/213 578.13 (53.01) 191/221 613.98 (52.21)
Other carer care Hours 76/214 95.75 (20.21) 73/222 50.14 (8.78)
A&E, accident and emergency; SALT, speech and language therapist.
a Combines home and office contacts.
b New categories of service use derived from textual descriptions of other health and social care services.
c New categories of day-care service use derived from textual descriptions of other day-care services.
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TABLE 127 Resources used by person with dementia over the prior 3 months, at 9 months. Sample: all available
cases for which the CSRI was partially or wholly completed
Resources Units
Treatment group
CR (N= 238) TAU (N= 236)
Users,
N/n valid
Sample mean
use (SE)
Users,
N/n valid
Sample mean
use (SE)
Hospital services
A&E Attendances 24/205 0.14 (0.03) 25/210 0.18 (0.05)
Inpatient Days 12/205 0.72 (0.36) 7/210 0.35 (0.17)
Outpatient Attendances 96/205 1.40 (0.24) 103/210 1.19 (0.21)
Day hospital Days 3/205 0.04 (0.02) 2/210 0.02 (0.01)
Primary and community health
GP Contactsa 139/205 1.42 (0.12) 145/210 1.56 (0.11)
Practice nurse Contactsa 108/205 1.17 (0.16) 104/210 0.91 (0.10)
Community nurse Contactsa 12/205 0.39 (0.17) 12/210 0.60 (0.23)
Physiotherapist Contactsa 21/205 0.22 (0.06) 28/210 0.60 (0.16)
OT Contactsa 22/205 0.24 (0.08) 19/210 0.13 (0.03)
Specialist nurse Contactsa 22/205 0.16 (0.04) 18/210 0.15 (0.05)
Dietitian Contactsa 4/205 0.02 (0.01) 1/210 0
Counsellor Contactsa 1/205 0.05 (0.05) 0/210 0
Optician Contactsa 48/205 0.27 (0.04) 52/210 0.28 (0.04)
Chiropodist Contactsa 67/205 0.46 (0.05) 84/210 0.65 (0.07)
Dentist Contactsa 75/205 0.48 (0.05) 83/210 0.57 (0.07)
Mental health
Mental health nurse Contactsa 8/205 0.05 (0.02) 12/210 0.08 (0.03)
Psychiatrist Contactsa 18/205 0.12 (0.03) 29/210 0.16 (0.03)
Psychologist Contactsa 8/205 0.10 (0.06) 12/210 0.06 (0.02)
Mental health team worker Contactsa 3/205 0.02 (0.01) 3/210 0.03 (0.02)
Community care
Social worker/care manager Contacts 14/205 0.12 (0.04) 22/210 0.16 (0.04)
Home care/home help Contacts 29/205 9.16 (2.16) 28/209 13.73 (3.49)
Home care/home help Hours 29/205 77.51 (8.18) 28/210 141.89 (17.13)
Cleaner Contacts 47/205 2.66 (0.52) 49/209 2.68 (0.42)
Meals on Wheels Contacts 3/205 0.48 (0.45) 6/209 0.31 (0.22)
Laundry service Contacts 5/205 0.29 (0.16) 7/209 0.29 (0.12)
Sitting service Contacts 3/205 0.26 (0.17) 5/209 0.11 (0.06)
Carer support worker Contacts 8/205 0.06 (0.02) 13/209 0.22 (0.10)
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TABLE 127 Resources used by person with dementia over the prior 3 months, at 9 months. Sample: all available
cases for which the CSRI was partially or wholly completed (continued )
Resources Units
Treatment group
CR (N= 238) TAU (N= 236)
Users,
N/n valid
Sample mean
use (SE)
Users,
N/n valid
Sample mean
use (SE)
Other health and social care services
SALTb Contacts 1/202 0.01 (0.01) 5/203 0.03 (0.02)
Health visitorb Contacts 0/202 0 0/203 0
Medical consultantb Contacts 0/202 0 1/203 0.01 (0.01)
Paramedicb Contacts 1/202 0 3/204 0.02 (0.02)
Audiologyb Contacts 0/202 0 2/204 0.01 (0.01)
Community pharmacistb Contacts 1/202 – 0/204 –
Health-care support workerb Contacts 2/202 0.07 (0.07) 2/203 0
Day care
Day centre Attendances 30/205 1.82 (0.39) 25/210 2.01 (0.48)
Lunch club Attendances 19/205 0.92 (0.26) 16/210 0.48 (0.14)
Patient education course Attendances 6/205 0.18 (0.12) 1/210 0.06 (0.06)
Other day services
Memory café/dementia supportc Attendances 26/205 0.84 (0.24) 17/210 0.40 (0.13)
Befrienderc Attendances 3/205 0.08 (0.07) 6/210 0.32 (0.16)
Singing for the brain/dementia choirsc Attendances 8/205 0.31 (0.12) 9/210 0.34 (0.13)
Exercise classes for older peoplec Attendances 1/205 0.05 (0.05) 1/210 0.19 (0.19)
Respiratory support groupsc Attendances 1/205 0.06 (0.06) 1/210 0.06 (0.06)
Other
Equipment (NHS/SSD) Items 92/205 1.26 (0.15) 79/210 1.07 (0.14)
Equipment privately purchased Items 129/205 1.47 (0.12) 141/210 1.67 (0.12)
Medications Items 162/205 1.20 (0.07) 175/210 1.16 (0.06)
Hypnotics and anxiolytics Units 4/205 0.02 (0.01) 2/210 0.01 (0.01)
Medications used in psychoses Units 5/205 0.02 (0.01) 5/210 0.02 (0.01)
Antidepressants Units 58/205 0.31 (0.04) 46/210 0.25 (0.03)
Antiepileptics Units 1/205 0.00 (0.00) 2/210 0.01 (0.01)
Dementia medications Units 150/205 0.80 (0.04) 163/210 0.81 (0.03)
Principal carer care Hours 181/203 660.67 (58.16) 209/209 647.52 (54.78)
Other carer care Hours 84/204 71.73 (14.28) 82/209 59.39 (12.40)
A&E, accident and emergency; SALT, speech and language therapist.
a Combines home and office contacts.
b New categories of service use derived from textual descriptions of other health and social care services.
c New categories of day-care service use derived from textual descriptions of other day-care services.
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TABLE 128 Types of care and support tasks provided by the principal carer. Sample: complete casesa
Type of care or support
Treatment group, n (%)
CR (N= 236) TAU (N= 233)
Baseline
Personal care 74 (31) 66 (28)
Helping with finances 179 (76) 175 (75)
Practical help 191 (81) 176 (76)
Taking the person to appointments 205 (87) 201 (87)
Medications 178 (75) 172 (74)
Keeping the person company 202 (86) 200 (86)
Making sure the person is safe (supervision) 146 (62) 148 (64)
Helping the person to organise their scheduleb 6 (3) 3 (2)
Helping the person’s mental state – moraleb 0 (0) 5 (3)
Driving or navigating for the personb 4 (2) 3 (2)
3-month follow-up
Personal care 64 (30) 80 (36)
Helping with finances 161 (75) 182 (83)
Practical help 171 (80) 179 (81)
Taking the person to appointments 185 (86) 199 (90)
Medications 163 (76) 168 (76)
Keeping the person company 183 (86) 195 (88)
Making sure the person is safe (supervision) 135 (63) 144 (65)
Helping person to organise scheduleb 2 (1) 3 (2)
Helping person’s mental state – moraleb 1 (1) 2 (1)
Driving or navigating for personb 3 (2) 5 (3)
9-month follow-up
Personal care 78 (38) 90 (43)
Helping with finances 162 (80) 171 (82)
Practical help 160 (79) 176 (84)
Taking the person to appointments 175 (86) 187 (89)
Medications 158 (78) 160 (77)
Keeping the person company 186 (92) 185 (89)
Making sure the person is safe (supervision) 135 (67) 146 (70)
Helping the person to organise their scheduleb 4 (3) 3 (2)
Helping the person’s mental state – moraleb 1 (1) 0 (0)
Driving or navigating for the personb 4 (3) 7 (5)
a Dyads completing baseline assessments: 236 in the CR group; 233 in the TAU group. Dyads completing 3-month
assessments: 213 in the CR group; 222 in the TAU group. Dyads completing 9-month assessments: 204 in the CR
group; 210 in the TAU group.
b Recoded from free-text responses describing ‘other’ care tasks.
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TABLE 129 Sensitivity analysis: replacement cost. Person with dementia: outcome scores and costs at 9 months from regression estimates. Sample: complete cases
Outcomes/costs CRa (N= 201) 95% CIb TAUa (N= 206) 95% CIb CR – TAU mean difference 95% CIb p-value
BGSI scorec 4.57 4.36 to 4.79 3.21 3.02 to 3.41 1.37 1.09 to 1.64 0.000
Societal costs (£)e 49,394 44,237 to 54,811 52,588 47,256 to 58,260 –3195 –9329 to 2760 0.350
(N = 190) (N = 199)
GSES scorec 20.14 19.70 to 20.56 19.92 19.45 to 20.37 0.23 –0.32 to 0.78 0.435
Societal costs (£)e 48,042 42,909 to 53,544 52,327 46,999 to 58,073 –4285 –10,480 to 1693 0.172
(N = 196) (N = 205)
QALYsc,d (DEMQOL-U) 0.45 0.44 to 0.46 0.45 0.44 to 0.46 0.00 –0.01 to 0.01 0.897
Societal costs (£)e 49,561 44,276 to 55,039 53,276 47,988 to 58,970 –3716 –9795 to 2230 0.278
a Estimated marginal means.
b Bias-corrected bootstrapped 95% CIs (60,000 replications).
c Estimates from outcome equation; adjusted for centre, age and sex of the person with dementia, stratified MMSE score, allocation to treatment, baseline outcome.
d QALY calculated using the area-under-the-curve method with linear interpolation between assessment points.
e Estimates from costs equation; adjusted for centre, age and sex of the person with dementia, stratified MMSE score, allocation to treatment, costs at 3 months pre baseline.
TABLE 130 Sensitivity analysis: replacement cost. Carer: outcome scores and costs at 9 months from regression estimates. Sample: complete cases
Outcomes/costs CRa (N= 192) 95% CIb TAUa (N= 198) 95% CIb CR – TAUa mean difference 95% CIb p-value
QALYsc,d (EQ-5D-3L) 0.56 0.54 to 0.58 0.56 0.54 to 0.58 0.00 –0.02 to 0.02 0.926
Societal costs (£)e 48,709 43,702 to 54,009 52,989 47,560 to 58,777 –4280 –10,423 to 1758 0.223
a Estimated marginal means.
b Bias-corrected bootstrapped 95% CIs (60,000 replications).
c Estimates from outcome equation; adjusted for centre, age and sex of the person with dementia, stratified MMSE score, allocation to treatment, baseline outcome.
d QALYs calculated using the area-under-the-curve method with linear interpolation between assessment points.
e Estimates from costs equation; adjusted for centre, age and sex of the person with dementia, stratified MMSE score, allocation to treatment, costs at 3 months pre baseline.
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TABLE 131 Sensitivity analysis: replacement cost. Person with dementia and carer: point ICERa for CR over TAU, from the health and social care and societal perspectives
Outcomes/costs BGSIa (N= 407) GSESb (N= 389) QALYs [DEMQOL-Uc (N= 401)] QALY [EQ-5D-3Lc (N= 390)]
Person with dementia, 9 months
Societal costs (£) –3195/1.37 = –2332 –4285/0.23 = –18,630 –3716/0.0005 = –7,432,000 NA
Carer, 9 months
Societal costs (£) NA NA NA –4280/0.001 = –4,280,000
NA, not applicable.
a Cost of achieving a 1.32-point difference between groups at 9 months.
b Cost of achieving a 1.53-point difference between groups at 9 months.
c Cost of achieving a QALY gain over 9 months; difference in QALY rounded to first non-zero decimal place.
TABLE 132 Sensitivity analysis: exclusion of high-cost outliers from health and social care costs. Person with dementia: outcome scores and costs at 9 months from regression
estimates. Sample: health and social care costs outlier excluded
Outcomes/costs CRa (N= 196) 95% CIb TAUa (N= 204) 95% CIb CR – TAU mean difference 95% CIa p-value
BGSIc 4.60 4.38 to 4.82 3.22 3.03 to 3.42 1.38 1.09 to 1.65 0.000
Health and social care costs (£)d 4595 4253 to 5026 3295 2807 to 3826 1300 696 to 1953 0.000
(N = 186) (N = 197)
GSESc 20.16 19.72 to 20.60 20.00 19.54 to 20.44 0.17 –0.395 to 0.732 0.564
Health and social care costs (£)d 4543 4174 to 4951 3288 2833 to 3822 1255 628 to 1831 0.000
(N = 191) (N = 203)
QALYc,e (DEMQOL-U) 0.45 0.44 to 0.46 0.45 0.44 to 0.46 0.00 –0.01 to 0.01 0.721
Health and social care costs (£)d 4592 4226 to 4986 3432 2960 to 3981 1160 520 to 1742 0.000
a Estimated marginal means.
b Bias-corrected bootstrapped 95% CIs (60,000 replications).
c Estimates from outcome equation; adjusted for centre, age and sex of the person with dementia, stratified MMSE score, allocation to treatment, baseline outcome.
d Estimates from costs equation; adjusted for centre, age and sex of the person with dementia, stratified MMSE score, allocation to treatment, costs at 3 months pre baseline.
e QALYs calculated using the area-under-the-curve method with linear interpolation between assessment points.
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TABLE 133 Sensitivity analysis: exclusion of high-cost outliers from health and social care costs. Carer: outcome scores and costs at 9 months from regression estimates.
Sample: health and social care costs outlier excluded
Outcomes/costs CR (N= 189)a 95% CIb TAU (N= 195)a 95% CIb CR – TAUa mean difference 95% CIa p-value
QALYsc,d (EQ-5D-3L) 0.56 0.54 to 0.58 0.56 0.54 to 0.58 0.01 –0.01 to 0.02 0.553
Health and social care costs (£)e 4647 4294 to 5090 3342 2819 to 3900 1305 669 to 2008 0.000
a Estimated marginal means.
b Bias-corrected bootstrapped 95% CIs (3000 replications).
c Estimates from outcome equation; adjusted for centre, age and sex of the person with dementia, stratified MMSE score, allocation to treatment, baseline outcome.
d QALYs calculated using the area-under-the-curve method with linear interpolation between assessment points.
e Estimates from costs equation; adjusted for centre, age and sex of the person with dementia, stratified MMSE score, allocation to treatment, costs at 3 months pre baseline.
TABLE 134 Sensitivity analysis: exclusion of high-cost outliers from health and social care costs. Person with dementia and carer: point ICERa for CR over TAU, from the health
and social care and societal perspectives. Sample: outliers excluded
Outcomes/costs BGSI (N= 400)a GSES (N= 383)b
QALY
DEMQOL-Uc (N= 394) EQ-5D-3Lc (N= 384)
Person with dementia, 9 months
Health and social care costs (£) 1300/1.38 = 942 1255/0.17 = 7382 1160/0.002 = 580,000
Carer, 9 months
Health and social care costs (£) NA NA NA 1305/0.01 = 130,500
NA, not applicable.
a Cost of achieving a 1.32-point difference between groups at 9 months.
b Cost of achieving a 1.53-point difference between groups at 9 months.
c Cost of achieving a QALY gain over 9 months.
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TABLE 135 Sensitivity analysis: imputed data. Person with dementia: outcome scores and costs at 9 months from regression estimates
Outcomes/costs CRa (N= 231) 95% CIb TAUa (N= 231) 95% CIb CR – TAU mean difference 95% CIb p-value
BGSIc 4.56 4.37 to 4.76 3.209 3.03 to 3.39 1.35 1.10 to 1.62 0.000
GSESc 20.160 19.791 to 20.537 19.946 19.559 to 20.337 0.21 –0.27 to 0.71 0.388
QALYc,d (DEMQOL-U) 0.45 0.44 to 0.45 0.45 0.44 to 0.46 0.00 –0.01 to 0.01 0.938
Health and social care costs (£)e 5426 4692 to 6452 4329 3357 to 5745 1097 –326 to 2258 0.102
Societal costs (£)e 23,359 21,404 to 25,659 23,343 21,407 to 25,468 –15 –2545 to 2279 0.990
a Estimated marginal means.
b Bias-corrected bootstrapped 95% CIs (3000 replications).
c Estimates from outcome equation; adjusted for centre, age and sex of the person with dementia, stratified MMSE score, allocation to treatment, baseline outcome.
d QALYs calculated using the area-under-the-curve method with linear interpolation between assessment points.
e Estimates from costs equation; adjusted for centre, age and sex of the person with dementia, stratified MMSE score, allocation to treatment, costs in 3 months pre baseline.
TABLE 136 Sensitivity analysis: imputed data. Carer: outcome scores and costs at 9 months from regression estimates
Outcomes/costs CRa (N= 231) 95% CIb TAUa (N= 231) 95% CIb CR – TAUa mean difference 95% CIb p-value
QALYc,d (EQ-5D-3L) 0.56 0.54 to 0.58 0.56 0.54 to 0.58 0.00 –0.01 to 0.01 0.715
Health and social care costs (£)e 5423 4689 to 6435 4332 3363 to 5771 1091 –337 to 2236 0.102
Societal costs (£)e 23,298 21,351 to 25,446 23,404 21,434 to 25,700 –106 –2560 to 2163 0.930
a Estimated marginal means.
b Bias-corrected bootstrapped 95% CIs (3000 replications).
c Estimates from outcome equation; adjusted for centre, age and sex of the person with dementia, stratified MMSE score, allocation to treatment, baseline outcome.
d QALYs calculated using the area-under-the-curve method with linear interpolation between assessment points.
e Estimates from costs equation; adjusted for centre, age and sex of the person with dementia, stratified MMSE score, allocation to treatment, costs in 3 months pre baseline.
Note
Imputed data: 25 complete data sets were generated by the imputation model.
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TABLE 137 Sensitivity analysis: imputed data. Person with dementia and the carer: point ICERa for CR over TAU, from the health and social care and societal perspectives.
Sample: imputed data
Outcomes/costs BGSIa (N= 462) GSESb (N= 462)
QALY
DEMQOL-Uc (N= 462) EQ-5D-3Lc (N= 462)
Person with dementia, 9 months
Health and social care costs (£) 1097/1.35 = 813 1097/0.21 = 5224 1097/0.0003 = 3,656,667 NA
Societal costs (£) –15/1.35= –11 –15/0.21 = –71 –15/0.0003 = –50,000 NA
Carer, 9 months
Health and social care costs (£) NA NA NA 1091/0.003 = 363,667
Societal costs (£) NA NA NA –106/0.003 = –35,333
NA, not applicable.
a Cost of achieving a 1.32-point difference between groups at 9 months.
b Cost of achieving a 1.53-point difference between groups at 9 months.
c Cost of achieving a QALY gain over 9 months; difference in QALY rounded to first non-zero decimal place.
Note
Imputed data: 25 complete data sets were generated by the imputation model. The numbers of observations given represent the maximum number of observations: the numbers of
observations varied between data sets (range of 460–462) because survival of the person with dementia was imputed.
A
PPEN
D
IX
16
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
230
Appendix 17 Cost-effectiveness acceptability
curves and cost-effectiveness planes
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FIGURE 15 Cost-effectiveness acceptability curve: BGSI, person with dementia; replacement costs of unpaid care.
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Pr
o
b
ab
ili
ty
 t
h
at
 C
R
 is
 c
o
st
-e
ff
ec
ti
ve
0 5 10 15 20 25 30 35 40 45 50
Willingness to pay (£000) for an increase of 1.53 points on the GSES
Perspective
Health and social care
Societal
FIGURE 16 Cost-effectiveness acceptability curve: GSES, person with dementia; replacement costs of unpaid care.
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FIGURE 17 Cost-effectiveness acceptability curve: QALYs (DEMQOL-U), person with dementia; replacement costs of
unpaid care.
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FIGURE 18 Cost-effectiveness acceptability curve: QALYs (EQ-5D-3L), carer; replacement costs of unpaid care.
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FIGURE 20 Cost-effectiveness plane: incremental costs and end-point difference in GSES score at 9 months, person
with dementia; replacement costs of unpaid care.
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FIGURE 19 Cost-effectiveness plane: incremental costs and end-point difference in BGSI score at 9 months, person
with dementia; replacement costs of unpaid care.
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FIGURE 21 Cost-effectiveness plane: incremental costs and QALYs (DEMQOL-U) at 9 months, person with dementia;
replacement costs of unpaid care.
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FIGURE 22 Cost-effectiveness plane: incremental costs and QALYs (EQ-5D-3L) at 9 months, carer; replacement costs
of unpaid care.
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FIGURE 23 Cost-effectiveness acceptability curve: BGSI, person with dementia; excluding high-cost outliers.
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FIGURE 24 Cost-effectiveness acceptability curve: GSES, person with dementia; excluding high-cost outliers.
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FIGURE 25 Cost-effectiveness acceptability curve: QALYs (EQ-5D-3L), carer; excluding high-cost outliers.
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FIGURE 27 Cost-effectiveness plane: incremental costs (excluding high-cost outliers) and end-point difference in
GSES at 9 months, person with dementia.
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FIGURE 28 Cost-effectiveness plane: incremental costs (excluding high-cost outliers) and QALYs (DEMQOL-U)
at 9 months, person with dementia.
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at 9 months, carer.
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FIGURE 30 Cost-effectiveness acceptability curve: BGSI, person with dementia; imputed data.
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FIGURE 31 Cost-effectiveness acceptability curve: GSES, person with dementia; imputed data.
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Pr
o
b
ab
ili
ty
 t
h
at
 C
R
 is
 c
o
st
-e
ff
ec
ti
ve
0 5 10 15 20 25 30 35 40 45 50
Perspective
Willingness to pay (£000) for an additional QALY (DEMQOL-U)
Health and social care
Societal
FIGURE 32 Cost-effectiveness acceptability curve: QALYs (DEMQOL-U), person with dementia; imputed data.
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FIGURE 33 Cost-effectiveness acceptability curve: QALYs (EQ-5D-3L), carer; imputed data.
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FIGURE 34 Cost-effectiveness plane: incremental costs and end-point difference in BGSI score at 9 months, person
with dementia; imputed data.
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FIGURE 35 Cost-effectiveness plane: incremental costs and end-point difference in GSES score at 9 months, person
with dementia; imputed data.
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FIGURE 36 Cost-effectiveness plane: incremental costs and QALYs (DEMQOL-U) at 9 months, person with dementia;
imputed data.
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FIGURE 37 Cost-effectiveness plane: incremental costs and QALYs (EQ-5D-3L) at 9 months, carer; imputed data.
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